Ubs (AMNA) 6-K 14 Aug 24 2024 Q2 Current report (foreign) Financial data

Document and Entity Information

Document and Entity Information	6 Months Ended
	Jun. 30, 2024
Entity Information [Line Items]
Entity registrant name	UBS Group AG
Entity central index key	0001610520
Current fiscal year end date	--12-31
Document type	6-K
Document period end date	Jun. 30, 2024
Amendment flag	false
Document fiscal year focus	2024
Document fiscal period focus	Q2

Consolidated Income Statement

Consolidated Income Statement - USD ($) $ in Millions	3 Months Ended			6 Months Ended
	Jun. 30, 2024	Mar. 31, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Income Statement [Line Items]
Interest income from financial instruments measured at amortized cost and fair value through other comprehensive income	$ 9,320	$ 10,078	$ 6,998	$ 19,399	$ 11,775
Interest expense from financial instruments measured at amortized cost	(9,319)	(9,724)	(5,880)	(19,042)	(9,695)
Net interest income from financial instruments measured at fair value through profit or loss and other	1,533	1,585	589	3,118	1,015
Net interest income	1,535	1,940	1,707	3,475	3,095
Other net income from financial instruments measured at fair value through profit or loss	3,684	4,182	2,517	7,866	5,198
Fee and commission income	7,211	7,080	5,635	14,291	10,688
Fee and commission expense	(679)	(588)	(507)	(1,268)	(954)
Net fee and commission income	6,531	6,492	5,128	13,023	9,734
Other income	154	124	188	278	258
Total revenues	11,904	12,739	9,540	24,642	18,284
Negative goodwill			27,264		27,264
Credit loss expense / (release)	95	106	623	201	662
Personnel expenses	7,119	6,949	5,651	14,068	10,271
General and administrative expenses	2,318	2,413	1,968	4,731	4,033
Depreciation, amortization and impairment of non-financial assets	903	895	866	1,798	1,391
Operating expenses	10,340	10,257	8,486	20,597	15,696
Operating profit / (loss) before tax	1,469	2,376	27,695	3,844	29,191
Tax expense / (benefit)	293	612	361	905	820
Net profit / (loss)	1,175	1,764	27,334	2,939	28,371
Net profit / (loss) attributable to non-controlling interests	40	9	3	48	11
Net profit / (loss) attributable to shareholders	$ 1,136	$ 1,755	$ 27,331	$ 2,890	$ 28,360
Earnings per share
Basic	$ 0.35	$ 0.55	$ 8.87	$ 0.90	$ 9.22
Diluted	$ 0.34	$ 0.52	$ 8.51	$ 0.86	$ 8.82
Credit Suisse
Income Statement [Line Items]
Negative goodwill			$ 27,264		$ 27,264
Operating profit / (loss) before tax					$ 27,264

Consolidated Statement of Compr

Consolidated Statement of Comprehensive Income - USD ($) $ in Millions	3 Months Ended			6 Months Ended
	Jun. 30, 2024	Mar. 31, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Statement Of Comprehensive Income [Line Items]
Net profit / (loss)	$ 1,175	$ 1,764	$ 27,334	$ 2,939	$ 28,371
Total comprehensive income
Total other comprehensive income	439	(2,008)	(867)	(1,570)	(71)
Total other comprehensive income that may be reclassified to the income statement, net of tax	262	(1,870)	(397)	(1,608)	312
Total other comprehensive income that will not be reclassified to the income statement, net of tax	176	(138)	(470)	38	(383)
Total comprehensive income	1,614	(245)	26,467	1,369	28,300
Comprehensive income attributable to shareholders
Statement Of Comprehensive Income [Line Items]
Net profit / (loss)	1,136	1,755	27,331	2,890	28,360
Foreign currency translation
Foreign currency translation movements related to net assets of foreign operations, before tax	(268)	(3,473)	754	(3,741)	991
Effective portion of changes in fair value of hedging instruments designated as net investment hedges, before tax	291	2,182	(379)	2,473	(506)
Foreign currency translation differences on foreign operations reclassified to the income statement	2	0	(3)	2	(3)
Effective portion of changes in fair value of hedging instruments designated as net investment hedges reclassified to the income statement	0	1	(1)	1	(2)
Income tax relating to foreign currency translations, including the effect of net investment hedges	0	13	(4)	13	(5)
Subtotal foreign currency translation, net of tax	25	(1,277)	368	(1,252)	474
Financial assets measured at fair value through other comprehensive income
Net unrealized gains / (losses), before tax	0	0	0	0	2
Net realized (gains) / losses reclassified to the income statement from equity	0	0	0	0	0
Income tax relating to net unrealized gains / (losses)	0	0	0	0	0
Subtotal financial assets measured at fair value through other comprehensive income, net of tax	0	0	0	0	2
Cash flow hedges of interest rate risk
Effective portion of changes in fair value of derivative instruments designated as cash flow hedges, before tax	(417)	(1,246)	(1,314)	(1,663)	(928)
Net (gains) / losses reclassified to the income statement from equity	668	544	410	1,212	759
Income tax relating to cash flow hedges	5	119	130	124	0
Subtotal cash flow hedges, net of tax	256	(583)	(775)	(327)	(169)
Cost of hedging
Cost of hedging, before tax	(19)	(9)	11	(28)	6
Income tax relating to cost of hedging	0	0	0	0	0
Subtotal cost of hedging, net of tax	(19)	(9)	11	(28)	6
Defined benefit plans
Gains / (losses) on defined benefit plans, before tax	(38)	(62)	(17)	(100)	8
Income tax relating to defined benefit plans	8	6	(35)	14	(29)
Subtotal defined benefit plans, net of tax	(30)	(56)	(53)	(87)	(21)
Own credit on financial liabilities designated at fair value
Gains / (losses) from own credit on financial liabilities designated at fair value, before tax	231	(69)	(473)	161	(404)
Income tax relating to own credit on financial liabilities designated at fair value	(3)	2	60	(1)	43
Subtotal own credit on financial liabilities designated at fair value, net of tax	228	(68)	(413)	160	(362)
Total comprehensive income
Total other comprehensive income	460	(1,994)	(862)	(1,535)	(71)
Total other comprehensive income that may be reclassified to the income statement, net of tax	262	(1,870)	(397)	(1,608)	312
Total other comprehensive income that will not be reclassified to the income statement, net of tax	198	(124)	(466)	73	(383)
Total comprehensive income	1,596	(240)	26,469	1,356	28,289
Comprehensive income attributable to non-controlling interests
Statement Of Comprehensive Income [Line Items]
Net profit / (loss)	40	9	3	48	11
Total comprehensive income
Total other comprehensive income that will not be reclassified to the income statement, net of tax	(21)	(14)	(5)	(35)	0
Total comprehensive income	$ 18	$ (5)	$ (2)	$ 13	$ 11

Consolidated Balance Sheet

Consolidated Balance Sheet - USD ($) $ in Millions	Jun. 30, 2024	Mar. 31, 2024	Dec. 31, 2023
Assets
Cash and balances at central banks	$ 248,336	$ 271,439	$ 314,060
Amounts due from banks	21,959	22,128	21,146
Receivables from securities financing transactions measured at amortized cost	82,028	101,650	99,039
Cash collateral receivables on derivative instruments	43,637	46,714	50,082
Loans and advances to customers	599,105	605,108	639,669
Other financial assets measured at amortized cost	60,431	62,707	65,455
Total financial assets measured at amortized cost	1,055,494	1,109,745	1,189,451
Financial assets at fair value held for trading	162,025	160,104	169,633
of which: assets pledged as collateral that may be sold or repledged by counterparties	43,452	49,382	51,263
Derivative financial instruments	139,597	159,229	176,084
Brokerage receivables	25,273	22,796	21,037
Financial assets measured at fair value through other comprehensive income	2,167	2,078	2,233
Total financial assets measured at fair value through profit or loss	450,161	441,741	470,773
Investments in associates	2,236	2,250	2,373
Property, equipment and software	16,440	16,770	17,849
Goodwill and intangible assets	7,313	7,384	7,515
Deferred tax assets	10,651	10,614	10,682
Other non-financial assets	16,514	16,217	16,049
Financial assets at fair value not held for trading	123,266	99,612	104,018
Total assets	1,560,976	1,606,798	1,716,924
Liabilities
Amounts due to banks	26,750	47,857	70,962
Payables from securities financing transactions measured at amortized cost	14,872	12,961	14,394
Cash collateral payables on derivative instruments	32,843	37,293	41,582
Customer deposits	756,830	763,959	792,029
Debt issued measured at amortized cost	229,223	226,251	237,817
Other financial liabilities measured at amortized cost	21,383	21,356	20,851
Total financial liabilities measured at amortized cost	1,081,902	1,109,677	1,177,633
Other financial liabilities designated at fair value	31,875	28,140	29,484
Financial liabilities at fair value held for trading	33,493	35,758	34,159
Derivative financial instruments	149,069	163,042	192,181
Brokerage payables designated at fair value	46,198	46,628	42,522
Debt issued designated at fair value	113,209	116,806	128,289
Provisions and contingent liabilities	9,293	11,076	12,412
Other non-financial liabilities	11,720	10,388	14,089
Total liabilities	1,476,758	1,521,515	1,630,769
Total financial liabilities measured at fair value through profit or loss	373,844	390,374	426,635
Equity
Share capital	346	346	346
Share premium	11,742	12,972	13,216
Treasury shares	(5,498)	(5,157)	(4,796)
Retained earnings	76,176	75,952	74,397
Other comprehensive income recognized directly in equity, net of tax	917	663	2,462
Equity attributable to shareholders	83,683	84,777	85,624
Equity attributable to non-controlling interests	535	506	531
Total equity	84,218	85,283	86,156
Total liabilities and equity	$ 1,560,976	$ 1,606,798	$ 1,716,924

Consolidated Statement of Chang

Consolidated Statement of Changes in Equity - USD ($) $ in Millions	Total	Share capital and share premium	Share capital and share premium Credit Suisse	Treasury shares	Treasury shares Credit Suisse	Retained earnings	Other comprehensive income recognized directly in equity, net of tax	of which: foreign currency translation	of which: cash flow hedges	Total equity attributable to shareholders	Total equity attributable to shareholders Credit Suisse	Non-controlling interests
Balance at Dec. 31, 2022		$ 13,850		$ (6,874)		$ 50,004	$ (103)	$ 4,128	$ (4,234)	$ 56,876
Impact of the settlement of pre-existing relationships					$ (61)						$ (61)
Acquisition of treasury shares				(2,318)						(2,318)
Delivery of treasury shares under share-based compensation plans		(798)		876						78
Other disposal of treasury shares		(1)		126						125
Cancellation of treasury shares related to the share repurchase program		(561)		1,115		(554)				0
Share-based compensation expensed in the income statement		445								445
Tax (expense) / benefit		5								5
Dividends		(839)				(839)				(1,679)
Equity classified as obligation to purchase own shares		(19)								(19)
Translation effects recognized directly in retained earnings						48	(48)		(48)	0
New consolidations / (deconsolidations) and other increases / (decreases)		2								2
Total comprehensive income for the period	$ 28,300					27,977	312	474	(169)	28,289		$ 11
of which: net profit / (loss)	28,371					28,360				28,360		11
of which: OCI, net of tax	(71)					(383)	312	474	(169)	(71)
Balance at Jun. 30, 2023	86,091	12,867		(4,208)		76,636	161	4,602	(4,451)	85,455		636
Purchase price consideration, before consideration of share-based compensation awards			$ 619		$ 2,928						3,547
Impact of share-based compensation awards			$ 162								$ 162
Equity attributable to non-controlling interests	531
Balance at Dec. 31, 2023	86,156	13,562		(4,796)		74,397	2,462	5,584	(3,109)	85,624
Equity attributable to shareholders at the beginning of the period at Dec. 31, 2023	85,624
Total comprehensive income for the period	(245)									(240)		(5)
of which: net profit / (loss)	1,764									1,755		9
of which: OCI, net of tax	(2,008)									(1,994)
Equity attributable to shareholders at the end of the period at Mar. 31, 2024	84,777
Balance at Mar. 31, 2024	85,283
Balance at Dec. 31, 2023	86,156	13,562		(4,796)		74,397	2,462	5,584	(3,109)	85,624
Equity attributable to shareholders at the beginning of the period at Dec. 31, 2023	85,624
Acquisition of treasury shares				(1,900)						(1,900)
Delivery of treasury shares under share-based compensation plans		(1,051)		1,133						82
Other disposal of treasury shares		1		65						66
Share-based compensation expensed in the income statement		610								610
Tax (expense) / benefit		14								14
Dividends		(1,128)				(1,128)				(2,256)
Equity classified as obligation to purchase own shares		(27)								(27)
Translation effects recognized directly in retained earnings						(63)	63		63	0
Share of changes in retained earnings of associates and joint ventures						(1)				(1)
New consolidations / (deconsolidations) and other increases / (decreases)		106				8				114
Total comprehensive income for the period	1,369					2,964	(1,608)	(1,252)	(327)	1,356		13
of which: net profit / (loss)	2,939					2,890				2,890		48
of which: OCI, net of tax	(1,570)					73	(1,608)	(1,252)	(327)	(1,535)
Equity attributable to shareholders at the end of the period at Jun. 30, 2024	83,683
Balance at Jun. 30, 2024	84,218	12,089		(5,498)		76,176	917	4,332	(3,373)	83,683		535
Equity attributable to non-controlling interests	506
Balance at Mar. 31, 2024	85,283
Equity attributable to shareholders at the beginning of the period at Mar. 31, 2024	84,777
Total comprehensive income for the period	1,614									1,596		18
of which: net profit / (loss)	1,175									1,136		40
of which: OCI, net of tax	439									460
Equity attributable to shareholders at the end of the period at Jun. 30, 2024	83,683
Balance at Jun. 30, 2024	84,218	$ 12,089		$ (5,498)		$ 76,176	$ 917	$ 4,332	$ (3,373)	$ 83,683		$ 535
Equity attributable to non-controlling interests	$ 535

Consolidated Statement of Cha_2

Consolidated Statement of Changes in Equity (Parenthetical) - USD ($) $ in Millions	1 Months Ended		3 Months Ended	6 Months Ended
	May 31, 2024	Apr. 30, 2023	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Ordinary cash dividends paid, ordinary shares per share	$ 0.70	$ 0.55
Maximum percentage of dividends that may be paid from capital contribution reserves				50%	50%
Own shares purchased and cancelled as part of the share repurchase program					62,548,000
Credit Suisse
Increase of equity attributable to non-controlling interests			$ 285

Consolidated Statement of Cash

Consolidated Statement of Cash Flows - USD ($) $ in Millions	6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023
Cash flow from / (used in) operating activities
Net profit / (loss)	$ 2,939	$ 28,371
Non-cash items included in net profit and other adjustments:
Depreciation, amortization and impairment of non-financial assets	1,798	1,391
Credit loss expense / (release)	201	662
Share of net (profit) / loss of associates and joint ventures and impairment related to associates	(110)	(36)
Deferred tax expense / (benefit)	127	(35)
Net loss / (gain) from investing activities	95	(84)
Net loss / (gain) from financing activities	(3,961)	4,843
Negative goodwill		(27,264)
Other net adjustments	18,094	(1,559)
Net change in operating assets and liabilities:
Amounts due from banks and amounts due to banks	675	6,017
Receivables from securities financing transactions measured at amortized cost	13,812	7,314
Payables from securities financing transactions measured at amortized cost	(38)	6,114
Cash collateral on derivative instruments	(2,120)	(3,409)
Loans and advances to customers	13,445	13,675
Customer deposits	(9,900)	(11,419)
Financial assets and liabilities at fair value held for trading and derivative financial instruments	(4,779)	(5,782)
Brokerage receivables and payables	(101)	(5,141)
Financial assets at fair value not held for trading and other financial assets and liabilities	(15,110)	4,033
Provisions and other non-financial assets and liabilities	(1,986)	901
Income taxes paid, net of refunds	(1,223)	(925)
Net cash flow from / (used in) operating activities	11,858	17,665
Cash flow from / (used in) investing activities
Cash and cash equivalents acquired on acquisition of the Credit Suisse Group		108,406
Purchase of subsidiaries, associates and intangible assets	0	1
Disposal of subsidiaries, associates and intangible assets	55	45
Purchase of property, equipment and software	(913)	(830)
Disposal of property, equipment and software	40	1
Net (purchase) / redemption of financial assets measured at fair value through other comprehensive income	369	24
Purchase of debt securities measured at amortized cost	(1,850)	(7,541)
Disposal and redemption of debt securities measured at amortized cost	4,848	4,659
Net cash flow from / (used in) investing activities	2,549	104,765
Cash flow from / (used in) financing activities
Repayment of Swiss National Bank funding	(42,587)	(27,813)
Net issuance (repayment) of short-term debt measured at amortized cost	(3,384)	5,203
Net movements in treasury shares and own equity derivative activity	(1,786)	(2,136)
Distributions paid on UBS shares	(2,256)	(1,679)
Issuance of debt designated at fair value and long-term debt measured at amortized cost	59,080	51,420
Repayment of debt designated at fair value and long-term debt measured at amortized cost	(71,389)	(49,777)
Inflows from securities financing transactions measured at amortized cost	2,863
Outflows from securities financing transactions measured at amortized cost	(2,052)
Net cash flows from other financing activities	(404)	(274)
Net cash flow from / (used in) financing activities	(61,916)	(25,056)
Total cash flow
Cash and cash equivalents at the beginning of the period	340,207	195,321
Net cash flow from / (used in) operating, investing and financing activities	(47,510)	97,374
Effects of exchange rate differences on cash and cash equivalents	(13,733)	2,960
Cash and cash equivalents at the end of the period	278,964	295,656
of which: cash and balances at central banks	248,336	261,415
of which: loans and advances to banks	19,811	21,981
of which: money market paper	10,818	12,259
Net cash flow from / (used in) operating activities includes:
Interest received in cash	28,362	17,243
Interest paid in cash	24,087	11,604
Dividends on equity investments, investment funds and associates received in cash	$ 1,529	1,314
Credit Suisse
Non-cash items included in net profit and other adjustments:
Negative goodwill		(27,264)
Cash flow from / (used in) investing activities
Cash and cash equivalents acquired on acquisition of the Credit Suisse Group		$ 108,406

Consolidated Statement of Cas_2

Consolidated Statement of Cash Flows (Parenthetical) - USD ($) $ in Millions	6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023
Statement Of Cash Flows [Line Items]
Money market paper in financial assets at fair value not held for trading	$ 9,479	$ 11,019
Money market paper in other financial assets measured at amortized cost	565	603
Money market paper in financial assets measured at fair value through other comprehensive income	344	0
Money market paper in financial assets at fair value held for trading	430	637
Non-core and Legacy
Statement Of Cash Flows [Line Items]
Cash receipts from the sale of loans and loan commitments within Non-core and Legacy	$ 9,857	$ 711

Basis of accounting

Basis of accounting	6 Months Ended
	Jun. 30, 2024
Disclosure Of Material Accounting Policy Information [Line Items]
Basis of preparation	Note 1 Basis of preparation The consolidated UBS Accounting Standards prepared in accordance with IAS 34, Interim Financial Reporting . In preparing been applied as in the 2023, except for the changes described in this Note and changes interim consolidated financial statements in of this report. In the opinion of management, all necessary adjustments the Group’s financial position, results of Preparation of these interim financial statements requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, income, expenses and disclosures of contingent assets and liabilities. These estimates and assumptions are based on the best available information. Actual results in the future could differ from such estimates and differences may be material to the financial statements. Revisions to estimates, based on regular reviews, are recognized in the period in which they occur. For more information about areas of estimation uncertainty that are considered to require critical judgment, refer to “Note 1a Material accounting policies” in the “Consolidated financial statements” section of the UBS Group Annual Report 2023.

Changes in accounting policies,

Changes in accounting policies, comparability and adjustments	6 Months Ended
	Jun. 30, 2024
Changes In Accounting Policies Comparability And Adjustments [Line Items]
Changes in accounting policies, comparability and adjustments	Amendments to IAS 12, UBS amendments to Income Taxes , issued in Base Erosion implement the Pillar The exception respect of such top-up taxes. Other amendments to IFRS Accounting Standards A number of minor amendments have had no material effect on the Group.
Description Of Expected Impact Of Initial Application Of New Standards Or Interpretations	IFRS 18, Presentation and Disclosure in Financial In April 2024, the IASB issued a new standard, Presentation and Disclosure in Financial Statements, replaces IAS 1, Presentation of Financial Statements . The main changes introduced by IFRS 18 relate – the structure of income statements; – new disclosure requirements for management performance – enhanced guidance on the notes thereto. IFRS 18 is effective from 1 January 2027 and new requirements in UBS is assessing the opportunity to refine the grouping of items in the primary financial statements and new principles of aggregation and disaggregation Amendments to IFRS 9, Financial Instruments , and IFRS 7, Financial Instruments: Disclosures In Amendments Amendments to IFRS 9 and IFRS 7 The Amendments relate to: – derecognition of financial liabilities settled – assessment environmental, social and linked instruments; and – disclosure of information about contractual income. The Amendments amendments or impact of the new requirements on its financial

Currency translation rates

Currency translation rates	6 Months Ended
	Jun. 30, 2024
Foreign Exchange Rates [Line Items]
Currency translation rates	Currency translation rates The operations with a functional currency other Closing exchange rate Average rate 1 As of For the quarter ended Year-to-date 30.6.24 31.3.24 31.12.23 30.6.23 30.6.24 31.3.24 30.6.23 30.6.24 30.6.23 1 CHF 1.11 1.11 1.19 1.12 1.10 1.13 1.11 1.12 1.11 1 EUR 1.07 1.08 1.10 1.09 1.07 1.08 1.09 1.08 1.09 1 GBP 1.26 1.26 1.28 1.27 1.26 1.26 1.27 1.26 1.24 100 JPY 0.62 0.66 0.71 0.69 0.63 0.67 0.71 0.65 0.73 1 Monthly income statement items of operations with a functional currency other than the US dollar are three month-end rates, weighted according to the income and expense volumes of may deviate from the weighted average rates for the Group.

Accounting for the acquisition

Accounting for the acquisition of Credit Suisse Group	6 Months Ended
	Jun. 30, 2024
Disclosure Of Business Combinations [Line items]
Accounting for the acquisition of Credit Suisse Group	Note 2 The transaction On 12 June assets and liabilities of Credit Suisse Group AG, and became the direct direct and indirect subsidiaries of business combination under IFRS 3, Business Combinations , and was required to be accounted for by applying the acquisition method of accounting. IFRS 3 measurement period adjustments The acquisition of the conventional time relevant facts and the initial acquisition accounting was applied for the purpose of the UBS Group second quarter 2023 report, with the amounts that form part of to further measurement period of the acquisition were to Group AG resulted in 27.7 bn reported For details year ended 31 December acquisition of Report 2023. In the date that became available to management, IFRS 3 measurement period adjustments of USD 0.2 bn were made in relation to Provisions and contingent liabilities (refer to “Change in provisions and contingent addition, 0.3 bn exposures associated with Russia, as well as detailed review. which are within a range of reasonably possible outcomes, relating to significant uncertainties that acquisition date. Comparative-period information The measurement goodwill to USD 27.3 bn from the provisional 27.7 bn previously reported Report 2023. Retained earnings net 0.5 bn. finalization of the amount of negative goodwill, Change in provisions and contingent liabilities In 1.3 bn recognized 5.6 bn Provisions provisions 1.6 bn assessment 4.0 bn contingent liabilities for certain purchase uncertain. potential outflows. The 4.0 bn of 0.2 bn from 3.8 bn previously reported in the UBS Group Annual Report 2023. Effect of measurement period adjustments on The table adjusted to reflect above. USD m Purchase price consideration, after consideration of share-based compensation awards 3,710 Credit Suisse Group net identifiable assets on the acquisition Assets As previously reported in the Annual Report 2023 Measurement period adjustment Revised Cash and balances at central banks 93,012 (89) 92,923 Amounts due from banks 13,590 (15) 13,575 Receivables from securities financing transactions measured at amortized 26,194 26,194 Cash collateral receivables on derivative instruments 20,878 20,878 Loans and advances to customers 247,219 (175) 247,044 Other financial assets measured at amortized cost 13,428 (43) 13,385 Total financial assets measured at amortized cost 414,322 (322) 414,000 Financial assets at fair value held for trading 56,237 56,237 Derivative financial instruments 62,162 62,162 Brokerage receivables 366 366 Financial assets at fair value not held for trading 54,199 54,199 Total financial assets measured at fair value through profit or loss 172,964 172,964 Financial assets measured at fair value through other comprehensive income 0 0 Investments in associates 1,569 1,569 Property, equipment and software 6,055 6,055 Intangible assets 1,287 1,287 Deferred tax assets 998 998 Other non-financial assets 6,892 6,892 Total assets 604,088 (322) 603,766 Liabilities Amounts due to banks 107,617 107,617 Payables from securities financing transactions measured at amortized cost 11,911 11,911 Cash collateral payables on derivative instruments 10,939 10,939 Customer deposits 183,119 183,119 Debt issued measured at amortized cost 110,491 110,491 Other financial liabilities measured at amortized cost 7,992 7,992 Total financial liabilities measured at amortized cost 432,070 432,070 Financial liabilities at fair value held for trading 5,711 5,711 Derivative financial instruments 67,782 67,782 Brokerage payables designated at fair value 316 316 Debt issued designated at fair value 44,909 44,909 Other financial liabilities designated at fair value 7,574 7,574 Total financial liabilities measured at fair value through profit or loss 126,292 126,292 Provisions and contingent liabilities 9,945 161 10,106 Other non-financial liabilities 3,901 3,901 Total liabilities 572,209 161 572,370 Non-controlling interests (285) (285) Fair value of net assets acquired 31,594 (483) 31,110 Settlement of pre-existing relationships 135 135 Negative goodwill resulting from the acquisition 27,748 (483) 27,264 The reported income statements for the the balance adjustments on the statement of cash flows Effect of the measurement period adjustments on the income statement for the six-month period and the quarter ended 30 June 2023 For the six-month period ended 30 June 2023 For the quarter ended 30 June 2023 USD m Including measurement period adjustments made in the third quarter 2023 Measurement period adjustment made in the Annual Report 2023 Measurement period adjustments made in the second quarter 2024 Revised As previously reported in the third quarter 2023 report Measurement period adjustment made in the Annual Report 2023 Measurement period adjustments made in the second quarter 2024 Revised Net interest income 3,095 3,095 1,707 1,707 Other net income from financial instruments measured at fair value through profit or loss 5,198 5,198 2,517 2,517 Fee and commission income 10,688 10,688 5,635 5,635 Fee and commission expense (954) (954) (507) (507) Net fee and commission income 9,734 9,734 5,128 5,128 Other income 258 258 188 188 Total revenues 18,284 18,284 9,540 9,540 Negative goodwill 28,925 (1,177) (483) 27,264 28,925 (1,177) (483) 27,264 Credit loss expense / (release) 662 662 623 623 Operating expenses 15,696 15,696 8,486 8,486 Operating profit / (loss) before tax 30,852 (1,177) (483) 29,191 29,356 (1,177) (483) 27,695 Tax expense / (benefit) 820 820 361 361 Net profit / (loss) 30,032 (1,177) (483) 28,371 28,995 (1,177) (483) 27,334 Net profit / (loss) attributable to non-controlling interests 11 11 3 3 Net profit / (loss) attributable to shareholders 30,021 (1,177) (483) 28,360 28,992 (1,177) (483) 27,331 Effect of the measurement period adjustments on the balance sheet as of 31 March 2024 and 31 December 2023 USD m As of 31 March 2024 As of 31 December 2023 Assets As previously reported in the first quarter 2024 report Measurement period adjustment made in the second quarter 2024 Revised As previously reported in the first quarter 2024 report Measurement period adjustment made in the second quarter 2024 Revised Total financial assets measured at amortized cost 1,110,067 (322) 1,109,745 1,189,773 (322) 1,189,451 of which: Cash and balances at central banks 271,527 (89) 271,439 314,148 (89) 314,060 of which: Amounts due from banks 22,143 (15) 22,128 21,161 (15) 21,146 of which: Loans and advances to customers 605,283 (175) 605,108 639,844 (175) 639,669 of which: Other financial assets measured at amortized cost 62,750 (43) 62,707 65,498 (43) 65,455 Total assets 1,607,120 (322) 1,606,798 1,717,246 (322) 1,716,924 Liabilities Provisions and contingent liabilities 10,914 161 11,076 12,250 161 12,412 Total liabilities 1,521,354 161 1,521,515 1,630,607 161 1,630,769 Equity Equity attributable to shareholders 85,260 (483) 84,777 86,108 (483) 85,624 of which: Retained earnings 76,436 (483) 75,952 74,880 (483) 74,397 Total equity 85,766 (483) 85,283 86,639 (483) 86,156 Total liabilities and equity 1,607,120 (322) 1,606,798 1,717,246 (322) 1,716,924 Effect of the measurement period adjustments on the statement of cash flows for the six-month period ended 30 June 2023 For the six-month period ended 30 June 2023 USD m As previously reported in the third quarter 2023 report Cumulative measurement period adjustment Revised Cash flow from / (used in) operating activities Net profit / (loss) 30,032 (1,661) 28,371 of which: Negative goodwill (28,925) 1,661 (27,264) Net cash flow from / (used in) operating activities 17,665 17,665 of which: Loans and advances to customers and customer deposits 1,542 714 2,256 of which: Financial assets and liabilities at fair value held for trading (7,050) 1,268 (5,782) of which: Financial assets at fair value not held for trading and other financial 6,015 (1,982) 4,033 Net cash flow from / (used in) investing activities 104,869 (104) 104,765 of which: Cash and cash equivalents acquired upon acquisition of 108,510 (104) 108,406 Net cash flow from / (used in) financing activities (25,056) (25,056) Total cash flow Cash and cash equivalents at the beginning of the period 195,321 195,321 Net cash flow from / (used in) operating, investing and financing activities 97,478 (104) 97,374 Effects of exchange rate differences on cash and cash equivalents 2,960 2,960 Cash and cash equivalents at the end of the period 295,759 (104) 295,656 of which: cash and balances at central banks 261,504 (89) 261,415 of which: amounts due from banks 21,996 (15) 21,981 of which: money market paper 12,259 12,259 Conclusion of an investment management agreement asset-based financing In Products Management Holdings to portfolio of previously managed by Atlas are to be managed in transition services entered into advised by 8.0 bn of financing, with 6.0 bn funded trading 5.5 bn 2.0 bn commitments at a fair 0.15 bn, with the fair values the Group’s balance swingline 750 m USD 750 m), which is accounted for as the Group recognized 0.3 bn from the closing of the acquisition of the Credit Suisse Group.

Segment reporting

Segment reporting	6 Months Ended
	Jun. 30, 2024
Disclosure Of Operating Segments [Line Items]
Disclosure Of Entitys Reportable Segments Explanatory	Note 3 As part of 2024 certain Items. Prior-period information has been adjusted – Change UBS Suisse), predominantly related to the high 72 bn in invested assets and approximately 0.6 bn in annualized executed between the business divisions in the – Changes to Group Treasury allocations: UBS has allocated to the business divisions nearly all Group Treasury costs that historically Items include costs related the internal funds methodology. 0.3 bn for Items aforementioned changes, UBS the business divisions. – Updated cost UBS has 0.3 bn of the integration process. Following the collective changes outlined above, prior-period information for the six-month period ended 30 June 2023 has been restated, resulting in increases in Operating profit 39 m for Global Wealth Management, USD 17 m for Personal & Corporate Banking, USD 3 m for Asset Management and USD 17 m for the Investment Bank, and decreases in Operating profit / 60 m for Group Items and USD 15 m for Non-core and Legacy. Prior-period information as USD 98.4 bn 13.3 bn 28.9 bn Investment 28.6 bn USD 169.2 bn in Group Items. These changes had no effect on the reported USD m Global Wealth Management Personal & Corporate Banking Asset Management Investment Bank Non-core and Legacy Group Items UBS Group For the six months ended 30 June 2024 1 Total revenues 12,196 4,695 1,543 5,554 1,402 (747) 24,642 Credit loss expense / (release) (4) 146 0 26 35 (2) 201 Operating expenses 10,228 2,800 1,303 4,496 1,818 (48) 20,597 Operating profit / (loss) before tax 1,972 1,748 241 1,032 (451) (699) 3,844 Tax expense / (benefit) 905 Net profit / (loss) 2,939 As of 30 June 2024 Total assets 557,716 450,835 22,439 419,978 96,574 13,435 1,560,976 USD m Global Wealth Management Personal & Corporate Banking Asset Management Investment Bank Non-core and Legacy Group Items Negative goodwill 2 UBS Group For the six months ended 30 June 2023 1 Total revenues 10,049 3,087 1,086 4,401 185 (524) 18,284 Negative goodwill 27,264 27,264 Credit loss expense / (release) 164 237 1 139 119 2 662 Operating expenses 7,646 1,597 911 3,891 1,235 416 15,696 Operating profit / (loss) before tax 2,239 1,253 174 372 (1,169) (942) 27,264 29,191 Tax expense / (benefit) 820 Net profit / (loss) 28,371 As of 31 December 2023 2, 3 Total assets 567,648 483,794 21,804 428,269 201,131 14,277 1,716,924 1 Refer to “Note 3 Segment reporting” in the “Consolidated financial statements” section of has been revised. Refer to Note 2 for more information.

Net interest income

Net interest income	6 Months Ended
	Jun. 30, 2024
Disclosure Net Interest Income [Line Items]
Net interest income	Note 4 For the quarter ended Year-to-date USD m 30.6.24 31.3.24 30.6.23 1 30.6.24 30.6.23 1 Interest income from loans and deposits 2 8,403 9,089 6,143 17,492 10,250 Interest income from securities financing transactions measured 3 1,136 1,217 1,004 2,354 1,769 Interest income from other financial instruments measured 328 347 282 675 540 Interest income from debt instruments measured at fair 26 27 26 54 48 Interest income from derivative instruments designated as cash (574) (602) (457) (1,175) (833) Total interest income from financial instruments measured at amortized cost and fair income 9,320 10,078 6,998 19,399 11,775 Interest expense on loans and deposits 4 5,074 5,439 3,024 10,513 5,018 Interest expense on securities financing transactions measured 5 541 495 616 1,035 981 Interest expense on debt issued 3,655 3,740 2,205 7,395 3,635 Interest expense on lease liabilities 49 50 35 99 61 Total interest expense from financial instruments measured at amortized cost 9,319 9,724 5,880 19,042 9,695 Total net interest income from financial instruments measured at amortized cost and fair income 2 355 1,117 357 2,080 Net interest income from financial instruments measured at fair value through profit 1,533 1,585 589 3,118 1,015 Total net interest income 1,535 1,940 1,707 3,475 3,095 1 Comparative-period information receivables on derivative instruments, as well as negative interest on amounts due to banks, customer deposits, and cash collateral payables on derivative instruments. securities financing transactions and negative interest, including instruments, and customer deposits, as well as negative interest on cash and balances on payables from securities financing transactions and negative interest, including fees,

Net fee and commission income

Net fee and commission income	6 Months Ended
	Jun. 30, 2024
Net fee And Commission Income [Line Items]
Net fee and commission income	Note 5 For the quarter ended Year-to-date USD m 30.6.24 31.3.24 30.6.23 1 30.6.24 30.6.23 1 Underwriting fees 233 194 153 427 280 M&A and corporate finance fees 272 259 199 530 378 Brokerage fees 1,144 1,150 930 2,295 1,809 Investment fund fees 1,401 1,257 1,196 2,658 2,374 Portfolio management and related services 3,071 3,051 2,485 6,121 4,695 Other 1,090 1,169 672 2,259 1,151 Total fee and commission income 2 7,211 7,080 5,635 14,291 10,688 of which: recurring 4,484 4,407 3,789 8,891 7,201 of which: transaction-based 2,697 2,641 1,836 5,338 3,452 of which: performance-based 30 32 10 62 34 Fee and commission expense 679 588 507 1,268 954 Net fee and commission income 6,531 6,492 5,128 13,023 9,734 1 Comparative-period 4,011 m for Global Management (first 3,986 m; second 3,333 m), USD 876 m for 708 m; second 554 m), USD 924 m for Asset Management 941 m; second quarter of 753 m), USD 1,322 m for the Investment 1,332 m; second quarter of 851 m), USD 125 m for Non-core and Legacy (first quarter of 2024: USD 108 m; second quarter of 2023: USD 70 m) and negative USD 47 m for Group Items (first quarter of 2024: USD 5 m; second quarter of 2023: USD 74 m). Comparative-period information has been restated for changes in business division perimeters, Group Treasury

Other income

Other income	6 Months Ended
	Jun. 30, 2024
Other Income [Line Items]
Disclosure Of Other Operating Income Explanatory	Note 6 For the quarter ended Year-to-date USD m 30.6.24 31.3.24 30.6.23 30.6.24 30.6.23 Associates, joint ventures and subsidiaries Net gains / (losses) from acquisitions and disposals of 1 (2) (1) 4 (3) 6 Net gains / (losses) from disposals of investments in associates 2 (2) 0 0 0 Share of net profits of associates and joint ventures 52 58 27 110 36 Total 52 55 31 107 43 Income from properties 2 15 14 9 29 13 Net gains / (losses) from properties held for sale (2) (1) 0 (4) 0 Other 89 56 148 145 203 Total other income 154 124 188 278 258 1 Includes foreign exchange gains / (losses) reclassified from other comprehensive income related to the disposal or closure of foreign operations.

Personnel expenses

Personnel expenses	6 Months Ended
	Jun. 30, 2024
Personnel Expenses [Line Items]
Personnel expenses	Note 7 For the quarter ended Year-to-date USD m 30.6.24 31.3.24 30.6.23 30.6.24 30.6.23 Salaries and variable compensation 1 6,058 5,863 4,804 11,922 8,689 of which: variable compensation – financial advisors 2 1,291 1,267 1,110 2,558 2,222 Contractors 82 86 77 168 147 Social security 419 409 294 828 572 Post-employment benefit plans 309 367 261 676 497 Other personnel expenses 251 225 215 476 366 Total personnel expenses 7,119 6,949 5,651 14,068 10,271 1 Includes role-based compensation commitments with financial advisors entered into at the time of recruitment that are subject to vesting requirements.

General and administrative expe

General and administrative expenses	6 Months Ended
	Jun. 30, 2024
General And Administrative Expenses [Line Items]
General and administrative expenses	Note 8 For the quarter ended Year-to-date USD m 30.6.24 31.3.24 30.6.23 30.6.24 30.6.23 Outsourcing costs 463 423 311 886 559 Technology costs 567 588 414 1,154 735 Consulting, legal and audit fees 394 403 351 797 532 Real estate and logistics costs 302 289 207 590 349 Market data services 188 199 151 387 264 Marketing and communication 137 115 89 251 140 Travel and entertainment 87 72 73 159 126 Litigation, regulatory and similar matters 1 (153) (5) 69 (158) 790 Other 334 330 304 665 536 Total general and administrative expenses 2,318 2,413 1,968 4,731 4,033 1 Reflects the net increase / (decrease) in provisions for litigation, regulatory and similar matters recognized in the income statement. Refer to Note 15b

Expected credit loss measuremen

Expected credit loss measurement	6 Months Ended
	Jun. 30, 2024
Disclosure Of Provision Matrix [Line Items]
Expected credit loss measurement	Note 9 a) Credit loss expense / release Total net 95 m, reflecting 22 m net to performing positions and USD 116 m net expenses on credit-impaired positions. Stage 1 and 22 m included 34 m, primarily real estate rate assumptions across Personal & Corporate for performing (stages Credit 116 m for Banking exposures with a small number of corporate Credit loss expense / (release) Performing positions Credit-impaired positions USD m Stages 1 and 2 Stage 3 Purchased Total For the quarter ended 30.6.24 Global Wealth Management (13) 12 0 (1) Personal & Corporate Banking (15) 132 (14) 103 Asset Management 0 0 0 0 Investment Bank 7 (14) 1 (6) Non-core and Legacy (1) 3 (2) (1) Group Items 0 0 0 0 Total (22) 132 (15) 95 For the quarter ended 31.3.24 Global Wealth Management (12) 7 2 (3) Personal & Corporate Banking (13) 64 (7) 44 Asset Management 0 0 0 0 Investment Bank 7 26 (1) 32 Non-core and Legacy (26) 37 25 36 Group Items (2) 0 0 (2) Total (45) 133 18 106 For the quarter ended 30.6.23 1 Global Wealth Management 134 9 7 149 Personal & Corporate Banking 193 28 0 221 Asset Management 1 0 0 1 Investment Bank 134 (4) 1 132 Non-core and Legacy 74 44 0 119 Group Items 2 0 0 2 Total 537 77 8 623 1 Comparative-period information UBS Group first quarter 2024 report, available under “Quarterly reporting” at ubs.com/investors, Note 9 b) Changes to ECL models, scenarios, scenario Scenarios and scenario weights The expected reviewed in light of of governance meetings, with input and feedback and regions. ECLs for same scenarios UBS kept the scenarios and scenario The baseline scenario was updated with the latest macroeconomic forecasts as of 30 June 2024. The assumptions on a calendar-year basis are included in the table The mild market data, but the assumptions remained The scenario-update-related ECL releases in the second quarter of in Switzerland, as well as interest rate assumptions Post-model adjustments Total 1,001 m as adjustments of 300 m (31 March 2024: 286 m). Post-model levels, including models for dedicated segments. Comparison of shock factors Baseline Key parameters 2023 2024 2025 Real GDP growth (annual percentage change) US 2.5 2.3 1.4 Eurozone 0.6 0.6 1.2 Switzerland 0.7 1.3 1.5 Unemployment rate (%, annual average) US 3.6 4.0 4.2 Eurozone 6.6 6.6 6.8 Switzerland 2.0 2.4 2.6 Fixed income: 10-year government bonds (%, Q4) USD 3.9 4.3 4.2 EUR 2.0 2.5 2.4 CHF 0.7 0.6 0.6 Real estate (annual percentage change, Q4) US 5.2 3.7 2.3 Eurozone (1.0) 1.0 3.4 Switzerland 0.1 1.0 2.5 Economic scenarios and weights applied Assigned weights in % ECL scenario 30.6.24 31.3.24 30.6.23 Baseline 60.0 60.0 60.0 Mild debt crisis 15.0 15.0 15.0 Stagflationary geopolitical crisis 25.0 25.0 25.0 c) ECL-relevant balance sheet and off-balance The following tables subject exposure to credit risk, taking through other comprehensive the allowance Instead, the In addition to recognized financial assets, certain off-balance sheet financial instruments and other credit lines are also subject to ECL. based on the maximum contractual amounts. USD m 30.6.24 Carrying amount 1 ECL allowances 2 Financial instruments measured at amortized cost Total Stage 1 Stage 2 Stage 3 PCI Total Stage 1 Stage 2 Stage 3 PCI Cash and balances at central banks 248,336 248,244 16 0 76 (60) (1) (27) 0 (32) Amounts due from banks 21,959 21,627 319 0 13 (28) (6) 0 0 (22) Receivables from securities financing transactions measured at amortized cost 82,028 82,028 0 0 0 (2) (2) 0 0 0 Cash collateral receivables on derivative instruments 43,637 43,637 0 0 0 0 0 0 0 0 Loans and advances to customers 599,105 569,476 25,249 3,287 1,093 (1,743) (355) (298) (937) (153) of which: Private clients with mortgages 252,724 241,499 10,077 1,062 86 (167) (57) (77) (30) (3) of which: Real estate financing 86,854 82,018 4,507 243 86 (53) (28) (31) (2) 8 of which: Large corporate clients 28,773 23,888 3,829 700 357 (526) (93) (94) (272) (67) of which: SME clients 23,406 19,585 2,531 1,049 241 (515) (60) (38) (414) (3) of which: Lombard 148,268 147,272 875 54 66 (41) (6) (2) (16) (16) of which: Credit cards 1,927 1,479 408 40 0 (41) (6) (11) (25) 0 of which: Commodity trade finance 5,792 5,556 222 11 2 (125) (19) (2) (104) 0 of which: Ship / aircraft financing 8,284 7,846 421 3 15 (44) (38) (4) 0 (2) of which: Consumer financing 2,902 2,703 119 39 41 (68) (20) (21) (27) 0 Other financial assets measured at amortized cost 60,431 59,710 533 171 16 (131) (34) (8) (84) (5) of which: Loans to financial advisors 2,601 2,408 83 110 0 (47) (4) (1) (41) 0 Total financial assets measured at amortized cost 1,055,494 1,024,721 26,117 3,458 1,198 (1,964) (397) (333) (1,021) (212) Financial assets measured at fair value through other comprehensive income 2,167 2,167 0 0 0 0 0 0 0 0 Total on-balance sheet financial assets in scope of ECL requirements 1,057,661 1,026,888 26,117 3,458 1,198 (1,964) (397) (333) (1,021) (212) Total exposure ECL provisions 2 Off-balance sheet (in scope of ECL) Total Stage 1 Stage 2 Stage 3 PCI Total Stage 1 Stage 2 Stage 3 PCI Guarantees 40,759 39,176 1,382 159 44 (63) (25) (14) (26) 2 of which: Large corporate clients 8,290 7,390 820 67 15 (24) (10) (8) (7) 0 of which: SME clients 2,540 2,153 287 77 22 (10) (5) (3) (4) 2 of which: Financial intermediaries and hedge funds 21,270 21,080 189 0 0 (11) (8) (3) 0 0 of which: Lombard 3,895 3,872 10 13 0 (4) 0 0 (4) 0 of which: Commodity trade finance 1,642 1,628 13 0 0 (1) (1) 0 0 0 Irrevocable loan commitments 81,867 77,447 4,236 145 39 (147) (104) (43) (6) 6 of which: Large corporate clients 46,697 42,890 3,699 73 34 (126) (84) (36) (6) 0 Forward starting reverse repurchase and securities borrowing agreements 9,724 9,724 0 0 0 0 0 0 0 0 Unconditionally revocable loan commitments 148,932 146,532 2,154 245 0 (81) (69) (12) 0 0 of which: Real estate financing 11,705 11,154 552 0 0 (7) (7) 0 0 0 of which: Large corporate clients 16,000 15,677 314 9 0 (23) (16) (4) (2) 0 of which: SME clients 11,002 10,575 346 80 0 (34) (29) (5) 0 0 of which: Lombard 60,962 60,934 26 1 0 0 0 0 0 0 of which: Credit cards 10,056 9,576 477 4 0 (8) (6) (2) 0 0 Irrevocable committed prolongation of existing loans 3,329 3,319 7 2 0 (2) (2) 0 0 0 Total off-balance sheet financial instruments and other credit lines 284,611 276,199 7,779 551 83 (294) (200) (70) (31) 8 Total allowances and provisions (2,258) (597) (404) (1,053) (204) 1 The carrying amount of financial assets measured at amortized cost represents the total gross exposure net of the respective credit quality since the acquisition of the respective financial instrument, which is reflected as a negative ECL allowance. USD m 31.3.24 Carrying amount 1,2 ECL allowances 3 Financial instruments measured at amortized cost Total Stage 1 Stage 2 Stage 3 PCI Total Stage 1 Stage 2 Stage 3 PCI Cash and balances at central banks 271,439 271,378 17 0 43 (55) 0 (25) 0 (30) Amounts due from banks 22,128 22,027 65 0 36 (24) (6) 0 0 (18) Receivables from securities financing transactions measured at amortized cost 101,650 101,650 0 0 0 (2) (2) 0 0 0 Cash collateral receivables on derivative instruments 46,714 46,714 0 0 0 0 0 0 0 0 Loans and advances to customers 605,108 571,400 28,773 3,742 1,194 (1,700) (362) (284) (920) (134) of which: Private clients with mortgages 251,891 239,416 11,319 923 233 (196) (55) (92) (39) (10) of which: Real estate financing 90,220 84,485 5,444 179 111 (64) (27) (28) (9) 0 of which: Large corporate clients 29,008 23,954 3,917 689 447 (580) (91) (83) (318) (87) of which: SME clients 24,276 20,506 2,745 951 74 (442) (64) (32) (335) (11) of which: Lombard 150,759 149,153 931 549 126 (61) (7) (1) (41) (12) of which: Credit cards 1,840 1,402 399 38 0 (40) (6) (10) (23) 0 of which: Commodity trade finance 5,358 5,169 165 11 12 (123) (17) (2) (104) 0 of which: Ship / aircraft financing 8,777 7,998 776 3 0 (47) (40) (7) 0 0 of which: Consumer financing 2,912 2,629 199 35 49 (64) (20) (19) (24) 0 Other financial assets measured at amortized cost 62,707 61,945 574 166 22 (134) (35) (9) (83) (6) of which: Loans to financial advisors 2,615 2,430 70 115 0 (49) (6) (1) (43) 0 Total financial assets measured at amortized cost 1,109,745 1,075,113 29,428 3,908 1,296 (1,915) (405) (318) (1,003) (189) Financial assets measured at fair value through other comprehensive income 2,078 2,078 0 0 0 0 0 0 0 0 Total on-balance sheet financial assets in scope of ECL requirements 1,111,823 1,077,191 29,428 3,908 1,296 (1,915) (405) (318) (1,003) (189) Total exposure ECL provisions 3 Off-balance sheet (in scope of ECL) Total Stage 1 Stage 2 Stage 3 PCI Total Stage 1 Stage 2 Stage 3 PCI Guarantees 41,744 40,211 1,314 173 45 (64) (27) (18) (19) 1 of which: Large corporate clients 8,643 7,710 841 78 14 (25) (10) (11) (4) 0 of which: SME clients 2,670 2,274 286 86 23 (9) (4) (3) (2) 1 of which: Financial intermediaries and hedge funds 20,920 20,865 55 0 0 (11) (8) (3) 0 0 of which: Lombard 3,959 3,947 6 5 0 (7) 0 0 (7) 0 of which: Commodity trade finance 2,088 2,077 11 0 0 (1) (1) 0 0 0 Irrevocable loan commitments 87,292 82,700 4,335 230 27 (173) (112) (54) (13) 6 of which: Large corporate clients 48,060 44,281 3,682 77 21 (152) (93) (47) (13) 0 Forward starting reverse repurchase and securities borrowing agreements 17,649 17,649 0 0 0 0 0 0 0 0 Unconditionally revocable loan commitments 150,918 148,116 2,616 186 0 (89) (73) (15) 0 0 of which: Real estate financing 12,318 11,616 703 0 0 (10) (10) 0 0 0 of which: Large corporate clients 16,793 16,422 358 12 0 (25) (18) (7) 0 0 of which: SME clients 10,548 10,205 313 30 0 (36) (31) (5) 0 0 of which: Lombard 61,036 60,901 133 1 0 0 0 0 0 0 of which: Credit cards 10,049 9,560 485 4 0 (9) (8) (2) 0 0 Irrevocable committed prolongation of existing loans 3,719 3,709 7 3 0 (3) (3) 0 0 0 Total off-balance sheet financial instruments and other credit lines 301,322 292,385 8,271 593 72 (328) (215) (88) (32) 7 Total allowances and provisions (2,243) (620) (406) (1,035) (182) 1 The carrying amount of financial assets measured at amortized cost represents the total gross exposure net of the respective ECL allowances. 3 Negative balances are representative of a net improvement in credit quality since the acquisition of the respective financial instrument, which is reflected USD m 31.12.23 Carrying amount 1 ECL allowances 2 Financial instruments measured at amortized cost Total Stage 1 Stage 2 Stage 3 PCI Total Stage 1 Stage 2 Stage 3 PCI Cash and balances at central banks 314,060 314,025 18 0 18 (48) 0 (26) 0 (22) Amounts due from banks 21,146 21,092 17 0 38 (12) (6) (1) 0 (5) Receivables from securities financing transactions measured at amortized cost 99,039 99,039 0 0 0 (2) (2) 0 0 0 Cash collateral receivables on derivative instruments 50,082 50,082 0 0 0 0 0 0 0 0 Loans and advances to customers 639,669 610,922 24,408 2,869 1,470 (1,698) (423) (289) (862) (123) of which: Private clients with mortgages 268,616 256,614 10,695 929 378 (209) (62) (97) (39) (11) of which: Real estate financing 97,817 92,084 5,367 270 97 (103) (41) (31) (21) (11) of which: Large corporate clients 30,084 25,671 3,182 700 532 (575) (105) (70) (312) (89) of which: SME clients 25,957 22,155 2,919 754 129 (402) (71) (42) (277) (13) of which: Lombard 156,353 156,299 3 50 0 (41) (13) (11) (17) 0 of which: Credit cards 2,041 1,564 438 39 0 (42) (6) (11) (24) 0 of which: Commodity trade finance 5,727 5,662 25 22 18 (130) (18) (1) (111) 0 of which: Ship / aircraft financing 9,214 8,920 273 4 17 (51) (48) (3) 0 (1) of which: Consumer financing 2,982 2,795 92 38 57 (59) (22) (17) (20) 0 Other financial assets measured at amortized cost 65,455 64,268 968 158 61 (151) (41) (10) (94) (5) of which: Loans to financial advisors 2,615 2,422 79 114 0 (49) (4) (1) (44) 0 Total financial assets measured at amortized cost 1,189,451 1,159,428 25,410 3,027 1,587 (1,911) (473) (326) (956) (156) Financial assets measured at fair value through other comprehensive income 2,233 2,233 0 0 0 0 0 0 0 0 Total on-balance sheet financial assets in scope of ECL requirements 1,191,684 1,161,661 25,410 3,027 1,587 (1,911) (473) (326) (956) (156) Total exposure ECL provisions 2 Off-balance sheet (in scope of ECL) Total Stage 1 Stage 2 Stage 3 PCI Total Stage 1 Stage 2 Stage 3 PCI Guarantees 46,191 44,487 1,495 151 58 (73) (28) (22) (23) 0 of which: Large corporate clients 9,267 8,138 1,023 89 17 (31) (11) (13) (7) 0 of which: SME clients 2,839 2,469 337 31 2 (14) (4) (5) (5) 0 of which: Financial intermediaries and hedge funds 22,922 22,876 46 0 0 (12) (8) (3) 0 0 of which: Lombard 5,045 5,045 0 0 0 (1) 0 0 (1) 0 of which: Commodity trade finance 2,037 2,027 9 0 0 (1) (1) 0 0 0 Irrevocable loan commitments 91,643 87,080 4,297 218 48 (178) (117) (51) (14) 4 of which: Large corporate clients 50,696 46,708 3,881 59 48 (149) (94) (41) (12) (2) Forward starting reverse repurchase and securities borrowing agreements 18,444 18,444 0 0 0 0 0 0 0 0 Unconditionally revocable loan commitments 163,256 160,456 2,654 146 0 (95) (78) (17) 0 0 of which: Real estate financing 15,846 15,033 813 0 0 (14) (11) (3) 0 0 of which: Large corporate clients 17,139 16,678 454 8 0 (23) (17) (6) 0 0 of which: SME clients 11,658 11,253 375 29 0 (38) (33) (5) 0 0 of which: Lombard 77,618 77,618 0 1 0 0 0 0 0 0 of which: Credit cards 10,458 9,932 522 4 0 (10) (8) (2) 0 0 Irrevocable committed prolongation of existing loans 4,608 4,593 11 4 0 (4) (4) 0 0 0 Total off-balance sheet financial instruments and other credit lines 324,141 315,060 8,456 519 106 (350) (226) (90) (37) 3 Total allowances and provisions (2,261) (700) (416) (993) (153) 1 The carrying amount of financial assets measured at amortized cost represents the total gross exposure net of the respective ECL allowances. quality since the acquisition of the respective financial instrument, which is reflected as a negative ECL allowance. The table coverage ratio for Loans and advances ) and Cash , Amounts , Receivables from , Cash collateral Financial assets measured lower sensitivity to ECL. ECL coverage ratios are calculated by dividing ECL related exposures. Coverage ratios for performing positions related to real estate lending (on-balance sheet) remained unchanged at 6 increased by 4 57 31 March 2024. Coverage ratios for core loan portfolio 30.6.24 Gross carrying amount (USD m) ECL coverage (bps) On-balance sheet Total Stage 1 Stage 2 Stage 3 PCI Total Stage 1 Stage 2 Stage 1&2 Stage 3 PCI Private clients with mortgages 252,892 241,557 10,154 1,092 89 7 2 76 5 272 337 Real estate financing 86,907 82,045 4,538 245 78 6 3 69 7 72 0 Total real estate lending 339,798 323,602 14,692 1,337 167 6 3 74 6 235 0 Large corporate clients 29,299 23,981 3,923 972 424 180 39 240 67 2,798 1,580 SME clients 23,922 19,646 2,569 1,463 244 215 31 146 44 2,831 123 Total corporate lending 53,221 43,627 6,491 2,435 668 196 35 203 57 2,818 1,048 Lombard 148,308 147,278 877 71 82 3 0 23 1 2,328 1,951 Credit cards 1,968 1,485 419 64 0 208 39 252 86 3,826 0 Commodity trade finance 5,917 5,575 224 115 2 211 33 92 36 9,037 0 Ship / aircraft financing 8,329 7,883 426 3 17 53 48 103 51 0 1,176 Consumer financing 2,970 2,723 140 66 41 229 73 1,500 143 4,091 0 Other loans and advances to customers 40,339 37,661 2,277 131 270 41 8 80 12 3,532 2,630 Loans to financial advisors 2,647 2,412 84 151 0 176 18 146 22 2,736 0 Total other lending 210,478 205,018 4,447 601 412 25 6 134 9 4,323 2,160 Total 1 603,497 572,247 25,631 4,372 1,247 30 6 117 11 2,235 1,236 Gross exposure (USD m) ECL coverage (bps) Off-balance sheet Total Stage 1 Stage 2 Stage 3 PCI Total Stage 1 Stage 2 Stage 1&2 Stage 3 PCI Private clients with mortgages 8,091 7,834 226 31 0 4 4 23 4 11 0 Real estate financing 12,715 12,143 572 0 0 5 6 0 5 0 0 Total real estate lending 20,805 19,977 798 31 0 5 5 0 5 11 0 Large corporate clients 71,060 66,029 4,833 149 49 24 17 100 22 987 0 SME clients 15,352 14,421 720 189 22 33 27 207 36 197 0 Total corporate lending 86,412 80,450 5,553 338 71 26 19 114 25 546 0 Lombard 68,071 68,017 40 14 0 1 0 0 0 2,887 0 Credit cards 10,056 9,576 477 4 0 8 7 35 8 0 0 Commodity trade finance 3,732 3,712 20 0 0 7 7 13 7 0 0 Ship / aircraft financing 1,836 1,817 19 0 0 11 11 0 11 0 0 Consumer financing 152 152 0 0 0 0 0 0 0 0 0 Financial intermediaries and hedge funds 46,338 45,878 461 0 0 3 2 74 3 0 0 Other off-balance sheet commitments 37,485 36,897 411 163 13 7 4 55 4 538 0 Total other lending 167,670 166,049 1,427 181 13 3 2 52 3 710 0 Total 2 274,888 266,475 7,778 550 84 11 7 90 10 570 0 Total on- and off-balance sheet 3 878,385 838,722 33,409 4,923 1,331 24 7 111 11 2,049 1,202 1 Includes Loans and advances repurchase and securities borrowing agreements. Coverage ratios for core loan portfolio 31.3.24 Gross carrying amount (USD m) ECL coverage (bps) On-balance sheet Total Stage 1 Stage 2 Stage 3 PCI Total Stage 1 Stage 2 Stage 1&2 Stage 3 PCI Private clients with mortgages 252,087 239,471 11,412 962 243 8 2 81 6 406 395 Real estate financing 90,284 84,512 5,472 188 111 7 3 50 6 493 0 Total real estate lending 342,372 323,984 16,884 1,150 354 8 3 71 6 420 270 Large corporate clients 29,587 24,045 4,001 1,008 534 196 38 208 62 3,160 1,632 SME clients 24,718 20,570 2,777 1,286 85 179 31 114 41 2,602 1,305 Total corporate lending 54,305 44,615 6,777 2,293 619 188 35 169 53 2,847 1,587 Lombard 150,820 149,160 932 590 138 4 0 10 1 699 840 Credit cards 1,879 1,408 410 61 0 211 41 256 89 3,802 0 Commodity trade finance 5,481 5,186 168 115 12 224 32 144 35 9,044 0 Ship / aircraft financing 8,823 8,038 782 3 0 53 50 84 53 0 0 Consumer financing 2,976 2,649 218 59 49 215 77 884 138 4,093 31 Other loans and advances to customers 40,152 36,721 2,886 389 156 21 9 31 11 657 939 Loans to financial advisors 2,664 2,435 71 157 0 186 23 160 27 2,716 0 Total other lending 212,796 205,598 5,466 1,375 356 22 6 91 9 1,900 739 Total 1 609,472 574,198 29,127 4,819 1,328 29 6 98 11 1,998 1,009 Gross exposure (USD m) ECL coverage (bps) Off-balance sheet Total Stage 1 Stage 2 Stage 3 PCI Total Stage 1 Stage 2 Stage 1&2 Stage 3 PCI Private clients with mortgages 7,907 7,590 289 29 0 7 6 34 7 24 0 Real estate financing 13,652 12,919 732 0 0 7 8 0 7 0 0 Total real estate lending 21,559 20,509 1,021 29 0 7 7 4 7 23 0 Large corporate clients 73,534 68,451 4,881 168 35 28 18 133 25 995 0 SME clients 15,269 14,438 678 130 23 34 29 216 38 181 0 Total corporate lending 88,803 82,889 5,559 297 58 29 20 143 27 640 0 Lombard 68,645 68,477 161 7 0 1 0 1 0 9,921 0 Credit cards 10,049 9,560 485 4 0 9 8 34 9 0 0 Commodity trade finance 4,446 4,429 18 0 0 6 6 127 6 0 0 Ship / aircraft financing 1,643 1,643 0 0 0 13 12 0 13 0 0 Consumer financing 167 167 0 0 0 0 0 0 0 0 0 Financial intermediaries and hedge funds 48,923 48,619 304 0 0 3 2 114 3 0 0 Other off-balance sheet commitments 39,437 38,444 723 256 14 6 4 40 4 257 0 Total other lending 173,310 171,338 1,691 267 14 3 2 49 3 493 0 Total 2 283,672 274,736 8,271 593 72 12 8 106 11 543 0 Total on- and off-balance sheet 3,4 893,144 848,933 37,399 5,412 1,401 23 7 100 11 1,838 908 1 Includes Loans and advances to repurchase and securities borrowing agreements. Refer to Note 2 for more information. Coverage ratios for core loan portfolio 31.12.23 Gross carrying amount (USD m) ECL coverage (bps) On-balance sheet Total Stage 1 Stage 2 Stage 3 PCI Total Stage 1 Stage 2 Stage 1&2 Stage 3 PCI Private clients with mortgages 268,825 256,675 10,792 968 389 8 2 90 6 399 283 Real estate financing 97,920 92,124 5,398 290 108 11 4 57 7 713 980 Total real estate lending 366,745 348,800 16,190 1,258 497 9 3 79 6 472 434 Large corporate clients 30,660 25,775 3,252 1,012 620 188 41 215 60 3,083 1,429 SME clients 26,359 22,226 2,961 1,031 142 153 32 141 45 2,689 893 Total corporate lending 57,019 48,001 6,213 2,042 762 172 37 180 53 2,884 1,329 Lombard 156,394 156,312 15 67 0 3 1 7,616 2 2,487 0 Credit cards 2,083 1,571 449 63 0 200 40 253 87 3,801 0 Commodity trade finance 5,858 5,681 26 133 18 223 32 365 34 8,333 6 Ship / aircraft financing 9,265 8,968 276 4 17 56 54 99 55 0 315 Consumer financing 3,041 2,817 110 58 57 195 79 1,559 135 3,422 7 Other loans and advances to customers 40,961 39,196 1,419 105 242 21 10 39 11 3,981 0 Loans to financial advisors 2,665 2,426 80 159 0 185 17 122 20 2,793 0 Total other lending 220,267 216,971 2,373 589 334 21 7 210 9 4,376 9 Total 1 644,031 613,772 24,777 3,889 1,593 27 7 117 11 2,329 773 Gross exposure (USD m) ECL coverage (bps) Off-balance sheet Total Stage 1 Stage 2 Stage 3 PCI Total Stage 1 Stage 2 Stage 1&2 Stage 3 PCI Private clients with mortgages 9,782 9,505 261 15 0 6 5 27 6 40 0 Real estate financing 17,107 16,281 826 0 0 9 8 44 9 0 0 Total real estate lending 26,889 25,786 1,088 15 0 8 7 40 8 40 0 Large corporate clients 77,103 71,524 5,357 157 65 26 17 111 24 1,217 242 SME clients 16,762 15,868 812 80 2 40 29 196 37 640 0 Total corporate lending 93,865 87,392 6,170 236 67 29 19 122 26 1,022 221 Lombard 86,173 86,173 0 1 0 0 0 0 0 0 0 Credit cards 10,458 9,932 522 4 0 10 8 35 10 0 0 Commodity trade finance 4,640 4,628 13 0 0 6 5 151 6 0 0 Ship / aircraft financing 1,053 1,053 0 0 0 26 26 0 26 0 0 Consumer financing 153 153 0 0 0 0 0 0 0 0 0 Financial intermediaries and hedge funds 42,578 42,325 253 0 0 3 3 142 3 0 0 Other off-balance sheet commitments 39,887 39,174 411 263 39 7 4 111 5 453 0 Total other lending 184,944 183,438 1,199 268 39 3 2 85 3 486 0 Total 2 305,697 296,616 8,456 519 106 11 8 107 10 717 0 Total on- and off-balance sheet 3 949,729 910,388 33,233 4,408 1,699 22 7 114 11 2,140 706 1 Includes Loans and advances to repurchase and securities borrowing agreements.

Fair value measurement

Fair value measurement	6 Months Ended
	Jun. 30, 2024
Disclosure Of Fair Value Measurement [Line Items]
Disclosure Of Fair Value Measurement Explanatory	Note 10 a) Fair value hierarchy The fair summarized in the table below. During the Level 1 to Level 2, and were held for the entire Determination of fair values from quoted market 1 30.6.24 31.3.24 31.12.23 USD m Level 1 Level 2 Level 3 Total Level 1 Level 2 Level 3 Total Level 1 Level 2 Level 3 Total Financial assets measured at fair value on a recurring basis Financial assets at fair value held for trading 124,602 29,381 8,042 162,025 116,980 30,734 12,390 160,104 118,975 28,045 22,613 169,633 of which: Equity instruments 112,416 827 185 113,429 103,929 344 247 104,520 102,602 1,403 321 104,325 of which: Government bills / bonds 5,603 5,319 75 10,997 5,972 6,652 35 12,659 6,995 8,763 73 15,830 of which: Investment fund units 5,677 1,222 240 7,139 6,022 1,943 234 8,198 8,392 1,124 129 9,645 of which: Corporate and municipal bonds 896 16,569 900 18,365 1,052 16,152 1,045 18,250 984 12,801 1,284 15,069 of which: Loans 0 5,246 6,419 11,666 0 5,499 10,606 16,105 0 3,837 19,618 23,456 of which: Asset-backed securities 10 192 169 370 4 139 119 262 3 112 133 248 Derivative financial instruments 836 136,437 2,325 139,597 1,146 155,710 2,373 159,229 622 172,903 2,559 176,084 of which: Foreign exchange 331 50,521 121 50,974 416 61,337 197 61,951 347 78,060 253 78,659 of which: Interest rate 0 48,437 403 48,840 0 52,144 402 52,546 0 55,190 407 55,597 of which: Equity / index 0 32,239 1,154 33,392 0 36,489 1,186 37,675 0 34,174 1,299 35,473 of which: Credit 0 2,553 478 3,031 0 2,590 434 3,024 0 3,456 513 3,969 of which: Commodities 3 2,563 16 2,582 7 3,001 2 3,011 1 1,869 13 1,883 Brokerage receivables 0 25,273 0 25,273 0 22,796 0 22,796 0 21,037 0 21,037 Financial assets at fair value not held for trading 34,766 80,555 7,945 123,266 31,065 59,843 8,704 99,612 30,717 64,865 8,435 104,018 of which: Financial assets for unit-linked investment contracts 16,957 6 0 16,963 16,458 25 0 16,482 15,877 7 0 15,884 of which: Corporate and municipal bonds 61 14,338 210 14,609 60 14,532 217 14,809 62 16,722 215 17,000 of which: Government bills / bonds 17,262 7,817 0 25,079 14,065 7,019 0 21,083 14,306 4,801 0 19,107 of which: Loans 0 3,699 2,553 6,252 0 3,710 2,167 5,878 0 4,252 2,258 6,510 of which: Securities financing transactions 0 53,069 268 53,337 0 32,840 98 32,938 0 36,857 52 36,909 of which: Asset-backed securities 0 1,108 500 1,608 0 1,169 500 1,668 0 1,525 180 1,704 of which: Auction rate securities 0 0 191 191 0 0 1,211 1,211 0 0 1,208 1,208 of which: Investment fund units 395 421 670 1,486 371 458 688 1,517 367 548 678 1,592 of which: Equity instruments 92 5 2,896 2,993 111 1 3,017 3,130 105 38 3,097 3,241 Financial assets measured at fair value through other comprehensive income on Financial assets measured at fair value through other comprehensive income 62 2,105 0 2,167 67 2,011 0 2,078 68 2,165 0 2,233 of which: Commercial paper and certificates of deposit 0 1,891 0 1,891 0 1,783 0 1,783 0 1,948 0 1,948 of which: Corporate and municipal bonds 62 205 0 267 67 179 0 246 68 207 0 276 Non-financial assets measured at fair value on a recurring basis Precious metals and other physical commodities 6,445 0 0 6,445 6,466 0 0 6,466 5,930 0 0 5,930 Non-financial assets measured at fair value on a non-recurring basis Other non-financial assets 2 0 0 43 43 0 0 35 35 0 0 31 31 Total assets measured at fair value 166,712 273,750 18,354 458,817 155,725 271,093 23,502 450,320 156,312 289,015 33,639 478,966 Determination of fair values from quoted market 1 30.6.24 31.3.24 31.12.23 USD m Level 1 Level 2 Level 3 Total Level 1 Level 2 Level 3 Total Level 1 Level 2 Level 3 Total Financial liabilities measured at fair value on a recurring basis Financial liabilities at fair value held for trading 24,476 8,906 111 33,493 26,785 8,771 202 35,758 27,684 6,315 161 34,159 of which: Equity instruments 16,956 417 66 17,438 18,996 294 66 19,356 18,266 248 92 18,606 of which: Corporate and municipal bonds 33 7,118 35 7,186 34 6,966 132 7,132 28 4,981 62 5,071 of which: Government bills / bonds 6,171 1,260 5 7,437 6,596 1,232 0 7,828 8,559 905 0 9,464 of which: Investment fund units 1,315 38 4 1,357 1,159 216 3 1,378 832 118 4 954 Derivative financial instruments 876 143,744 4,448 149,069 967 156,208 5,867 163,042 771 185,815 5,595 192,181 of which: Foreign exchange 326 51,640 48 52,014 372 58,684 51 59,107 457 89,394 36 89,887 of which: Interest rate 0 47,021 243 47,264 0 49,966 307 50,273 0 52,673 246 52,920 of which: Equity / index 0 38,001 3,379 41,380 0 41,522 4,302 45,825 0 38,046 3,333 41,380 of which: Credit 0 3,456 371 3,827 0 3,205 525 3,731 0 4,081 619 4,700 of which: Commodities 2 1,951 14 1,967 3 2,618 20 2,642 0 1,437 21 1,458 of which: Loan commitments measured at FVTPL 3 0 1,547 288 1,835 0 127 555 682 0 135 1,037 1,172 Financial liabilities designated at fair value on a recurring basis Brokerage payables designated at fair value 0 46,198 0 46,198 0 46,628 0 46,628 0 42,522 0 42,522 Debt issued designated at fair value 0 100,223 12,986 113,209 0 102,823 13,983 116,806 0 113,012 15,276 128,289 Other financial liabilities designated at fair value 0 28,484 3,391 31,875 0 25,490 2,650 28,140 0 26,878 2,606 29,484 of which: Financial liabilities related to unit- linked investment contracts 0 17,080 0 17,080 0 16,612 0 16,612 0 15,992 0 15,992 of which: Securities financing transactions 0 7,699 0 7,699 0 5,121 0 5,121 0 7,416 0 7,416 of which: Over-the-counter debt instruments and others 0 3,705 3,391 7,096 0 3,757 2,650 6,407 0 3,471 2,606 6,076 Total liabilities measured at fair value 25,352 327,555 20,936 373,844 27,752 339,920 22,703 390,374 28,454 374,542 23,638 426,635 1 Bifurcated embedded derivatives are presented on the same balance sheet 2 Other non-financial assets primarily consist of properties and of 30 June 2024 also includes UBS’s funding obligation arising from the offer by the Credit Suisse supply chain finance funds to redeem the outstanding units which was note 15). b) Valuation adjustments The table below summarizes the changes Deferred day-1 profit or loss is generally released into Other net income from financial instruments measured value observable or when the transaction is closed out. Deferred day-1 profit or loss reserves For the quarter ended Year-to-date USD m 30.6.24 31.3.24 30.6.23 30.6.24 30.6.23 Reserve balance at the beginning of the period 384 404 399 404 422 Profit / (loss) deferred on new transactions 59 42 78 101 169 (Profit) / loss recognized in the income statement (55) (62) (75) (116) (188) Foreign currency translation (1) 0 (1) (1) (1) Reserve balance at the end of the period 388 384 402 388 402 The table below summarizes other valuation Other valuation adjustment reserves on the As of USD m 30.6.24 31.3.24 31.12.23 Own credit adjustments on financial liabilities designated at fair value 1 (1,062) (1,315) (1,287) of which: debt issued designated at fair value (1,085) (1,334) (1,297) of which: other financial liabilities designated at fair value 23 19 10 Credit valuation adjustments 2 (104) (118) (145) Funding and debit valuation adjustments (81) (107) (116) Other valuation adjustments (1,745) (2,135) (2,654) of which: liquidity (1,230) (1,588) (2,051) of which: model uncertainty (516) (547) (603) 1 Own credit adjustments on financial liabilities designated at fair value includes amounts for TLAC notes. c) Level 3 instruments: valuation techniques The measure fair value, 30 June 2024 and unobservable, and a range The range of values range does not reflect the level of uncertainty regarding a particular input or an assessment of the reasonableness of the Group’s estimates and assumptions, but rather the different underlying characteristics of the relevant liabilities held by the Group. The significant unobservable value measurement” in the “Consolidated financial Valuation techniques and inputs Fair value Significant unobservable input(s) 1 Range of inputs Assets Liabilities Valuation technique(s) 30.6.24 31.12.23 USD bn 30.6.24 31.12.23 30.6.24 31.12.23 low high weighted average 2 low high weighted average 2 unit 1 Financial assets and liabilities at fair value held for Corporate and municipal bonds 1.1 1.5 0.0 0.1 Relative value to market comparable Bond price equivalent 19 126 95 5 126 99 points Discounted expected cash flows Discount margin 243 3,055 687 135 491 463 basis points Traded loans, designated at fair value and guarantees 9.3 22.0 0.0 0.0 Relative value to market comparable Loan price equivalent 1 114 74 1 120 88 points Discounted expected cash flows Credit spread 19 1,779 367 19 2,681 614 basis points Investment fund units 3 0.9 0.8 0.0 0.0 Relative value to market comparable Net asset value Equity instruments 3 3.1 3.4 0.1 0.1 Relative value to market comparable Price Debt issued designated at fair value 4 13.0 15.3 Other financial liabilities designated at fair value 3.4 2.6 Discounted expected cash flows Funding spread 106 201 51 201 basis points Derivative financial instruments Interest rate 0.4 0.4 0.2 0.2 Option model Volatility of interest rates 48 149 45 154 basis points Volatility of inflation 1 6 1 6 % IR-to-IR correlation 71 99 4 100 % Credit 0.5 0.5 0.4 0.6 Discounted expected cash flows Credit spreads 3 2,967 1 2,421 basis points Credit correlation 50 66 50 66 % Credit volatility 60 60 60 60 % Recovery rates 0 100 14 100 % Equity / index 1.2 1.3 3.4 3.3 Option model Equity dividend yields 0 19 0 17 % Volatility of equity stocks, equity and other indices 4 135 4 142 % Equity-to-FX correlation (40) 77 (40) 77 % Equity-to-equity correlation 10 100 (50) 100 % Loan commitments measured at FVTPL 0.3 1.0 Relative value to market comparable Loan price equivalent 15 100 35 102 points 1 The ranges of significant unobservable inputs are represented in points, percentages and basis points. most non-derivative financial instruments and were calculated designated at fair value 4 Debt issued designated at fair value primarily consists of UBS structured notes, which include variable maturity notes with various equity and foreign exchange underlying risks, as well as rates-linked and credit-linked notes, all of instruments are presented in the respective derivative financial instruments lines in this table. d) Level 3 instruments: sensitivity to changes The table below summarizes those financial assets and liabilities classified as Level 3 for more of significantly, and the estimated effect thereof. The alternative values for Level 3 scenarios. Typically, Although well-defined interdependencies may exist between interest rates, have not been incorporated not a significant element of the valuation uncertainty. Sensitivity of fair value measurements to changes 1 30.6.24 31.3.24 31.12.23 USD m Favorable changes Unfavorable changes Favorable changes Unfavorable changes Favorable changes Unfavorable changes Traded loans, loans measured at fair value and guarantees 453 (433) 441 (407) 635 (600) Securities financing transactions 34 (31) 37 (33) 30 (32) Auction rate securities 8 (6) 39 (25) 67 (21) Asset-backed securities 44 (48) 54 (58) 39 (36) Equity instruments 428 (403) 447 (428) 430 (413) Investment fund units 140 (141) 142 (144) 135 (137) Loan commitments measured at FVTPL 85 (110) 148 (176) 313 (343) Interest rate derivatives, net 139 (81) 209 (102) 217 (103) Credit derivatives, net 124 (128) 117 (117) 140 (131) Foreign exchange derivatives, net 3 (4) 4 (4) 5 (4) Equity / index derivatives, net 651 (546) 563 (498) 521 (443) Other 83 (90) 126 (141) 281 (276) Total 2,192 (2,021) 2,327 (2,133) 2,815 (2,538) 1 Sensitivity of issued and over-the-counter debt instruments is reported with the equivalent derivative e) Level 3 instruments: movements during The table below presents additional information about material Level 3 assets and liabilities measured at fair value on a recurring basis. Level 3 assets and liabilities the fair include the effect of related hedging in the table are not observable and unobservable parameters. Assets transferred on 1 January 2024. Movements of Level 3 instruments USD bn Balance at the beginning of the period Credit Suisse Level 3 assets and liabilities acquired Net gains / losses included in compre- hensive income 1 of which: related to instruments held at the end of the period Purchases Sales Issuances Settlements Transfers into Level 3 Transfers out of Level 3 Foreign currency translation Balance at the end of the period For the six months ended 30 June 2024 2 Financial assets at fair value held for trading 22.6 0.3 (0.3) 0.9 (11.6) 0.8 (5.7) 1.6 (0.7) (0.1) 8.0 of which: Equity instruments 0.3 (0.0) (0.0) 0.0 (0.0) 0.0 (0.0) 0.0 (0.1) (0.0) 0.2 of which: Corporate and municipal bonds 1.3 (0.1) (0.0) 0.3 (0.5) 0.0 0.0 0.0 (0.1) (0.0) 0.9 of which: Loans 19.6 0.5 (0.2) 0.4 (9.9) 0.8 (5.7) 1.4 (0.6) (0.1) 6.4 Derivative financial instruments – assets 2.6 (0.0) 0.0 0.0 (0.0) 0.6 (0.5) 0.3 (0.6) (0.0) 2.3 of which: Interest rate 0.4 0.0 0.1 0.0 (0.0) 0.0 (0.1) 0.1 (0.0) 0.0 0.4 of which: Equity / index 1.3 (0.0) (0.0) 0.0 (0.0) 0.5 (0.2) 0.1 (0.4) (0.0) 1.2 of which: Credit 0.5 (0.1) (0.0) 0.0 (0.0) 0.1 (0.1) 0.1 (0.0) (0.0) 0.5 Financial assets at fair value not held for trading 8.4 (0.2) (0.3) 0.3 (0.2) 1.1 (1.7) 0.5 (0.2) (0.1) 7.9 of which: Loans 2.3 (0.1) (0.1) 0.2 (0.0) 0.7 (0.3) 0.0 (0.1) (0.1) 2.6 of which: Auction rate securities 1.2 0.0 (0.0) 0.0 0.0 0.0 (1.1) 0.0 0.0 0.0 0.2 of which: Equity instruments 3.1 (0.1) (0.1) 0.0 (0.1) 0.0 0.0 0.0 0.0 (0.1) 2.9 Derivative financial instruments – liabilities 5.6 (0.8) (0.3) 0.0 (0.2) 1.7 (1.4) 0.3 (0.6) (0.0) 4.4 of which: Interest rate 0.2 (0.1) 0.1 0.0 (0.0) 0.0 (0.0) 0.1 (0.0) 0.0 0.2 of which: Equity / index 3.3 0.0 0.0 0.0 (0.1) 1.5 (1.1) 0.2 (0.5) (0.0) 3.4 of which: Credit 0.6 (0.1) (0.1) 0.0 (0.0) 0.1 (0.2) 0.0 (0.0) (0.0) 0.4 of which: Loan commitments measured at FVTPL 1.0 (0.6) (0.2) 0.0 (0.1) 0.0 (0.0) 0.0 0.0 (0.0) 0.3 Debt issued designated at fair value 15.3 (0.4) (0.0) 0.0 0.0 3.0 (2.9) 0.7 (2.7) (0.1) 13.0 Other financial liabilities designated at fair value 2.6 (0.1) (0.0) 0.0 (0.0) 1.1 (0.5) 0.4 (0.1) (0.0) 3.4 For the six months ended 30 June 2023 3 Financial assets at fair value held for trading 1.5 26.2 (0.5) (0.6) 0.5 (1.9) 1.1 0.0 0.1 (0.3) 0.0 26.7 of which: Investment fund units 0.1 0.1 (0.0) (0.0) 0.0 (0.0) 0.0 0.0 0.0 (0.0) (0.0) 0.1 of which: Corporate and municipal bonds 0.5 1.1 (0.4) (0.4) 0.3 (0.6) 0.0 0.0 0.0 (0.0) 0.0 1.0 of which: Loans 0.6 23.1 (0.1) (0.1) 0.0 (1.1) 1.1 0.0 (0.0) (0.2) (0.0) 23.5 Derivative financial instruments – assets 1.5 1.4 (0.1) (0.1) 0.0 (0.0) 0.5 (0.3) 0.1 (0.2) 0.0 3.0 of which: Interest rate 0.5 0.2 0.1 0.1 0.0 0.0 0.1 (0.0) 0.0 (0.0) (0.0) 0.8 of which: Equity / index 0.7 0.5 (0.1) (0.1) 0.0 (0.0) 0.3 (0.2) 0.0 (0.2) (0.0) 1.1 of which: Credit 0.3 0.2 (0.0) (0.0) 0.0 (0.0) 0.1 (0.0) 0.0 (0.0) 0.0 0.6 Financial assets at fair value not held for trading 3.7 4.2 0.0 0.0 0.5 (0.4) 0.0 (0.0) 0.1 (0.1) 0.0 8.0 of which: Loans 0.7 0.8 0.0 0.0 0.2 (0.0) 0.0 (0.0) 0.0 (0.1) (0.0) 1.6 of which: Auction rate securities 1.3 0.0 0.0 0.0 0.0 (0.0) 0.0 0.0 0.0 0.0 0.0 1.3 of which: Equity instruments 0.8 2.1 (0.0) (0.0) 0.2 (0.1) 0.0 0.0 0.0 0.0 0.0 3.1 Derivative financial instruments – liabilities 1.7 4.5 0.4 0.3 0.0 (0.2) 0.8 (0.4) 0.1 (0.3) 0.0 6.6 of which: Interest rate 0.1 0.2 0.0 0.0 0.0 0.0 0.1 (0.1) 0.0 0.0 0.0 0.4 of which: Equity / index 1.2 1.7 0.5 0.5 0.0 (0.0) 0.6 (0.3) 0.0 (0.1) 0.0 3.7 of which: Credit 0.3 0.3 0.0 0.0 0.0 (0.0) 0.1 (0.0) 0.1 (0.2) (0.0) 0.6 of which: Loan commitments measured at FVTPL 0.0 2.0 (0.2) (0.2) 0.0 (0.2) 0.0 0.0 0.0 0.0 0.0 1.6 Debt issued designated at fair value 10.5 8.5 0.4 0.4 0.0 0.0 2.4 (2.5) 0.6 (0.8) (0.0) 19.1 Other financial liabilities designated at fair value 0.7 2.1 0.0 0.0 0.0 0.0 0.2 (0.1) 0.0 (0.0) (0.0) 3.0 1 Net gains / losses included and also in 18.4 bn (31 December 2023: USD 33.6 bn). Total Level 3 20.9 bn (31 December 2023: 23.6 bn). Accounting for the acquisition of the Credit Suisse Group” in the UBS Group Annual Report 2023 for more information about the IFRS 3 measurement period f) Financial instruments not measured The table principles applied consistent with those described in “Note 21 section of the UBS Group Annual Report 2023. Financial instruments not measured at fair value 30.6.24 31.3.24 31.12.23 USD bn Carrying amount Fair value Carrying amount 1 Fair value Carrying amount 1 Fair value Assets Cash and balances at central banks 248.3 248.3 271.4 271.4 314.1 314.1 Amounts due from banks 22.0 22.0 22.1 22.1 21.1 21.2 Receivables from securities financing transactions measured at amortized 82.0 82.0 101.6 101.7 99.0 99.0 Cash collateral receivables on derivative instruments 43.6 43.6 46.7 46.7 50.1 50.1 Loans and advances to customers 599.1 594.6 605.1 600.0 639.7 633.5 Other financial assets measured at amortized cost 60.4 58.2 62.7 60.6 65.5 63.9 Liabilities Amounts due to banks 26.8 26.8 47.9 47.8 71.0 71.0 Payables from securities financing transactions measured at amortized cost 14.9 14.9 13.0 12.9 14.4 14.4 Cash collateral payables on derivative instruments 32.8 32.8 37.3 37.3 41.6 41.5 Customer deposits 756.8 757.3 764.0 764.8 792.0 792.9 Debt issued measured at amortized cost 229.2 233.8 226.3 230.9 237.8 241.3 Other financial liabilities measured at amortized cost 2 16.3 16.2 16.2 16.0 15.3 15.2 1 Comparative-period information has been revised. Refer to Note 2 for more information.

Derivative instruments

Derivative instruments	6 Months Ended
	Jun. 30, 2024
Disclosure Of Derivative Financial Instruments [Line Items]
Disclosure Of Derivative Financial Instruments Explanatory	Note 11 Derivative instruments a) Derivative instruments As of 30.6.24, USD bn Derivative financial assets Derivative financial liabilities Notional values related to derivative financial assets and liabilities 1 Other notional values 2 Derivative financial instruments Interest rate 48.8 47.3 3,472 20,200 Credit derivatives 3.0 3.8 170 Foreign exchange 51.0 52.0 7,148 213 Equity / index 33.4 41.4 1,432 96 Commodities 2.6 2.0 153 18 Other 3 0.8 2.6 151 Total derivative financial instruments, based on netting under IFRS Accounting Standards 4 139.6 149.1 12,526 20,526 Further netting potential not recognized on the balance 5 (124.4) (132.4) of which: netting of recognized financial liabilities / assets (101.3) (101.3) of which: netting with collateral received / pledged (23.1) (31.1) Total derivative financial instruments, after consideration of further netting potential 15.2 16.7 As of 31.3.24, USD bn Derivative financial instruments Interest rate 52.5 50.3 3,469 21,010 Credit derivatives 3.0 3.7 206 Foreign exchange 62.0 59.1 7,014 224 Equity / index 37.7 45.8 1,439 92 Commodities 3.0 2.6 152 20 Other 3 1.0 1.5 182 Total derivative financial instruments, based on netting under IFRS Accounting Standards 4 159.2 163.0 12,461 21,346 Further netting potential not recognized on the balance 5 (141.5) (147.9) of which: netting of recognized financial liabilities / assets (115.7) (115.7) of which: netting with collateral received / pledged (25.8) (32.1) Total derivative financial instruments, after consideration of further netting potential 17.7 15.2 As of 31.12.23, USD bn Derivative financial instruments Interest rate 55.6 52.9 3,524 20,074 Credit derivatives 4.0 4.7 275 Foreign exchange 78.7 89.9 6,913 180 Equity / index 35.5 41.4 1,397 95 Commodities 2.0 1.6 143 16 Other 3 0.4 1.6 117 Total derivative financial instruments, based on netting under IFRS Accounting Standards 4 176.1 192.2 12,369 20,366 Further netting potential not recognized on the balance 5 (162.8) 167.9 of which: netting of recognized financial liabilities / assets (133.0) (133.0) of which: netting with collateral received / pledged (29.8) (35.0) Total derivative financial instruments, after consideration of further netting potential 13.3 24.2 1 In cases where Notional amounts of client-cleared ETD and OTC transacti that are cleared through either financial assets and Derivative financial liabilities).The fair value of these derivatives is presented on the balance sheet net of the corresponding cash margin under Cash collateral receivables on derivative instruments and Cash collateral payables on derivative financial instruments for which the changes obligation arising from the offer by the Credit Suisse are presented net on the balance insolvency of UBS or its counterparties, and intends either to settle on a net basis or to realize the asset netting and similar arrangements where not all criteria for a net presentation on the balance sheet have statements” section of the UBS Group Annual Report 2023 for more information. b) Cash collateral on derivative instruments USD bn Receivables 30.6.24 Payables 30.6.24 Receivables 31.3.24 Payables 31.3.24 Receivables 31.12.23 Payables 31.12.23 Cash collateral on derivative instruments, based on netting under IFRS Accounting Standards 1 43.6 32.8 46.7 37.3 50.1 41.6 Further netting potential not recognized on the balance 2 (27.2) (19.0) (28.8) (22.6) (32.9) (26.4) of which: netting of recognized financial liabilities / assets (24.6) (16.5) (26.0) (19.8) (29.7) (23.2) of which: netting with collateral received / pledged (2.5) (2.5) (2.8) (2.8) (3.2) (3.2) Cash collateral on derivative instruments, after consideration of further netting potential 16.5 13.8 17.9 14.7 17.2 15.2 1 Financial assets and liabilities are presented event of default, accordance with enforceable liabilities” in the “Consolidated financial statements” section of the UBS Group Annual Report 2023 for more information.

Other assets and liabilities

Other assets and liabilities	6 Months Ended
	Jun. 30, 2024
Other Assets And Other Liabilities [Line Items]
Disclosure Of Other Assets And Other Liabilities Explanatory	Note 12 Other assets and liabilities a) Other financial assets measured at USD m 30.6.24 31.3.24 1 31.12.23 1 Debt securities 41,489 43,031 45,057 Loans to financial advisors 2,601 2,615 2,615 Fee- and commission-related receivables 2,460 2,429 2,576 Finance lease receivables 6,001 5,948 6,288 Settlement and clearing accounts 529 395 338 Accrued interest income 2,599 2,981 3,163 Other 2 4,752 5,308 5,418 Total other financial assets measured at amortized cost 60,431 62,707 65,455 1 Comparative-period information has through those counterparties. b) Other non-financial assets USD m 30.6.24 31.3.24 31.12.23 Precious metals and other physical commodities 6,445 6,466 5,930 Deposits and collateral provided in connection with litigation, 1 2,761 2,736 2,726 Prepaid expenses 1,889 2,048 2,080 Current tax assets 1,866 1,620 1,456 VAT, 1,106 952 1,327 Properties and other non-current assets held for sale 151 156 188 Other 2,295 2,239 2,342 Total other non-financial assets 16,514 16,217 16,049 1 Refer to Note 15 for more information. c) Other financial liabilities measured at USD m 30.6.24 31.3.24 31.12.23 Other accrued expenses 3,115 3,063 3,270 Accrued interest expenses 6,872 6,482 6,692 Settlement and clearing accounts 1,815 2,234 1,519 Lease liabilities 5,097 5,213 5,502 Other 4,484 4,364 3,868 Total other financial liabilities measured at amortized cost 21,383 21,356 20,851 e) Other non-financial liabilities USD m 30.6.24 31.3.24 31.12.23 Compensation-related liabilities 7,771 6,530 9,746 of which: net defined benefit liability 757 772 796 Current tax liabilities 1,303 1,447 1,460 Deferred tax liabilities 319 330 325 VAT, 1,070 888 1,120 Deferred income 763 670 635 Other 494 524 802 Total other non-financial liabilities 11,720 10,388 14,089 d) Other financial liabilities designated at USD m 30.6.24 31.3.24 31.12.23 Financial liabilities related to unit-linked investment contracts 17,080 16,612 15,992 Securities financing transactions 7,699 5,121 7,416 Over-the-counter debt instruments and other 7,096 6,407 6,076 Total other financial liabilities designated at fair value 31,875 28,140 29,484

Debt issued designated at fair

Debt issued designated at fair value	6 Months Ended
	Jun. 30, 2024
Disclosure Of Financial Liabilities [Line Items]
Disclosure Of Financial Instruments Designated At Fair Value Through Profit Or Loss Explanatory	Note 13 Debt issued designated at fair value USD m 30.6.24 31.3.24 31.12.23 Equity-linked 1 55,911 56,608 60,573 Rates-linked 25,811 25,940 28,883 Credit-linked 6,510 6,756 7,730 Fixed-rate 15,271 17,359 20,541 Commodity-linked 3,507 3,618 3,844 Other 6,200 6,525 6,718 of which: debt that contributes to total loss-absorbing capacity 4,585 4,476 4,629 Total debt issued designated at fair value 2 113,209 116,806 128,289 of which: issued by UBS AG standalone with original maturity greater 3 93,943 70,648 73,544 of which: issued by Credit Suisse AG standalone with original maturity 3 26,089 29,948 of which: issued by Credit Suisse International standalone 3 721 946 1,471 1 Includes investment fund unit-linked instruments issued. 99 % of Total debt issued designated at fair value was unsecured (31 March 2024: 99 %). without considering any early redemption features.

Debt issued measured at amortiz

Debt issued measured at amortized cost	6 Months Ended
	Jun. 30, 2024
Disclosure Of Financial Liabilities [Line Items]
Disclosure Of Debt Securities Explanatory	Note 14 Debt issued measured at amortized cost USD m 30.6.24 31.3.24 31.12.23 Short-term debt 1 34,944 32,485 38,530 Senior unsecured debt 143,832 143,540 147,547 of which: contributes to total loss-absorbing capacity 100,765 98,973 101,939 of which: issued by UBS AG standalone with original maturity greater 38,938 16,069 18,446 of which: issued by Credit Suisse AG standalone with original maturity 22,529 24,609 Covered bonds 8,524 6,498 5,214 Subordinated debt 14,350 16,446 17,644 of which: eligible as high-trigger loss-absorbing additional 12,400 12,021 10,744 of which: eligible as low-trigger loss-absorbing additional 1,225 1,217 1,214 of which: eligible as non-Basel III-compliant tier 2 capital 536 537 538 Debt issued through the Swiss central mortgage institutions 26,011 25,669 27,377 Other long-term debt 1,563 1,613 1,506 Long-term debt 2 194,279 193,766 199,288 Total debt issued measured at amortized cost 3,4 229,223 226,251 237,817 1 Debt with an original contractual maturity classification of debt presented. 100 % secured), Debt issued through the Swiss central mortgage institutions ( 100 % secured) and Other long-term debt ( 92 % secured), 100 % of the balance was unsecured as of 30 June 2024.

Provisions

Provisions	6 Months Ended
	Jun. 30, 2024
Disclosure Of Other Provisions [Line Items]
Disclosure Of Provisions Explanatory	Note 15 a) Provisions and contingent liabilities The table below presents an overview of total provisions USD m 30.6.24 31.3.24 1 31.12.23 1 Provisions related to expected credit losses (IFRS 9, Financial Instruments ) 2 294 328 350 Provisions related to Credit Suisse loan commitments (IFRS Business Combinations ) 1,367 1,667 1,924 Provisions related to litigation, regulatory and similar matters Provisions, Contingent Liabilities and Contingent Assets ) 3,630 3,920 4,020 Acquisition-related contingent liabilities (IFRS 3, Business Combinations ) 2,619 3,945 3,993 Restructuring, real-estate and other provisions (IAS 37, Provisions, Contingent Liabilities and Contingent Assets ) 1,382 1,216 2,123 Total provisions and contingent liabilities 9,293 11,076 12,412 1 Comparative-period information has been revised. Refer to Note 2 for more information. The table below presents additional information for provisions under IAS 37, Provisions, Contingent Liabilities and Contingent Assets . USD m Litigation, regulatory and similar matters 1 Restructuring 2 Real estate 3 Other 4 Total Balance as of 31 December 2023 4,020 741 259 1,123 6,144 Balance as of 31 March 2024 3,920 662 238 317 5,136 Increase in provisions recognized in the income statement 37 315 2 41 395 Release of provisions recognized in the income statement (41) (16) 0 (16) (73) Reclassification of IFRS 3 contingent liabilities to IAS 37 provisions 1,171 5 0 0 0 1,171 Provisions used in conformity with designated purpose (1,442) 5 (138) (5) (21) (1,605) Foreign currency translation and other movements (15) 4 (1) 0 (11) Balance as of 30 June 2024 3,630 827 233 322 5,013 1 Consists of provisions for losses resulting 461 m of provisions for onerous contracts related 443 m; 31 December 2023: USD 448 m) and USD 365 m of personnel-related 218 m; 31 December 2023: 294 m). reinstatement costs with respect Credit Suisse supply chain finance funds to redeem all of the outstanding units of the respective funds. As a result, UBS reclassified USD 944 m from IFRS 3 acquisition-related contingent liabilities to IAS 37 provisions related to litigation, regulatory and similar matters, as the probability of an outflow of resources increased, bringing the total IAS 37 provision for this matter to USD 1,421 m, with no impact on the income statement. The provision has been used to recognize the funding obligation, which was accounted for as a derivative 1,421 m as of 30 June 2024. Information about provisions and class, provisions.

Litigation, regulatory and simi

Litigation, regulatory and similar matters	6 Months Ended
	Jun. 30, 2024
Disclosure Of Litigation Regulatory And Similar Matters [Line Items]
Disclosure Of Contingent Liabilities Explanatory	Note 15 b) Litigation, regulatory and similar matters The Group operates in arising from disputes UBS proceedings, including litigation, arbitration, Such matters are subject predict, settlement implications of exonerated. The uncertainties inherent in all such matters affect the amount and timing of any potential outflows for both matters makes advice, it events, it these factors against the claims. obligation cannot probable. Accordingly, no matters could be significant. Developments relating to a matter that occur after the relevant reporting period, but prior matter reporting financial statements for the reporting period. Specific litigation, regulatory and other matters are considers to be material and others that management believes to be of significance to the Group due to potential financial, information is potential exposures. In the case of certain matters below, we state that we have established a provision, and for the other matters, we make no such statement. When we prejudice seriously our the confidentiality obligations whether we have a provision because it would reveal the fact that With respect to certain litigation, regulatory able to those matters for which we levels of liquidity over the relevant time periods. The “Provisions” table in Note 15a above. UBS provides regulatory and imprecise and proceedings that involve stages of account these uncertainties from litigation, by existing Suisse), are in the range of USD 0 bn to USD 1.7 bn. Litigation, regulatory to, or conviction of, a crime could have material consequences for UBS. Resolution of regulatory proceedings may require UBS to obtain waivers of regulatory disqualifications to maintain certain operations, may entitle regulatory authorities to limit, suspend or terminate utilities to limitation, suspension for UBS. The amounts principles. purchase accounting under IFRS 3 a liabilities for all present not recognition threshold for The 2.6 bn outflows, 0.2 bn information about upon resolution of the relevant matter. Provisions for litigation, regulatory and similar matters, 1 USD m Global Wealth Management Personal & Corporate Banking Asset Management Investment Bank Non-core and Legacy Group Items UBS Group Balance as of 31 December 2023 1,235 157 15 294 2,186 134 4,020 Balance as of 31 March 2024 1,201 152 2 288 2,142 134 3,920 Increase in provisions recognized in the income statement 28 0 0 6 0 3 37 Release of provisions recognized in the income statement (11) 0 0 (7) (22) 0 (41) Reclassification of IFRS 3 contingent liabilities to IAS 37 provisions 2 0 0 0 0 1,171 0 1,171 Provisions used in conformity with designated purpose 2 (10) 0 0 (5) (1,425) (1) (1,442) Foreign currency translation and other movements (8) (1) 0 (1) (4) 0 (15) Balance as of 30 June 2024 1,199 152 2 280 1,862 135 3,630 1 Provisions, if any, recorded in Non-core and Legacy. Provisions, if any, for the matters described between Global Wealth Management, core and Legacy and Group Items. matters described in item 12 of this Note are allocated between the Investment finance funds to 944 m from IFRS regulatory and similar matters, as the 1,421 m, with no impact on the income been used to recognize the funding obligation, which was accounted for as a derivative liability with a fair value 1,421 m as of 30 June 2024. 1. Inquiries regarding cross-border wealth management Tax examined services provided by the Netherlands, France and records and information border basis and closed. UBS is continuing to cooperate with Since 2013, UBS relation to UBS’s cross-border business with French judges ordered UBS AG to provide bail (“ caution ”) of EUR 1.1 bn. In 2019, French territory and aggravated abetting unlawful EUR 3.7 bn on UBS AG and UBS (France) S.A. and awarded EUR 800 m of civil damages to the French state. A trial in the guilty of unlawful solicitation and aggravated laundering of the proceeds of tax fraud. The court ordered a fine of EUR 3.75 m, 1 bn, 800 m. appealed the decision to the 2023. It proceeds of tax fraud, but overturned the confiscation of EUR 1 bn, the penalty of EUR 3.75 m and the EUR 800 m of civil regarding these overturned elements. 800 m of civil damages to UBS AG. In Department of returns. Credit Suisse continued to report under the In this connection, held by clients at ongoing reviews. In history regarding with the 2014 plea. In February 2021, a violated the allowed Credit Suisse to pay a criminal fine moved to Federal Court of Appeals for the Fourth Circuit. Our balance sheet at 30 the applicable accounting standard. As in the case of other matters for future available information provision that we have recognized. 2. Madoff In relation to S.A. (now UBS by a Commission under Luxembourg offshore Luxembourg funds are in liquidation. The documentation establishing both funds identifies UBS entities in various roles, serve as board members. In 2009 and 2010, the liquidators and certain individuals, including 2.1 bn, which (BMIS Trustee). A large number of alleged beneficiaries have filed claims losses relating to that the claims in eight test cases were inadmissible have been affirmed by the Luxembourg Court of Appeal, and the Luxembourg Supreme Court has dismissed In the funds and one of than USD 2 bn. In dismissing all 125 m of alleged to be entities seeking to recover UBS entities and Trustee’s remaining claims. The case has been 3. Foreign exchange, LIBOR and benchmark rates, Foreign exchange-related regulatory matters: concerning possible investigations, Commission. UBS jurisdictions metals businesses. In December 2021, the European Commission issued a 83.3 m on Suisse has was assessed. Foreign exchange-related civil litigation: in engaged in foreign currency actions relating to foreign currency transactions with the defendant banks and persons who exchange futures an aggregate of USD 141 m. Certain class members have excluded themselves from that settlement and individual actions European competition In persons and conspirators for Credit Suisse in Israel, which made allegations an agreement to settle all claims. The settlement LIBOR and other benchmark-related regulatory regarding potential improper attempts by UBS, among others, to manipulate LIBOR and other benchmark rates at certain benchmark interest immunity Competition Commission (WEKO), in certain rates. that UBS does not qualify for full immunity. LIBOR and in the federal certain interest rate benchmark-based derivatives. Also of other benchmarks, including depository through various GBP LIBOR and seek unspecified compensatory USD LIBOR class and individual actions in the Beginning in 2013, putative class actions district instruments, complaints allege unjust enrichment. Following various rulings causes of action and allowing others to proceed, one class instruments and several actions brought by Suisse instruments, bonds and loans. court in dismissed as against UBS, Credit used as the basis for LIBOR-based consumer an amended complaint with of Appeals. Other benchmark The Yen been dismissal of the EURIBOR and GBP LIBOR actions. In November 2022, defendants have moved to dismiss the approved a settlement by Credit Suisse of the Government bonds: breached European European Also Commission antitrust commission fined Credit Suisse EUR 11.9 m. Putative class actions on behalf of persons who participated in was filed in securities sold at auction and in the secondary market and asserting claims under the antitrust enrichment. In February 2024, now government bonds. Credit Suisse, together with other financial institutions, was named in two Canadian putative class actions, which allege that purchased 2020. settlement remains subject to court approval. Credit default In June in a of credit default swap (CDS) final auction prices. Defendants filed a motion to enforce a previous CDS class action settlement in the SDNY. In January 2024, from conduct prior to 30 June 2014, the SDNY decision. With respect above, our balance sheet at 30 June 2024 under the the future outflow of resources in respect of such matters available information provision that we have recognized. 4. Swiss retrocessions The Federal Supreme Court of Switzerland ruled in 2012, in a firm for distributing third-party surrendered waiver. FINMA issued a the FINMA requirements and has notified all potentially The Supreme Court potentially surrender retrocessions. Client requests are assessed on a case-by-case account when whether or not the client documentation contained Our amount that UBS believes to be appropriate under the applicable accounting standard. The ultimate exposure will depend on client the case of such matters ultimately prove to be substantially greater (or 5. Mortgage-related matters Government and : DOJ RMBS LLC Department of conducted through Suisse entities’ to the terms of the required housing independent continues amount of the consumer relief obligation increased after 2021 by 5 % per annum of the outstanding amount due until these obligations are settled. The monitor Civil litigation: to their roles as issuer, sponsor, depositor, underwriter and/or servicer of RMBS transactions. These cases currently include representations and required losses to alleged in these actions. DLJ Mortgage Capital, Inc. (DLJ) is a defendant in New Backed USD 374 m. notice-based damages of not 436 m. An than USD 420 m. A pending. An action by Home Equity Asset Trust 2007-2 alleges damages of not less than USD 495 m. An action by CSMC Asset-Backed Trust 2007-NC1 does not 6. ATA litigation Since November 2014, a the US District Court States Anti-Terrorism lawsuits are, or are relatives of, victims of various terrorist abetting based on allegations that various alter, concealing the allege that actively engaged for the Second Circuit affirmed a September 2019 ruling by the EDNY granting defendants’ motion to dismiss the first certiorari. seven cases, four prior to entry of the stay, and in three plaintiffs have filed amended complaints. 7. Customer account matters Several authority investment losses. Credit Suisse AG filed a criminal complaint against the former relationship manager with the Geneva Prosecutor’s Office upon which the filed criminal complaints with the was sentenced to five years and ordered 130 m. On and, subsequently, the Swiss Federal Supreme Court upheld the main findings of the Civil lawsuits have been initiated against the findings established in the criminal proceedings In Singapore, issued a judgment 742.73 m, excluding post-judgment against Credit Suisse Life (Bermuda) shall be no double in adjustments to the that damages awarded and post-judgment In Bermuda, in the civil issued a 607.35 m to Life (Bermuda) Ltd. issued by the contractual fraudulent misrepresentations. In Life (Bermuda) Ltd for leave to appeal the judgment to the Judicial Committee of the Privy Council and the notice of such appeal was filed. of the at the Bermuda statutory rate of 3.5 %. In December 2023, USD 75 m was released from the escrow paid to plaintiffs. In Switzerland, civil with statements of claim served in March 2023 8. Mozambique matter Credit regarding certain Credit S.A. and Empresa Moçambicana de Atum notes (LPN) related role in arranging the exchange former Credit Suisse employees pleaded guilty in the EDNY to accepting improper personal benefits in connection with financing transactions carried out with In (SEC), the that Credit risks. Credit connection with the criminal information and CSSEL entered into a Plea Agreement and pleaded guilty to one count wire continue compliance efforts complied with, concluding its enforcement proceeding, ordered Beginning in 2019, Credit Suisse English High Court connection with the cross claims against several entities related to the project several of the banks that participated in the ProIndicus loan syndicate brought claims against seeking compensation for any stemming from defamation claims resolved all claims involving Credit Suisse 9. ETN-related litigation XIV litigation: Since March 2018, three class action complaints of purchasers Short-Term Suisse for in the value of XIV ETNs in February 2018. On appeal from an order of the SDNY dismissing all claims, the Second Circuit issued an denied class certification for two of 10. Bulgarian former clients matter Credit concerning the alleged to against Credit Suisse AG Swiss framework and ordered to pay 2 m. In addition, the court seized of 12 m approximately CHF 19 m. In 11. Supply chain finance funds Credit enforcement and other other regulatory and governmental agencies. The Luxembourg reviewing the authorities. In connection with the Swiss supervisory FINMA governance requirement that 600 This proceedings against former managers of Credit In May 2023, supervisory requirements in response to inquiries The Attorney and several fund investors have joined the procedure as interested parties. Certain former and active Credit Suisse employees, procedure. Certain civil actions have and directors in various diligence and investors to around 92 % of offer were redeemed at 90 % of the net asset value determined on 25 by the relevant they may have had against the SCFFs, Credit Suisse units of feeder sub-funds. 12. Archegos Credit investigations including from FINMA the Regulation Authority (PRA), governmental agencies. entered into a settlement agreement July 2023, FINMA Cease and Desist. Under the terms of the order, certain remedial financial risk management, as well as enhancements to board oversight and governance. UBS Group, as successor to Credit Suisse Group AG, Order. and/or certain officers and directors, including claims for 13. Credit Suisse financial disclosures Credit Suisse complaints pending tier 1 capital notes, and other securities customer adequacy of AG’s merger with UBS Group AG. Many of the actions have been consolidated, and a motion to dismiss has filed and remains pending. One on whether it should be consolidated with the Credit Suisse has received requests for documents and information from regulatory and governmental agencies in connection with inquiries, regarding Credit Suisse’s financial condition, the authorities in these matters. 14. Merger-related litigation Certain Credit action complaints pending in breaches of fiduciary duty the court granted claims pending defendants’ acceptance of jurisdiction in Switzerland. In March 2024, having received consents to Swiss jurisdiction from all defendants served those defendants. notes (AT1 misconduct, which AT1 noteholders. The motion to dismiss the first of these complaints Switzerland is the most appropriate forum for litigation.

Basis of accounting (Policy)

Basis of accounting (Policy)	6 Months Ended
	Jun. 30, 2024
Disclosure Of Material Accounting Policies Descriptions [Line Items]
Basis of preparation	Basis of preparation The consolidated UBS Accounting Standards prepared in accordance with IAS 34, Interim Financial Reporting . In preparing been applied as in the 2023, except for the changes described in this Note and changes interim consolidated financial statements in of this report. In the opinion of management, all necessary adjustments the Group’s financial position, results of
Critical accounting estimates and judgments	Preparation of these interim financial statements requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, income, expenses and disclosures of contingent assets and liabilities. These estimates and assumptions are based on the best available information. Actual results in the future could differ from such estimates and differences may be material to the financial statements. Revisions to estimates, based on regular reviews, are recognized in the period in which they occur. For more information about areas of estimation uncertainty that are considered to require critical judgment, refer to “Note 1a Material accounting policies” in the “Consolidated financial statements” section of the UBS Group Annual Report 2023.

Basis of accounting (Tables)

Basis of accounting (Tables)	6 Months Ended
	Jun. 30, 2024
Foreign Exchange Rates [Line Items]
Currency translation rates	Closing exchange rate Average rate 1 As of For the quarter ended Year-to-date 30.6.24 31.3.24 31.12.23 30.6.23 30.6.24 31.3.24 30.6.23 30.6.24 30.6.23 1 CHF 1.11 1.11 1.19 1.12 1.10 1.13 1.11 1.12 1.11 1 EUR 1.07 1.08 1.10 1.09 1.07 1.08 1.09 1.08 1.09 1 GBP 1.26 1.26 1.28 1.27 1.26 1.26 1.27 1.26 1.24 100 JPY 0.62 0.66 0.71 0.69 0.63 0.67 0.71 0.65 0.73 1 Monthly income statement items of operations with a functional currency other than the US dollar are three month-end rates, weighted according to the income and expense volumes of may deviate from the weighted average rates for the Group.

Accounting for the acquisitio_2

Accounting for the acquisition of Credit Suisse Group (Tables)	6 Months Ended
	Jun. 30, 2024
Disclosure Of Business Combinations [Line items]
Recognized amounts of indetifiable assets acquited and liabilities assumed	USD m Purchase price consideration, after consideration of share-based compensation awards 3,710 Credit Suisse Group net identifiable assets on the acquisition Assets As previously reported in the Annual Report 2023 Measurement period adjustment Revised Cash and balances at central banks 93,012 (89) 92,923 Amounts due from banks 13,590 (15) 13,575 Receivables from securities financing transactions measured at amortized 26,194 26,194 Cash collateral receivables on derivative instruments 20,878 20,878 Loans and advances to customers 247,219 (175) 247,044 Other financial assets measured at amortized cost 13,428 (43) 13,385 Total financial assets measured at amortized cost 414,322 (322) 414,000 Financial assets at fair value held for trading 56,237 56,237 Derivative financial instruments 62,162 62,162 Brokerage receivables 366 366 Financial assets at fair value not held for trading 54,199 54,199 Total financial assets measured at fair value through profit or loss 172,964 172,964 Financial assets measured at fair value through other comprehensive income 0 0 Investments in associates 1,569 1,569 Property, equipment and software 6,055 6,055 Intangible assets 1,287 1,287 Deferred tax assets 998 998 Other non-financial assets 6,892 6,892 Total assets 604,088 (322) 603,766 Liabilities Amounts due to banks 107,617 107,617 Payables from securities financing transactions measured at amortized cost 11,911 11,911 Cash collateral payables on derivative instruments 10,939 10,939 Customer deposits 183,119 183,119 Debt issued measured at amortized cost 110,491 110,491 Other financial liabilities measured at amortized cost 7,992 7,992 Total financial liabilities measured at amortized cost 432,070 432,070 Financial liabilities at fair value held for trading 5,711 5,711 Derivative financial instruments 67,782 67,782 Brokerage payables designated at fair value 316 316 Debt issued designated at fair value 44,909 44,909 Other financial liabilities designated at fair value 7,574 7,574 Total financial liabilities measured at fair value through profit or loss 126,292 126,292 Provisions and contingent liabilities 9,945 161 10,106 Other non-financial liabilities 3,901 3,901 Total liabilities 572,209 161 572,370 Non-controlling interests (285) (285) Fair value of net assets acquired 31,594 (483) 31,110 Settlement of pre-existing relationships 135 135 Negative goodwill resulting from the acquisition 27,748 (483) 27,264
Effect of the measurement period adjustments on the Income statement	Effect of the measurement period adjustments on the income statement for the six-month period and the quarter ended 30 June 2023 For the six-month period ended 30 June 2023 For the quarter ended 30 June 2023 USD m Including measurement period adjustments made in the third quarter 2023 Measurement period adjustment made in the Annual Report 2023 Measurement period adjustments made in the second quarter 2024 Revised As previously reported in the third quarter 2023 report Measurement period adjustment made in the Annual Report 2023 Measurement period adjustments made in the second quarter 2024 Revised Net interest income 3,095 3,095 1,707 1,707 Other net income from financial instruments measured at fair value through profit or loss 5,198 5,198 2,517 2,517 Fee and commission income 10,688 10,688 5,635 5,635 Fee and commission expense (954) (954) (507) (507) Net fee and commission income 9,734 9,734 5,128 5,128 Other income 258 258 188 188 Total revenues 18,284 18,284 9,540 9,540 Negative goodwill 28,925 (1,177) (483) 27,264 28,925 (1,177) (483) 27,264 Credit loss expense / (release) 662 662 623 623 Operating expenses 15,696 15,696 8,486 8,486 Operating profit / (loss) before tax 30,852 (1,177) (483) 29,191 29,356 (1,177) (483) 27,695 Tax expense / (benefit) 820 820 361 361 Net profit / (loss) 30,032 (1,177) (483) 28,371 28,995 (1,177) (483) 27,334 Net profit / (loss) attributable to non-controlling interests 11 11 3 3 Net profit / (loss) attributable to shareholders 30,021 (1,177) (483) 28,360 28,992 (1,177) (483) 27,331
Effect of the measurement period adjustments on the balance sheet	Effect of the measurement period adjustments on the balance sheet as of 31 March 2024 and 31 December 2023 USD m As of 31 March 2024 As of 31 December 2023 Assets As previously reported in the first quarter 2024 report Measurement period adjustment made in the second quarter 2024 Revised As previously reported in the first quarter 2024 report Measurement period adjustment made in the second quarter 2024 Revised Total financial assets measured at amortized cost 1,110,067 (322) 1,109,745 1,189,773 (322) 1,189,451 of which: Cash and balances at central banks 271,527 (89) 271,439 314,148 (89) 314,060 of which: Amounts due from banks 22,143 (15) 22,128 21,161 (15) 21,146 of which: Loans and advances to customers 605,283 (175) 605,108 639,844 (175) 639,669 of which: Other financial assets measured at amortized cost 62,750 (43) 62,707 65,498 (43) 65,455 Total assets 1,607,120 (322) 1,606,798 1,717,246 (322) 1,716,924 Liabilities Provisions and contingent liabilities 10,914 161 11,076 12,250 161 12,412 Total liabilities 1,521,354 161 1,521,515 1,630,607 161 1,630,769 Equity Equity attributable to shareholders 85,260 (483) 84,777 86,108 (483) 85,624 of which: Retained earnings 76,436 (483) 75,952 74,880 (483) 74,397 Total equity 85,766 (483) 85,283 86,639 (483) 86,156 Total liabilities and equity 1,607,120 (322) 1,606,798 1,717,246 (322) 1,716,924
Effect of the measurement period adjustments on the statement of cash flows	Effect of the measurement period adjustments on the statement of cash flows for the six-month period ended 30 June 2023 For the six-month period ended 30 June 2023 USD m As previously reported in the third quarter 2023 report Cumulative measurement period adjustment Revised Cash flow from / (used in) operating activities Net profit / (loss) 30,032 (1,661) 28,371 of which: Negative goodwill (28,925) 1,661 (27,264) Net cash flow from / (used in) operating activities 17,665 17,665 of which: Loans and advances to customers and customer deposits 1,542 714 2,256 of which: Financial assets and liabilities at fair value held for trading (7,050) 1,268 (5,782) of which: Financial assets at fair value not held for trading and other financial 6,015 (1,982) 4,033 Net cash flow from / (used in) investing activities 104,869 (104) 104,765 of which: Cash and cash equivalents acquired upon acquisition of 108,510 (104) 108,406 Net cash flow from / (used in) financing activities (25,056) (25,056) Total cash flow Cash and cash equivalents at the beginning of the period 195,321 195,321 Net cash flow from / (used in) operating, investing and financing activities 97,478 (104) 97,374 Effects of exchange rate differences on cash and cash equivalents 2,960 2,960 Cash and cash equivalents at the end of the period 295,759 (104) 295,656 of which: cash and balances at central banks 261,504 (89) 261,415 of which: amounts due from banks 21,996 (15) 21,981 of which: money market paper 12,259 12,259

Segment reporting (Tables)

Segment reporting (Tables)	6 Months Ended
	Jun. 30, 2024
Disclosure Of Operating Segments [Line Items]
Disclosure Of Operating Segments Explanatory	USD m Global Wealth Management Personal & Corporate Banking Asset Management Investment Bank Non-core and Legacy Group Items UBS Group For the six months ended 30 June 2024 1 Total revenues 12,196 4,695 1,543 5,554 1,402 (747) 24,642 Credit loss expense / (release) (4) 146 0 26 35 (2) 201 Operating expenses 10,228 2,800 1,303 4,496 1,818 (48) 20,597 Operating profit / (loss) before tax 1,972 1,748 241 1,032 (451) (699) 3,844 Tax expense / (benefit) 905 Net profit / (loss) 2,939 As of 30 June 2024 Total assets 557,716 450,835 22,439 419,978 96,574 13,435 1,560,976 USD m Global Wealth Management Personal & Corporate Banking Asset Management Investment Bank Non-core and Legacy Group Items Negative goodwill 2 UBS Group For the six months ended 30 June 2023 1 Total revenues 10,049 3,087 1,086 4,401 185 (524) 18,284 Negative goodwill 27,264 27,264 Credit loss expense / (release) 164 237 1 139 119 2 662 Operating expenses 7,646 1,597 911 3,891 1,235 416 15,696 Operating profit / (loss) before tax 2,239 1,253 174 372 (1,169) (942) 27,264 29,191 Tax expense / (benefit) 820 Net profit / (loss) 28,371 As of 31 December 2023 2, 3 Total assets 567,648 483,794 21,804 428,269 201,131 14,277 1,716,924 1 Refer to “Note 3 Segment reporting” in the “Consolidated financial statements” section of has been revised. Refer to Note 2 for more information.

Net interest income (Tables)

Net interest income (Tables)	6 Months Ended
	Jun. 30, 2024
Disclosure Net Interest Income [Line Items]
Net interest income	For the quarter ended Year-to-date USD m 30.6.24 31.3.24 30.6.23 1 30.6.24 30.6.23 1 Interest income from loans and deposits 2 8,403 9,089 6,143 17,492 10,250 Interest income from securities financing transactions measured 3 1,136 1,217 1,004 2,354 1,769 Interest income from other financial instruments measured 328 347 282 675 540 Interest income from debt instruments measured at fair 26 27 26 54 48 Interest income from derivative instruments designated as cash (574) (602) (457) (1,175) (833) Total interest income from financial instruments measured at amortized cost and fair income 9,320 10,078 6,998 19,399 11,775 Interest expense on loans and deposits 4 5,074 5,439 3,024 10,513 5,018 Interest expense on securities financing transactions measured 5 541 495 616 1,035 981 Interest expense on debt issued 3,655 3,740 2,205 7,395 3,635 Interest expense on lease liabilities 49 50 35 99 61 Total interest expense from financial instruments measured at amortized cost 9,319 9,724 5,880 19,042 9,695 Total net interest income from financial instruments measured at amortized cost and fair income 2 355 1,117 357 2,080 Net interest income from financial instruments measured at fair value through profit 1,533 1,585 589 3,118 1,015 Total net interest income 1,535 1,940 1,707 3,475 3,095 1 Comparative-period information receivables on derivative instruments, as well as negative interest on amounts due to banks, customer deposits, and cash collateral payables on derivative instruments. securities financing transactions and negative interest, including instruments, and customer deposits, as well as negative interest on cash and balances on payables from securities financing transactions and negative interest, including fees,

Net fee and commission income (

Net fee and commission income (Tables)	6 Months Ended
	Jun. 30, 2024
Net fee And Commission Income [Line Items]
Net fee and commission income	For the quarter ended Year-to-date USD m 30.6.24 31.3.24 30.6.23 1 30.6.24 30.6.23 1 Underwriting fees 233 194 153 427 280 M&A and corporate finance fees 272 259 199 530 378 Brokerage fees 1,144 1,150 930 2,295 1,809 Investment fund fees 1,401 1,257 1,196 2,658 2,374 Portfolio management and related services 3,071 3,051 2,485 6,121 4,695 Other 1,090 1,169 672 2,259 1,151 Total fee and commission income 2 7,211 7,080 5,635 14,291 10,688 of which: recurring 4,484 4,407 3,789 8,891 7,201 of which: transaction-based 2,697 2,641 1,836 5,338 3,452 of which: performance-based 30 32 10 62 34 Fee and commission expense 679 588 507 1,268 954 Net fee and commission income 6,531 6,492 5,128 13,023 9,734 1 Comparative-period 4,011 m for Global Management (first 3,986 m; second 3,333 m), USD 876 m for 708 m; second 554 m), USD 924 m for Asset Management 941 m; second quarter of 753 m), USD 1,322 m for the Investment 1,332 m; second quarter of 851 m), USD 125 m for Non-core and Legacy (first quarter of 2024: USD 108 m; second quarter of 2023: USD 70 m) and negative USD 47 m for Group Items (first quarter of 2024: USD 5 m; second quarter of 2023: USD 74 m). Comparative-period information has been restated for changes in business division perimeters, Group Treasury

Other income (Tables)

Other income (Tables)	6 Months Ended
	Jun. 30, 2024
Other Income Tables [Line Items]
Disclosure Of Other Operating Income Tables Explanatory	For the quarter ended Year-to-date USD m 30.6.24 31.3.24 30.6.23 30.6.24 30.6.23 Associates, joint ventures and subsidiaries Net gains / (losses) from acquisitions and disposals of 1 (2) (1) 4 (3) 6 Net gains / (losses) from disposals of investments in associates 2 (2) 0 0 0 Share of net profits of associates and joint ventures 52 58 27 110 36 Total 52 55 31 107 43 Income from properties 2 15 14 9 29 13 Net gains / (losses) from properties held for sale (2) (1) 0 (4) 0 Other 89 56 148 145 203 Total other income 154 124 188 278 258 1 Includes foreign exchange gains / (losses) reclassified from other comprehensive income related to the disposal or closure of foreign operations.

Personnel expenses (Tables)

Personnel expenses (Tables)	6 Months Ended
	Jun. 30, 2024
Personnel Expenses [Line Items]
Personnel expenses	For the quarter ended Year-to-date USD m 30.6.24 31.3.24 30.6.23 30.6.24 30.6.23 Salaries and variable compensation 1 6,058 5,863 4,804 11,922 8,689 of which: variable compensation – financial advisors 2 1,291 1,267 1,110 2,558 2,222 Contractors 82 86 77 168 147 Social security 419 409 294 828 572 Post-employment benefit plans 309 367 261 676 497 Other personnel expenses 251 225 215 476 366 Total personnel expenses 7,119 6,949 5,651 14,068 10,271 1 Includes role-based compensation commitments with financial advisors entered into at the time of recruitment that are subject to vesting requirements.

General and administrative ex_2

General and administrative expenses (Tables)	6 Months Ended
	Jun. 30, 2024
General And Administrative Expenses [Line Items]
General and administrative expenses	For the quarter ended Year-to-date USD m 30.6.24 31.3.24 30.6.23 30.6.24 30.6.23 Outsourcing costs 463 423 311 886 559 Technology costs 567 588 414 1,154 735 Consulting, legal and audit fees 394 403 351 797 532 Real estate and logistics costs 302 289 207 590 349 Market data services 188 199 151 387 264 Marketing and communication 137 115 89 251 140 Travel and entertainment 87 72 73 159 126 Litigation, regulatory and similar matters 1 (153) (5) 69 (158) 790 Other 334 330 304 665 536 Total general and administrative expenses 2,318 2,413 1,968 4,731 4,033 1 Reflects the net increase / (decrease) in provisions for litigation, regulatory and similar matters recognized in the income statement. Refer to Note 15b

Expected credit loss measurem_2

Expected credit loss measurement (Tables)	6 Months Ended
	Jun. 30, 2024
Disclosure Of Financial Assets [Line Item]
Credit loss expense recovery	Credit loss expense / (release) Performing positions Credit-impaired positions USD m Stages 1 and 2 Stage 3 Purchased Total For the quarter ended 30.6.24 Global Wealth Management (13) 12 0 (1) Personal & Corporate Banking (15) 132 (14) 103 Asset Management 0 0 0 0 Investment Bank 7 (14) 1 (6) Non-core and Legacy (1) 3 (2) (1) Group Items 0 0 0 0 Total (22) 132 (15) 95 For the quarter ended 31.3.24 Global Wealth Management (12) 7 2 (3) Personal & Corporate Banking (13) 64 (7) 44 Asset Management 0 0 0 0 Investment Bank 7 26 (1) 32 Non-core and Legacy (26) 37 25 36 Group Items (2) 0 0 (2) Total (45) 133 18 106 For the quarter ended 30.6.23 1 Global Wealth Management 134 9 7 149 Personal & Corporate Banking 193 28 0 221 Asset Management 1 0 0 1 Investment Bank 134 (4) 1 132 Non-core and Legacy 74 44 0 119 Group Items 2 0 0 2 Total 537 77 8 623 1 Comparative-period information UBS Group first quarter 2024 report, available under “Quarterly reporting” at ubs.com/investors,
Key macro economic variables	Comparison of shock factors Baseline Key parameters 2023 2024 2025 Real GDP growth (annual percentage change) US 2.5 2.3 1.4 Eurozone 0.6 0.6 1.2 Switzerland 0.7 1.3 1.5 Unemployment rate (%, annual average) US 3.6 4.0 4.2 Eurozone 6.6 6.6 6.8 Switzerland 2.0 2.4 2.6 Fixed income: 10-year government bonds (%, Q4) USD 3.9 4.3 4.2 EUR 2.0 2.5 2.4 CHF 0.7 0.6 0.6 Real estate (annual percentage change, Q4) US 5.2 3.7 2.3 Eurozone (1.0) 1.0 3.4 Switzerland 0.1 1.0 2.5 Economic scenarios and weights applied Assigned weights in % ECL scenario 30.6.24 31.3.24 30.6.23 Baseline 60.0 60.0 60.0 Mild debt crisis 15.0 15.0 15.0 Stagflationary geopolitical crisis 25.0 25.0 25.0
Credit risk exposure	USD m 30.6.24 Carrying amount 1 ECL allowances 2 Financial instruments measured at amortized cost Total Stage 1 Stage 2 Stage 3 PCI Total Stage 1 Stage 2 Stage 3 PCI Cash and balances at central banks 248,336 248,244 16 0 76 (60) (1) (27) 0 (32) Amounts due from banks 21,959 21,627 319 0 13 (28) (6) 0 0 (22) Receivables from securities financing transactions measured at amortized cost 82,028 82,028 0 0 0 (2) (2) 0 0 0 Cash collateral receivables on derivative instruments 43,637 43,637 0 0 0 0 0 0 0 0 Loans and advances to customers 599,105 569,476 25,249 3,287 1,093 (1,743) (355) (298) (937) (153) of which: Private clients with mortgages 252,724 241,499 10,077 1,062 86 (167) (57) (77) (30) (3) of which: Real estate financing 86,854 82,018 4,507 243 86 (53) (28) (31) (2) 8 of which: Large corporate clients 28,773 23,888 3,829 700 357 (526) (93) (94) (272) (67) of which: SME clients 23,406 19,585 2,531 1,049 241 (515) (60) (38) (414) (3) of which: Lombard 148,268 147,272 875 54 66 (41) (6) (2) (16) (16) of which: Credit cards 1,927 1,479 408 40 0 (41) (6) (11) (25) 0 of which: Commodity trade finance 5,792 5,556 222 11 2 (125) (19) (2) (104) 0 of which: Ship / aircraft financing 8,284 7,846 421 3 15 (44) (38) (4) 0 (2) of which: Consumer financing 2,902 2,703 119 39 41 (68) (20) (21) (27) 0 Other financial assets measured at amortized cost 60,431 59,710 533 171 16 (131) (34) (8) (84) (5) of which: Loans to financial advisors 2,601 2,408 83 110 0 (47) (4) (1) (41) 0 Total financial assets measured at amortized cost 1,055,494 1,024,721 26,117 3,458 1,198 (1,964) (397) (333) (1,021) (212) Financial assets measured at fair value through other comprehensive income 2,167 2,167 0 0 0 0 0 0 0 0 Total on-balance sheet financial assets in scope of ECL requirements 1,057,661 1,026,888 26,117 3,458 1,198 (1,964) (397) (333) (1,021) (212) Total exposure ECL provisions 2 Off-balance sheet (in scope of ECL) Total Stage 1 Stage 2 Stage 3 PCI Total Stage 1 Stage 2 Stage 3 PCI Guarantees 40,759 39,176 1,382 159 44 (63) (25) (14) (26) 2 of which: Large corporate clients 8,290 7,390 820 67 15 (24) (10) (8) (7) 0 of which: SME clients 2,540 2,153 287 77 22 (10) (5) (3) (4) 2 of which: Financial intermediaries and hedge funds 21,270 21,080 189 0 0 (11) (8) (3) 0 0 of which: Lombard 3,895 3,872 10 13 0 (4) 0 0 (4) 0 of which: Commodity trade finance 1,642 1,628 13 0 0 (1) (1) 0 0 0 Irrevocable loan commitments 81,867 77,447 4,236 145 39 (147) (104) (43) (6) 6 of which: Large corporate clients 46,697 42,890 3,699 73 34 (126) (84) (36) (6) 0 Forward starting reverse repurchase and securities borrowing agreements 9,724 9,724 0 0 0 0 0 0 0 0 Unconditionally revocable loan commitments 148,932 146,532 2,154 245 0 (81) (69) (12) 0 0 of which: Real estate financing 11,705 11,154 552 0 0 (7) (7) 0 0 0 of which: Large corporate clients 16,000 15,677 314 9 0 (23) (16) (4) (2) 0 of which: SME clients 11,002 10,575 346 80 0 (34) (29) (5) 0 0 of which: Lombard 60,962 60,934 26 1 0 0 0 0 0 0 of which: Credit cards 10,056 9,576 477 4 0 (8) (6) (2) 0 0 Irrevocable committed prolongation of existing loans 3,329 3,319 7 2 0 (2) (2) 0 0 0 Total off-balance sheet financial instruments and other credit lines 284,611 276,199 7,779 551 83 (294) (200) (70) (31) 8 Total allowances and provisions (2,258) (597) (404) (1,053) (204) 1 The carrying amount of financial assets measured at amortized cost represents the total gross exposure net of the respective credit quality since the acquisition of the respective financial instrument, which is reflected as a negative ECL allowance. USD m 31.3.24 Carrying amount 1,2 ECL allowances 3 Financial instruments measured at amortized cost Total Stage 1 Stage 2 Stage 3 PCI Total Stage 1 Stage 2 Stage 3 PCI Cash and balances at central banks 271,439 271,378 17 0 43 (55) 0 (25) 0 (30) Amounts due from banks 22,128 22,027 65 0 36 (24) (6) 0 0 (18) Receivables from securities financing transactions measured at amortized cost 101,650 101,650 0 0 0 (2) (2) 0 0 0 Cash collateral receivables on derivative instruments 46,714 46,714 0 0 0 0 0 0 0 0 Loans and advances to customers 605,108 571,400 28,773 3,742 1,194 (1,700) (362) (284) (920) (134) of which: Private clients with mortgages 251,891 239,416 11,319 923 233 (196) (55) (92) (39) (10) of which: Real estate financing 90,220 84,485 5,444 179 111 (64) (27) (28) (9) 0 of which: Large corporate clients 29,008 23,954 3,917 689 447 (580) (91) (83) (318) (87) of which: SME clients 24,276 20,506 2,745 951 74 (442) (64) (32) (335) (11) of which: Lombard 150,759 149,153 931 549 126 (61) (7) (1) (41) (12) of which: Credit cards 1,840 1,402 399 38 0 (40) (6) (10) (23) 0 of which: Commodity trade finance 5,358 5,169 165 11 12 (123) (17) (2) (104) 0 of which: Ship / aircraft financing 8,777 7,998 776 3 0 (47) (40) (7) 0 0 of which: Consumer financing 2,912 2,629 199 35 49 (64) (20) (19) (24) 0 Other financial assets measured at amortized cost 62,707 61,945 574 166 22 (134) (35) (9) (83) (6) of which: Loans to financial advisors 2,615 2,430 70 115 0 (49) (6) (1) (43) 0 Total financial assets measured at amortized cost 1,109,745 1,075,113 29,428 3,908 1,296 (1,915) (405) (318) (1,003) (189) Financial assets measured at fair value through other comprehensive income 2,078 2,078 0 0 0 0 0 0 0 0 Total on-balance sheet financial assets in scope of ECL requirements 1,111,823 1,077,191 29,428 3,908 1,296 (1,915) (405) (318) (1,003) (189) Total exposure ECL provisions 3 Off-balance sheet (in scope of ECL) Total Stage 1 Stage 2 Stage 3 PCI Total Stage 1 Stage 2 Stage 3 PCI Guarantees 41,744 40,211 1,314 173 45 (64) (27) (18) (19) 1 of which: Large corporate clients 8,643 7,710 841 78 14 (25) (10) (11) (4) 0 of which: SME clients 2,670 2,274 286 86 23 (9) (4) (3) (2) 1 of which: Financial intermediaries and hedge funds 20,920 20,865 55 0 0 (11) (8) (3) 0 0 of which: Lombard 3,959 3,947 6 5 0 (7) 0 0 (7) 0 of which: Commodity trade finance 2,088 2,077 11 0 0 (1) (1) 0 0 0 Irrevocable loan commitments 87,292 82,700 4,335 230 27 (173) (112) (54) (13) 6 of which: Large corporate clients 48,060 44,281 3,682 77 21 (152) (93) (47) (13) 0 Forward starting reverse repurchase and securities borrowing agreements 17,649 17,649 0 0 0 0 0 0 0 0 Unconditionally revocable loan commitments 150,918 148,116 2,616 186 0 (89) (73) (15) 0 0 of which: Real estate financing 12,318 11,616 703 0 0 (10) (10) 0 0 0 of which: Large corporate clients 16,793 16,422 358 12 0 (25) (18) (7) 0 0 of which: SME clients 10,548 10,205 313 30 0 (36) (31) (5) 0 0 of which: Lombard 61,036 60,901 133 1 0 0 0 0 0 0 of which: Credit cards 10,049 9,560 485 4 0 (9) (8) (2) 0 0 Irrevocable committed prolongation of existing loans 3,719 3,709 7 3 0 (3) (3) 0 0 0 Total off-balance sheet financial instruments and other credit lines 301,322 292,385 8,271 593 72 (328) (215) (88) (32) 7 Total allowances and provisions (2,243) (620) (406) (1,035) (182) 1 The carrying amount of financial assets measured at amortized cost represents the total gross exposure net of the respective ECL allowances. 3 Negative balances are representative of a net improvement in credit quality since the acquisition of the respective financial instrument, which is reflected USD m 31.12.23 Carrying amount 1 ECL allowances 2 Financial instruments measured at amortized cost Total Stage 1 Stage 2 Stage 3 PCI Total Stage 1 Stage 2 Stage 3 PCI Cash and balances at central banks 314,060 314,025 18 0 18 (48) 0 (26) 0 (22) Amounts due from banks 21,146 21,092 17 0 38 (12) (6) (1) 0 (5) Receivables from securities financing transactions measured at amortized cost 99,039 99,039 0 0 0 (2) (2) 0 0 0 Cash collateral receivables on derivative instruments 50,082 50,082 0 0 0 0 0 0 0 0 Loans and advances to customers 639,669 610,922 24,408 2,869 1,470 (1,698) (423) (289) (862) (123) of which: Private clients with mortgages 268,616 256,614 10,695 929 378 (209) (62) (97) (39) (11) of which: Real estate financing 97,817 92,084 5,367 270 97 (103) (41) (31) (21) (11) of which: Large corporate clients 30,084 25,671 3,182 700 532 (575) (105) (70) (312) (89) of which: SME clients 25,957 22,155 2,919 754 129 (402) (71) (42) (277) (13) of which: Lombard 156,353 156,299 3 50 0 (41) (13) (11) (17) 0 of which: Credit cards 2,041 1,564 438 39 0 (42) (6) (11) (24) 0 of which: Commodity trade finance 5,727 5,662 25 22 18 (130) (18) (1) (111) 0 of which: Ship / aircraft financing 9,214 8,920 273 4 17 (51) (48) (3) 0 (1) of which: Consumer financing 2,982 2,795 92 38 57 (59) (22) (17) (20) 0 Other financial assets measured at amortized cost 65,455 64,268 968 158 61 (151) (41) (10) (94) (5) of which: Loans to financial advisors 2,615 2,422 79 114 0 (49) (4) (1) (44) 0 Total financial assets measured at amortized cost 1,189,451 1,159,428 25,410 3,027 1,587 (1,911) (473) (326) (956) (156) Financial assets measured at fair value through other comprehensive income 2,233 2,233 0 0 0 0 0 0 0 0 Total on-balance sheet financial assets in scope of ECL requirements 1,191,684 1,161,661 25,410 3,027 1,587 (1,911) (473) (326) (956) (156) Total exposure ECL provisions 2 Off-balance sheet (in scope of ECL) Total Stage 1 Stage 2 Stage 3 PCI Total Stage 1 Stage 2 Stage 3 PCI Guarantees 46,191 44,487 1,495 151 58 (73) (28) (22) (23) 0 of which: Large corporate clients 9,267 8,138 1,023 89 17 (31) (11) (13) (7) 0 of which: SME clients 2,839 2,469 337 31 2 (14) (4) (5) (5) 0 of which: Financial intermediaries and hedge funds 22,922 22,876 46 0 0 (12) (8) (3) 0 0 of which: Lombard 5,045 5,045 0 0 0 (1) 0 0 (1) 0 of which: Commodity trade finance 2,037 2,027 9 0 0 (1) (1) 0 0 0 Irrevocable loan commitments 91,643 87,080 4,297 218 48 (178) (117) (51) (14) 4 of which: Large corporate clients 50,696 46,708 3,881 59 48 (149) (94) (41) (12) (2) Forward starting reverse repurchase and securities borrowing agreements 18,444 18,444 0 0 0 0 0 0 0 0 Unconditionally revocable loan commitments 163,256 160,456 2,654 146 0 (95) (78) (17) 0 0 of which: Real estate financing 15,846 15,033 813 0 0 (14) (11) (3) 0 0 of which: Large corporate clients 17,139 16,678 454 8 0 (23) (17) (6) 0 0 of which: SME clients 11,658 11,253 375 29 0 (38) (33) (5) 0 0 of which: Lombard 77,618 77,618 0 1 0 0 0 0 0 0 of which: Credit cards 10,458 9,932 522 4 0 (10) (8) (2) 0 0 Irrevocable committed prolongation of existing loans 4,608 4,593 11 4 0 (4) (4) 0 0 0 Total off-balance sheet financial instruments and other credit lines 324,141 315,060 8,456 519 106 (350) (226) (90) (37) 3 Total allowances and provisions (2,261) (700) (416) (993) (153) 1 The carrying amount of financial assets measured at amortized cost represents the total gross exposure net of the respective ECL allowances. quality since the acquisition of the respective financial instrument, which is reflected as a negative ECL allowance.
Coverage ratios	Coverage ratios for core loan portfolio 30.6.24 Gross carrying amount (USD m) ECL coverage (bps) On-balance sheet Total Stage 1 Stage 2 Stage 3 PCI Total Stage 1 Stage 2 Stage 1&2 Stage 3 PCI Private clients with mortgages 252,892 241,557 10,154 1,092 89 7 2 76 5 272 337 Real estate financing 86,907 82,045 4,538 245 78 6 3 69 7 72 0 Total real estate lending 339,798 323,602 14,692 1,337 167 6 3 74 6 235 0 Large corporate clients 29,299 23,981 3,923 972 424 180 39 240 67 2,798 1,580 SME clients 23,922 19,646 2,569 1,463 244 215 31 146 44 2,831 123 Total corporate lending 53,221 43,627 6,491 2,435 668 196 35 203 57 2,818 1,048 Lombard 148,308 147,278 877 71 82 3 0 23 1 2,328 1,951 Credit cards 1,968 1,485 419 64 0 208 39 252 86 3,826 0 Commodity trade finance 5,917 5,575 224 115 2 211 33 92 36 9,037 0 Ship / aircraft financing 8,329 7,883 426 3 17 53 48 103 51 0 1,176 Consumer financing 2,970 2,723 140 66 41 229 73 1,500 143 4,091 0 Other loans and advances to customers 40,339 37,661 2,277 131 270 41 8 80 12 3,532 2,630 Loans to financial advisors 2,647 2,412 84 151 0 176 18 146 22 2,736 0 Total other lending 210,478 205,018 4,447 601 412 25 6 134 9 4,323 2,160 Total 1 603,497 572,247 25,631 4,372 1,247 30 6 117 11 2,235 1,236 Gross exposure (USD m) ECL coverage (bps) Off-balance sheet Total Stage 1 Stage 2 Stage 3 PCI Total Stage 1 Stage 2 Stage 1&2 Stage 3 PCI Private clients with mortgages 8,091 7,834 226 31 0 4 4 23 4 11 0 Real estate financing 12,715 12,143 572 0 0 5 6 0 5 0 0 Total real estate lending 20,805 19,977 798 31 0 5 5 0 5 11 0 Large corporate clients 71,060 66,029 4,833 149 49 24 17 100 22 987 0 SME clients 15,352 14,421 720 189 22 33 27 207 36 197 0 Total corporate lending 86,412 80,450 5,553 338 71 26 19 114 25 546 0 Lombard 68,071 68,017 40 14 0 1 0 0 0 2,887 0 Credit cards 10,056 9,576 477 4 0 8 7 35 8 0 0 Commodity trade finance 3,732 3,712 20 0 0 7 7 13 7 0 0 Ship / aircraft financing 1,836 1,817 19 0 0 11 11 0 11 0 0 Consumer financing 152 152 0 0 0 0 0 0 0 0 0 Financial intermediaries and hedge funds 46,338 45,878 461 0 0 3 2 74 3 0 0 Other off-balance sheet commitments 37,485 36,897 411 163 13 7 4 55 4 538 0 Total other lending 167,670 166,049 1,427 181 13 3 2 52 3 710 0 Total 2 274,888 266,475 7,778 550 84 11 7 90 10 570 0 Total on- and off-balance sheet 3 878,385 838,722 33,409 4,923 1,331 24 7 111 11 2,049 1,202 1 Includes Loans and advances repurchase and securities borrowing agreements. Coverage ratios for core loan portfolio 31.3.24 Gross carrying amount (USD m) ECL coverage (bps) On-balance sheet Total Stage 1 Stage 2 Stage 3 PCI Total Stage 1 Stage 2 Stage 1&2 Stage 3 PCI Private clients with mortgages 252,087 239,471 11,412 962 243 8 2 81 6 406 395 Real estate financing 90,284 84,512 5,472 188 111 7 3 50 6 493 0 Total real estate lending 342,372 323,984 16,884 1,150 354 8 3 71 6 420 270 Large corporate clients 29,587 24,045 4,001 1,008 534 196 38 208 62 3,160 1,632 SME clients 24,718 20,570 2,777 1,286 85 179 31 114 41 2,602 1,305 Total corporate lending 54,305 44,615 6,777 2,293 619 188 35 169 53 2,847 1,587 Lombard 150,820 149,160 932 590 138 4 0 10 1 699 840 Credit cards 1,879 1,408 410 61 0 211 41 256 89 3,802 0 Commodity trade finance 5,481 5,186 168 115 12 224 32 144 35 9,044 0 Ship / aircraft financing 8,823 8,038 782 3 0 53 50 84 53 0 0 Consumer financing 2,976 2,649 218 59 49 215 77 884 138 4,093 31 Other loans and advances to customers 40,152 36,721 2,886 389 156 21 9 31 11 657 939 Loans to financial advisors 2,664 2,435 71 157 0 186 23 160 27 2,716 0 Total other lending 212,796 205,598 5,466 1,375 356 22 6 91 9 1,900 739 Total 1 609,472 574,198 29,127 4,819 1,328 29 6 98 11 1,998 1,009 Gross exposure (USD m) ECL coverage (bps) Off-balance sheet Total Stage 1 Stage 2 Stage 3 PCI Total Stage 1 Stage 2 Stage 1&2 Stage 3 PCI Private clients with mortgages 7,907 7,590 289 29 0 7 6 34 7 24 0 Real estate financing 13,652 12,919 732 0 0 7 8 0 7 0 0 Total real estate lending 21,559 20,509 1,021 29 0 7 7 4 7 23 0 Large corporate clients 73,534 68,451 4,881 168 35 28 18 133 25 995 0 SME clients 15,269 14,438 678 130 23 34 29 216 38 181 0 Total corporate lending 88,803 82,889 5,559 297 58 29 20 143 27 640 0 Lombard 68,645 68,477 161 7 0 1 0 1 0 9,921 0 Credit cards 10,049 9,560 485 4 0 9 8 34 9 0 0 Commodity trade finance 4,446 4,429 18 0 0 6 6 127 6 0 0 Ship / aircraft financing 1,643 1,643 0 0 0 13 12 0 13 0 0 Consumer financing 167 167 0 0 0 0 0 0 0 0 0 Financial intermediaries and hedge funds 48,923 48,619 304 0 0 3 2 114 3 0 0 Other off-balance sheet commitments 39,437 38,444 723 256 14 6 4 40 4 257 0 Total other lending 173,310 171,338 1,691 267 14 3 2 49 3 493 0 Total 2 283,672 274,736 8,271 593 72 12 8 106 11 543 0 Total on- and off-balance sheet 3,4 893,144 848,933 37,399 5,412 1,401 23 7 100 11 1,838 908 1 Includes Loans and advances to repurchase and securities borrowing agreements. Refer to Note 2 for more information. Coverage ratios for core loan portfolio 31.12.23 Gross carrying amount (USD m) ECL coverage (bps) On-balance sheet Total Stage 1 Stage 2 Stage 3 PCI Total Stage 1 Stage 2 Stage 1&2 Stage 3 PCI Private clients with mortgages 268,825 256,675 10,792 968 389 8 2 90 6 399 283 Real estate financing 97,920 92,124 5,398 290 108 11 4 57 7 713 980 Total real estate lending 366,745 348,800 16,190 1,258 497 9 3 79 6 472 434 Large corporate clients 30,660 25,775 3,252 1,012 620 188 41 215 60 3,083 1,429 SME clients 26,359 22,226 2,961 1,031 142 153 32 141 45 2,689 893 Total corporate lending 57,019 48,001 6,213 2,042 762 172 37 180 53 2,884 1,329 Lombard 156,394 156,312 15 67 0 3 1 7,616 2 2,487 0 Credit cards 2,083 1,571 449 63 0 200 40 253 87 3,801 0 Commodity trade finance 5,858 5,681 26 133 18 223 32 365 34 8,333 6 Ship / aircraft financing 9,265 8,968 276 4 17 56 54 99 55 0 315 Consumer financing 3,041 2,817 110 58 57 195 79 1,559 135 3,422 7 Other loans and advances to customers 40,961 39,196 1,419 105 242 21 10 39 11 3,981 0 Loans to financial advisors 2,665 2,426 80 159 0 185 17 122 20 2,793 0 Total other lending 220,267 216,971 2,373 589 334 21 7 210 9 4,376 9 Total 1 644,031 613,772 24,777 3,889 1,593 27 7 117 11 2,329 773 Gross exposure (USD m) ECL coverage (bps) Off-balance sheet Total Stage 1 Stage 2 Stage 3 PCI Total Stage 1 Stage 2 Stage 1&2 Stage 3 PCI Private clients with mortgages 9,782 9,505 261 15 0 6 5 27 6 40 0 Real estate financing 17,107 16,281 826 0 0 9 8 44 9 0 0 Total real estate lending 26,889 25,786 1,088 15 0 8 7 40 8 40 0 Large corporate clients 77,103 71,524 5,357 157 65 26 17 111 24 1,217 242 SME clients 16,762 15,868 812 80 2 40 29 196 37 640 0 Total corporate lending 93,865 87,392 6,170 236 67 29 19 122 26 1,022 221 Lombard 86,173 86,173 0 1 0 0 0 0 0 0 0 Credit cards 10,458 9,932 522 4 0 10 8 35 10 0 0 Commodity trade finance 4,640 4,628 13 0 0 6 5 151 6 0 0 Ship / aircraft financing 1,053 1,053 0 0 0 26 26 0 26 0 0 Consumer financing 153 153 0 0 0 0 0 0 0 0 0 Financial intermediaries and hedge funds 42,578 42,325 253 0 0 3 3 142 3 0 0 Other off-balance sheet commitments 39,887 39,174 411 263 39 7 4 111 5 453 0 Total other lending 184,944 183,438 1,199 268 39 3 2 85 3 486 0 Total 2 305,697 296,616 8,456 519 106 11 8 107 10 717 0 Total on- and off-balance sheet 3 949,729 910,388 33,233 4,408 1,699 22 7 114 11 2,140 706 1 Includes Loans and advances to repurchase and securities borrowing agreements.

Fair value measurement (Tables)

Fair value measurement (Tables)	6 Months Ended
	Jun. 30, 2024
Fair Value Measurement [Line Items]
Disclosure Of Fair Value Measurement Of Assets Explanatory	Determination of fair values from quoted market 1 30.6.24 31.3.24 31.12.23 USD m Level 1 Level 2 Level 3 Total Level 1 Level 2 Level 3 Total Level 1 Level 2 Level 3 Total Financial assets measured at fair value on a recurring basis Financial assets at fair value held for trading 124,602 29,381 8,042 162,025 116,980 30,734 12,390 160,104 118,975 28,045 22,613 169,633 of which: Equity instruments 112,416 827 185 113,429 103,929 344 247 104,520 102,602 1,403 321 104,325 of which: Government bills / bonds 5,603 5,319 75 10,997 5,972 6,652 35 12,659 6,995 8,763 73 15,830 of which: Investment fund units 5,677 1,222 240 7,139 6,022 1,943 234 8,198 8,392 1,124 129 9,645 of which: Corporate and municipal bonds 896 16,569 900 18,365 1,052 16,152 1,045 18,250 984 12,801 1,284 15,069 of which: Loans 0 5,246 6,419 11,666 0 5,499 10,606 16,105 0 3,837 19,618 23,456 of which: Asset-backed securities 10 192 169 370 4 139 119 262 3 112 133 248 Derivative financial instruments 836 136,437 2,325 139,597 1,146 155,710 2,373 159,229 622 172,903 2,559 176,084 of which: Foreign exchange 331 50,521 121 50,974 416 61,337 197 61,951 347 78,060 253 78,659 of which: Interest rate 0 48,437 403 48,840 0 52,144 402 52,546 0 55,190 407 55,597 of which: Equity / index 0 32,239 1,154 33,392 0 36,489 1,186 37,675 0 34,174 1,299 35,473 of which: Credit 0 2,553 478 3,031 0 2,590 434 3,024 0 3,456 513 3,969 of which: Commodities 3 2,563 16 2,582 7 3,001 2 3,011 1 1,869 13 1,883 Brokerage receivables 0 25,273 0 25,273 0 22,796 0 22,796 0 21,037 0 21,037 Financial assets at fair value not held for trading 34,766 80,555 7,945 123,266 31,065 59,843 8,704 99,612 30,717 64,865 8,435 104,018 of which: Financial assets for unit-linked investment contracts 16,957 6 0 16,963 16,458 25 0 16,482 15,877 7 0 15,884 of which: Corporate and municipal bonds 61 14,338 210 14,609 60 14,532 217 14,809 62 16,722 215 17,000 of which: Government bills / bonds 17,262 7,817 0 25,079 14,065 7,019 0 21,083 14,306 4,801 0 19,107 of which: Loans 0 3,699 2,553 6,252 0 3,710 2,167 5,878 0 4,252 2,258 6,510 of which: Securities financing transactions 0 53,069 268 53,337 0 32,840 98 32,938 0 36,857 52 36,909 of which: Asset-backed securities 0 1,108 500 1,608 0 1,169 500 1,668 0 1,525 180 1,704 of which: Auction rate securities 0 0 191 191 0 0 1,211 1,211 0 0 1,208 1,208 of which: Investment fund units 395 421 670 1,486 371 458 688 1,517 367 548 678 1,592 of which: Equity instruments 92 5 2,896 2,993 111 1 3,017 3,130 105 38 3,097 3,241 Financial assets measured at fair value through other comprehensive income on Financial assets measured at fair value through other comprehensive income 62 2,105 0 2,167 67 2,011 0 2,078 68 2,165 0 2,233 of which: Commercial paper and certificates of deposit 0 1,891 0 1,891 0 1,783 0 1,783 0 1,948 0 1,948 of which: Corporate and municipal bonds 62 205 0 267 67 179 0 246 68 207 0 276 Non-financial assets measured at fair value on a recurring basis Precious metals and other physical commodities 6,445 0 0 6,445 6,466 0 0 6,466 5,930 0 0 5,930 Non-financial assets measured at fair value on a non-recurring basis Other non-financial assets 2 0 0 43 43 0 0 35 35 0 0 31 31 Total assets measured at fair value 166,712 273,750 18,354 458,817 155,725 271,093 23,502 450,320 156,312 289,015 33,639 478,966
Disclosure Of Fair Value Measurement Of Liabilities Explanatory	Determination of fair values from quoted market 1 30.6.24 31.3.24 31.12.23 USD m Level 1 Level 2 Level 3 Total Level 1 Level 2 Level 3 Total Level 1 Level 2 Level 3 Total Financial liabilities measured at fair value on a recurring basis Financial liabilities at fair value held for trading 24,476 8,906 111 33,493 26,785 8,771 202 35,758 27,684 6,315 161 34,159 of which: Equity instruments 16,956 417 66 17,438 18,996 294 66 19,356 18,266 248 92 18,606 of which: Corporate and municipal bonds 33 7,118 35 7,186 34 6,966 132 7,132 28 4,981 62 5,071 of which: Government bills / bonds 6,171 1,260 5 7,437 6,596 1,232 0 7,828 8,559 905 0 9,464 of which: Investment fund units 1,315 38 4 1,357 1,159 216 3 1,378 832 118 4 954 Derivative financial instruments 876 143,744 4,448 149,069 967 156,208 5,867 163,042 771 185,815 5,595 192,181 of which: Foreign exchange 326 51,640 48 52,014 372 58,684 51 59,107 457 89,394 36 89,887 of which: Interest rate 0 47,021 243 47,264 0 49,966 307 50,273 0 52,673 246 52,920 of which: Equity / index 0 38,001 3,379 41,380 0 41,522 4,302 45,825 0 38,046 3,333 41,380 of which: Credit 0 3,456 371 3,827 0 3,205 525 3,731 0 4,081 619 4,700 of which: Commodities 2 1,951 14 1,967 3 2,618 20 2,642 0 1,437 21 1,458 of which: Loan commitments measured at FVTPL 3 0 1,547 288 1,835 0 127 555 682 0 135 1,037 1,172 Financial liabilities designated at fair value on a recurring basis Brokerage payables designated at fair value 0 46,198 0 46,198 0 46,628 0 46,628 0 42,522 0 42,522 Debt issued designated at fair value 0 100,223 12,986 113,209 0 102,823 13,983 116,806 0 113,012 15,276 128,289 Other financial liabilities designated at fair value 0 28,484 3,391 31,875 0 25,490 2,650 28,140 0 26,878 2,606 29,484 of which: Financial liabilities related to unit- linked investment contracts 0 17,080 0 17,080 0 16,612 0 16,612 0 15,992 0 15,992 of which: Securities financing transactions 0 7,699 0 7,699 0 5,121 0 5,121 0 7,416 0 7,416 of which: Over-the-counter debt instruments and others 0 3,705 3,391 7,096 0 3,757 2,650 6,407 0 3,471 2,606 6,076 Total liabilities measured at fair value 25,352 327,555 20,936 373,844 27,752 339,920 22,703 390,374 28,454 374,542 23,638 426,635 1 Bifurcated embedded derivatives are presented on the same balance sheet 2 Other non-financial assets primarily consist of properties and of 30 June 2024 also includes UBS’s funding obligation arising from the offer by the Credit Suisse supply chain finance funds to redeem the outstanding units which was note 15).
Disclosure Of Deferred Day-One Profit Or Loss Explanatory	Deferred day-1 profit or loss reserves For the quarter ended Year-to-date USD m 30.6.24 31.3.24 30.6.23 30.6.24 30.6.23 Reserve balance at the beginning of the period 384 404 399 404 422 Profit / (loss) deferred on new transactions 59 42 78 101 169 (Profit) / loss recognized in the income statement (55) (62) (75) (116) (188) Foreign currency translation (1) 0 (1) (1) (1) Reserve balance at the end of the period 388 384 402 388 402
Disclosure Of Valuation Adjustment Reserves On The Balance Sheet Explanatory	Other valuation adjustment reserves on the As of USD m 30.6.24 31.3.24 31.12.23 Own credit adjustments on financial liabilities designated at fair value 1 (1,062) (1,315) (1,287) of which: debt issued designated at fair value (1,085) (1,334) (1,297) of which: other financial liabilities designated at fair value 23 19 10 Credit valuation adjustments 2 (104) (118) (145) Funding and debit valuation adjustments (81) (107) (116) Other valuation adjustments (1,745) (2,135) (2,654) of which: liquidity (1,230) (1,588) (2,051) of which: model uncertainty (516) (547) (603) 1 Own credit adjustments on financial liabilities designated at fair value includes amounts for TLAC notes.
Disclosure Of Significant Unobservable Inputs Used In Fair Value Measurement Of Assets And Liabilities Explanatory	Valuation techniques and inputs Fair value Significant unobservable input(s) 1 Range of inputs Assets Liabilities Valuation technique(s) 30.6.24 31.12.23 USD bn 30.6.24 31.12.23 30.6.24 31.12.23 low high weighted average 2 low high weighted average 2 unit 1 Financial assets and liabilities at fair value held for Corporate and municipal bonds 1.1 1.5 0.0 0.1 Relative value to market comparable Bond price equivalent 19 126 95 5 126 99 points Discounted expected cash flows Discount margin 243 3,055 687 135 491 463 basis points Traded loans, designated at fair value and guarantees 9.3 22.0 0.0 0.0 Relative value to market comparable Loan price equivalent 1 114 74 1 120 88 points Discounted expected cash flows Credit spread 19 1,779 367 19 2,681 614 basis points Investment fund units 3 0.9 0.8 0.0 0.0 Relative value to market comparable Net asset value Equity instruments 3 3.1 3.4 0.1 0.1 Relative value to market comparable Price Debt issued designated at fair value 4 13.0 15.3 Other financial liabilities designated at fair value 3.4 2.6 Discounted expected cash flows Funding spread 106 201 51 201 basis points Derivative financial instruments Interest rate 0.4 0.4 0.2 0.2 Option model Volatility of interest rates 48 149 45 154 basis points Volatility of inflation 1 6 1 6 % IR-to-IR correlation 71 99 4 100 % Credit 0.5 0.5 0.4 0.6 Discounted expected cash flows Credit spreads 3 2,967 1 2,421 basis points Credit correlation 50 66 50 66 % Credit volatility 60 60 60 60 % Recovery rates 0 100 14 100 % Equity / index 1.2 1.3 3.4 3.3 Option model Equity dividend yields 0 19 0 17 % Volatility of equity stocks, equity and other indices 4 135 4 142 % Equity-to-FX correlation (40) 77 (40) 77 % Equity-to-equity correlation 10 100 (50) 100 % Loan commitments measured at FVTPL 0.3 1.0 Relative value to market comparable Loan price equivalent 15 100 35 102 points 1 The ranges of significant unobservable inputs are represented in points, percentages and basis points. most non-derivative financial instruments and were calculated designated at fair value 4 Debt issued designated at fair value primarily consists of UBS structured notes, which include variable maturity notes with various equity and foreign exchange underlying risks, as well as rates-linked and credit-linked notes, all of instruments are presented in the respective derivative financial instruments lines in this table.
Disclosure Of Sensitivity Analysis Of Fair Value Measurement To Changes In Unobservable Inputs Assets And Liabilities Explanatory	Sensitivity of fair value measurements to changes 1 30.6.24 31.3.24 31.12.23 USD m Favorable changes Unfavorable changes Favorable changes Unfavorable changes Favorable changes Unfavorable changes Traded loans, loans measured at fair value and guarantees 453 (433) 441 (407) 635 (600) Securities financing transactions 34 (31) 37 (33) 30 (32) Auction rate securities 8 (6) 39 (25) 67 (21) Asset-backed securities 44 (48) 54 (58) 39 (36) Equity instruments 428 (403) 447 (428) 430 (413) Investment fund units 140 (141) 142 (144) 135 (137) Loan commitments measured at FVTPL 85 (110) 148 (176) 313 (343) Interest rate derivatives, net 139 (81) 209 (102) 217 (103) Credit derivatives, net 124 (128) 117 (117) 140 (131) Foreign exchange derivatives, net 3 (4) 4 (4) 5 (4) Equity / index derivatives, net 651 (546) 563 (498) 521 (443) Other 83 (90) 126 (141) 281 (276) Total 2,192 (2,021) 2,327 (2,133) 2,815 (2,538) 1 Sensitivity of issued and over-the-counter debt instruments is reported with the equivalent derivative
Disclosure Of Level 3 Of Fair Value Of Financial Instruments Explanatory	Movements of Level 3 instruments USD bn Balance at the beginning of the period Credit Suisse Level 3 assets and liabilities acquired Net gains / losses included in compre- hensive income 1 of which: related to instruments held at the end of the period Purchases Sales Issuances Settlements Transfers into Level 3 Transfers out of Level 3 Foreign currency translation Balance at the end of the period For the six months ended 30 June 2024 2 Financial assets at fair value held for trading 22.6 0.3 (0.3) 0.9 (11.6) 0.8 (5.7) 1.6 (0.7) (0.1) 8.0 of which: Equity instruments 0.3 (0.0) (0.0) 0.0 (0.0) 0.0 (0.0) 0.0 (0.1) (0.0) 0.2 of which: Corporate and municipal bonds 1.3 (0.1) (0.0) 0.3 (0.5) 0.0 0.0 0.0 (0.1) (0.0) 0.9 of which: Loans 19.6 0.5 (0.2) 0.4 (9.9) 0.8 (5.7) 1.4 (0.6) (0.1) 6.4 Derivative financial instruments – assets 2.6 (0.0) 0.0 0.0 (0.0) 0.6 (0.5) 0.3 (0.6) (0.0) 2.3 of which: Interest rate 0.4 0.0 0.1 0.0 (0.0) 0.0 (0.1) 0.1 (0.0) 0.0 0.4 of which: Equity / index 1.3 (0.0) (0.0) 0.0 (0.0) 0.5 (0.2) 0.1 (0.4) (0.0) 1.2 of which: Credit 0.5 (0.1) (0.0) 0.0 (0.0) 0.1 (0.1) 0.1 (0.0) (0.0) 0.5 Financial assets at fair value not held for trading 8.4 (0.2) (0.3) 0.3 (0.2) 1.1 (1.7) 0.5 (0.2) (0.1) 7.9 of which: Loans 2.3 (0.1) (0.1) 0.2 (0.0) 0.7 (0.3) 0.0 (0.1) (0.1) 2.6 of which: Auction rate securities 1.2 0.0 (0.0) 0.0 0.0 0.0 (1.1) 0.0 0.0 0.0 0.2 of which: Equity instruments 3.1 (0.1) (0.1) 0.0 (0.1) 0.0 0.0 0.0 0.0 (0.1) 2.9 Derivative financial instruments – liabilities 5.6 (0.8) (0.3) 0.0 (0.2) 1.7 (1.4) 0.3 (0.6) (0.0) 4.4 of which: Interest rate 0.2 (0.1) 0.1 0.0 (0.0) 0.0 (0.0) 0.1 (0.0) 0.0 0.2 of which: Equity / index 3.3 0.0 0.0 0.0 (0.1) 1.5 (1.1) 0.2 (0.5) (0.0) 3.4 of which: Credit 0.6 (0.1) (0.1) 0.0 (0.0) 0.1 (0.2) 0.0 (0.0) (0.0) 0.4 of which: Loan commitments measured at FVTPL 1.0 (0.6) (0.2) 0.0 (0.1) 0.0 (0.0) 0.0 0.0 (0.0) 0.3 Debt issued designated at fair value 15.3 (0.4) (0.0) 0.0 0.0 3.0 (2.9) 0.7 (2.7) (0.1) 13.0 Other financial liabilities designated at fair value 2.6 (0.1) (0.0) 0.0 (0.0) 1.1 (0.5) 0.4 (0.1) (0.0) 3.4 For the six months ended 30 June 2023 3 Financial assets at fair value held for trading 1.5 26.2 (0.5) (0.6) 0.5 (1.9) 1.1 0.0 0.1 (0.3) 0.0 26.7 of which: Investment fund units 0.1 0.1 (0.0) (0.0) 0.0 (0.0) 0.0 0.0 0.0 (0.0) (0.0) 0.1 of which: Corporate and municipal bonds 0.5 1.1 (0.4) (0.4) 0.3 (0.6) 0.0 0.0 0.0 (0.0) 0.0 1.0 of which: Loans 0.6 23.1 (0.1) (0.1) 0.0 (1.1) 1.1 0.0 (0.0) (0.2) (0.0) 23.5 Derivative financial instruments – assets 1.5 1.4 (0.1) (0.1) 0.0 (0.0) 0.5 (0.3) 0.1 (0.2) 0.0 3.0 of which: Interest rate 0.5 0.2 0.1 0.1 0.0 0.0 0.1 (0.0) 0.0 (0.0) (0.0) 0.8 of which: Equity / index 0.7 0.5 (0.1) (0.1) 0.0 (0.0) 0.3 (0.2) 0.0 (0.2) (0.0) 1.1 of which: Credit 0.3 0.2 (0.0) (0.0) 0.0 (0.0) 0.1 (0.0) 0.0 (0.0) 0.0 0.6 Financial assets at fair value not held for trading 3.7 4.2 0.0 0.0 0.5 (0.4) 0.0 (0.0) 0.1 (0.1) 0.0 8.0 of which: Loans 0.7 0.8 0.0 0.0 0.2 (0.0) 0.0 (0.0) 0.0 (0.1) (0.0) 1.6 of which: Auction rate securities 1.3 0.0 0.0 0.0 0.0 (0.0) 0.0 0.0 0.0 0.0 0.0 1.3 of which: Equity instruments 0.8 2.1 (0.0) (0.0) 0.2 (0.1) 0.0 0.0 0.0 0.0 0.0 3.1 Derivative financial instruments – liabilities 1.7 4.5 0.4 0.3 0.0 (0.2) 0.8 (0.4) 0.1 (0.3) 0.0 6.6 of which: Interest rate 0.1 0.2 0.0 0.0 0.0 0.0 0.1 (0.1) 0.0 0.0 0.0 0.4 of which: Equity / index 1.2 1.7 0.5 0.5 0.0 (0.0) 0.6 (0.3) 0.0 (0.1) 0.0 3.7 of which: Credit 0.3 0.3 0.0 0.0 0.0 (0.0) 0.1 (0.0) 0.1 (0.2) (0.0) 0.6 of which: Loan commitments measured at FVTPL 0.0 2.0 (0.2) (0.2) 0.0 (0.2) 0.0 0.0 0.0 0.0 0.0 1.6 Debt issued designated at fair value 10.5 8.5 0.4 0.4 0.0 0.0 2.4 (2.5) 0.6 (0.8) (0.0) 19.1 Other financial liabilities designated at fair value 0.7 2.1 0.0 0.0 0.0 0.0 0.2 (0.1) 0.0 (0.0) (0.0) 3.0 1 Net gains / losses included and also in 18.4 bn (31 December 2023: USD 33.6 bn). Total Level 3 20.9 bn (31 December 2023: 23.6 bn). Accounting for the acquisition of the Credit Suisse Group” in the UBS Group Annual Report 2023 for more information about the IFRS 3 measurement period
Disclosure Of Fair Value Of Financial Instruments Not Measured At Fair Value Explanatory	Financial instruments not measured at fair value 30.6.24 31.3.24 31.12.23 USD bn Carrying amount Fair value Carrying amount 1 Fair value Carrying amount 1 Fair value Assets Cash and balances at central banks 248.3 248.3 271.4 271.4 314.1 314.1 Amounts due from banks 22.0 22.0 22.1 22.1 21.1 21.2 Receivables from securities financing transactions measured at amortized 82.0 82.0 101.6 101.7 99.0 99.0 Cash collateral receivables on derivative instruments 43.6 43.6 46.7 46.7 50.1 50.1 Loans and advances to customers 599.1 594.6 605.1 600.0 639.7 633.5 Other financial assets measured at amortized cost 60.4 58.2 62.7 60.6 65.5 63.9 Liabilities Amounts due to banks 26.8 26.8 47.9 47.8 71.0 71.0 Payables from securities financing transactions measured at amortized cost 14.9 14.9 13.0 12.9 14.4 14.4 Cash collateral payables on derivative instruments 32.8 32.8 37.3 37.3 41.6 41.5 Customer deposits 756.8 757.3 764.0 764.8 792.0 792.9 Debt issued measured at amortized cost 229.2 233.8 226.3 230.9 237.8 241.3 Other financial liabilities measured at amortized cost 2 16.3 16.2 16.2 16.0 15.3 15.2 1 Comparative-period information has been revised. Refer to Note 2 for more information.

Derivative instruments (Tables)

Derivative instruments (Tables)	6 Months Ended
	Jun. 30, 2024
Disclosure Of Derivative Financial Assets And Liabilities [Line Items]
Disclosure Of Derivative Financial Assets And Liabilities Explanatory	As of 30.6.24, USD bn Derivative financial assets Derivative financial liabilities Notional values related to derivative financial assets and liabilities 1 Other notional values 2 Derivative financial instruments Interest rate 48.8 47.3 3,472 20,200 Credit derivatives 3.0 3.8 170 Foreign exchange 51.0 52.0 7,148 213 Equity / index 33.4 41.4 1,432 96 Commodities 2.6 2.0 153 18 Other 3 0.8 2.6 151 Total derivative financial instruments, based on netting under IFRS Accounting Standards 4 139.6 149.1 12,526 20,526 Further netting potential not recognized on the balance 5 (124.4) (132.4) of which: netting of recognized financial liabilities / assets (101.3) (101.3) of which: netting with collateral received / pledged (23.1) (31.1) Total derivative financial instruments, after consideration of further netting potential 15.2 16.7 As of 31.3.24, USD bn Derivative financial instruments Interest rate 52.5 50.3 3,469 21,010 Credit derivatives 3.0 3.7 206 Foreign exchange 62.0 59.1 7,014 224 Equity / index 37.7 45.8 1,439 92 Commodities 3.0 2.6 152 20 Other 3 1.0 1.5 182 Total derivative financial instruments, based on netting under IFRS Accounting Standards 4 159.2 163.0 12,461 21,346 Further netting potential not recognized on the balance 5 (141.5) (147.9) of which: netting of recognized financial liabilities / assets (115.7) (115.7) of which: netting with collateral received / pledged (25.8) (32.1) Total derivative financial instruments, after consideration of further netting potential 17.7 15.2 As of 31.12.23, USD bn Derivative financial instruments Interest rate 55.6 52.9 3,524 20,074 Credit derivatives 4.0 4.7 275 Foreign exchange 78.7 89.9 6,913 180 Equity / index 35.5 41.4 1,397 95 Commodities 2.0 1.6 143 16 Other 3 0.4 1.6 117 Total derivative financial instruments, based on netting under IFRS Accounting Standards 4 176.1 192.2 12,369 20,366 Further netting potential not recognized on the balance 5 (162.8) 167.9 of which: netting of recognized financial liabilities / assets (133.0) (133.0) of which: netting with collateral received / pledged (29.8) (35.0) Total derivative financial instruments, after consideration of further netting potential 13.3 24.2 1 In cases where Notional amounts of client-cleared ETD and OTC transacti that are cleared through either financial assets and Derivative financial liabilities).The fair value of these derivatives is presented on the balance sheet net of the corresponding cash margin under Cash collateral receivables on derivative instruments and Cash collateral payables on derivative financial instruments for which the changes obligation arising from the offer by the Credit Suisse are presented net on the balance insolvency of UBS or its counterparties, and intends either to settle on a net basis or to realize the asset netting and similar arrangements where not all criteria for a net presentation on the balance sheet have statements” section of the UBS Group Annual Report 2023 for more information.
Disclosure Of Offsetting Of Financial Assets And Liabilities Explanatory	USD bn Receivables 30.6.24 Payables 30.6.24 Receivables 31.3.24 Payables 31.3.24 Receivables 31.12.23 Payables 31.12.23 Cash collateral on derivative instruments, based on netting under IFRS Accounting Standards 1 43.6 32.8 46.7 37.3 50.1 41.6 Further netting potential not recognized on the balance 2 (27.2) (19.0) (28.8) (22.6) (32.9) (26.4) of which: netting of recognized financial liabilities / assets (24.6) (16.5) (26.0) (19.8) (29.7) (23.2) of which: netting with collateral received / pledged (2.5) (2.5) (2.8) (2.8) (3.2) (3.2) Cash collateral on derivative instruments, after consideration of further netting potential 16.5 13.8 17.9 14.7 17.2 15.2 1 Financial assets and liabilities are presented event of default, accordance with enforceable liabilities” in the “Consolidated financial statements” section of the UBS Group Annual Report 2023 for more information.

Other assets and liabilities (T

Other assets and liabilities (Tables)	6 Months Ended
	Jun. 30, 2024
Other Assets And Other Liabilities [Line Items]
Disclosure Of Other Financial Assets Measured At Amortised Cost Explanatory	USD m 30.6.24 31.3.24 1 31.12.23 1 Debt securities 41,489 43,031 45,057 Loans to financial advisors 2,601 2,615 2,615 Fee- and commission-related receivables 2,460 2,429 2,576 Finance lease receivables 6,001 5,948 6,288 Settlement and clearing accounts 529 395 338 Accrued interest income 2,599 2,981 3,163 Other 2 4,752 5,308 5,418 Total other financial assets measured at amortized cost 60,431 62,707 65,455 1 Comparative-period information has through those counterparties.
Disclosure Of Other Non Financial Assets Explanatory	USD m 30.6.24 31.3.24 31.12.23 Precious metals and other physical commodities 6,445 6,466 5,930 Deposits and collateral provided in connection with litigation, 1 2,761 2,736 2,726 Prepaid expenses 1,889 2,048 2,080 Current tax assets 1,866 1,620 1,456 VAT, 1,106 952 1,327 Properties and other non-current assets held for sale 151 156 188 Other 2,295 2,239 2,342 Total other non-financial assets 16,514 16,217 16,049 1 Refer to Note 15 for more information.
Disclosure Of Other Financial Liabilities Measured At Amortized Cost Explanatory	USD m 30.6.24 31.3.24 31.12.23 Other accrued expenses 3,115 3,063 3,270 Accrued interest expenses 6,872 6,482 6,692 Settlement and clearing accounts 1,815 2,234 1,519 Lease liabilities 5,097 5,213 5,502 Other 4,484 4,364 3,868 Total other financial liabilities measured at amortized cost 21,383 21,356 20,851
Disclosure Of Other Financial Liabilities Measured At Fair Value Explanatory	USD m 30.6.24 31.3.24 31.12.23 Financial liabilities related to unit-linked investment contracts 17,080 16,612 15,992 Securities financing transactions 7,699 5,121 7,416 Over-the-counter debt instruments and other 7,096 6,407 6,076 Total other financial liabilities designated at fair value 31,875 28,140 29,484
Disclosure Of Other Non Financial Liabilities Explanatory	USD m 30.6.24 31.3.24 31.12.23 Compensation-related liabilities 7,771 6,530 9,746 of which: net defined benefit liability 757 772 796 Current tax liabilities 1,303 1,447 1,460 Deferred tax liabilities 319 330 325 VAT, 1,070 888 1,120 Deferred income 763 670 635 Other 494 524 802 Total other non-financial liabilities 11,720 10,388 14,089

Debt issued designated at fai_2

Debt issued designated at fair value (Table)	6 Months Ended
	Jun. 30, 2024
Disclosure Of Financial Liabilities [Line Items]
Disclosure Of Designated Financial Liabilities At Fair Value Through Profit Or Loss	USD m 30.6.24 31.3.24 31.12.23 Equity-linked 1 55,911 56,608 60,573 Rates-linked 25,811 25,940 28,883 Credit-linked 6,510 6,756 7,730 Fixed-rate 15,271 17,359 20,541 Commodity-linked 3,507 3,618 3,844 Other 6,200 6,525 6,718 of which: debt that contributes to total loss-absorbing capacity 4,585 4,476 4,629 Total debt issued designated at fair value 2 113,209 116,806 128,289 of which: issued by UBS AG standalone with original maturity greater 3 93,943 70,648 73,544 of which: issued by Credit Suisse AG standalone with original maturity 3 26,089 29,948 of which: issued by Credit Suisse International standalone 3 721 946 1,471 1 Includes investment fund unit-linked instruments issued. 99 % of Total debt issued designated at fair value was unsecured (31 March 2024: 99 %). without considering any early redemption features.

Debt issued measured at amort_2

Debt issued measured at amortized cost (Tables)	6 Months Ended
	Jun. 30, 2024
Disclosure Of Financial Liabilities [Line Items]
Disclosure Of Detailed Information About Borrowings Explanatory	USD m 30.6.24 31.3.24 31.12.23 Short-term debt 1 34,944 32,485 38,530 Senior unsecured debt 143,832 143,540 147,547 of which: contributes to total loss-absorbing capacity 100,765 98,973 101,939 of which: issued by UBS AG standalone with original maturity greater 38,938 16,069 18,446 of which: issued by Credit Suisse AG standalone with original maturity 22,529 24,609 Covered bonds 8,524 6,498 5,214 Subordinated debt 14,350 16,446 17,644 of which: eligible as high-trigger loss-absorbing additional 12,400 12,021 10,744 of which: eligible as low-trigger loss-absorbing additional 1,225 1,217 1,214 of which: eligible as non-Basel III-compliant tier 2 capital 536 537 538 Debt issued through the Swiss central mortgage institutions 26,011 25,669 27,377 Other long-term debt 1,563 1,613 1,506 Long-term debt 2 194,279 193,766 199,288 Total debt issued measured at amortized cost 3,4 229,223 226,251 237,817 1 Debt with an original contractual maturity classification of debt presented. 100 % secured), Debt issued through the Swiss central mortgage institutions ( 100 % secured) and Other long-term debt ( 92 % secured), 100 % of the balance was unsecured as of 30 June 2024.

Provisions and contingent liabi

Provisions and contingent liabilities (Tables)	6 Months Ended
	Jun. 30, 2024
Disclosure Of Other Provisions [Line Items]
Disclosure Of Provisions Breakdown Explanatory	USD m 30.6.24 31.3.24 1 31.12.23 1 Provisions related to expected credit losses (IFRS 9, Financial Instruments ) 2 294 328 350 Provisions related to Credit Suisse loan commitments (IFRS Business Combinations ) 1,367 1,667 1,924 Provisions related to litigation, regulatory and similar matters Provisions, Contingent Liabilities and Contingent Assets ) 3,630 3,920 4,020 Acquisition-related contingent liabilities (IFRS 3, Business Combinations ) 2,619 3,945 3,993 Restructuring, real-estate and other provisions (IAS 37, Provisions, Contingent Liabilities and Contingent Assets ) 1,382 1,216 2,123 Total provisions and contingent liabilities 9,293 11,076 12,412 1 Comparative-period information has been revised. Refer to Note 2 for more information.
Disclosure Of Other Provisions Explanatory	USD m Litigation, regulatory and similar matters 1 Restructuring 2 Real estate 3 Other 4 Total Balance as of 31 December 2023 4,020 741 259 1,123 6,144 Balance as of 31 March 2024 3,920 662 238 317 5,136 Increase in provisions recognized in the income statement 37 315 2 41 395 Release of provisions recognized in the income statement (41) (16) 0 (16) (73) Reclassification of IFRS 3 contingent liabilities to IAS 37 provisions 1,171 5 0 0 0 1,171 Provisions used in conformity with designated purpose (1,442) 5 (138) (5) (21) (1,605) Foreign currency translation and other movements (15) 4 (1) 0 (11) Balance as of 30 June 2024 3,630 827 233 322 5,013 1 Consists of provisions for losses resulting 461 m of provisions for onerous contracts related 443 m; 31 December 2023: USD 448 m) and USD 365 m of personnel-related 218 m; 31 December 2023: 294 m). reinstatement costs with respect Credit Suisse supply chain finance funds to redeem all of the outstanding units of the respective funds. As a result, UBS reclassified USD 944 m from IFRS 3 acquisition-related contingent liabilities to IAS 37 provisions related to litigation, regulatory and similar matters, as the probability of an outflow of resources increased, bringing the total IAS 37 provision for this matter to USD 1,421 m, with no impact on the income statement. The provision has been used to recognize the funding obligation, which was accounted for as a derivative 1,421 m as of 30 June 2024.

Litigation, regulatory and si_2

Litigation, regulatory and similar matters (Tables)	6 Months Ended
	Jun. 30, 2024
Notes Litigation Regulatory And Similar Matters [Line Items]
Disclosure of provisions for litigation, regulatory and similar matters [text block]	Provisions for litigation, regulatory and similar matters, 1 USD m Global Wealth Management Personal & Corporate Banking Asset Management Investment Bank Non-core and Legacy Group Items UBS Group Balance as of 31 December 2023 1,235 157 15 294 2,186 134 4,020 Balance as of 31 March 2024 1,201 152 2 288 2,142 134 3,920 Increase in provisions recognized in the income statement 28 0 0 6 0 3 37 Release of provisions recognized in the income statement (11) 0 0 (7) (22) 0 (41) Reclassification of IFRS 3 contingent liabilities to IAS 37 provisions 2 0 0 0 0 1,171 0 1,171 Provisions used in conformity with designated purpose 2 (10) 0 0 (5) (1,425) (1) (1,442) Foreign currency translation and other movements (8) (1) 0 (1) (4) 0 (15) Balance as of 30 June 2024 1,199 152 2 280 1,862 135 3,630 1 Provisions, if any, recorded in Non-core and Legacy. Provisions, if any, for the matters described between Global Wealth Management, core and Legacy and Group Items. matters described in item 12 of this Note are allocated between the Investment finance funds to 944 m from IFRS regulatory and similar matters, as the 1,421 m, with no impact on the income been used to recognize the funding obligation, which was accounted for as a derivative liability with a fair value 1,421 m as of 30 June 2024.

Basis of accounting, Currency t

Basis of accounting, Currency translation rates (Detail)	3 Months Ended			6 Months Ended
	Jun. 30, 2024	Mar. 31, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023	Dec. 31, 2023
1 CHF
Foreign Exchange Rates [Line Items]
Closing exchange rate	1.11	1.11	1.12	1.11	1.12	1.19
Average rate	1.10	1.13	1.11	1.12	1.11
1 EUR
Foreign Exchange Rates [Line Items]
Closing exchange rate	1.07	1.08	1.09	1.07	1.09	1.10
Average rate	1.07	1.08	1.09	1.08	1.09
1 GBP
Foreign Exchange Rates [Line Items]
Closing exchange rate	1.26	1.26	1.27	1.26	1.27	1.28
Average rate	1.26	1.26	1.27	1.26	1.24
100 JPY
Foreign Exchange Rates [Line Items]
Closing exchange rate	0.62	0.66	0.69	0.62	0.69	0.71
Average rate	0.63	0.67	0.71	0.65	0.73

Accounting for the acquisitio_3

Accounting for the acquisition of the Credit Suisse Group (Narrative) (Detail) - USD ($) $ in Millions		3 Months Ended			6 Months Ended
	Jun. 12, 2023	Jun. 30, 2024	Mar. 31, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023	Dec. 31, 2023
Disclosure Of Business Combinations [Line items]
Provisional negative goodwill				$ 27,264		$ 27,264
Increase in contingent liabilities related to litigation					$ 200
Measurement period adjustments
Disclosure Of Business Combinations [Line items]
Provisional negative goodwill						(1,661)
Credit Suisse
Disclosure Of Business Combinations [Line items]
Provisional negative goodwill	$ 27,264			$ 27,264		$ 27,264
Fair value measurement adjustments made to the acquisition date fair values		$ 300
Retained earnings revision to reflect the impact on the prior-period income statement		500
Additional provisions and contingent liabilities	5,600
Litigation provisions	1,600
Existing provisions recognized by Credit Suisse Group	1,300
Increase in contingent liabilities related to litigation		200
Contingent liabilities for certain obligations in respect of litigation	4,000
Contingent liabilities for certain obligations in respect of litigation recognised in business combination as of acquisition date as reported in the Annual Report 2023	3,800
Senior secured asset-based financing transferred							$ 8,000
Senior secured asset-based financing funded as of 31 December 2023							6,000
The fair value of senior secured asset-based financing transferred to another entity							5,500
The notional amount of derivative loan commitments transferred							2,000
Fair value of derivative loan commitments transferred							$ 150
One-year extended swingline facility		$ 750	$ 750		$ 750
Gains from investment agreement conclusion and assignment of loan facilities			$ 300
Credit Suisse | As previously reported in the Annual Report 2023
Disclosure Of Business Combinations [Line items]
Provisional negative goodwill	27,748
Credit Suisse | Measurement period adjustments
Disclosure Of Business Combinations [Line items]
Provisional negative goodwill	$ (483)

Accounting for the acquisitio_4

Accounting for the acquisition of the Credit Suisse Group - Credit Suisse Group net identifiable assets on the acquisition date (Detail) - USD ($) $ in Millions		3 Months Ended	6 Months Ended
	Jun. 12, 2023	Jun. 30, 2023	Jun. 30, 2023
Liabilities
Provisional negative goodwill		$ 27,264	$ 27,264
Measurement period adjustments
Liabilities
Provisional negative goodwill			(1,661)
Credit Suisse
Disclosure Of Recognized Amounts Of Identifiable Assets Acquired And Liabilities Assumed [Line Items]
Purchase price consideration, after consideration of share-based compensation awards	$ 3,710
Assets
Cash and balances at central banks	92,923
Amounts due from banks	13,575
Receivables from securities financing transactions	26,194
Cash collateral receivables on derivative instruments	20,878
Loans and advances to customers	247,044
Other financial assets measured at amortized cost	13,385
Total financial assets measured at amortized cost	414,000
Financial assets at fair value held for trading	56,237
Derivative financial instruments	62,162
Brokerage receivables	366
Financial assets at fair value not held for trading	54,199
Total financial assets measured at fair value through profit or loss	172,964
Financial assets measured at fair value through other comprehensive income	0
Investments in associates	1,569
Property, equipment and software	6,055
Intangible assets	1,287
Deferred tax assets	998
Other non-financial assets	6,892
Total assets	603,766
Liabilities
Amounts due to banks	107,617
Payables from securities financing transactions	11,911
Cash collateral payables on derivative instruments	10,939
Customer deposits	183,119
Debt issued measured at amortized cost	110,491
Other financial liabilities measured at amortized cost	7,992
Total financial liabilities measured at amortized cost	432,070
Financial liabilities at fair value held for trading	5,711
Derivative financial instruments	67,782
Brokerage payables designated at fair value	316
Debt issued designated at fair value	44,909
Other financial liabilities designated at fair value	7,574
Total financial liabilities measured at fair value through profit or loss	126,292
Provisions and contingent liabilities	10,106
Other non-financial liabilities	3,901
Total liabilities	572,370
Non-controlling interests	(285)
Fair value of net assets acquired	31,110
Settlement of pre-existing relationships	135
Provisional negative goodwill	27,264	$ 27,264	$ 27,264
Credit Suisse | As previously reported in the Annual Report 2023
Assets
Cash and balances at central banks	93,012
Amounts due from banks	13,590
Receivables from securities financing transactions	26,194
Cash collateral receivables on derivative instruments	20,878
Loans and advances to customers	247,219
Other financial assets measured at amortized cost	13,428
Total financial assets measured at amortized cost	414,322
Financial assets at fair value held for trading	56,237
Derivative financial instruments	62,162
Brokerage receivables	366
Financial assets at fair value not held for trading	54,199
Total financial assets measured at fair value through profit or loss	172,964
Financial assets measured at fair value through other comprehensive income	0
Investments in associates	1,569
Property, equipment and software	6,055
Intangible assets	1,287
Deferred tax assets	998
Other non-financial assets	6,892
Total assets	604,088
Liabilities
Amounts due to banks	107,617
Payables from securities financing transactions	11,911
Cash collateral payables on derivative instruments	10,939
Customer deposits	183,119
Debt issued measured at amortized cost	110,491
Other financial liabilities measured at amortized cost	7,992
Total financial liabilities measured at amortized cost	432,070
Financial liabilities at fair value held for trading	5,711
Derivative financial instruments	67,782
Brokerage payables designated at fair value	316
Debt issued designated at fair value	44,909
Other financial liabilities designated at fair value	7,574
Total financial liabilities measured at fair value through profit or loss	126,292
Provisions and contingent liabilities	9,945
Other non-financial liabilities	3,901
Total liabilities	572,209
Non-controlling interests	(285)
Fair value of net assets acquired	31,594
Settlement of pre-existing relationships	135
Provisional negative goodwill	27,748
Credit Suisse | Measurement period adjustments
Assets
Cash and balances at central banks	(89)
Amounts due from banks	(15)
Loans and advances to customers	(175)
Other financial assets measured at amortized cost	(43)
Total financial assets measured at amortized cost	(322)
Total assets	(322)
Liabilities
Provisions and contingent liabilities	161
Total liabilities	161
Fair value of net assets acquired	(483)
Provisional negative goodwill	$ (483)

Accounting for the acquisitio_5

Accounting for the acquisition of the Credit Suisse Group - Effect of the measurement period adjustments on the income statement (Detail) - USD ($) $ in Millions		3 Months Ended			6 Months Ended
	Jun. 12, 2023	Jun. 30, 2024	Mar. 31, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Disclosure Of Effect Of The Measurement Period Adjustments On The Income Statement [Line Items]
Net interest income		$ 1,535	$ 1,940	$ 1,707	$ 3,475	$ 3,095
Other net income from financial instruments measured at fair value through profit or loss		3,684	4,182	2,517	7,866	5,198
Fee and commission income		7,211	7,080	5,635	14,291	10,688
Fee and commission expense		(679)	(588)	(507)	(1,268)	(954)
Net fee and commission income		6,531	6,492	5,128	13,023	9,734
Other income		154	124	188	278	258
Total revenues		11,904	12,739	9,540	24,642	18,284
Negative goodwill				27,264		27,264
Credit loss expense / (release)		95	106	623	201	662
Operating expenses		10,340	10,257	8,486	20,597	15,696
Operating profit / (loss) before tax		1,469	2,376	27,695	3,844	29,191
Tax expense / (benefit)		293	612	361	905	820
Net profit / (loss)		1,175	1,764	27,334	2,939	28,371
Net profit / (loss) attributable to non-controlling interests		40	9	3	48	11
Net profit / (loss) attributable to shareholders		$ 1,136	$ 1,755	27,331	$ 2,890	28,360
Including measurement period adjustments made in the third quarter 2023
Disclosure Of Effect Of The Measurement Period Adjustments On The Income Statement [Line Items]
Net interest income						3,095
Other net income from financial instruments measured at fair value through profit or loss						5,198
Fee and commission income						10,688
Fee and commission expense						(954)
Net fee and commission income						9,734
Other income						258
Total revenues						18,284
Negative goodwill						28,925
Credit loss expense / (release)						662
Operating expenses						15,696
Operating profit / (loss) before tax						30,852
Tax expense / (benefit)						820
Net profit / (loss)						30,032
Net profit / (loss) attributable to non-controlling interests						11
Net profit / (loss) attributable to shareholders						30,021
As previously reported in the third quarter 2023 report
Disclosure Of Effect Of The Measurement Period Adjustments On The Income Statement [Line Items]
Net interest income				1,707
Other net income from financial instruments measured at fair value through profit or loss				2,517
Fee and commission income				5,635
Fee and commission expense				(507)
Net fee and commission income				5,128
Other income				188
Total revenues				9,540
Negative goodwill				28,925		28,925
Credit loss expense / (release)				623
Operating expenses				8,486
Operating profit / (loss) before tax				29,356
Tax expense / (benefit)				361
Net profit / (loss)				28,995		30,032
Net profit / (loss) attributable to non-controlling interests				3
Net profit / (loss) attributable to shareholders				28,992
Cumulative restatement effect
Disclosure Of Effect Of The Measurement Period Adjustments On The Income Statement [Line Items]
Negative goodwill						(1,661)
Net profit / (loss)						(1,661)
Measurement period adjustment made in the Annual Report 2023
Disclosure Of Effect Of The Measurement Period Adjustments On The Income Statement [Line Items]
Negative goodwill				(1,177)		(1,177)
Operating profit / (loss) before tax				(1,177)		(1,177)
Net profit / (loss)				(1,177)		(1,177)
Net profit / (loss) attributable to shareholders				(1,177)		(1,177)
Measurement period adjustments made in the second quarter 2024
Disclosure Of Effect Of The Measurement Period Adjustments On The Income Statement [Line Items]
Negative goodwill				(483)		(483)
Operating profit / (loss) before tax				(483)		(483)
Net profit / (loss)				(483)		(483)
Net profit / (loss) attributable to shareholders				(483)		(483)
Credit Suisse
Disclosure Of Effect Of The Measurement Period Adjustments On The Income Statement [Line Items]
Negative goodwill	$ 27,264			$ 27,264		27,264
Operating profit / (loss) before tax						$ 27,264
Credit Suisse | Cumulative restatement effect
Disclosure Of Effect Of The Measurement Period Adjustments On The Income Statement [Line Items]
Negative goodwill	$ (483)

Accounting for the acquisitio_6

Accounting for the acquisition of the Credit Suisse Group - Effect of the measurement period adjustments on the balance sheet (Detail) - USD ($) $ in Millions	Jun. 30, 2024	Mar. 31, 2024	Dec. 31, 2023	Jun. 30, 2023
Assets
Total financial assets measured at amortized cost	$ 1,055,494	$ 1,109,745	$ 1,189,451
of which: Cash and balances with central banks	248,336	271,439	314,060
of which: Amounts due from banks	21,959	22,128	21,146
of which: Loans and advances to customers	599,105	605,108	639,669
of which: Other financial assets measured at amortized cost	60,431	62,707	65,455
Total assets	1,560,976	1,606,798	1,716,924
Liabilities
Provisions and contingent liabilities	9,293	11,076	12,412
Total liabilities	1,476,758	1,521,515	1,630,769
Equity
Equity attributable to shareholders	83,683	84,777	85,624
of which: Retained earnings	76,176	75,952	74,397
Total equity	84,218	85,283	86,156	$ 86,091
Total liabilities and equity	$ 1,560,976	1,606,798	1,716,924
As previously reported in the first quarter 2024 report
Assets
Total financial assets measured at amortized cost		1,110,067	1,189,773
of which: Cash and balances with central banks		271,527	314,148
of which: Amounts due from banks		22,143	21,161
of which: Loans and advances to customers		605,283	639,844
of which: Other financial assets measured at amortized cost		62,750	65,498
Total assets		1,607,120	1,717,246
Liabilities
Provisions and contingent liabilities		10,914	12,250
Total liabilities		1,521,354	1,630,607
Equity
Equity attributable to shareholders		85,260	86,108
of which: Retained earnings		76,436	74,880
Total equity		85,766	86,639
Total liabilities and equity		1,607,120	1,717,246
Measurement period adjustments made in the second quarter 2024
Assets
Total financial assets measured at amortized cost		(322)	(322)
of which: Cash and balances with central banks		(89)	(89)
of which: Amounts due from banks		(15)	(15)
of which: Loans and advances to customers		(175)	(175)
of which: Other financial assets measured at amortized cost		(43)	(43)
Total assets		(322)	(322)
Liabilities
Provisions and contingent liabilities		161	161
Total liabilities		161	161
Equity
Equity attributable to shareholders		(483)	(483)
of which: Retained earnings		(483)	(483)
Total equity		(483)	(483)
Total liabilities and equity		$ (322)	$ (322)

Accounting for the acquisitio_7

Accounting for the acquisition of the Credit Suisse Group - Effect of the measurement period adjustments on the statement of cash flows (Detail) - USD ($) $ in Millions		3 Months Ended			6 Months Ended
	Jun. 12, 2023	Jun. 30, 2024	Mar. 31, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Cash flow from / (used in) operating activities
Net profit / (loss)		$ 1,175	$ 1,764	$ 27,334	$ 2,939	$ 28,371
of which: Negative goodwill				(27,264)		(27,264)
Net cash flow from / (used in) operating activities					11,858	17,665
of which: Loans and advances to customers and customer deposits						2,256
of which: Financial assets and liabilities at fair value held for trading and derivative financial instruments					(4,779)	(5,782)
of which: Financial assets at fair value not held for trading and other financial assets and liabilities					(15,110)	4,033
Cash flow from / (used in) investing activities
Net cash flow from / (used in) investing activities					2,549	104,765
of which: Cash and cash equivalents acquired upon acquisition of the Credit Suisse Group						108,406
Cash flow from / (used in) financing activities
Net cash flow from / (used in) financing activities					(61,916)	(25,056)
Total cash flow
Cash and cash equivalents at the beginning of the period			$ 340,207		340,207	195,321
Net cash flow from / (used in) operating, investing and financing activities					(47,510)	97,374
Effects of exchange rate differences on cash and cash equivalents					(13,733)	2,960
Cash and cash equivalents at the end of the period		278,964		295,656	278,964	295,656
of which: cash and balances at central banks		248,336		261,415	248,336	261,415
of which: loans and advances to banks		19,811		21,981	19,811	21,981
of which: money market paper		$ 10,818		12,259	$ 10,818	12,259
As previously reported in the third quarter 2023 report
Cash flow from / (used in) operating activities
Net profit / (loss)				28,995		30,032
of which: Negative goodwill				(28,925)		(28,925)
Net cash flow from / (used in) operating activities						17,665
of which: Loans and advances to customers and customer deposits						1,542
of which: Financial assets and liabilities at fair value held for trading and derivative financial instruments						(7,050)
of which: Financial assets at fair value not held for trading and other financial assets and liabilities						6,015
Cash flow from / (used in) investing activities
Net cash flow from / (used in) investing activities						104,869
of which: Cash and cash equivalents acquired upon acquisition of the Credit Suisse Group						108,510
Cash flow from / (used in) financing activities
Net cash flow from / (used in) financing activities						(25,056)
Total cash flow
Cash and cash equivalents at the beginning of the period						195,321
Net cash flow from / (used in) operating, investing and financing activities						97,478
Effects of exchange rate differences on cash and cash equivalents						2,960
Cash and cash equivalents at the end of the period				295,759		295,759
of which: cash and balances at central banks				261,504		261,504
of which: loans and advances to banks				21,996		21,996
of which: money market paper				12,259		12,259
Measurement period adjustments
Cash flow from / (used in) operating activities
Net profit / (loss)						(1,661)
of which: Negative goodwill						1,661
of which: Loans and advances to customers and customer deposits						714
of which: Financial assets and liabilities at fair value held for trading and derivative financial instruments						1,268
of which: Financial assets at fair value not held for trading and other financial assets and liabilities						(1,982)
Cash flow from / (used in) investing activities
Net cash flow from / (used in) investing activities						(104)
of which: Cash and cash equivalents acquired upon acquisition of the Credit Suisse Group						(104)
Total cash flow
Net cash flow from / (used in) operating, investing and financing activities						(104)
Cash and cash equivalents at the end of the period				(104)		(104)
of which: cash and balances at central banks				(89)		(89)
of which: loans and advances to banks				(15)		(15)
Credit Suisse
Cash flow from / (used in) operating activities
of which: Negative goodwill	$ (27,264)			$ (27,264)		(27,264)
Cash flow from / (used in) investing activities
of which: Cash and cash equivalents acquired upon acquisition of the Credit Suisse Group						$ 108,406
Credit Suisse | Measurement period adjustments
Cash flow from / (used in) operating activities
of which: Negative goodwill	$ 483

Segment reporting (Narrative) (

Segment reporting (Narrative) (Detail) - USD ($) $ in Millions	3 Months Ended	6 Months Ended
	Mar. 31, 2024	Jun. 30, 2023	Dec. 31, 2023
Global Wealth Management
Disclosure Of Operating Segments [Line Items]
Invested assets reallocated to a business division	$ 72,000
Annualized revenues reallocated to a business division	600
Increase / (decrease) in operating profit / (loss) before tax due to restatement		$ 39
Increase / (decrease) in total assets due to restatement			$ 98,400
Personal & Corporate Banking
Disclosure Of Operating Segments [Line Items]
Increase / (decrease) in operating profit / (loss) before tax due to restatement		17
Increase / (decrease) in total assets due to restatement			13,300
Asset Management
Disclosure Of Operating Segments [Line Items]
Increase / (decrease) in operating profit / (loss) before tax due to restatement		3
Investment Bank
Disclosure Of Operating Segments [Line Items]
Increase / (decrease) in operating profit / (loss) before tax due to restatement		17
Increase / (decrease) in total assets due to restatement			28,900
Non-core and Legacy
Disclosure Of Operating Segments [Line Items]
Increase / (decrease) in operating profit / (loss) before tax due to restatement		(15)
Increase / (decrease) in total assets due to restatement			28,600
Group Items
Disclosure Of Operating Segments [Line Items]
Funding costs reallocated to business divisions	$ 300
Increase / (decrease) in operating profit / (loss) before tax due to restatement		$ (60)
Increase / (decrease) in total assets due to restatement			$ (169,200)

Segment reporting (Detail)

Segment reporting (Detail) - USD ($) $ in Millions		3 Months Ended			6 Months Ended
	Jun. 12, 2023	Jun. 30, 2024	Mar. 31, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023	Dec. 31, 2023
Disclosure Of Operating Segments [Line Items]
Total revenues		$ 11,904	$ 12,739	$ 9,540	$ 24,642	$ 18,284
Negative goodwill				27,264		27,264
Credit loss expense / (release)		95	106	623	201	662
Operating expenses		10,340	10,257	8,486	20,597	15,696
Operating profit / (loss) before tax		1,469	2,376	27,695	3,844	29,191
Tax expense / (benefit)		293	612	361	905	820
Net profit / (loss)		1,175	1,764	27,334	2,939	28,371
Additional information
Total assets		1,560,976	1,606,798		1,560,976		$ 1,716,924
Credit Suisse
Disclosure Of Operating Segments [Line Items]
Negative goodwill	$ 27,264			27,264		27,264
Operating profit / (loss) before tax						27,264
Global Wealth Management
Disclosure Of Operating Segments [Line Items]
Total revenues					12,196	10,049
Credit loss expense / (release)		(1)	(3)	149	(4)	164
Operating expenses					10,228	7,646
Operating profit / (loss) before tax					1,972	2,239
Additional information
Total assets		557,716			557,716		567,648
Personal & Corporate Banking
Disclosure Of Operating Segments [Line Items]
Total revenues					4,695	3,087
Credit loss expense / (release)		103	44	221	146	237
Operating expenses					2,800	1,597
Operating profit / (loss) before tax					1,748	1,253
Additional information
Total assets		450,835			450,835		483,794
Asset Management
Disclosure Of Operating Segments [Line Items]
Total revenues					1,543	1,086
Credit loss expense / (release)		0	0	1	0	1
Operating expenses					1,303	911
Operating profit / (loss) before tax					241	174
Additional information
Total assets		22,439			22,439		21,804
Investment Bank
Disclosure Of Operating Segments [Line Items]
Total revenues					5,554	4,401
Credit loss expense / (release)		(6)	32	132	26	139
Operating expenses					4,496	3,891
Operating profit / (loss) before tax					1,032	372
Additional information
Total assets		419,978			419,978		428,269
Non-core and Legacy
Disclosure Of Operating Segments [Line Items]
Total revenues					1,402	185
Credit loss expense / (release)		(1)	36	119	35	119
Operating expenses					1,818	1,235
Operating profit / (loss) before tax					(451)	(1,169)
Additional information
Total assets		96,574			96,574		201,131
Group Items
Disclosure Of Operating Segments [Line Items]
Total revenues					(747)	(524)
Credit loss expense / (release)		0	$ (2)	$ 2	(2)	2
Operating expenses					(48)	416
Operating profit / (loss) before tax					(699)	$ (942)
Additional information
Total assets		$ 13,435			$ 13,435		$ 14,277

Net interest income (Detail)

Net interest income (Detail) - USD ($) $ in Millions	3 Months Ended			6 Months Ended
	Jun. 30, 2024	Mar. 31, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Net Interest Income [Line Items]
Interest income from loans and deposits	$ 8,403	$ 9,089	$ 6,143	$ 17,492	$ 10,250
Interest income from securities financing transactions measured at amortized cost	1,136	1,217	1,004	2,354	1,769
Interest income from other financial instruments measured at amortized cost	328	347	282	675	540
Interest income from debt instruments measured at fair value through other comprehensive income	26	27	26	54	48
Interest income from derivative instruments designated as cash flow hedges	(574)	(602)	(457)	(1,175)	(833)
Total interest income from financial instruments measured at amortized cost and fair value through other comprehensive income	9,320	10,078	6,998	19,399	11,775
Interest expense on loans and deposits	5,074	5,439	3,024	10,513	5,018
Interest expense on securities financing transactions measured at amortized cost	541	495	616	1,035	981
Interest expense on debt issued	3,655	3,740	2,205	7,395	3,635
Interest expense on lease liabilities	49	50	35	99	61
Total interest expense from financial instruments measured at amortized cost	9,319	9,724	5,880	19,042	9,695
Total net interest income from financial instruments measured at amortized cost and fair value through other comprehensive income	2	355	1,117	357	2,080
Net interest income from financial instruments measured at fair value through profit or loss and other	1,533	1,585	589	3,118	1,015
Total net interest income	$ 1,535	$ 1,940	$ 1,707	$ 3,475	$ 3,095

Net fee and commission income_2

Net fee and commission income (Detail) - USD ($) $ in Millions	3 Months Ended			6 Months Ended
	Jun. 30, 2024	Mar. 31, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Net fee And Commission Income [Line Items]
Underwriting Fees	$ 233	$ 194	$ 153	$ 427	$ 280
M&A and corporate finance fees	272	259	199	530	378
Brokerage fees	1,144	1,150	930	2,295	1,809
Investment fund fees	1,401	1,257	1,196	2,658	2,374
Portfolio management and related services	3,071	3,051	2,485	6,121	4,695
Other	1,090	1,169	672	2,259	1,151
Total fee and commission income	7,211	7,080	5,635	14,291	10,688
Fee and commission expense	679	588	507	1,268	954
Net fee and commission income	6,531	6,492	5,128	13,023	9,734
Global Wealth Management
Net fee And Commission Income [Line Items]
Total fee and commission income	4,011	3,986	3,333
Personal & Corporate Banking
Net fee And Commission Income [Line Items]
Total fee and commission income	876	708	554
Asset Management
Net fee And Commission Income [Line Items]
Total fee and commission income	924	941	753
Investment Bank
Net fee And Commission Income [Line Items]
Total fee and commission income	1,322	1,332	851
Group Items
Net fee And Commission Income [Line Items]
Total fee and commission income	(47)	5	74
Non-core and Legacy
Net fee And Commission Income [Line Items]
Total fee and commission income	125	108	70
of which: recurring
Net fee And Commission Income [Line Items]
Total fee and commission income	4,484	4,407	3,789	8,891	7,201
of which: transaction-based
Net fee And Commission Income [Line Items]
Total fee and commission income	2,697	2,641	1,836	5,338	3,452
of which: performance-based
Net fee And Commission Income [Line Items]
Total fee and commission income	$ 30	$ 32	$ 10	$ 62	$ 34

Other income (Narrative) (Detai

Other income (Narrative) (Detail) - USD ($) $ in Millions	3 Months Ended			6 Months Ended
	Jun. 30, 2024	Mar. 31, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Other Income [Line Items]
Net gains / (losses) from acquisitions and disposals of subsidiaries	$ (2)	$ (1)	$ 4	$ (3)	$ 6
Net gains / (losses) from disposals of investments in associates and joint ventures	2	(2)	0	0	0
Share of net profits of associates and joint ventures	52	58	27	110	36
Total	52	55	31	107	43
Income from properties	15	14	9	29	13
Net gains / (losses) from properties held for sale	(2)	(1)	0	(4)	0
Other	89	56	148	145	203
Total other income	$ 154	$ 124	$ 188	$ 278	$ 258

Personnel expenses (Detail)

Personnel expenses (Detail) - USD ($) $ in Millions	3 Months Ended			6 Months Ended
	Jun. 30, 2024	Mar. 31, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Personnel Expenses [Line Items]
Salaries and variable compensation	$ 6,058	$ 5,863	$ 4,804	$ 11,922	$ 8,689
of which: variable compensation - financial advisors	1,291	1,267	1,110	2,558	2,222
Contractors	82	86	77	168	147
Social security	419	409	294	828	572
Post-employment benefit plans	309	367	261	676	497
Other personnel expenses	251	225	215	476	366
Total personnel expenses	$ 7,119	$ 6,949	$ 5,651	$ 14,068	$ 10,271

General and administrative ex_3

General and administrative expenses (Detail) - USD ($) $ in Millions	3 Months Ended			6 Months Ended
	Jun. 30, 2024	Mar. 31, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
General And Administrative Expenses [Line Items]
Outsourcing costs	$ 463	$ 423	$ 311	$ 886	$ 559
Technology costs	567	588	414	1,154	735
Consulting, legal and audit fees	394	403	351	797	532
Real estate and logistics costs	302	289	207	590	349
Market data services	188	199	151	387	264
Marketing and communication	137	115	89	251	140
Travel and entertainment	87	72	73	159	126
Litigation, regulatory and similar matters	(153)	(5)	69	(158)	790
Other	334	330	304	665	536
Total general and administrative expenses	$ 2,318	$ 2,413	$ 1,968	$ 4,731	$ 4,033

Expected credit loss measurem_3

Expected credit loss measurement - Credit loss expense / release (Narrative) (Detail) - USD ($) $ in Millions	3 Months Ended			6 Months Ended
	Jun. 30, 2024	Mar. 31, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Disclosure Of Provision Matrix [Line Items]
Credit loss expense / (release)	$ 95	$ 106	$ 623	$ 201	$ 662
Stage 1 and 2 positions
Disclosure Of Provision Matrix [Line Items]
Credit loss expense / (release)	(22)	(45)	537
Stage 1 and 2 positions | Scenario related
Disclosure Of Provision Matrix [Line Items]
Credit loss expense / (release)	(34)
Credit-impaired (stage 3 and purchased credit-impaired) positions
Disclosure Of Provision Matrix [Line Items]
Credit loss expense / (release)	116
Lifetime Expected Credit Losses [Member] | Stage 3 positions
Disclosure Of Provision Matrix [Line Items]
Credit loss expense / (release)	132	133	77
Lifetime Expected Credit Losses [Member] | Purchased credit-impaired (PCI)
Disclosure Of Provision Matrix [Line Items]
Credit loss expense / (release)	$ (15)	$ 18	$ 8

Expected credit loss measurem_4

Expected credit loss measurement - Credit loss expense / (release) (Detail) - USD ($) $ in Millions	3 Months Ended			6 Months Ended
	Jun. 30, 2024	Mar. 31, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Disclosure Of Provision Matrix [Line Items]
Credit loss expense / (release)	$ 95	$ 106	$ 623	$ 201	$ 662
Global Wealth Management
Disclosure Of Provision Matrix [Line Items]
Credit loss expense / (release)	(1)	(3)	149	(4)	164
Personal & Corporate Banking
Disclosure Of Provision Matrix [Line Items]
Credit loss expense / (release)	103	44	221	146	237
Asset Management
Disclosure Of Provision Matrix [Line Items]
Credit loss expense / (release)	0	0	1	0	1
Investment Bank
Disclosure Of Provision Matrix [Line Items]
Credit loss expense / (release)	(6)	32	132	26	139
Non-core and Legacy
Disclosure Of Provision Matrix [Line Items]
Credit loss expense / (release)	(1)	36	119	35	119
Group Items
Disclosure Of Provision Matrix [Line Items]
Credit loss expense / (release)	0	(2)	2	$ (2)	$ 2
Stages 1 and 2
Disclosure Of Provision Matrix [Line Items]
Credit loss expense / (release)	(22)	(45)	537
Stages 1 and 2 | Global Wealth Management
Disclosure Of Provision Matrix [Line Items]
Credit loss expense / (release)	(13)	(12)	134
Stages 1 and 2 | Personal & Corporate Banking
Disclosure Of Provision Matrix [Line Items]
Credit loss expense / (release)	(15)	(13)	193
Stages 1 and 2 | Asset Management
Disclosure Of Provision Matrix [Line Items]
Credit loss expense / (release)	0	0	1
Stages 1 and 2 | Investment Bank
Disclosure Of Provision Matrix [Line Items]
Credit loss expense / (release)	7	7	134
Stages 1 and 2 | Non-core and Legacy
Disclosure Of Provision Matrix [Line Items]
Credit loss expense / (release)	(1)	(26)	74
Stages 1 and 2 | Group Items
Disclosure Of Provision Matrix [Line Items]
Credit loss expense / (release)	0	(2)	2
Lifetime expected credit losses | Stage 3
Disclosure Of Provision Matrix [Line Items]
Credit loss expense / (release)	132	133	77
Lifetime expected credit losses | Stage 3 | Global Wealth Management
Disclosure Of Provision Matrix [Line Items]
Credit loss expense / (release)	12	7	9
Lifetime expected credit losses | Stage 3 | Personal & Corporate Banking
Disclosure Of Provision Matrix [Line Items]
Credit loss expense / (release)	132	64	28
Lifetime expected credit losses | Stage 3 | Asset Management
Disclosure Of Provision Matrix [Line Items]
Credit loss expense / (release)	0	0	0
Lifetime expected credit losses | Stage 3 | Investment Bank
Disclosure Of Provision Matrix [Line Items]
Credit loss expense / (release)	(14)	26	(4)
Lifetime expected credit losses | Stage 3 | Non-core and Legacy
Disclosure Of Provision Matrix [Line Items]
Credit loss expense / (release)	3	37	44
Lifetime expected credit losses | Stage 3 | Group Items
Disclosure Of Provision Matrix [Line Items]
Credit loss expense / (release)	0	0	0
Lifetime expected credit losses | Purchased
Disclosure Of Provision Matrix [Line Items]
Credit loss expense / (release)	(15)	18	8
Lifetime expected credit losses | Purchased | Global Wealth Management
Disclosure Of Provision Matrix [Line Items]
Credit loss expense / (release)	0	2	7
Lifetime expected credit losses | Purchased | Personal & Corporate Banking
Disclosure Of Provision Matrix [Line Items]
Credit loss expense / (release)	(14)	(7)	0
Lifetime expected credit losses | Purchased | Asset Management
Disclosure Of Provision Matrix [Line Items]
Credit loss expense / (release)	0	0	0
Lifetime expected credit losses | Purchased | Investment Bank
Disclosure Of Provision Matrix [Line Items]
Credit loss expense / (release)	1	(1)	1
Lifetime expected credit losses | Purchased | Non-core and Legacy
Disclosure Of Provision Matrix [Line Items]
Credit loss expense / (release)	(2)	25	0
Lifetime expected credit losses | Purchased | Group Items
Disclosure Of Provision Matrix [Line Items]
Credit loss expense / (release)	$ 0	$ 0	$ 0

Expected credit loss measurem_5

Expected credit loss measurement - Changes to ECL models, scenarios, scenario weights and post-model adjustments (Narrative) (Detail) - USD ($) $ in Millions	Jun. 30, 2024	Mar. 31, 2024	Dec. 31, 2023
Disclosure Of Provision Matrix [Line Items]
Total ECL allowances and provisions	$ (2,258)	$ (2,243)	$ (2,261)
Stages 1 and 2
Disclosure Of Provision Matrix [Line Items]
Total ECL allowances and provisions	1,001
Stages 1 and 2 | Post-model adjustment
Disclosure Of Provision Matrix [Line Items]
Total ECL allowances and provisions	$ 300	$ 286

Expected credit loss measurem_6

Expected credit loss measurement - Comparison of shock factors (Detail) - Baseline	6 Months Ended
	Jun. 30, 2024
2023 | Real GDP growth (annual percentage change) | US
Disclosure of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items]
Economic forecast	2.50%
2023 | Real GDP growth (annual percentage change) | Eurozone
Disclosure of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items]
Economic forecast	0.60%
2023 | Real GDP growth (annual percentage change) | Switzerland
Disclosure of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items]
Economic forecast	0.70%
2023 | Unemployment rate (%, annual average) | US
Disclosure of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items]
Economic forecast	3.60%
2023 | Unemployment rate (%, annual average) | Eurozone
Disclosure of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items]
Economic forecast	6.60%
2023 | Unemployment rate (%, annual average) | Switzerland
Disclosure of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items]
Economic forecast	2%
2023 | Fixed income: 10-year government bonds (%, Q4) | USD
Disclosure of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items]
Economic forecast	3.90%
2023 | Fixed income: 10-year government bonds (%, Q4) | EUR
Disclosure of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items]
Economic forecast	2%
2023 | Fixed income: 10-year government bonds (%, Q4) | CHF
Disclosure of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items]
Economic forecast	0.70%
2023 | Real estate (annual percentage change, Q4) | US
Disclosure of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items]
Economic forecast	5.20%
2023 | Real estate (annual percentage change, Q4) | Eurozone
Disclosure of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items]
Economic forecast	(1.00%)
2023 | Real estate (annual percentage change, Q4) | Switzerland
Disclosure of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items]
Economic forecast	0.10%
2024 | Real GDP growth (annual percentage change) | US
Disclosure of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items]
Economic forecast	2.30%
2024 | Real GDP growth (annual percentage change) | Eurozone
Disclosure of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items]
Economic forecast	0.60%
2024 | Real GDP growth (annual percentage change) | Switzerland
Disclosure of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items]
Economic forecast	1.30%
2024 | Unemployment rate (%, annual average) | US
Disclosure of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items]
Economic forecast	4%
2024 | Unemployment rate (%, annual average) | Eurozone
Disclosure of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items]
Economic forecast	6.60%
2024 | Unemployment rate (%, annual average) | Switzerland
Disclosure of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items]
Economic forecast	2.40%
2024 | Fixed income: 10-year government bonds (%, Q4) | USD
Disclosure of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items]
Economic forecast	4.30%
2024 | Fixed income: 10-year government bonds (%, Q4) | EUR
Disclosure of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items]
Economic forecast	2.50%
2024 | Fixed income: 10-year government bonds (%, Q4) | CHF
Disclosure of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items]
Economic forecast	0.60%
2024 | Real estate (annual percentage change, Q4) | US
Disclosure of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items]
Economic forecast	3.70%
2024 | Real estate (annual percentage change, Q4) | Eurozone
Disclosure of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items]
Economic forecast	1%
2024 | Real estate (annual percentage change, Q4) | Switzerland
Disclosure of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items]
Economic forecast	1%
2025 | Real GDP growth (annual percentage change) | US
Disclosure of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items]
Economic forecast	1.40%
2025 | Real GDP growth (annual percentage change) | Eurozone
Disclosure of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items]
Economic forecast	1.20%
2025 | Real GDP growth (annual percentage change) | Switzerland
Disclosure of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items]
Economic forecast	1.50%
2025 | Unemployment rate (%, annual average) | US
Disclosure of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items]
Economic forecast	4.20%
2025 | Unemployment rate (%, annual average) | Eurozone
Disclosure of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items]
Economic forecast	6.80%
2025 | Unemployment rate (%, annual average) | Switzerland
Disclosure of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items]
Economic forecast	2.60%
2025 | Fixed income: 10-year government bonds (%, Q4) | USD
Disclosure of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items]
Economic forecast	4.20%
2025 | Fixed income: 10-year government bonds (%, Q4) | EUR
Disclosure of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items]
Economic forecast	2.40%
2025 | Fixed income: 10-year government bonds (%, Q4) | CHF
Disclosure of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items]
Economic forecast	0.60%
2025 | Real estate (annual percentage change, Q4) | US
Disclosure of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items]
Economic forecast	2.30%
2025 | Real estate (annual percentage change, Q4) | Eurozone
Disclosure of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items]
Economic forecast	3.40%
2025 | Real estate (annual percentage change, Q4) | Switzerland
Disclosure of Key Macro Economic Variables Used For Expected Credit Loss Model [Line Items]
Economic forecast	2.50%

Expected credit loss measurem_7

Expected credit loss measurement - Economic scenarios and weights applied (Detail)	3 Months Ended
	Jun. 30, 2024	Mar. 31, 2024	Jun. 30, 2023
Baseline
Disclosure Of Provision Matrix [Line Items]
Assigned weights	60%	60%	60%
Mild debt crisis
Disclosure Of Provision Matrix [Line Items]
Assigned weights	15%	15%	15%
Stagflationary geopolitical crisis
Disclosure Of Provision Matrix [Line Items]
Assigned weights	25%	25%	25%

Expected credit loss measurem_8

Expected credit loss measurement - ECL-relevant balance sheet and off-balance sheet positions including ECL allowances and provisions (Narrative) (Detail)	Jun. 30, 2024	Mar. 31, 2024	Dec. 31, 2023
Disclosure Of Provision Matrix [Line Items]
ECL coverage	0.24%	0.23%	0.22%
Stage 1 and 2 positions
Disclosure Of Provision Matrix [Line Items]
ECL coverage	0.11%	0.11%	0.11%
Allowance for expected credit loss | Total
Disclosure Of Provision Matrix [Line Items]
ECL coverage	0.30%	0.29%	0.27%
Allowance for expected credit loss | Total real estate lending | Total
Disclosure Of Provision Matrix [Line Items]
ECL coverage	0.06%	0.08%	0.09%
Allowance for expected credit loss | Total corporate lending | Total
Disclosure Of Provision Matrix [Line Items]
ECL coverage	1.96%	1.88%	1.72%
Allowance for expected credit loss | Stage 1 and 2 positions | Total
Disclosure Of Provision Matrix [Line Items]
ECL coverage	0.11%	0.11%	0.11%
Allowance for expected credit loss | Stage 1 and 2 positions | Total real estate lending | Total
Disclosure Of Provision Matrix [Line Items]
ECL coverage	0.06%	0.06%	0.06%
Allowance for expected credit loss | Stage 1 and 2 positions | Total corporate lending | Total
Disclosure Of Provision Matrix [Line Items]
ECL coverage	0.57%	0.53%	0.53%
Increase decrease in ECL coverage	0.04%

Expected credit loss measurem_9

Expected credit loss measurement - On-balance sheet financial assets subject to ECL (Detail) - USD ($) $ in Millions	Jun. 30, 2024	Mar. 31, 2024	Dec. 31, 2023
Disclosure Of Credit Risk Exposure [Line Items]
Total ECL allowances and provisions	$ (2,258)	$ (2,243)	$ (2,261)
Total on-balance sheet financial assets in scope of ECL requirements
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	1,057,661	1,111,823	1,191,684
Total financial assets measured at amortized cost
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	1,055,494	1,109,745	1,189,451
Cash and balances at central banks
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	248,336	271,439	314,060
Amounts due from banks
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	21,959	22,128	21,146
Receivables from securities financing transactions measured at amortized cost
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	82,028	101,650	99,039
Cash collateral receivables on derivative instruments
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	43,637	46,714	50,082
Loans and advances to customers
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	599,105	605,108	639,669
Loans and advances to customers | of which: Private clients with mortgages
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	252,724	251,891	268,616
Loans and advances to customers | of which: Real estate financing
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	86,854	90,220	97,817
Loans and advances to customers | of which: Large corporate clients
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	28,773	29,008	30,084
Loans and advances to customers | of which: SME clients
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	23,406	24,276	25,957
Loans and advances to customers | of which: Lombard
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	148,268	150,759	156,353
Loans and advances to customers | of which: Credit cards
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	1,927	1,840	2,041
Loans and advances to customers | of which: Commodity trade finance
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	5,792	5,358	5,727
Loans and advances to customers | of which: Ship / aircraft financing
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	8,284	8,777	9,214
Loans and advances to customers | of which: Consumer financing
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	2,902	2,912	2,982
Other financial assets measured at amortized cost
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	60,431	62,707	65,455
Loans to financial advisors
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	2,601	2,615	2,615
Financial assets measured at fair value through other comprehensive income
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	2,167	2,078	2,233
Stages 1 and 2
Disclosure Of Credit Risk Exposure [Line Items]
Total ECL allowances and provisions	1,001
Twelve-month expected credit losses | Stages 1 and 2
Disclosure Of Credit Risk Exposure [Line Items]
Total ECL allowances and provisions	(597)	(620)	(700)
Twelve-month expected credit losses | Stages 1 and 2 | Total on-balance sheet financial assets in scope of ECL requirements
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	1,026,888	1,077,191	1,161,661
Twelve-month expected credit losses | Stages 1 and 2 | Total financial assets measured at amortized cost
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	1,024,721	1,075,113	1,159,428
Twelve-month expected credit losses | Stages 1 and 2 | Cash and balances at central banks
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	248,244	271,378	314,025
Twelve-month expected credit losses | Stages 1 and 2 | Amounts due from banks
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	21,627	22,027	21,092
Twelve-month expected credit losses | Stages 1 and 2 | Receivables from securities financing transactions measured at amortized cost
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	82,028	101,650	99,039
Twelve-month expected credit losses | Stages 1 and 2 | Cash collateral receivables on derivative instruments
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	43,637	46,714	50,082
Twelve-month expected credit losses | Stages 1 and 2 | Loans and advances to customers
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	569,476	571,400	610,922
Twelve-month expected credit losses | Stages 1 and 2 | Loans and advances to customers | of which: Private clients with mortgages
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	241,499	239,416	256,614
Twelve-month expected credit losses | Stages 1 and 2 | Loans and advances to customers | of which: Real estate financing
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	82,018	84,485	92,084
Twelve-month expected credit losses | Stages 1 and 2 | Loans and advances to customers | of which: Large corporate clients
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	23,888	23,954	25,671
Twelve-month expected credit losses | Stages 1 and 2 | Loans and advances to customers | of which: SME clients
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	19,585	20,506	22,155
Twelve-month expected credit losses | Stages 1 and 2 | Loans and advances to customers | of which: Lombard
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	147,272	149,153	156,299
Twelve-month expected credit losses | Stages 1 and 2 | Loans and advances to customers | of which: Credit cards
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	1,479	1,402	1,564
Twelve-month expected credit losses | Stages 1 and 2 | Loans and advances to customers | of which: Commodity trade finance
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	5,556	5,169	5,662
Twelve-month expected credit losses | Stages 1 and 2 | Loans and advances to customers | of which: Ship / aircraft financing
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	7,846	7,998	8,920
Twelve-month expected credit losses | Stages 1 and 2 | Loans and advances to customers | of which: Consumer financing
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	2,703	2,629	2,795
Twelve-month expected credit losses | Stages 1 and 2 | Other financial assets measured at amortized cost
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	59,710	61,945	64,268
Twelve-month expected credit losses | Stages 1 and 2 | Loans to financial advisors
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	2,408	2,430	2,422
Twelve-month expected credit losses | Stages 1 and 2 | Financial assets measured at fair value through other comprehensive income
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	2,167	2,078	2,233
Lifetime expected credit losses | Stages 1 and 2
Disclosure Of Credit Risk Exposure [Line Items]
Total ECL allowances and provisions	(404)	(406)	(416)
Lifetime expected credit losses | Stages 1 and 2 | Total on-balance sheet financial assets in scope of ECL requirements
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	26,117	29,428	25,410
Lifetime expected credit losses | Stages 1 and 2 | Total financial assets measured at amortized cost
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	26,117	29,428	25,410
Lifetime expected credit losses | Stages 1 and 2 | Cash and balances at central banks
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	16	17	18
Lifetime expected credit losses | Stages 1 and 2 | Amounts due from banks
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	319	65	17
Lifetime expected credit losses | Stages 1 and 2 | Receivables from securities financing transactions measured at amortized cost
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	0	0	0
Lifetime expected credit losses | Stages 1 and 2 | Cash collateral receivables on derivative instruments
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	0	0	0
Lifetime expected credit losses | Stages 1 and 2 | Loans and advances to customers
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	25,249	28,773	24,408
Lifetime expected credit losses | Stages 1 and 2 | Loans and advances to customers | of which: Private clients with mortgages
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	10,077	11,319	10,695
Lifetime expected credit losses | Stages 1 and 2 | Loans and advances to customers | of which: Real estate financing
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	4,507	5,444	5,367
Lifetime expected credit losses | Stages 1 and 2 | Loans and advances to customers | of which: Large corporate clients
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	3,829	3,917	3,182
Lifetime expected credit losses | Stages 1 and 2 | Loans and advances to customers | of which: SME clients
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	2,531	2,745	2,919
Lifetime expected credit losses | Stages 1 and 2 | Loans and advances to customers | of which: Lombard
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	875	931	3
Lifetime expected credit losses | Stages 1 and 2 | Loans and advances to customers | of which: Credit cards
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	408	399	438
Lifetime expected credit losses | Stages 1 and 2 | Loans and advances to customers | of which: Commodity trade finance
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	222	165	25
Lifetime expected credit losses | Stages 1 and 2 | Loans and advances to customers | of which: Ship / aircraft financing
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	421	776	273
Lifetime expected credit losses | Stages 1 and 2 | Loans and advances to customers | of which: Consumer financing
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	119	199	92
Lifetime expected credit losses | Stages 1 and 2 | Other financial assets measured at amortized cost
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	533	574	968
Lifetime expected credit losses | Stages 1 and 2 | Loans to financial advisors
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	83	70	79
Lifetime expected credit losses | Stages 1 and 2 | Financial assets measured at fair value through other comprehensive income
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	0	0	0
Lifetime expected credit losses | Stage 3
Disclosure Of Credit Risk Exposure [Line Items]
Total ECL allowances and provisions	(1,053)	(1,035)	(993)
Lifetime expected credit losses | Stage 3 | Total on-balance sheet financial assets in scope of ECL requirements
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	3,458	3,908	3,027
Lifetime expected credit losses | Stage 3 | Total financial assets measured at amortized cost
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	3,458	3,908	3,027
Lifetime expected credit losses | Stage 3 | Cash and balances at central banks
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	0	0	0
Lifetime expected credit losses | Stage 3 | Amounts due from banks
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	0	0	0
Lifetime expected credit losses | Stage 3 | Receivables from securities financing transactions measured at amortized cost
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	0	0	0
Lifetime expected credit losses | Stage 3 | Cash collateral receivables on derivative instruments
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	0	0	0
Lifetime expected credit losses | Stage 3 | Loans and advances to customers
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	3,287	3,742	2,869
Lifetime expected credit losses | Stage 3 | Loans and advances to customers | of which: Private clients with mortgages
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	1,062	923	929
Lifetime expected credit losses | Stage 3 | Loans and advances to customers | of which: Real estate financing
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	243	179	270
Lifetime expected credit losses | Stage 3 | Loans and advances to customers | of which: Large corporate clients
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	700	689	700
Lifetime expected credit losses | Stage 3 | Loans and advances to customers | of which: SME clients
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	1,049	951	754
Lifetime expected credit losses | Stage 3 | Loans and advances to customers | of which: Lombard
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	54	549	50
Lifetime expected credit losses | Stage 3 | Loans and advances to customers | of which: Credit cards
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	40	38	39
Lifetime expected credit losses | Stage 3 | Loans and advances to customers | of which: Commodity trade finance
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	11	11	22
Lifetime expected credit losses | Stage 3 | Loans and advances to customers | of which: Ship / aircraft financing
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	3	3	4
Lifetime expected credit losses | Stage 3 | Loans and advances to customers | of which: Consumer financing
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	39	35	38
Lifetime expected credit losses | Stage 3 | Other financial assets measured at amortized cost
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	171	166	158
Lifetime expected credit losses | Stage 3 | Loans to financial advisors
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	110	115	114
Lifetime expected credit losses | Stage 3 | Financial assets measured at fair value through other comprehensive income
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	0	0	0
Lifetime expected credit losses | Purchased credit-impaired (PCI)
Disclosure Of Credit Risk Exposure [Line Items]
Total ECL allowances and provisions	(204)	(182)	(153)
Lifetime expected credit losses | Purchased credit-impaired (PCI) | Total on-balance sheet financial assets in scope of ECL requirements
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	1,198	1,296	1,587
Lifetime expected credit losses | Purchased credit-impaired (PCI) | Total financial assets measured at amortized cost
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	1,198	1,296	1,587
Lifetime expected credit losses | Purchased credit-impaired (PCI) | Cash and balances at central banks
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	76	43	18
Lifetime expected credit losses | Purchased credit-impaired (PCI) | Amounts due from banks
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	13	36	38
Lifetime expected credit losses | Purchased credit-impaired (PCI) | Receivables from securities financing transactions measured at amortized cost
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	0	0	0
Lifetime expected credit losses | Purchased credit-impaired (PCI) | Cash collateral receivables on derivative instruments
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	0	0	0
Lifetime expected credit losses | Purchased credit-impaired (PCI) | Loans and advances to customers
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	1,093	1,194	1,470
Lifetime expected credit losses | Purchased credit-impaired (PCI) | Loans and advances to customers | of which: Private clients with mortgages
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	86	233	378
Lifetime expected credit losses | Purchased credit-impaired (PCI) | Loans and advances to customers | of which: Real estate financing
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	86	111	97
Lifetime expected credit losses | Purchased credit-impaired (PCI) | Loans and advances to customers | of which: Large corporate clients
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	357	447	532
Lifetime expected credit losses | Purchased credit-impaired (PCI) | Loans and advances to customers | of which: SME clients
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	241	74	129
Lifetime expected credit losses | Purchased credit-impaired (PCI) | Loans and advances to customers | of which: Lombard
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	66	126	0
Lifetime expected credit losses | Purchased credit-impaired (PCI) | Loans and advances to customers | of which: Credit cards
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	0	0	0
Lifetime expected credit losses | Purchased credit-impaired (PCI) | Loans and advances to customers | of which: Commodity trade finance
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	2	12	18
Lifetime expected credit losses | Purchased credit-impaired (PCI) | Loans and advances to customers | of which: Ship / aircraft financing
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	15	0	17
Lifetime expected credit losses | Purchased credit-impaired (PCI) | Loans and advances to customers | of which: Consumer financing
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	41	49	57
Lifetime expected credit losses | Purchased credit-impaired (PCI) | Other financial assets measured at amortized cost
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	16	22	61
Lifetime expected credit losses | Purchased credit-impaired (PCI) | Loans to financial advisors
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	0	0	0
Lifetime expected credit losses | Purchased credit-impaired (PCI) | Financial assets measured at fair value through other comprehensive income
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	0	0	0
Gross carrying amount | Loans and advances to customers | of which: Private clients with mortgages
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	252,892	252,087	268,825
Gross carrying amount | Loans and advances to customers | of which: Real estate financing
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	86,907	90,284	97,920
Gross carrying amount | Loans and advances to customers | of which: Large corporate clients
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	29,299	29,587	30,660
Gross carrying amount | Loans and advances to customers | of which: SME clients
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	23,922	24,718	26,359
Gross carrying amount | Loans and advances to customers | of which: Lombard
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	148,308	150,820	156,394
Gross carrying amount | Loans and advances to customers | of which: Credit cards
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	1,968	1,879	2,083
Gross carrying amount | Loans and advances to customers | of which: Commodity trade finance
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	5,917	5,481	5,858
Gross carrying amount | Loans and advances to customers | of which: Ship / aircraft financing
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	8,329	8,823	9,265
Gross carrying amount | Loans and advances to customers | of which: Consumer financing
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	2,970	2,976	3,041
Gross carrying amount | Loans to financial advisors
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	2,647	2,664	2,665
Gross carrying amount | Twelve-month expected credit losses | Stages 1 and 2 | Loans and advances to customers | of which: Private clients with mortgages
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	241,557	239,471	256,675
Gross carrying amount | Twelve-month expected credit losses | Stages 1 and 2 | Loans and advances to customers | of which: Real estate financing
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	82,045	84,512	92,124
Gross carrying amount | Twelve-month expected credit losses | Stages 1 and 2 | Loans and advances to customers | of which: Large corporate clients
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	23,981	24,045	25,775
Gross carrying amount | Twelve-month expected credit losses | Stages 1 and 2 | Loans and advances to customers | of which: SME clients
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	19,646	20,570	22,226
Gross carrying amount | Twelve-month expected credit losses | Stages 1 and 2 | Loans and advances to customers | of which: Lombard
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	147,278	149,160	156,312
Gross carrying amount | Twelve-month expected credit losses | Stages 1 and 2 | Loans and advances to customers | of which: Credit cards
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	1,485	1,408	1,571
Gross carrying amount | Twelve-month expected credit losses | Stages 1 and 2 | Loans and advances to customers | of which: Commodity trade finance
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	5,575	5,186	5,681
Gross carrying amount | Twelve-month expected credit losses | Stages 1 and 2 | Loans and advances to customers | of which: Ship / aircraft financing
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	7,883	8,038	8,968
Gross carrying amount | Twelve-month expected credit losses | Stages 1 and 2 | Loans and advances to customers | of which: Consumer financing
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	2,723	2,649	2,817
Gross carrying amount | Twelve-month expected credit losses | Stages 1 and 2 | Loans to financial advisors
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	2,412	2,435	2,426
Gross carrying amount | Lifetime expected credit losses | Stages 1 and 2 | Loans and advances to customers | of which: Private clients with mortgages
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	10,154	11,412	10,792
Gross carrying amount | Lifetime expected credit losses | Stages 1 and 2 | Loans and advances to customers | of which: Real estate financing
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	4,538	5,472	5,398
Gross carrying amount | Lifetime expected credit losses | Stages 1 and 2 | Loans and advances to customers | of which: Large corporate clients
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	3,923	4,001	3,252
Gross carrying amount | Lifetime expected credit losses | Stages 1 and 2 | Loans and advances to customers | of which: SME clients
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	2,569	2,777	2,961
Gross carrying amount | Lifetime expected credit losses | Stages 1 and 2 | Loans and advances to customers | of which: Lombard
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	877	932	15
Gross carrying amount | Lifetime expected credit losses | Stages 1 and 2 | Loans and advances to customers | of which: Credit cards
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	419	410	449
Gross carrying amount | Lifetime expected credit losses | Stages 1 and 2 | Loans and advances to customers | of which: Commodity trade finance
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	224	168	26
Gross carrying amount | Lifetime expected credit losses | Stages 1 and 2 | Loans and advances to customers | of which: Ship / aircraft financing
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	426	782	276
Gross carrying amount | Lifetime expected credit losses | Stages 1 and 2 | Loans and advances to customers | of which: Consumer financing
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	140	218	110
Gross carrying amount | Lifetime expected credit losses | Stages 1 and 2 | Loans to financial advisors
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	84	71	80
Gross carrying amount | Lifetime expected credit losses | Stage 3 | Loans and advances to customers | of which: Private clients with mortgages
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	1,092	962	968
Gross carrying amount | Lifetime expected credit losses | Stage 3 | Loans and advances to customers | of which: Real estate financing
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	245	188	290
Gross carrying amount | Lifetime expected credit losses | Stage 3 | Loans and advances to customers | of which: Large corporate clients
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	972	1,008	1,012
Gross carrying amount | Lifetime expected credit losses | Stage 3 | Loans and advances to customers | of which: SME clients
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	1,463	1,286	1,031
Gross carrying amount | Lifetime expected credit losses | Stage 3 | Loans and advances to customers | of which: Lombard
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	71	590	67
Gross carrying amount | Lifetime expected credit losses | Stage 3 | Loans and advances to customers | of which: Credit cards
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	64	61	63
Gross carrying amount | Lifetime expected credit losses | Stage 3 | Loans and advances to customers | of which: Commodity trade finance
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	115	115	133
Gross carrying amount | Lifetime expected credit losses | Stage 3 | Loans and advances to customers | of which: Ship / aircraft financing
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	3	3	4
Gross carrying amount | Lifetime expected credit losses | Stage 3 | Loans and advances to customers | of which: Consumer financing
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	66	59	58
Gross carrying amount | Lifetime expected credit losses | Stage 3 | Loans to financial advisors
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	151	157	159
Gross carrying amount | Lifetime expected credit losses | Purchased credit-impaired (PCI) | Loans and advances to customers | of which: Private clients with mortgages
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	89	243	389
Gross carrying amount | Lifetime expected credit losses | Purchased credit-impaired (PCI) | Loans and advances to customers | of which: Real estate financing
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	78	111	108
Gross carrying amount | Lifetime expected credit losses | Purchased credit-impaired (PCI) | Loans and advances to customers | of which: Large corporate clients
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	424	534	620
Gross carrying amount | Lifetime expected credit losses | Purchased credit-impaired (PCI) | Loans and advances to customers | of which: SME clients
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	244	85	142
Gross carrying amount | Lifetime expected credit losses | Purchased credit-impaired (PCI) | Loans and advances to customers | of which: Lombard
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	82	138	0
Gross carrying amount | Lifetime expected credit losses | Purchased credit-impaired (PCI) | Loans and advances to customers | of which: Credit cards
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	0	0	0
Gross carrying amount | Lifetime expected credit losses | Purchased credit-impaired (PCI) | Loans and advances to customers | of which: Commodity trade finance
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	2	12	18
Gross carrying amount | Lifetime expected credit losses | Purchased credit-impaired (PCI) | Loans and advances to customers | of which: Ship / aircraft financing
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	17	0	17
Gross carrying amount | Lifetime expected credit losses | Purchased credit-impaired (PCI) | Loans and advances to customers | of which: Consumer financing
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	41	49	57
Gross carrying amount | Lifetime expected credit losses | Purchased credit-impaired (PCI) | Loans to financial advisors
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	0	0	0
Allowance for expected credit loss | Total on-balance sheet financial assets in scope of ECL requirements
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	(1,964)	(1,915)	(1,911)
Allowance for expected credit loss | Total financial assets measured at amortized cost
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	(1,964)	(1,915)	(1,911)
Allowance for expected credit loss | Cash and balances at central banks
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	(60)	(55)	(48)
Allowance for expected credit loss | Amounts due from banks
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	(28)	(24)	(12)
Allowance for expected credit loss | Receivables from securities financing transactions measured at amortized cost
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	(2)	(2)	(2)
Allowance for expected credit loss | Cash collateral receivables on derivative instruments
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	0	0	0
Allowance for expected credit loss | Loans and advances to customers
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	(1,743)	(1,700)	(1,698)
Allowance for expected credit loss | Loans and advances to customers | of which: Private clients with mortgages
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	(167)	(196)	(209)
Allowance for expected credit loss | Loans and advances to customers | of which: Real estate financing
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	(53)	(64)	(103)
Allowance for expected credit loss | Loans and advances to customers | of which: Large corporate clients
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	(526)	(580)	(575)
Allowance for expected credit loss | Loans and advances to customers | of which: SME clients
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	(515)	(442)	(402)
Allowance for expected credit loss | Loans and advances to customers | of which: Lombard
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	(41)	(61)	(41)
Allowance for expected credit loss | Loans and advances to customers | of which: Credit cards
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	(41)	(40)	(42)
Allowance for expected credit loss | Loans and advances to customers | of which: Commodity trade finance
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	(125)	(123)	(130)
Allowance for expected credit loss | Loans and advances to customers | of which: Ship / aircraft financing
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	(44)	(47)	(51)
Allowance for expected credit loss | Loans and advances to customers | of which: Consumer financing
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	(68)	(64)	(59)
Allowance for expected credit loss | Other financial assets measured at amortized cost
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	(131)	(134)	(151)
Allowance for expected credit loss | Loans to financial advisors
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	(47)	(49)	(49)
Allowance for expected credit loss | Financial assets measured at fair value through other comprehensive income
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	0	0	0
Allowance for expected credit loss | Twelve-month expected credit losses | Stages 1 and 2 | Total on-balance sheet financial assets in scope of ECL requirements
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	(397)	(405)	(473)
Allowance for expected credit loss | Twelve-month expected credit losses | Stages 1 and 2 | Total financial assets measured at amortized cost
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	(397)	(405)	(473)
Allowance for expected credit loss | Twelve-month expected credit losses | Stages 1 and 2 | Cash and balances at central banks
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	(1)	0	0
Allowance for expected credit loss | Twelve-month expected credit losses | Stages 1 and 2 | Amounts due from banks
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	(6)	(6)	(6)
Allowance for expected credit loss | Twelve-month expected credit losses | Stages 1 and 2 | Receivables from securities financing transactions measured at amortized cost
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	(2)	(2)	(2)
Allowance for expected credit loss | Twelve-month expected credit losses | Stages 1 and 2 | Cash collateral receivables on derivative instruments
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	0	0	0
Allowance for expected credit loss | Twelve-month expected credit losses | Stages 1 and 2 | Loans and advances to customers
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	(355)	(362)	(423)
Allowance for expected credit loss | Twelve-month expected credit losses | Stages 1 and 2 | Loans and advances to customers | of which: Private clients with mortgages
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	(57)	(55)	(62)
Allowance for expected credit loss | Twelve-month expected credit losses | Stages 1 and 2 | Loans and advances to customers | of which: Real estate financing
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	(28)	(27)	(41)
Allowance for expected credit loss | Twelve-month expected credit losses | Stages 1 and 2 | Loans and advances to customers | of which: Large corporate clients
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	(93)	(91)	(105)
Allowance for expected credit loss | Twelve-month expected credit losses | Stages 1 and 2 | Loans and advances to customers | of which: SME clients
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	(60)	(64)	(71)
Allowance for expected credit loss | Twelve-month expected credit losses | Stages 1 and 2 | Loans and advances to customers | of which: Lombard
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	(6)	(7)	(13)
Allowance for expected credit loss | Twelve-month expected credit losses | Stages 1 and 2 | Loans and advances to customers | of which: Credit cards
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	(6)	(6)	(6)
Allowance for expected credit loss | Twelve-month expected credit losses | Stages 1 and 2 | Loans and advances to customers | of which: Commodity trade finance
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	(19)	(17)	(18)
Allowance for expected credit loss | Twelve-month expected credit losses | Stages 1 and 2 | Loans and advances to customers | of which: Ship / aircraft financing
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	(38)	(40)	(48)
Allowance for expected credit loss | Twelve-month expected credit losses | Stages 1 and 2 | Loans and advances to customers | of which: Consumer financing
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	(20)	(20)	(22)
Allowance for expected credit loss | Twelve-month expected credit losses | Stages 1 and 2 | Other financial assets measured at amortized cost
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	(34)	(35)	(41)
Allowance for expected credit loss | Twelve-month expected credit losses | Stages 1 and 2 | Loans to financial advisors
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	(4)	(6)	(4)
Allowance for expected credit loss | Twelve-month expected credit losses | Stages 1 and 2 | Financial assets measured at fair value through other comprehensive income
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	0	0	0
Allowance for expected credit loss | Lifetime expected credit losses | Stages 1 and 2 | Total on-balance sheet financial assets in scope of ECL requirements
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	(333)	(318)	(326)
Allowance for expected credit loss | Lifetime expected credit losses | Stages 1 and 2 | Total financial assets measured at amortized cost
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	(333)	(318)	(326)
Allowance for expected credit loss | Lifetime expected credit losses | Stages 1 and 2 | Cash and balances at central banks
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	(27)	(25)	(26)
Allowance for expected credit loss | Lifetime expected credit losses | Stages 1 and 2 | Amounts due from banks
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	0	0	(1)
Allowance for expected credit loss | Lifetime expected credit losses | Stages 1 and 2 | Receivables from securities financing transactions measured at amortized cost
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	0	0	0
Allowance for expected credit loss | Lifetime expected credit losses | Stages 1 and 2 | Cash collateral receivables on derivative instruments
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	0	0	0
Allowance for expected credit loss | Lifetime expected credit losses | Stages 1 and 2 | Loans and advances to customers
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	(298)	(284)	(289)
Allowance for expected credit loss | Lifetime expected credit losses | Stages 1 and 2 | Loans and advances to customers | of which: Private clients with mortgages
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	(77)	(92)	(97)
Allowance for expected credit loss | Lifetime expected credit losses | Stages 1 and 2 | Loans and advances to customers | of which: Real estate financing
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	(31)	(28)	(31)
Allowance for expected credit loss | Lifetime expected credit losses | Stages 1 and 2 | Loans and advances to customers | of which: Large corporate clients
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	(94)	(83)	(70)
Allowance for expected credit loss | Lifetime expected credit losses | Stages 1 and 2 | Loans and advances to customers | of which: SME clients
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	(38)	(32)	(42)
Allowance for expected credit loss | Lifetime expected credit losses | Stages 1 and 2 | Loans and advances to customers | of which: Lombard
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	(2)	(1)	(11)
Allowance for expected credit loss | Lifetime expected credit losses | Stages 1 and 2 | Loans and advances to customers | of which: Credit cards
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	(11)	(10)	(11)
Allowance for expected credit loss | Lifetime expected credit losses | Stages 1 and 2 | Loans and advances to customers | of which: Commodity trade finance
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	(2)	(2)	(1)
Allowance for expected credit loss | Lifetime expected credit losses | Stages 1 and 2 | Loans and advances to customers | of which: Ship / aircraft financing
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	(4)	(7)	(3)
Allowance for expected credit loss | Lifetime expected credit losses | Stages 1 and 2 | Loans and advances to customers | of which: Consumer financing
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	(21)	(19)	(17)
Allowance for expected credit loss | Lifetime expected credit losses | Stages 1 and 2 | Other financial assets measured at amortized cost
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	(8)	(9)	(10)
Allowance for expected credit loss | Lifetime expected credit losses | Stages 1 and 2 | Loans to financial advisors
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	(1)	(1)	(1)
Allowance for expected credit loss | Lifetime expected credit losses | Stages 1 and 2 | Financial assets measured at fair value through other comprehensive income
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	0	0	0
Allowance for expected credit loss | Lifetime expected credit losses | Stage 3 | Total on-balance sheet financial assets in scope of ECL requirements
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	(1,021)	(1,003)	(956)
Allowance for expected credit loss | Lifetime expected credit losses | Stage 3 | Total financial assets measured at amortized cost
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	(1,021)	(1,003)	(956)
Allowance for expected credit loss | Lifetime expected credit losses | Stage 3 | Cash and balances at central banks
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	0	0	0
Allowance for expected credit loss | Lifetime expected credit losses | Stage 3 | Amounts due from banks
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	0	0	0
Allowance for expected credit loss | Lifetime expected credit losses | Stage 3 | Receivables from securities financing transactions measured at amortized cost
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	0	0	0
Allowance for expected credit loss | Lifetime expected credit losses | Stage 3 | Cash collateral receivables on derivative instruments
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	0	0	0
Allowance for expected credit loss | Lifetime expected credit losses | Stage 3 | Loans and advances to customers
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	(937)	(920)	(862)
Allowance for expected credit loss | Lifetime expected credit losses | Stage 3 | Loans and advances to customers | of which: Private clients with mortgages
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	(30)	(39)	(39)
Allowance for expected credit loss | Lifetime expected credit losses | Stage 3 | Loans and advances to customers | of which: Real estate financing
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	(2)	(9)	(21)
Allowance for expected credit loss | Lifetime expected credit losses | Stage 3 | Loans and advances to customers | of which: Large corporate clients
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	(272)	(318)	(312)
Allowance for expected credit loss | Lifetime expected credit losses | Stage 3 | Loans and advances to customers | of which: SME clients
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	(414)	(335)	(277)
Allowance for expected credit loss | Lifetime expected credit losses | Stage 3 | Loans and advances to customers | of which: Lombard
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	(16)	(41)	(17)
Allowance for expected credit loss | Lifetime expected credit losses | Stage 3 | Loans and advances to customers | of which: Credit cards
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	(25)	(23)	(24)
Allowance for expected credit loss | Lifetime expected credit losses | Stage 3 | Loans and advances to customers | of which: Commodity trade finance
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	(104)	(104)	(111)
Allowance for expected credit loss | Lifetime expected credit losses | Stage 3 | Loans and advances to customers | of which: Ship / aircraft financing
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	0	0	0
Allowance for expected credit loss | Lifetime expected credit losses | Stage 3 | Loans and advances to customers | of which: Consumer financing
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	(27)	(24)	(20)
Allowance for expected credit loss | Lifetime expected credit losses | Stage 3 | Other financial assets measured at amortized cost
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	(84)	(83)	(94)
Allowance for expected credit loss | Lifetime expected credit losses | Stage 3 | Loans to financial advisors
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	(41)	(43)	(44)
Allowance for expected credit loss | Lifetime expected credit losses | Stage 3 | Financial assets measured at fair value through other comprehensive income
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	0	0	0
Allowance for expected credit loss | Lifetime expected credit losses | Purchased credit-impaired (PCI) | Total on-balance sheet financial assets in scope of ECL requirements
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	(212)	(189)	(156)
Allowance for expected credit loss | Lifetime expected credit losses | Purchased credit-impaired (PCI) | Total financial assets measured at amortized cost
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	(212)	(189)	(156)
Allowance for expected credit loss | Lifetime expected credit losses | Purchased credit-impaired (PCI) | Cash and balances at central banks
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	(32)	(30)	(22)
Allowance for expected credit loss | Lifetime expected credit losses | Purchased credit-impaired (PCI) | Amounts due from banks
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	(22)	(18)	(5)
Allowance for expected credit loss | Lifetime expected credit losses | Purchased credit-impaired (PCI) | Receivables from securities financing transactions measured at amortized cost
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	0	0	0
Allowance for expected credit loss | Lifetime expected credit losses | Purchased credit-impaired (PCI) | Cash collateral receivables on derivative instruments
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	0	0	0
Allowance for expected credit loss | Lifetime expected credit losses | Purchased credit-impaired (PCI) | Loans and advances to customers
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	(153)	(134)	(123)
Allowance for expected credit loss | Lifetime expected credit losses | Purchased credit-impaired (PCI) | Loans and advances to customers | of which: Private clients with mortgages
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	(3)	(10)	(11)
Allowance for expected credit loss | Lifetime expected credit losses | Purchased credit-impaired (PCI) | Loans and advances to customers | of which: Real estate financing
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	8	0	(11)
Allowance for expected credit loss | Lifetime expected credit losses | Purchased credit-impaired (PCI) | Loans and advances to customers | of which: Large corporate clients
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	(67)	(87)	(89)
Allowance for expected credit loss | Lifetime expected credit losses | Purchased credit-impaired (PCI) | Loans and advances to customers | of which: SME clients
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	(3)	(11)	(13)
Allowance for expected credit loss | Lifetime expected credit losses | Purchased credit-impaired (PCI) | Loans and advances to customers | of which: Lombard
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	(16)	(12)	0
Allowance for expected credit loss | Lifetime expected credit losses | Purchased credit-impaired (PCI) | Loans and advances to customers | of which: Credit cards
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	0	0	0
Allowance for expected credit loss | Lifetime expected credit losses | Purchased credit-impaired (PCI) | Loans and advances to customers | of which: Commodity trade finance
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	0	0	0
Allowance for expected credit loss | Lifetime expected credit losses | Purchased credit-impaired (PCI) | Loans and advances to customers | of which: Ship / aircraft financing
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	(2)	0	(1)
Allowance for expected credit loss | Lifetime expected credit losses | Purchased credit-impaired (PCI) | Loans and advances to customers | of which: Consumer financing
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	0	0	0
Allowance for expected credit loss | Lifetime expected credit losses | Purchased credit-impaired (PCI) | Other financial assets measured at amortized cost
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	(5)	(6)	(5)
Allowance for expected credit loss | Lifetime expected credit losses | Purchased credit-impaired (PCI) | Loans to financial advisors
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	0	0	0
Allowance for expected credit loss | Lifetime expected credit losses | Purchased credit-impaired (PCI) | Financial assets measured at fair value through other comprehensive income
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	$ 0	$ 0	$ 0

Expected credit loss measure_10

Expected credit loss measurement - Off-balance sheet financial assets subject to ECL (Detail) - USD ($) $ in Millions	Jun. 30, 2024	Mar. 31, 2024	Dec. 31, 2023
Disclosure Of Provision Matrix [Line Items]
Total off-balance sheet financial instruments and other credit lines	$ 284,611	$ 301,322	$ 324,141
Total ECL provisions	(294)	(328)	(350)
Total allowance and provisions	(2,258)	(2,243)	(2,261)
Guarantees
Disclosure Of Provision Matrix [Line Items]
Total off-balance sheet financial instruments and other credit lines	40,759	41,744	46,191
Total ECL provisions	(63)	(64)	(73)
Guarantees | of which: Large corporate clients
Disclosure Of Provision Matrix [Line Items]
Total off-balance sheet financial instruments and other credit lines	8,290	8,643	9,267
Total ECL provisions	(24)	(25)	(31)
Guarantees | of which: SME clients
Disclosure Of Provision Matrix [Line Items]
Total off-balance sheet financial instruments and other credit lines	2,540	2,670	2,839
Total ECL provisions	(10)	(9)	(14)
Guarantees | of which: Financial intermediaries and hedge funds
Disclosure Of Provision Matrix [Line Items]
Total off-balance sheet financial instruments and other credit lines	21,270	20,920	22,922
Total ECL provisions	(11)	(11)	(12)
Guarantees | of which: Lombard
Disclosure Of Provision Matrix [Line Items]
Total off-balance sheet financial instruments and other credit lines	3,895	3,959	5,045
Total ECL provisions	(4)	(7)	(1)
Guarantees | of which: Commodity trade finance
Disclosure Of Provision Matrix [Line Items]
Total off-balance sheet financial instruments and other credit lines	1,642	2,088	2,037
Total ECL provisions	(1)	(1)	(1)
Irrevocable loan commitments
Disclosure Of Provision Matrix [Line Items]
Total off-balance sheet financial instruments and other credit lines	81,867	87,292	91,643
Total ECL provisions	(147)	(173)	(178)
Irrevocable loan commitments | of which: Large corporate clients
Disclosure Of Provision Matrix [Line Items]
Total off-balance sheet financial instruments and other credit lines	46,697	48,060	50,696
Total ECL provisions	(126)	(152)	(149)
Forward starting reverse repurchase and securities borrowing agreements
Disclosure Of Provision Matrix [Line Items]
Total off-balance sheet financial instruments and other credit lines	9,724	17,649	18,444
Total ECL provisions	0	0	0
Unconditionally revocable loan commitments
Disclosure Of Provision Matrix [Line Items]
Total off-balance sheet financial instruments and other credit lines	148,932	150,918	163,256
Total ECL provisions	(81)	(89)	(95)
Unconditionally revocable loan commitments | of which: Real estate financing
Disclosure Of Provision Matrix [Line Items]
Total off-balance sheet financial instruments and other credit lines	11,705	12,318	15,846
Total ECL provisions	(7)	(10)	(14)
Unconditionally revocable loan commitments | of which: Large corporate clients
Disclosure Of Provision Matrix [Line Items]
Total off-balance sheet financial instruments and other credit lines	16,000	16,793	17,139
Total ECL provisions	(23)	(25)	(23)
Unconditionally revocable loan commitments | of which: SME clients
Disclosure Of Provision Matrix [Line Items]
Total off-balance sheet financial instruments and other credit lines	11,002	10,548	11,658
Total ECL provisions	(34)	(36)	(38)
Unconditionally revocable loan commitments | of which: Lombard
Disclosure Of Provision Matrix [Line Items]
Total off-balance sheet financial instruments and other credit lines	60,962	61,036	77,618
Total ECL provisions	0	0	0
Unconditionally revocable loan commitments | of which: Credit cards
Disclosure Of Provision Matrix [Line Items]
Total off-balance sheet financial instruments and other credit lines	10,056	10,049	10,458
Total ECL provisions	(8)	(9)	(10)
Irrevocable committed prolongation of existing loans
Disclosure Of Provision Matrix [Line Items]
Total off-balance sheet financial instruments and other credit lines	3,329	3,719	4,608
Total ECL provisions	(2)	(3)	(4)
Stages 1 and 2
Disclosure Of Provision Matrix [Line Items]
Total allowance and provisions	1,001
Twelve-month expected credit losses | Stages 1 and 2
Disclosure Of Provision Matrix [Line Items]
Total off-balance sheet financial instruments and other credit lines	276,199	292,385	315,060
Total ECL provisions	(200)	(215)	(226)
Total allowance and provisions	(597)	(620)	(700)
Twelve-month expected credit losses | Stages 1 and 2 | Guarantees
Disclosure Of Provision Matrix [Line Items]
Total off-balance sheet financial instruments and other credit lines	39,176	40,211	44,487
Total ECL provisions	(25)	(27)	(28)
Twelve-month expected credit losses | Stages 1 and 2 | Guarantees | of which: Large corporate clients
Disclosure Of Provision Matrix [Line Items]
Total off-balance sheet financial instruments and other credit lines	7,390	7,710	8,138
Total ECL provisions	(10)	(10)	(11)
Twelve-month expected credit losses | Stages 1 and 2 | Guarantees | of which: SME clients
Disclosure Of Provision Matrix [Line Items]
Total off-balance sheet financial instruments and other credit lines	2,153	2,274	2,469
Total ECL provisions	(5)	(4)	(4)
Twelve-month expected credit losses | Stages 1 and 2 | Guarantees | of which: Financial intermediaries and hedge funds
Disclosure Of Provision Matrix [Line Items]
Total off-balance sheet financial instruments and other credit lines	21,080	20,865	22,876
Total ECL provisions	(8)	(8)	(8)
Twelve-month expected credit losses | Stages 1 and 2 | Guarantees | of which: Lombard
Disclosure Of Provision Matrix [Line Items]
Total off-balance sheet financial instruments and other credit lines	3,872	3,947	5,045
Total ECL provisions	0	0	0
Twelve-month expected credit losses | Stages 1 and 2 | Guarantees | of which: Commodity trade finance
Disclosure Of Provision Matrix [Line Items]
Total off-balance sheet financial instruments and other credit lines	1,628	2,077	2,027
Total ECL provisions	(1)	(1)	(1)
Twelve-month expected credit losses | Stages 1 and 2 | Irrevocable loan commitments
Disclosure Of Provision Matrix [Line Items]
Total off-balance sheet financial instruments and other credit lines	77,447	82,700	87,080
Total ECL provisions	(104)	(112)	(117)
Twelve-month expected credit losses | Stages 1 and 2 | Irrevocable loan commitments | of which: Large corporate clients
Disclosure Of Provision Matrix [Line Items]
Total off-balance sheet financial instruments and other credit lines	42,890	44,281	46,708
Total ECL provisions	(84)	(93)	(94)
Twelve-month expected credit losses | Stages 1 and 2 | Forward starting reverse repurchase and securities borrowing agreements
Disclosure Of Provision Matrix [Line Items]
Total off-balance sheet financial instruments and other credit lines	9,724	17,649	18,444
Total ECL provisions	0	0	0
Twelve-month expected credit losses | Stages 1 and 2 | Unconditionally revocable loan commitments
Disclosure Of Provision Matrix [Line Items]
Total off-balance sheet financial instruments and other credit lines	146,532	148,116	160,456
Total ECL provisions	(69)	(73)	(78)
Twelve-month expected credit losses | Stages 1 and 2 | Unconditionally revocable loan commitments | of which: Real estate financing
Disclosure Of Provision Matrix [Line Items]
Total off-balance sheet financial instruments and other credit lines	11,154	11,616	15,033
Total ECL provisions	(7)	(10)	(11)
Twelve-month expected credit losses | Stages 1 and 2 | Unconditionally revocable loan commitments | of which: Large corporate clients
Disclosure Of Provision Matrix [Line Items]
Total off-balance sheet financial instruments and other credit lines	15,677	16,422	16,678
Total ECL provisions	(16)	(18)	(17)
Twelve-month expected credit losses | Stages 1 and 2 | Unconditionally revocable loan commitments | of which: SME clients
Disclosure Of Provision Matrix [Line Items]
Total off-balance sheet financial instruments and other credit lines	10,575	10,205	11,253
Total ECL provisions	(29)	(31)	(33)
Twelve-month expected credit losses | Stages 1 and 2 | Unconditionally revocable loan commitments | of which: Lombard
Disclosure Of Provision Matrix [Line Items]
Total off-balance sheet financial instruments and other credit lines	60,934	60,901	77,618
Total ECL provisions	0	0	0
Twelve-month expected credit losses | Stages 1 and 2 | Unconditionally revocable loan commitments | of which: Credit cards
Disclosure Of Provision Matrix [Line Items]
Total off-balance sheet financial instruments and other credit lines	9,576	9,560	9,932
Total ECL provisions	(6)	(8)	(8)
Twelve-month expected credit losses | Stages 1 and 2 | Irrevocable committed prolongation of existing loans
Disclosure Of Provision Matrix [Line Items]
Total off-balance sheet financial instruments and other credit lines	3,319	3,709	4,593
Total ECL provisions	(2)	(3)	(4)
Lifetime expected credit losses | Stages 1 and 2
Disclosure Of Provision Matrix [Line Items]
Total off-balance sheet financial instruments and other credit lines	7,779	8,271	8,456
Total ECL provisions	(70)	(88)	(90)
Total allowance and provisions	(404)	(406)	(416)
Lifetime expected credit losses | Stages 1 and 2 | Guarantees
Disclosure Of Provision Matrix [Line Items]
Total off-balance sheet financial instruments and other credit lines	1,382	1,314	1,495
Total ECL provisions	(14)	(18)	(22)
Lifetime expected credit losses | Stages 1 and 2 | Guarantees | of which: Large corporate clients
Disclosure Of Provision Matrix [Line Items]
Total off-balance sheet financial instruments and other credit lines	820	841	1,023
Total ECL provisions	(8)	(11)	(13)
Lifetime expected credit losses | Stages 1 and 2 | Guarantees | of which: SME clients
Disclosure Of Provision Matrix [Line Items]
Total off-balance sheet financial instruments and other credit lines	287	286	337
Total ECL provisions	(3)	(3)	(5)
Lifetime expected credit losses | Stages 1 and 2 | Guarantees | of which: Financial intermediaries and hedge funds
Disclosure Of Provision Matrix [Line Items]
Total off-balance sheet financial instruments and other credit lines	189	55	46
Total ECL provisions	(3)	(3)	(3)
Lifetime expected credit losses | Stages 1 and 2 | Guarantees | of which: Lombard
Disclosure Of Provision Matrix [Line Items]
Total off-balance sheet financial instruments and other credit lines	10	6	0
Total ECL provisions	0	0	0
Lifetime expected credit losses | Stages 1 and 2 | Guarantees | of which: Commodity trade finance
Disclosure Of Provision Matrix [Line Items]
Total off-balance sheet financial instruments and other credit lines	13	11	9
Total ECL provisions	0	0	0
Lifetime expected credit losses | Stages 1 and 2 | Irrevocable loan commitments
Disclosure Of Provision Matrix [Line Items]
Total off-balance sheet financial instruments and other credit lines	4,236	4,335	4,297
Total ECL provisions	(43)	(54)	(51)
Lifetime expected credit losses | Stages 1 and 2 | Irrevocable loan commitments | of which: Large corporate clients
Disclosure Of Provision Matrix [Line Items]
Total off-balance sheet financial instruments and other credit lines	3,699	3,682	3,881
Total ECL provisions	(36)	(47)	(41)
Lifetime expected credit losses | Stages 1 and 2 | Forward starting reverse repurchase and securities borrowing agreements
Disclosure Of Provision Matrix [Line Items]
Total off-balance sheet financial instruments and other credit lines	0	0	0
Total ECL provisions	0	0	0
Lifetime expected credit losses | Stages 1 and 2 | Unconditionally revocable loan commitments
Disclosure Of Provision Matrix [Line Items]
Total off-balance sheet financial instruments and other credit lines	2,154	2,616	2,654
Total ECL provisions	(12)	(15)	(17)
Lifetime expected credit losses | Stages 1 and 2 | Unconditionally revocable loan commitments | of which: Real estate financing
Disclosure Of Provision Matrix [Line Items]
Total off-balance sheet financial instruments and other credit lines	552	703	813
Total ECL provisions	0	0	(3)
Lifetime expected credit losses | Stages 1 and 2 | Unconditionally revocable loan commitments | of which: Large corporate clients
Disclosure Of Provision Matrix [Line Items]
Total off-balance sheet financial instruments and other credit lines	314	358	454
Total ECL provisions	(4)	(7)	(6)
Lifetime expected credit losses | Stages 1 and 2 | Unconditionally revocable loan commitments | of which: SME clients
Disclosure Of Provision Matrix [Line Items]
Total off-balance sheet financial instruments and other credit lines	346	313	375
Total ECL provisions	(5)	(5)	(5)
Lifetime expected credit losses | Stages 1 and 2 | Unconditionally revocable loan commitments | of which: Lombard
Disclosure Of Provision Matrix [Line Items]
Total off-balance sheet financial instruments and other credit lines	26	133	0
Total ECL provisions	0	0	0
Lifetime expected credit losses | Stages 1 and 2 | Unconditionally revocable loan commitments | of which: Credit cards
Disclosure Of Provision Matrix [Line Items]
Total off-balance sheet financial instruments and other credit lines	477	485	522
Total ECL provisions	(2)	(2)	(2)
Lifetime expected credit losses | Stages 1 and 2 | Irrevocable committed prolongation of existing loans
Disclosure Of Provision Matrix [Line Items]
Total off-balance sheet financial instruments and other credit lines	7	7	11
Total ECL provisions	0	0	0
Lifetime expected credit losses | Stage 3
Disclosure Of Provision Matrix [Line Items]
Total off-balance sheet financial instruments and other credit lines	551	593	519
Total ECL provisions	(31)	(32)	(37)
Total allowance and provisions	(1,053)	(1,035)	(993)
Lifetime expected credit losses | Stage 3 | Guarantees
Disclosure Of Provision Matrix [Line Items]
Total off-balance sheet financial instruments and other credit lines	159	173	151
Total ECL provisions	(26)	(19)	(23)
Lifetime expected credit losses | Stage 3 | Guarantees | of which: Large corporate clients
Disclosure Of Provision Matrix [Line Items]
Total off-balance sheet financial instruments and other credit lines	67	78	89
Total ECL provisions	(7)	(4)	(7)
Lifetime expected credit losses | Stage 3 | Guarantees | of which: SME clients
Disclosure Of Provision Matrix [Line Items]
Total off-balance sheet financial instruments and other credit lines	77	86	31
Total ECL provisions	(4)	(2)	(5)
Lifetime expected credit losses | Stage 3 | Guarantees | of which: Financial intermediaries and hedge funds
Disclosure Of Provision Matrix [Line Items]
Total off-balance sheet financial instruments and other credit lines	0	0	0
Total ECL provisions	0	0	0
Lifetime expected credit losses | Stage 3 | Guarantees | of which: Lombard
Disclosure Of Provision Matrix [Line Items]
Total off-balance sheet financial instruments and other credit lines	13	5	0
Total ECL provisions	(4)	(7)	(1)
Lifetime expected credit losses | Stage 3 | Guarantees | of which: Commodity trade finance
Disclosure Of Provision Matrix [Line Items]
Total off-balance sheet financial instruments and other credit lines	0	0	0
Total ECL provisions	0	0	0
Lifetime expected credit losses | Stage 3 | Irrevocable loan commitments
Disclosure Of Provision Matrix [Line Items]
Total off-balance sheet financial instruments and other credit lines	145	230	218
Total ECL provisions	(6)	(13)	(14)
Lifetime expected credit losses | Stage 3 | Irrevocable loan commitments | of which: Large corporate clients
Disclosure Of Provision Matrix [Line Items]
Total off-balance sheet financial instruments and other credit lines	73	77	59
Total ECL provisions	(6)	(13)	(12)
Lifetime expected credit losses | Stage 3 | Forward starting reverse repurchase and securities borrowing agreements
Disclosure Of Provision Matrix [Line Items]
Total off-balance sheet financial instruments and other credit lines	0	0	0
Total ECL provisions	0	0	0
Lifetime expected credit losses | Stage 3 | Unconditionally revocable loan commitments
Disclosure Of Provision Matrix [Line Items]
Total off-balance sheet financial instruments and other credit lines	245	186	146
Total ECL provisions	0	0	0
Lifetime expected credit losses | Stage 3 | Unconditionally revocable loan commitments | of which: Real estate financing
Disclosure Of Provision Matrix [Line Items]
Total off-balance sheet financial instruments and other credit lines	0	0	0
Total ECL provisions	0	0	0
Lifetime expected credit losses | Stage 3 | Unconditionally revocable loan commitments | of which: Large corporate clients
Disclosure Of Provision Matrix [Line Items]
Total off-balance sheet financial instruments and other credit lines	9	12	8
Total ECL provisions	(2)	0	0
Lifetime expected credit losses | Stage 3 | Unconditionally revocable loan commitments | of which: SME clients
Disclosure Of Provision Matrix [Line Items]
Total off-balance sheet financial instruments and other credit lines	80	30	29
Total ECL provisions	0	0	0
Lifetime expected credit losses | Stage 3 | Unconditionally revocable loan commitments | of which: Lombard
Disclosure Of Provision Matrix [Line Items]
Total off-balance sheet financial instruments and other credit lines	1	1	1
Total ECL provisions	0	0	0
Lifetime expected credit losses | Stage 3 | Unconditionally revocable loan commitments | of which: Credit cards
Disclosure Of Provision Matrix [Line Items]
Total off-balance sheet financial instruments and other credit lines	4	4	4
Total ECL provisions	0	0	0
Lifetime expected credit losses | Stage 3 | Irrevocable committed prolongation of existing loans
Disclosure Of Provision Matrix [Line Items]
Total off-balance sheet financial instruments and other credit lines	2	3	4
Total ECL provisions	0	0	0
Lifetime expected credit losses | Purchased credit-impaired (PCI)
Disclosure Of Provision Matrix [Line Items]
Total off-balance sheet financial instruments and other credit lines	83	72	106
Total ECL provisions	8	7	3
Total allowance and provisions	(204)	(182)	(153)
Lifetime expected credit losses | Purchased credit-impaired (PCI) | Guarantees
Disclosure Of Provision Matrix [Line Items]
Total off-balance sheet financial instruments and other credit lines	44	45	58
Total ECL provisions	2	1	0
Lifetime expected credit losses | Purchased credit-impaired (PCI) | Guarantees | of which: Large corporate clients
Disclosure Of Provision Matrix [Line Items]
Total off-balance sheet financial instruments and other credit lines	15	14	17
Total ECL provisions	0	0	0
Lifetime expected credit losses | Purchased credit-impaired (PCI) | Guarantees | of which: SME clients
Disclosure Of Provision Matrix [Line Items]
Total off-balance sheet financial instruments and other credit lines	22	23	2
Total ECL provisions	2	1	0
Lifetime expected credit losses | Purchased credit-impaired (PCI) | Guarantees | of which: Financial intermediaries and hedge funds
Disclosure Of Provision Matrix [Line Items]
Total off-balance sheet financial instruments and other credit lines	0	0	0
Total ECL provisions	0	0	0
Lifetime expected credit losses | Purchased credit-impaired (PCI) | Guarantees | of which: Lombard
Disclosure Of Provision Matrix [Line Items]
Total off-balance sheet financial instruments and other credit lines	0	0	0
Total ECL provisions	0	0	0
Lifetime expected credit losses | Purchased credit-impaired (PCI) | Guarantees | of which: Commodity trade finance
Disclosure Of Provision Matrix [Line Items]
Total off-balance sheet financial instruments and other credit lines	0	0	0
Total ECL provisions	0	0	0
Lifetime expected credit losses | Purchased credit-impaired (PCI) | Irrevocable loan commitments
Disclosure Of Provision Matrix [Line Items]
Total off-balance sheet financial instruments and other credit lines	39	27	48
Total ECL provisions	6	6	4
Lifetime expected credit losses | Purchased credit-impaired (PCI) | Irrevocable loan commitments | of which: Large corporate clients
Disclosure Of Provision Matrix [Line Items]
Total off-balance sheet financial instruments and other credit lines	34	21	48
Total ECL provisions	0	0	(2)
Lifetime expected credit losses | Purchased credit-impaired (PCI) | Forward starting reverse repurchase and securities borrowing agreements
Disclosure Of Provision Matrix [Line Items]
Total off-balance sheet financial instruments and other credit lines	0	0	0
Total ECL provisions	0	0	0
Lifetime expected credit losses | Purchased credit-impaired (PCI) | Unconditionally revocable loan commitments
Disclosure Of Provision Matrix [Line Items]
Total off-balance sheet financial instruments and other credit lines	0	0	0
Total ECL provisions	0	0	0
Lifetime expected credit losses | Purchased credit-impaired (PCI) | Unconditionally revocable loan commitments | of which: Real estate financing
Disclosure Of Provision Matrix [Line Items]
Total off-balance sheet financial instruments and other credit lines	0	0	0
Total ECL provisions	0	0	0
Lifetime expected credit losses | Purchased credit-impaired (PCI) | Unconditionally revocable loan commitments | of which: Large corporate clients
Disclosure Of Provision Matrix [Line Items]
Total off-balance sheet financial instruments and other credit lines	0	0	0
Total ECL provisions	0	0	0
Lifetime expected credit losses | Purchased credit-impaired (PCI) | Unconditionally revocable loan commitments | of which: SME clients
Disclosure Of Provision Matrix [Line Items]
Total off-balance sheet financial instruments and other credit lines	0	0	0
Total ECL provisions	0	0	0
Lifetime expected credit losses | Purchased credit-impaired (PCI) | Unconditionally revocable loan commitments | of which: Lombard
Disclosure Of Provision Matrix [Line Items]
Total off-balance sheet financial instruments and other credit lines	0	0	0
Total ECL provisions	0	0	0
Lifetime expected credit losses | Purchased credit-impaired (PCI) | Unconditionally revocable loan commitments | of which: Credit cards
Disclosure Of Provision Matrix [Line Items]
Total off-balance sheet financial instruments and other credit lines	0	0	0
Total ECL provisions	0	0	0
Lifetime expected credit losses | Purchased credit-impaired (PCI) | Irrevocable committed prolongation of existing loans
Disclosure Of Provision Matrix [Line Items]
Total off-balance sheet financial instruments and other credit lines	0	0	0
Total ECL provisions	$ 0	$ 0	$ 0

Expected credit loss measure_11

Expected credit loss measurement - Coverage ratios (Detail 1) - USD ($) $ in Millions	Jun. 30, 2024	Mar. 31, 2024	Dec. 31, 2023
Disclosure Of Credit Risk Exposure [Line Items]
Total on- and off-balance sheet	$ 878,385	$ 893,144	$ 949,729
ECL coverage	0.24%	0.23%	0.22%
Total on-balance sheet financial assets in scope of ECL requirements
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	$ 1,057,661	$ 1,111,823	$ 1,191,684
Total financial assets measured at amortized cost
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	1,055,494	1,109,745	1,189,451
Loans and advances to customers
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	599,105	605,108	639,669
Loans and advances to customers | Private clients with mortgages
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	252,724	251,891	268,616
Loans and advances to customers | Real estate financing
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	86,854	90,220	97,817
Loans and advances to customers | Large corporate clients
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	28,773	29,008	30,084
Loans and advances to customers | SME clients
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	23,406	24,276	25,957
Loans and advances to customers | Lombard
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	148,268	150,759	156,353
Loans and advances to customers | Credit cards
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	1,927	1,840	2,041
Loans and advances to customers | Commodity trade finance
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	5,792	5,358	5,727
Loans and advances to customers | Ship / aircraft financing
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	8,284	8,777	9,214
Loans and advances to customers | Consumer financing
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	2,902	2,912	2,982
Other financial assets measured at amortized cost
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	60,431	62,707	65,455
Loans to financial advisors
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	$ 2,601	$ 2,615	$ 2,615
Stages 1 and 2
Disclosure Of Credit Risk Exposure [Line Items]
ECL coverage	0.11%	0.11%	0.11%
Twelve-month expected credit losses | Stages 1 and 2
Disclosure Of Credit Risk Exposure [Line Items]
Total on- and off-balance sheet	$ 838,722	$ 848,933	$ 910,388
ECL coverage	0.07%	0.07%	0.07%
Twelve-month expected credit losses | Stages 1 and 2 | Total on-balance sheet financial assets in scope of ECL requirements
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	$ 1,026,888	$ 1,077,191	$ 1,161,661
Twelve-month expected credit losses | Stages 1 and 2 | Total financial assets measured at amortized cost
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	1,024,721	1,075,113	1,159,428
Twelve-month expected credit losses | Stages 1 and 2 | Loans and advances to customers
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	569,476	571,400	610,922
Twelve-month expected credit losses | Stages 1 and 2 | Loans and advances to customers | Private clients with mortgages
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	241,499	239,416	256,614
Twelve-month expected credit losses | Stages 1 and 2 | Loans and advances to customers | Real estate financing
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	82,018	84,485	92,084
Twelve-month expected credit losses | Stages 1 and 2 | Loans and advances to customers | Large corporate clients
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	23,888	23,954	25,671
Twelve-month expected credit losses | Stages 1 and 2 | Loans and advances to customers | SME clients
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	19,585	20,506	22,155
Twelve-month expected credit losses | Stages 1 and 2 | Loans and advances to customers | Lombard
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	147,272	149,153	156,299
Twelve-month expected credit losses | Stages 1 and 2 | Loans and advances to customers | Credit cards
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	1,479	1,402	1,564
Twelve-month expected credit losses | Stages 1 and 2 | Loans and advances to customers | Commodity trade finance
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	5,556	5,169	5,662
Twelve-month expected credit losses | Stages 1 and 2 | Loans and advances to customers | Ship / aircraft financing
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	7,846	7,998	8,920
Twelve-month expected credit losses | Stages 1 and 2 | Loans and advances to customers | Consumer financing
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	2,703	2,629	2,795
Twelve-month expected credit losses | Stages 1 and 2 | Other financial assets measured at amortized cost
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	59,710	61,945	64,268
Twelve-month expected credit losses | Stages 1 and 2 | Loans to financial advisors
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	2,408	2,430	2,422
Lifetime expected credit losses | Stages 1 and 2
Disclosure Of Credit Risk Exposure [Line Items]
Total on- and off-balance sheet	$ 33,409	$ 37,399	$ 33,233
ECL coverage	1.11%	1%	1.14%
Lifetime expected credit losses | Stages 1 and 2 | Total on-balance sheet financial assets in scope of ECL requirements
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	$ 26,117	$ 29,428	$ 25,410
Lifetime expected credit losses | Stages 1 and 2 | Total financial assets measured at amortized cost
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	26,117	29,428	25,410
Lifetime expected credit losses | Stages 1 and 2 | Loans and advances to customers
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	25,249	28,773	24,408
Lifetime expected credit losses | Stages 1 and 2 | Loans and advances to customers | Private clients with mortgages
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	10,077	11,319	10,695
Lifetime expected credit losses | Stages 1 and 2 | Loans and advances to customers | Real estate financing
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	4,507	5,444	5,367
Lifetime expected credit losses | Stages 1 and 2 | Loans and advances to customers | Large corporate clients
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	3,829	3,917	3,182
Lifetime expected credit losses | Stages 1 and 2 | Loans and advances to customers | SME clients
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	2,531	2,745	2,919
Lifetime expected credit losses | Stages 1 and 2 | Loans and advances to customers | Lombard
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	875	931	3
Lifetime expected credit losses | Stages 1 and 2 | Loans and advances to customers | Credit cards
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	408	399	438
Lifetime expected credit losses | Stages 1 and 2 | Loans and advances to customers | Commodity trade finance
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	222	165	25
Lifetime expected credit losses | Stages 1 and 2 | Loans and advances to customers | Ship / aircraft financing
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	421	776	273
Lifetime expected credit losses | Stages 1 and 2 | Loans and advances to customers | Consumer financing
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	119	199	92
Lifetime expected credit losses | Stages 1 and 2 | Other financial assets measured at amortized cost
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	533	574	968
Lifetime expected credit losses | Stages 1 and 2 | Loans to financial advisors
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	83	70	79
Lifetime expected credit losses | Stage 3
Disclosure Of Credit Risk Exposure [Line Items]
Total on- and off-balance sheet	$ 4,923	$ 5,412	$ 4,408
ECL coverage	20.49%	18.38%	21.40%
Lifetime expected credit losses | Stage 3 | Total on-balance sheet financial assets in scope of ECL requirements
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	$ 3,458	$ 3,908	$ 3,027
Lifetime expected credit losses | Stage 3 | Total financial assets measured at amortized cost
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	3,458	3,908	3,027
Lifetime expected credit losses | Stage 3 | Loans and advances to customers
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	3,287	3,742	2,869
Lifetime expected credit losses | Stage 3 | Loans and advances to customers | Private clients with mortgages
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	1,062	923	929
Lifetime expected credit losses | Stage 3 | Loans and advances to customers | Real estate financing
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	243	179	270
Lifetime expected credit losses | Stage 3 | Loans and advances to customers | Large corporate clients
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	700	689	700
Lifetime expected credit losses | Stage 3 | Loans and advances to customers | SME clients
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	1,049	951	754
Lifetime expected credit losses | Stage 3 | Loans and advances to customers | Lombard
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	54	549	50
Lifetime expected credit losses | Stage 3 | Loans and advances to customers | Credit cards
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	40	38	39
Lifetime expected credit losses | Stage 3 | Loans and advances to customers | Commodity trade finance
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	11	11	22
Lifetime expected credit losses | Stage 3 | Loans and advances to customers | Ship / aircraft financing
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	3	3	4
Lifetime expected credit losses | Stage 3 | Loans and advances to customers | Consumer financing
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	39	35	38
Lifetime expected credit losses | Stage 3 | Other financial assets measured at amortized cost
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	171	166	158
Lifetime expected credit losses | Stage 3 | Loans to financial advisors
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	110	115	114
Lifetime expected credit losses | Purchased credit-impaired (PCI)
Disclosure Of Credit Risk Exposure [Line Items]
Total on- and off-balance sheet	$ 1,331	$ 1,401	$ 1,699
ECL coverage	12.02%	9.08%	7.06%
Lifetime expected credit losses | Purchased credit-impaired (PCI) | Total on-balance sheet financial assets in scope of ECL requirements
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	$ 1,198	$ 1,296	$ 1,587
Lifetime expected credit losses | Purchased credit-impaired (PCI) | Total financial assets measured at amortized cost
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	1,198	1,296	1,587
Lifetime expected credit losses | Purchased credit-impaired (PCI) | Loans and advances to customers
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	1,093	1,194	1,470
Lifetime expected credit losses | Purchased credit-impaired (PCI) | Loans and advances to customers | Private clients with mortgages
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	86	233	378
Lifetime expected credit losses | Purchased credit-impaired (PCI) | Loans and advances to customers | Real estate financing
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	86	111	97
Lifetime expected credit losses | Purchased credit-impaired (PCI) | Loans and advances to customers | Large corporate clients
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	357	447	532
Lifetime expected credit losses | Purchased credit-impaired (PCI) | Loans and advances to customers | SME clients
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	241	74	129
Lifetime expected credit losses | Purchased credit-impaired (PCI) | Loans and advances to customers | Lombard
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	66	126	0
Lifetime expected credit losses | Purchased credit-impaired (PCI) | Loans and advances to customers | Credit cards
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	0	0	0
Lifetime expected credit losses | Purchased credit-impaired (PCI) | Loans and advances to customers | Commodity trade finance
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	2	12	18
Lifetime expected credit losses | Purchased credit-impaired (PCI) | Loans and advances to customers | Ship / aircraft financing
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	15	0	17
Lifetime expected credit losses | Purchased credit-impaired (PCI) | Loans and advances to customers | Consumer financing
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	41	49	57
Lifetime expected credit losses | Purchased credit-impaired (PCI) | Other financial assets measured at amortized cost
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	16	22	61
Lifetime expected credit losses | Purchased credit-impaired (PCI) | Loans to financial advisors
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	0	0	0
Gross carrying amount | Total
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	603,497	609,472	644,031
Gross carrying amount | Total | Total real estate lending
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	339,798	342,372	366,745
Gross carrying amount | Total | Total corporate lending
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	53,221	54,305	57,019
Gross carrying amount | Total | Total other lending
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	210,478	212,796	220,267
Gross carrying amount | Loans and advances to customers | Private clients with mortgages
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	252,892	252,087	268,825
Gross carrying amount | Loans and advances to customers | Real estate financing
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	86,907	90,284	97,920
Gross carrying amount | Loans and advances to customers | Large corporate clients
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	29,299	29,587	30,660
Gross carrying amount | Loans and advances to customers | SME clients
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	23,922	24,718	26,359
Gross carrying amount | Loans and advances to customers | Lombard
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	148,308	150,820	156,394
Gross carrying amount | Loans and advances to customers | Credit cards
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	1,968	1,879	2,083
Gross carrying amount | Loans and advances to customers | Commodity trade finance
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	5,917	5,481	5,858
Gross carrying amount | Loans and advances to customers | Ship / aircraft financing
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	8,329	8,823	9,265
Gross carrying amount | Loans and advances to customers | Consumer financing
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	2,970	2,976	3,041
Gross carrying amount | Loans and advances to customers | Other loans and advances to customers
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	40,339	40,152	40,961
Gross carrying amount | Loans to financial advisors
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	2,647	2,664	2,665
Gross carrying amount | Twelve-month expected credit losses | Stages 1 and 2 | Total
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	572,247	574,198	613,772
Gross carrying amount | Twelve-month expected credit losses | Stages 1 and 2 | Total | Total real estate lending
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	323,602	323,984	348,800
Gross carrying amount | Twelve-month expected credit losses | Stages 1 and 2 | Total | Total corporate lending
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	43,627	44,615	48,001
Gross carrying amount | Twelve-month expected credit losses | Stages 1 and 2 | Total | Total other lending
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	205,018	205,598	216,971
Gross carrying amount | Twelve-month expected credit losses | Stages 1 and 2 | Loans and advances to customers | Private clients with mortgages
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	241,557	239,471	256,675
Gross carrying amount | Twelve-month expected credit losses | Stages 1 and 2 | Loans and advances to customers | Real estate financing
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	82,045	84,512	92,124
Gross carrying amount | Twelve-month expected credit losses | Stages 1 and 2 | Loans and advances to customers | Large corporate clients
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	23,981	24,045	25,775
Gross carrying amount | Twelve-month expected credit losses | Stages 1 and 2 | Loans and advances to customers | SME clients
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	19,646	20,570	22,226
Gross carrying amount | Twelve-month expected credit losses | Stages 1 and 2 | Loans and advances to customers | Lombard
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	147,278	149,160	156,312
Gross carrying amount | Twelve-month expected credit losses | Stages 1 and 2 | Loans and advances to customers | Credit cards
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	1,485	1,408	1,571
Gross carrying amount | Twelve-month expected credit losses | Stages 1 and 2 | Loans and advances to customers | Commodity trade finance
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	5,575	5,186	5,681
Gross carrying amount | Twelve-month expected credit losses | Stages 1 and 2 | Loans and advances to customers | Ship / aircraft financing
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	7,883	8,038	8,968
Gross carrying amount | Twelve-month expected credit losses | Stages 1 and 2 | Loans and advances to customers | Consumer financing
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	2,723	2,649	2,817
Gross carrying amount | Twelve-month expected credit losses | Stages 1 and 2 | Loans and advances to customers | Other loans and advances to customers
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	37,661	36,721	39,196
Gross carrying amount | Twelve-month expected credit losses | Stages 1 and 2 | Loans to financial advisors
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	2,412	2,435	2,426
Gross carrying amount | Lifetime expected credit losses | Stages 1 and 2 | Total
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	25,631	29,127	24,777
Gross carrying amount | Lifetime expected credit losses | Stages 1 and 2 | Total | Total real estate lending
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	14,692	16,884	16,190
Gross carrying amount | Lifetime expected credit losses | Stages 1 and 2 | Total | Total corporate lending
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	6,491	6,777	6,213
Gross carrying amount | Lifetime expected credit losses | Stages 1 and 2 | Total | Total other lending
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	4,447	5,466	2,373
Gross carrying amount | Lifetime expected credit losses | Stages 1 and 2 | Loans and advances to customers | Private clients with mortgages
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	10,154	11,412	10,792
Gross carrying amount | Lifetime expected credit losses | Stages 1 and 2 | Loans and advances to customers | Real estate financing
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	4,538	5,472	5,398
Gross carrying amount | Lifetime expected credit losses | Stages 1 and 2 | Loans and advances to customers | Large corporate clients
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	3,923	4,001	3,252
Gross carrying amount | Lifetime expected credit losses | Stages 1 and 2 | Loans and advances to customers | SME clients
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	2,569	2,777	2,961
Gross carrying amount | Lifetime expected credit losses | Stages 1 and 2 | Loans and advances to customers | Lombard
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	877	932	15
Gross carrying amount | Lifetime expected credit losses | Stages 1 and 2 | Loans and advances to customers | Credit cards
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	419	410	449
Gross carrying amount | Lifetime expected credit losses | Stages 1 and 2 | Loans and advances to customers | Commodity trade finance
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	224	168	26
Gross carrying amount | Lifetime expected credit losses | Stages 1 and 2 | Loans and advances to customers | Ship / aircraft financing
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	426	782	276
Gross carrying amount | Lifetime expected credit losses | Stages 1 and 2 | Loans and advances to customers | Consumer financing
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	140	218	110
Gross carrying amount | Lifetime expected credit losses | Stages 1 and 2 | Loans and advances to customers | Other loans and advances to customers
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	2,277	2,886	1,419
Gross carrying amount | Lifetime expected credit losses | Stages 1 and 2 | Loans to financial advisors
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	84	71	80
Gross carrying amount | Lifetime expected credit losses | Stage 3 | Total
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	4,372	4,819	3,889
Gross carrying amount | Lifetime expected credit losses | Stage 3 | Total | Total real estate lending
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	1,337	1,150	1,258
Gross carrying amount | Lifetime expected credit losses | Stage 3 | Total | Total corporate lending
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	2,435	2,293	2,042
Gross carrying amount | Lifetime expected credit losses | Stage 3 | Total | Total other lending
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	601	1,375	589
Gross carrying amount | Lifetime expected credit losses | Stage 3 | Loans and advances to customers | Private clients with mortgages
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	1,092	962	968
Gross carrying amount | Lifetime expected credit losses | Stage 3 | Loans and advances to customers | Real estate financing
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	245	188	290
Gross carrying amount | Lifetime expected credit losses | Stage 3 | Loans and advances to customers | Large corporate clients
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	972	1,008	1,012
Gross carrying amount | Lifetime expected credit losses | Stage 3 | Loans and advances to customers | SME clients
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	1,463	1,286	1,031
Gross carrying amount | Lifetime expected credit losses | Stage 3 | Loans and advances to customers | Lombard
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	71	590	67
Gross carrying amount | Lifetime expected credit losses | Stage 3 | Loans and advances to customers | Credit cards
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	64	61	63
Gross carrying amount | Lifetime expected credit losses | Stage 3 | Loans and advances to customers | Commodity trade finance
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	115	115	133
Gross carrying amount | Lifetime expected credit losses | Stage 3 | Loans and advances to customers | Ship / aircraft financing
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	3	3	4
Gross carrying amount | Lifetime expected credit losses | Stage 3 | Loans and advances to customers | Consumer financing
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	66	59	58
Gross carrying amount | Lifetime expected credit losses | Stage 3 | Loans and advances to customers | Other loans and advances to customers
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	131	389	105
Gross carrying amount | Lifetime expected credit losses | Stage 3 | Loans to financial advisors
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	151	157	159
Gross carrying amount | Lifetime expected credit losses | Purchased credit-impaired (PCI) | Total
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	1,247	1,328	1,593
Gross carrying amount | Lifetime expected credit losses | Purchased credit-impaired (PCI) | Total | Total real estate lending
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	167	354	497
Gross carrying amount | Lifetime expected credit losses | Purchased credit-impaired (PCI) | Total | Total corporate lending
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	668	619	762
Gross carrying amount | Lifetime expected credit losses | Purchased credit-impaired (PCI) | Total | Total other lending
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	412	356	334
Gross carrying amount | Lifetime expected credit losses | Purchased credit-impaired (PCI) | Loans and advances to customers | Private clients with mortgages
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	89	243	389
Gross carrying amount | Lifetime expected credit losses | Purchased credit-impaired (PCI) | Loans and advances to customers | Real estate financing
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	78	111	108
Gross carrying amount | Lifetime expected credit losses | Purchased credit-impaired (PCI) | Loans and advances to customers | Large corporate clients
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	424	534	620
Gross carrying amount | Lifetime expected credit losses | Purchased credit-impaired (PCI) | Loans and advances to customers | SME clients
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	244	85	142
Gross carrying amount | Lifetime expected credit losses | Purchased credit-impaired (PCI) | Loans and advances to customers | Lombard
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	82	138	0
Gross carrying amount | Lifetime expected credit losses | Purchased credit-impaired (PCI) | Loans and advances to customers | Credit cards
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	0	0	0
Gross carrying amount | Lifetime expected credit losses | Purchased credit-impaired (PCI) | Loans and advances to customers | Commodity trade finance
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	2	12	18
Gross carrying amount | Lifetime expected credit losses | Purchased credit-impaired (PCI) | Loans and advances to customers | Ship / aircraft financing
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	17	0	17
Gross carrying amount | Lifetime expected credit losses | Purchased credit-impaired (PCI) | Loans and advances to customers | Consumer financing
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	41	49	57
Gross carrying amount | Lifetime expected credit losses | Purchased credit-impaired (PCI) | Loans and advances to customers | Other loans and advances to customers
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	270	156	242
Gross carrying amount | Lifetime expected credit losses | Purchased credit-impaired (PCI) | Loans to financial advisors
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	0	0	0
Allowance for expected credit loss | Total on-balance sheet financial assets in scope of ECL requirements
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	(1,964)	(1,915)	(1,911)
Allowance for expected credit loss | Total financial assets measured at amortized cost
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	$ (1,964)	$ (1,915)	$ (1,911)
Allowance for expected credit loss | Total
Disclosure Of Credit Risk Exposure [Line Items]
ECL coverage	0.30%	0.29%	0.27%
Allowance for expected credit loss | Total | Total real estate lending
Disclosure Of Credit Risk Exposure [Line Items]
ECL coverage	0.06%	0.08%	0.09%
Allowance for expected credit loss | Total | Total corporate lending
Disclosure Of Credit Risk Exposure [Line Items]
ECL coverage	1.96%	1.88%	1.72%
Allowance for expected credit loss | Total | Total other lending
Disclosure Of Credit Risk Exposure [Line Items]
ECL coverage	0.25%	0.22%	0.21%
Allowance for expected credit loss | Loans and advances to customers
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	$ (1,743)	$ (1,700)	$ (1,698)
Allowance for expected credit loss | Loans and advances to customers | Private clients with mortgages
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	$ (167)	$ (196)	$ (209)
ECL coverage	0.07%	0.08%	0.08%
Allowance for expected credit loss | Loans and advances to customers | Real estate financing
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	$ (53)	$ (64)	$ (103)
ECL coverage	0.06%	0.07%	0.11%
Allowance for expected credit loss | Loans and advances to customers | Large corporate clients
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	$ (526)	$ (580)	$ (575)
ECL coverage	1.80%	1.96%	1.88%
Allowance for expected credit loss | Loans and advances to customers | SME clients
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	$ (515)	$ (442)	$ (402)
ECL coverage	2.15%	1.79%	1.53%
Allowance for expected credit loss | Loans and advances to customers | Lombard
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	$ (41)	$ (61)	$ (41)
ECL coverage	0.03%	0.04%	0.03%
Allowance for expected credit loss | Loans and advances to customers | Credit cards
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	$ (41)	$ (40)	$ (42)
ECL coverage	2.08%	2.11%	2%
Allowance for expected credit loss | Loans and advances to customers | Commodity trade finance
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	$ (125)	$ (123)	$ (130)
ECL coverage	2.11%	2.24%	2.23%
Allowance for expected credit loss | Loans and advances to customers | Ship / aircraft financing
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	$ (44)	$ (47)	$ (51)
ECL coverage	0.53%	0.53%	0.56%
Allowance for expected credit loss | Loans and advances to customers | Consumer financing
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	$ (68)	$ (64)	$ (59)
ECL coverage	2.29%	2.15%	1.95%
Allowance for expected credit loss | Loans and advances to customers | Other loans and advances to customers
Disclosure Of Credit Risk Exposure [Line Items]
ECL coverage	0.41%	0.21%	0.21%
Allowance for expected credit loss | Other financial assets measured at amortized cost
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	$ (131)	$ (134)	$ (151)
Allowance for expected credit loss | Loans to financial advisors
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	$ (47)	$ (49)	$ (49)
ECL coverage	1.76%	1.86%	1.85%
Allowance for expected credit loss | Stages 1 and 2 | Total
Disclosure Of Credit Risk Exposure [Line Items]
ECL coverage	0.11%	0.11%	0.11%
Allowance for expected credit loss | Stages 1 and 2 | Total | Total real estate lending
Disclosure Of Credit Risk Exposure [Line Items]
ECL coverage	0.06%	0.06%	0.06%
Allowance for expected credit loss | Stages 1 and 2 | Total | Total corporate lending
Disclosure Of Credit Risk Exposure [Line Items]
ECL coverage	0.57%	0.53%	0.53%
Increase decrease in ECL coverage	0.04%
Allowance for expected credit loss | Stages 1 and 2 | Total | Total other lending
Disclosure Of Credit Risk Exposure [Line Items]
ECL coverage	0.09%	0.09%	0.09%
Allowance for expected credit loss | Stages 1 and 2 | Loans and advances to customers | Private clients with mortgages
Disclosure Of Credit Risk Exposure [Line Items]
ECL coverage	0.05%	0.06%	0.06%
Allowance for expected credit loss | Stages 1 and 2 | Loans and advances to customers | Real estate financing
Disclosure Of Credit Risk Exposure [Line Items]
ECL coverage	0.07%	0.06%	0.07%
Allowance for expected credit loss | Stages 1 and 2 | Loans and advances to customers | Large corporate clients
Disclosure Of Credit Risk Exposure [Line Items]
ECL coverage	0.67%	0.62%	0.60%
Allowance for expected credit loss | Stages 1 and 2 | Loans and advances to customers | SME clients
Disclosure Of Credit Risk Exposure [Line Items]
ECL coverage	0.44%	0.41%	0.45%
Allowance for expected credit loss | Stages 1 and 2 | Loans and advances to customers | Lombard
Disclosure Of Credit Risk Exposure [Line Items]
ECL coverage	0.01%	0.01%	0.02%
Allowance for expected credit loss | Stages 1 and 2 | Loans and advances to customers | Credit cards
Disclosure Of Credit Risk Exposure [Line Items]
ECL coverage	0.86%	0.89%	0.87%
Allowance for expected credit loss | Stages 1 and 2 | Loans and advances to customers | Commodity trade finance
Disclosure Of Credit Risk Exposure [Line Items]
ECL coverage	0.36%	0.35%	0.34%
Allowance for expected credit loss | Stages 1 and 2 | Loans and advances to customers | Ship / aircraft financing
Disclosure Of Credit Risk Exposure [Line Items]
ECL coverage	0.51%	0.53%	0.55%
Allowance for expected credit loss | Stages 1 and 2 | Loans and advances to customers | Consumer financing
Disclosure Of Credit Risk Exposure [Line Items]
ECL coverage	1.43%	1.38%	1.35%
Allowance for expected credit loss | Stages 1 and 2 | Loans and advances to customers | Other loans and advances to customers
Disclosure Of Credit Risk Exposure [Line Items]
ECL coverage	0.12%	0.11%	0.11%
Allowance for expected credit loss | Stages 1 and 2 | Loans to financial advisors
Disclosure Of Credit Risk Exposure [Line Items]
ECL coverage	0.22%	0.27%	0.20%
Allowance for expected credit loss | Twelve-month expected credit losses | Stages 1 and 2 | Total on-balance sheet financial assets in scope of ECL requirements
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	$ (397)	$ (405)	$ (473)
Allowance for expected credit loss | Twelve-month expected credit losses | Stages 1 and 2 | Total financial assets measured at amortized cost
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	$ (397)	$ (405)	$ (473)
Allowance for expected credit loss | Twelve-month expected credit losses | Stages 1 and 2 | Total
Disclosure Of Credit Risk Exposure [Line Items]
ECL coverage	0.06%	0.06%	0.07%
Allowance for expected credit loss | Twelve-month expected credit losses | Stages 1 and 2 | Total | Total real estate lending
Disclosure Of Credit Risk Exposure [Line Items]
ECL coverage	0.03%	0.03%	0.03%
Allowance for expected credit loss | Twelve-month expected credit losses | Stages 1 and 2 | Total | Total corporate lending
Disclosure Of Credit Risk Exposure [Line Items]
ECL coverage	0.35%	0.35%	0.37%
Allowance for expected credit loss | Twelve-month expected credit losses | Stages 1 and 2 | Total | Total other lending
Disclosure Of Credit Risk Exposure [Line Items]
ECL coverage	0.06%	0.06%	0.07%
Allowance for expected credit loss | Twelve-month expected credit losses | Stages 1 and 2 | Loans and advances to customers
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	$ (355)	$ (362)	$ (423)
Allowance for expected credit loss | Twelve-month expected credit losses | Stages 1 and 2 | Loans and advances to customers | Private clients with mortgages
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	$ (57)	$ (55)	$ (62)
ECL coverage	0.02%	0.02%	0.02%
Allowance for expected credit loss | Twelve-month expected credit losses | Stages 1 and 2 | Loans and advances to customers | Real estate financing
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	$ (28)	$ (27)	$ (41)
ECL coverage	0.03%	0.03%	0.04%
Allowance for expected credit loss | Twelve-month expected credit losses | Stages 1 and 2 | Loans and advances to customers | Large corporate clients
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	$ (93)	$ (91)	$ (105)
ECL coverage	0.39%	0.38%	0.41%
Allowance for expected credit loss | Twelve-month expected credit losses | Stages 1 and 2 | Loans and advances to customers | SME clients
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	$ (60)	$ (64)	$ (71)
ECL coverage	0.31%	0.31%	0.32%
Allowance for expected credit loss | Twelve-month expected credit losses | Stages 1 and 2 | Loans and advances to customers | Lombard
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	$ (6)	$ (7)	$ (13)
ECL coverage	0%	0%	0.01%
Allowance for expected credit loss | Twelve-month expected credit losses | Stages 1 and 2 | Loans and advances to customers | Credit cards
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	$ (6)	$ (6)	$ (6)
ECL coverage	0.39%	0.41%	0.40%
Allowance for expected credit loss | Twelve-month expected credit losses | Stages 1 and 2 | Loans and advances to customers | Commodity trade finance
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	$ (19)	$ (17)	$ (18)
ECL coverage	0.33%	0.32%	0.32%
Allowance for expected credit loss | Twelve-month expected credit losses | Stages 1 and 2 | Loans and advances to customers | Ship / aircraft financing
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	$ (38)	$ (40)	$ (48)
ECL coverage	0.48%	0.50%	0.54%
Allowance for expected credit loss | Twelve-month expected credit losses | Stages 1 and 2 | Loans and advances to customers | Consumer financing
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	$ (20)	$ (20)	$ (22)
ECL coverage	0.73%	0.77%	0.79%
Allowance for expected credit loss | Twelve-month expected credit losses | Stages 1 and 2 | Loans and advances to customers | Other loans and advances to customers
Disclosure Of Credit Risk Exposure [Line Items]
ECL coverage	0.08%	0.09%	0.10%
Allowance for expected credit loss | Twelve-month expected credit losses | Stages 1 and 2 | Other financial assets measured at amortized cost
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	$ (34)	$ (35)	$ (41)
Allowance for expected credit loss | Twelve-month expected credit losses | Stages 1 and 2 | Loans to financial advisors
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	$ (4)	$ (6)	$ (4)
ECL coverage	0.18%	0.23%	0.17%
Allowance for expected credit loss | Lifetime expected credit losses | Stages 1 and 2 | Total on-balance sheet financial assets in scope of ECL requirements
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	$ (333)	$ (318)	$ (326)
Allowance for expected credit loss | Lifetime expected credit losses | Stages 1 and 2 | Total financial assets measured at amortized cost
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	$ (333)	$ (318)	$ (326)
Allowance for expected credit loss | Lifetime expected credit losses | Stages 1 and 2 | Total
Disclosure Of Credit Risk Exposure [Line Items]
ECL coverage	1.17%	0.98%	1.17%
Allowance for expected credit loss | Lifetime expected credit losses | Stages 1 and 2 | Total | Total real estate lending
Disclosure Of Credit Risk Exposure [Line Items]
ECL coverage	0.74%	0.71%	0.79%
Allowance for expected credit loss | Lifetime expected credit losses | Stages 1 and 2 | Total | Total corporate lending
Disclosure Of Credit Risk Exposure [Line Items]
ECL coverage	2.03%	1.69%	1.80%
Allowance for expected credit loss | Lifetime expected credit losses | Stages 1 and 2 | Total | Total other lending
Disclosure Of Credit Risk Exposure [Line Items]
ECL coverage	1.34%	0.91%	2.10%
Allowance for expected credit loss | Lifetime expected credit losses | Stages 1 and 2 | Loans and advances to customers
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	$ (298)	$ (284)	$ (289)
Allowance for expected credit loss | Lifetime expected credit losses | Stages 1 and 2 | Loans and advances to customers | Private clients with mortgages
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	$ (77)	$ (92)	$ (97)
ECL coverage	0.76%	0.81%	0.90%
Allowance for expected credit loss | Lifetime expected credit losses | Stages 1 and 2 | Loans and advances to customers | Real estate financing
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	$ (31)	$ (28)	$ (31)
ECL coverage	0.69%	0.50%	0.57%
Allowance for expected credit loss | Lifetime expected credit losses | Stages 1 and 2 | Loans and advances to customers | Large corporate clients
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	$ (94)	$ (83)	$ (70)
ECL coverage	2.40%	2.08%	2.15%
Allowance for expected credit loss | Lifetime expected credit losses | Stages 1 and 2 | Loans and advances to customers | SME clients
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	$ (38)	$ (32)	$ (42)
ECL coverage	1.46%	1.14%	1.41%
Allowance for expected credit loss | Lifetime expected credit losses | Stages 1 and 2 | Loans and advances to customers | Lombard
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	$ (2)	$ (1)	$ (11)
ECL coverage	0.23%	0.10%	76.16%
Allowance for expected credit loss | Lifetime expected credit losses | Stages 1 and 2 | Loans and advances to customers | Credit cards
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	$ (11)	$ (10)	$ (11)
ECL coverage	2.52%	2.56%	2.53%
Allowance for expected credit loss | Lifetime expected credit losses | Stages 1 and 2 | Loans and advances to customers | Commodity trade finance
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	$ (2)	$ (2)	$ (1)
ECL coverage	0.92%	1.44%	3.65%
Allowance for expected credit loss | Lifetime expected credit losses | Stages 1 and 2 | Loans and advances to customers | Ship / aircraft financing
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	$ (4)	$ (7)	$ (3)
ECL coverage	1.03%	0.84%	0.99%
Allowance for expected credit loss | Lifetime expected credit losses | Stages 1 and 2 | Loans and advances to customers | Consumer financing
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	$ (21)	$ (19)	$ (17)
ECL coverage	15%	8.84%	15.59%
Allowance for expected credit loss | Lifetime expected credit losses | Stages 1 and 2 | Loans and advances to customers | Other loans and advances to customers
Disclosure Of Credit Risk Exposure [Line Items]
ECL coverage	0.80%	0.31%	0.39%
Allowance for expected credit loss | Lifetime expected credit losses | Stages 1 and 2 | Other financial assets measured at amortized cost
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	$ (8)	$ (9)	$ (10)
Allowance for expected credit loss | Lifetime expected credit losses | Stages 1 and 2 | Loans to financial advisors
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	$ (1)	$ (1)	$ (1)
ECL coverage	1.46%	1.60%	1.22%
Allowance for expected credit loss | Lifetime expected credit losses | Stage 3 | Total on-balance sheet financial assets in scope of ECL requirements
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	$ (1,021)	$ (1,003)	$ (956)
Allowance for expected credit loss | Lifetime expected credit losses | Stage 3 | Total financial assets measured at amortized cost
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	$ (1,021)	$ (1,003)	$ (956)
Allowance for expected credit loss | Lifetime expected credit losses | Stage 3 | Total
Disclosure Of Credit Risk Exposure [Line Items]
ECL coverage	22.35%	19.98%	23.29%
Allowance for expected credit loss | Lifetime expected credit losses | Stage 3 | Total | Total real estate lending
Disclosure Of Credit Risk Exposure [Line Items]
ECL coverage	2.35%	4.20%	4.72%
Allowance for expected credit loss | Lifetime expected credit losses | Stage 3 | Total | Total corporate lending
Disclosure Of Credit Risk Exposure [Line Items]
ECL coverage	28.18%	28.47%	28.84%
Allowance for expected credit loss | Lifetime expected credit losses | Stage 3 | Total | Total other lending
Disclosure Of Credit Risk Exposure [Line Items]
ECL coverage	43.23%	19%	43.76%
Allowance for expected credit loss | Lifetime expected credit losses | Stage 3 | Loans and advances to customers
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	$ (937)	$ (920)	$ (862)
Allowance for expected credit loss | Lifetime expected credit losses | Stage 3 | Loans and advances to customers | Private clients with mortgages
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	$ (30)	$ (39)	$ (39)
ECL coverage	2.72%	4.06%	3.99%
Allowance for expected credit loss | Lifetime expected credit losses | Stage 3 | Loans and advances to customers | Real estate financing
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	$ (2)	$ (9)	$ (21)
ECL coverage	0.72%	4.93%	7.13%
Allowance for expected credit loss | Lifetime expected credit losses | Stage 3 | Loans and advances to customers | Large corporate clients
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	$ (272)	$ (318)	$ (312)
ECL coverage	27.98%	31.60%	30.83%
Allowance for expected credit loss | Lifetime expected credit losses | Stage 3 | Loans and advances to customers | SME clients
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	$ (414)	$ (335)	$ (277)
ECL coverage	28.31%	26.02%	26.89%
Allowance for expected credit loss | Lifetime expected credit losses | Stage 3 | Loans and advances to customers | Lombard
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	$ (16)	$ (41)	$ (17)
ECL coverage	23.28%	6.99%	24.87%
Allowance for expected credit loss | Lifetime expected credit losses | Stage 3 | Loans and advances to customers | Credit cards
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	$ (25)	$ (23)	$ (24)
ECL coverage	38.26%	38.02%	38.01%
Allowance for expected credit loss | Lifetime expected credit losses | Stage 3 | Loans and advances to customers | Commodity trade finance
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	$ (104)	$ (104)	$ (111)
ECL coverage	90.37%	90.44%	83.33%
Allowance for expected credit loss | Lifetime expected credit losses | Stage 3 | Loans and advances to customers | Ship / aircraft financing
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	$ 0	$ 0	$ 0
ECL coverage	0%	0%	0%
Allowance for expected credit loss | Lifetime expected credit losses | Stage 3 | Loans and advances to customers | Consumer financing
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	$ (27)	$ (24)	$ (20)
ECL coverage	40.91%	40.93%	34.22%
Allowance for expected credit loss | Lifetime expected credit losses | Stage 3 | Loans and advances to customers | Other loans and advances to customers
Disclosure Of Credit Risk Exposure [Line Items]
ECL coverage	35.32%	6.57%	39.81%
Allowance for expected credit loss | Lifetime expected credit losses | Stage 3 | Other financial assets measured at amortized cost
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	$ (84)	$ (83)	$ (94)
Allowance for expected credit loss | Lifetime expected credit losses | Stage 3 | Loans to financial advisors
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	$ (41)	$ (43)	$ (44)
ECL coverage	27.36%	27.16%	27.93%
Allowance for expected credit loss | Lifetime expected credit losses | Purchased credit-impaired (PCI) | Total on-balance sheet financial assets in scope of ECL requirements
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	$ (212)	$ (189)	$ (156)
Allowance for expected credit loss | Lifetime expected credit losses | Purchased credit-impaired (PCI) | Total financial assets measured at amortized cost
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	$ (212)	$ (189)	$ (156)
Allowance for expected credit loss | Lifetime expected credit losses | Purchased credit-impaired (PCI) | Total
Disclosure Of Credit Risk Exposure [Line Items]
ECL coverage	12.36%	10.09%	7.73%
Allowance for expected credit loss | Lifetime expected credit losses | Purchased credit-impaired (PCI) | Total | Total real estate lending
Disclosure Of Credit Risk Exposure [Line Items]
ECL coverage	0%	2.70%	4.34%
Allowance for expected credit loss | Lifetime expected credit losses | Purchased credit-impaired (PCI) | Total | Total corporate lending
Disclosure Of Credit Risk Exposure [Line Items]
ECL coverage	10.48%	15.87%	13.29%
Allowance for expected credit loss | Lifetime expected credit losses | Purchased credit-impaired (PCI) | Total | Total other lending
Disclosure Of Credit Risk Exposure [Line Items]
ECL coverage	21.60%	7.39%	0.09%
Allowance for expected credit loss | Lifetime expected credit losses | Purchased credit-impaired (PCI) | Loans and advances to customers
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	$ (153)	$ (134)	$ (123)
Allowance for expected credit loss | Lifetime expected credit losses | Purchased credit-impaired (PCI) | Loans and advances to customers | Private clients with mortgages
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	$ (3)	$ (10)	$ (11)
ECL coverage	3.37%	3.95%	2.83%
Allowance for expected credit loss | Lifetime expected credit losses | Purchased credit-impaired (PCI) | Loans and advances to customers | Real estate financing
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	$ 8	$ 0	$ (11)
ECL coverage	0%	0%	9.80%
Allowance for expected credit loss | Lifetime expected credit losses | Purchased credit-impaired (PCI) | Loans and advances to customers | Large corporate clients
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	$ (67)	$ (87)	$ (89)
ECL coverage	15.80%	16.32%	14.29%
Allowance for expected credit loss | Lifetime expected credit losses | Purchased credit-impaired (PCI) | Loans and advances to customers | SME clients
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	$ (3)	$ (11)	$ (13)
ECL coverage	1.23%	13.05%	8.93%
Allowance for expected credit loss | Lifetime expected credit losses | Purchased credit-impaired (PCI) | Loans and advances to customers | Lombard
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	$ (16)	$ (12)	$ 0
ECL coverage	19.51%	8.40%	0%
Allowance for expected credit loss | Lifetime expected credit losses | Purchased credit-impaired (PCI) | Loans and advances to customers | Credit cards
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	$ 0	$ 0	$ 0
ECL coverage	0%	0%	0%
Allowance for expected credit loss | Lifetime expected credit losses | Purchased credit-impaired (PCI) | Loans and advances to customers | Commodity trade finance
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	$ 0	$ 0	$ 0
ECL coverage	0%	0%	0.06%
Allowance for expected credit loss | Lifetime expected credit losses | Purchased credit-impaired (PCI) | Loans and advances to customers | Ship / aircraft financing
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	$ (2)	$ 0	$ (1)
ECL coverage	11.76%	0%	3.15%
Allowance for expected credit loss | Lifetime expected credit losses | Purchased credit-impaired (PCI) | Loans and advances to customers | Consumer financing
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	$ 0	$ 0	$ 0
ECL coverage	0%	0.31%	0.07%
Allowance for expected credit loss | Lifetime expected credit losses | Purchased credit-impaired (PCI) | Loans and advances to customers | Other loans and advances to customers
Disclosure Of Credit Risk Exposure [Line Items]
ECL coverage	26.30%	9.39%	0%
Allowance for expected credit loss | Lifetime expected credit losses | Purchased credit-impaired (PCI) | Other financial assets measured at amortized cost
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	$ (5)	$ (6)	$ (5)
Allowance for expected credit loss | Lifetime expected credit losses | Purchased credit-impaired (PCI) | Loans to financial advisors
Disclosure Of Credit Risk Exposure [Line Items]
Financial assets	$ 0	$ 0	$ 0
ECL coverage	0%	0%	0%

Expected credit loss measure_12

Expected credit loss measurement - Coverage ratios (Detail 2) - USD ($) $ in Millions	Jun. 30, 2024	Mar. 31, 2024	Dec. 31, 2023
Disclosure Of Provision Matrix [Line Items]
Total exposure	$ 284,611	$ 301,322	$ 324,141
Total on- and off-balance sheet	$ 878,385	$ 893,144	$ 949,729
ECL coverage	0.24%	0.23%	0.22%
Total
Disclosure Of Provision Matrix [Line Items]
Total exposure	$ 274,888	$ 283,672	$ 305,697
ECL coverage	0.11%	0.12%	0.11%
Total | Private clients with mortgages
Disclosure Of Provision Matrix [Line Items]
Total exposure	$ 8,091	$ 7,907	$ 9,782
ECL coverage	0.04%	0.07%	0.06%
Total | Real estate financing
Disclosure Of Provision Matrix [Line Items]
Total exposure	$ 12,715	$ 13,652	$ 17,107
ECL coverage	0.05%	0.07%	0.09%
Total | Total real estate lending
Disclosure Of Provision Matrix [Line Items]
Total exposure	$ 20,805	$ 21,559	$ 26,889
ECL coverage	0.05%	0.07%	0.08%
Total | Large corporate clients
Disclosure Of Provision Matrix [Line Items]
Total exposure	$ 71,060	$ 73,534	$ 77,103
ECL coverage	0.24%	0.28%	0.26%
Total | SME clients
Disclosure Of Provision Matrix [Line Items]
Total exposure	$ 15,352	$ 15,269	$ 16,762
ECL coverage	0.33%	0.34%	0.40%
Total | Total corporate lending
Disclosure Of Provision Matrix [Line Items]
Total exposure	$ 86,412	$ 88,803	$ 93,865
ECL coverage	0.26%	0.29%	0.29%
Total | Lombard
Disclosure Of Provision Matrix [Line Items]
Total exposure	$ 68,071	$ 68,645	$ 86,173
ECL coverage	0.01%	0.01%	0%
Total | Credit cards
Disclosure Of Provision Matrix [Line Items]
Total exposure	$ 10,056	$ 10,049	$ 10,458
ECL coverage	0.08%	0.09%	0.10%
Total | Commodity trade finance
Disclosure Of Provision Matrix [Line Items]
Total exposure	$ 3,732	$ 4,446	$ 4,640
ECL coverage	0.07%	0.06%	0.06%
Total | Ship / aircraft financing
Disclosure Of Provision Matrix [Line Items]
Total exposure	$ 1,836	$ 1,643	$ 1,053
ECL coverage	0.11%	0.13%	0.26%
Total | Consumer financing
Disclosure Of Provision Matrix [Line Items]
Total exposure	$ 152	$ 167	$ 153
ECL coverage	0%	0%	0%
Total | Financial intermediaries and hedge funds
Disclosure Of Provision Matrix [Line Items]
Total exposure	$ 46,338	$ 48,923	$ 42,578
ECL coverage	0.03%	0.03%	0.03%
Total | Other off-balance sheet commitments
Disclosure Of Provision Matrix [Line Items]
Total exposure	$ 37,485	$ 39,437	$ 39,887
ECL coverage	0.07%	0.06%	0.07%
Total | Total other lending
Disclosure Of Provision Matrix [Line Items]
Total exposure	$ 167,670	$ 173,310	$ 184,944
ECL coverage	0.03%	0.03%	0.03%
Stages 1 and 2
Disclosure Of Provision Matrix [Line Items]
ECL coverage	0.11%	0.11%	0.11%
Stages 1 and 2 | Total
Disclosure Of Provision Matrix [Line Items]
ECL coverage	0.10%	0.11%	0.10%
Stages 1 and 2 | Total | Private clients with mortgages
Disclosure Of Provision Matrix [Line Items]
ECL coverage	0.04%	0.07%	0.06%
Stages 1 and 2 | Total | Real estate financing
Disclosure Of Provision Matrix [Line Items]
ECL coverage	0.05%	0.07%	0.09%
Stages 1 and 2 | Total | Total real estate lending
Disclosure Of Provision Matrix [Line Items]
ECL coverage	0.05%	0.07%	0.08%
Stages 1 and 2 | Total | Large corporate clients
Disclosure Of Provision Matrix [Line Items]
ECL coverage	0.22%	0.25%	0.24%
Stages 1 and 2 | Total | SME clients
Disclosure Of Provision Matrix [Line Items]
ECL coverage	0.36%	0.38%	0.37%
Stages 1 and 2 | Total | Total corporate lending
Disclosure Of Provision Matrix [Line Items]
ECL coverage	0.25%	0.27%	0.26%
Stages 1 and 2 | Total | Lombard
Disclosure Of Provision Matrix [Line Items]
ECL coverage	0%	0%	0%
Stages 1 and 2 | Total | Credit cards
Disclosure Of Provision Matrix [Line Items]
ECL coverage	0.08%	0.09%	0.10%
Stages 1 and 2 | Total | Commodity trade finance
Disclosure Of Provision Matrix [Line Items]
ECL coverage	0.07%	0.06%	0.06%
Stages 1 and 2 | Total | Ship / aircraft financing
Disclosure Of Provision Matrix [Line Items]
ECL coverage	0.11%	0.13%	0.26%
Stages 1 and 2 | Total | Consumer financing
Disclosure Of Provision Matrix [Line Items]
ECL coverage	0%	0%	0%
Stages 1 and 2 | Total | Financial intermediaries and hedge funds
Disclosure Of Provision Matrix [Line Items]
ECL coverage	0.03%	0.03%	0.03%
Stages 1 and 2 | Total | Other off-balance sheet commitments
Disclosure Of Provision Matrix [Line Items]
ECL coverage	0.04%	0.04%	0.05%
Stages 1 and 2 | Total | Total other lending
Disclosure Of Provision Matrix [Line Items]
ECL coverage	0.03%	0.03%	0.03%
Twelve-month expected credit losses | Stages 1 and 2
Disclosure Of Provision Matrix [Line Items]
Total exposure	$ 276,199	$ 292,385	$ 315,060
Total on- and off-balance sheet	$ 838,722	$ 848,933	$ 910,388
ECL coverage	0.07%	0.07%	0.07%
Twelve-month expected credit losses | Stages 1 and 2 | Total
Disclosure Of Provision Matrix [Line Items]
Total exposure	$ 266,475	$ 274,736	$ 296,616
ECL coverage	0.07%	0.08%	0.08%
Twelve-month expected credit losses | Stages 1 and 2 | Total | Private clients with mortgages
Disclosure Of Provision Matrix [Line Items]
Total exposure	$ 7,834	$ 7,590	$ 9,505
ECL coverage	0.04%	0.06%	0.05%
Twelve-month expected credit losses | Stages 1 and 2 | Total | Real estate financing
Disclosure Of Provision Matrix [Line Items]
Total exposure	$ 12,143	$ 12,919	$ 16,281
ECL coverage	0.06%	0.08%	0.08%
Twelve-month expected credit losses | Stages 1 and 2 | Total | Total real estate lending
Disclosure Of Provision Matrix [Line Items]
Total exposure	$ 19,977	$ 20,509	$ 25,786
ECL coverage	0.05%	0.07%	0.07%
Twelve-month expected credit losses | Stages 1 and 2 | Total | Large corporate clients
Disclosure Of Provision Matrix [Line Items]
Total exposure	$ 66,029	$ 68,451	$ 71,524
ECL coverage	0.17%	0.18%	0.17%
Twelve-month expected credit losses | Stages 1 and 2 | Total | SME clients
Disclosure Of Provision Matrix [Line Items]
Total exposure	$ 14,421	$ 14,438	$ 15,868
ECL coverage	0.27%	0.29%	0.29%
Twelve-month expected credit losses | Stages 1 and 2 | Total | Total corporate lending
Disclosure Of Provision Matrix [Line Items]
Total exposure	$ 80,450	$ 82,889	$ 87,392
ECL coverage	0.19%	0.20%	0.19%
Twelve-month expected credit losses | Stages 1 and 2 | Total | Lombard
Disclosure Of Provision Matrix [Line Items]
Total exposure	$ 68,017	$ 68,477	$ 86,173
ECL coverage	0%	0%	0%
Twelve-month expected credit losses | Stages 1 and 2 | Total | Credit cards
Disclosure Of Provision Matrix [Line Items]
Total exposure	$ 9,576	$ 9,560	$ 9,932
ECL coverage	0.07%	0.08%	0.08%
Twelve-month expected credit losses | Stages 1 and 2 | Total | Commodity trade finance
Disclosure Of Provision Matrix [Line Items]
Total exposure	$ 3,712	$ 4,429	$ 4,628
ECL coverage	0.07%	0.06%	0.05%
Twelve-month expected credit losses | Stages 1 and 2 | Total | Ship / aircraft financing
Disclosure Of Provision Matrix [Line Items]
Total exposure	$ 1,817	$ 1,643	$ 1,053
ECL coverage	0.11%	0.12%	0.26%
Twelve-month expected credit losses | Stages 1 and 2 | Total | Consumer financing
Disclosure Of Provision Matrix [Line Items]
Total exposure	$ 152	$ 167	$ 153
ECL coverage	0%	0%	0%
Twelve-month expected credit losses | Stages 1 and 2 | Total | Financial intermediaries and hedge funds
Disclosure Of Provision Matrix [Line Items]
Total exposure	$ 45,878	$ 48,619	$ 42,325
ECL coverage	0.02%	0.02%	0.03%
Twelve-month expected credit losses | Stages 1 and 2 | Total | Other off-balance sheet commitments
Disclosure Of Provision Matrix [Line Items]
Total exposure	$ 36,897	$ 38,444	$ 39,174
ECL coverage	0.04%	0.04%	0.04%
Twelve-month expected credit losses | Stages 1 and 2 | Total | Total other lending
Disclosure Of Provision Matrix [Line Items]
Total exposure	$ 166,049	$ 171,338	$ 183,438
ECL coverage	0.02%	0.02%	0.02%
Lifetime expected credit losses | Stages 1 and 2
Disclosure Of Provision Matrix [Line Items]
Total exposure	$ 7,779	$ 8,271	$ 8,456
Total on- and off-balance sheet	$ 33,409	$ 37,399	$ 33,233
ECL coverage	1.11%	1%	1.14%
Lifetime expected credit losses | Stages 1 and 2 | Total
Disclosure Of Provision Matrix [Line Items]
Total exposure	$ 7,778	$ 8,271	$ 8,456
ECL coverage	0.90%	1.06%	1.07%
Lifetime expected credit losses | Stages 1 and 2 | Total | Private clients with mortgages
Disclosure Of Provision Matrix [Line Items]
Total exposure	$ 226	$ 289	$ 261
ECL coverage	0.23%	0.34%	0.27%
Lifetime expected credit losses | Stages 1 and 2 | Total | Real estate financing
Disclosure Of Provision Matrix [Line Items]
Total exposure	$ 572	$ 732	$ 826
ECL coverage	0%	0%	0.44%
Lifetime expected credit losses | Stages 1 and 2 | Total | Total real estate lending
Disclosure Of Provision Matrix [Line Items]
Total exposure	$ 798	$ 1,021	$ 1,088
ECL coverage	0%	0.04%	0.40%
Lifetime expected credit losses | Stages 1 and 2 | Total | Large corporate clients
Disclosure Of Provision Matrix [Line Items]
Total exposure	$ 4,833	$ 4,881	$ 5,357
ECL coverage	1%	1.33%	1.11%
Lifetime expected credit losses | Stages 1 and 2 | Total | SME clients
Disclosure Of Provision Matrix [Line Items]
Total exposure	$ 720	$ 678	$ 812
ECL coverage	2.07%	2.16%	1.96%
Lifetime expected credit losses | Stages 1 and 2 | Total | Total corporate lending
Disclosure Of Provision Matrix [Line Items]
Total exposure	$ 5,553	$ 5,559	$ 6,170
ECL coverage	1.14%	1.43%	1.22%
Lifetime expected credit losses | Stages 1 and 2 | Total | Lombard
Disclosure Of Provision Matrix [Line Items]
Total exposure	$ 40	$ 161	$ 0
ECL coverage	0%	0.01%	0%
Lifetime expected credit losses | Stages 1 and 2 | Total | Credit cards
Disclosure Of Provision Matrix [Line Items]
Total exposure	$ 477	$ 485	$ 522
ECL coverage	0.35%	0.34%	0.35%
Lifetime expected credit losses | Stages 1 and 2 | Total | Commodity trade finance
Disclosure Of Provision Matrix [Line Items]
Total exposure	$ 20	$ 18	$ 13
ECL coverage	0.13%	1.27%	1.51%
Lifetime expected credit losses | Stages 1 and 2 | Total | Ship / aircraft financing
Disclosure Of Provision Matrix [Line Items]
Total exposure	$ 19	$ 0	$ 0
ECL coverage	0%	0%	0%
Lifetime expected credit losses | Stages 1 and 2 | Total | Consumer financing
Disclosure Of Provision Matrix [Line Items]
Total exposure	$ 0	$ 0	$ 0
ECL coverage	0%	0%	0%
Lifetime expected credit losses | Stages 1 and 2 | Total | Financial intermediaries and hedge funds
Disclosure Of Provision Matrix [Line Items]
Total exposure	$ 461	$ 304	$ 253
ECL coverage	0.74%	1.14%	1.42%
Lifetime expected credit losses | Stages 1 and 2 | Total | Other off-balance sheet commitments
Disclosure Of Provision Matrix [Line Items]
Total exposure	$ 411	$ 723	$ 411
ECL coverage	0.55%	0.40%	1.11%
Lifetime expected credit losses | Stages 1 and 2 | Total | Total other lending
Disclosure Of Provision Matrix [Line Items]
Total exposure	$ 1,427	$ 1,691	$ 1,199
ECL coverage	0.52%	0.49%	0.85%
Lifetime expected credit losses | Stage 3
Disclosure Of Provision Matrix [Line Items]
Total exposure	$ 551	$ 593	$ 519
Total on- and off-balance sheet	$ 4,923	$ 5,412	$ 4,408
ECL coverage	20.49%	18.38%	21.40%
Lifetime expected credit losses | Stage 3 | Total
Disclosure Of Provision Matrix [Line Items]
Total exposure	$ 550	$ 593	$ 519
ECL coverage	5.70%	5.43%	7.17%
Lifetime expected credit losses | Stage 3 | Total | Private clients with mortgages
Disclosure Of Provision Matrix [Line Items]
Total exposure	$ 31	$ 29	$ 15
ECL coverage	0.11%	0.24%	0.40%
Lifetime expected credit losses | Stage 3 | Total | Real estate financing
Disclosure Of Provision Matrix [Line Items]
Total exposure	$ 0	$ 0	$ 0
ECL coverage	0%	0%	0%
Lifetime expected credit losses | Stage 3 | Total | Total real estate lending
Disclosure Of Provision Matrix [Line Items]
Total exposure	$ 31	$ 29	$ 15
ECL coverage	0.11%	0.23%	0.40%
Lifetime expected credit losses | Stage 3 | Total | Large corporate clients
Disclosure Of Provision Matrix [Line Items]
Total exposure	$ 149	$ 168	$ 157
ECL coverage	9.87%	9.95%	12.17%
Lifetime expected credit losses | Stage 3 | Total | SME clients
Disclosure Of Provision Matrix [Line Items]
Total exposure	$ 189	$ 130	$ 80
ECL coverage	1.97%	1.81%	6.40%
Lifetime expected credit losses | Stage 3 | Total | Total corporate lending
Disclosure Of Provision Matrix [Line Items]
Total exposure	$ 338	$ 297	$ 236
ECL coverage	5.46%	6.40%	10.22%
Lifetime expected credit losses | Stage 3 | Total | Lombard
Disclosure Of Provision Matrix [Line Items]
Total exposure	$ 14	$ 7	$ 1
ECL coverage	28.87%	99.21%	0%
Lifetime expected credit losses | Stage 3 | Total | Credit cards
Disclosure Of Provision Matrix [Line Items]
Total exposure	$ 4	$ 4	$ 4
ECL coverage	0%	0%	0%
Lifetime expected credit losses | Stage 3 | Total | Commodity trade finance
Disclosure Of Provision Matrix [Line Items]
Total exposure	$ 0	$ 0	$ 0
ECL coverage	0%	0%	0%
Lifetime expected credit losses | Stage 3 | Total | Ship / aircraft financing
Disclosure Of Provision Matrix [Line Items]
Total exposure	$ 0	$ 0	$ 0
ECL coverage	0%	0%	0%
Lifetime expected credit losses | Stage 3 | Total | Consumer financing
Disclosure Of Provision Matrix [Line Items]
Total exposure	$ 0	$ 0	$ 0
ECL coverage	0%	0%	0%
Lifetime expected credit losses | Stage 3 | Total | Financial intermediaries and hedge funds
Disclosure Of Provision Matrix [Line Items]
Total exposure	$ 0	$ 0	$ 0
ECL coverage	0%	0%	0%
Lifetime expected credit losses | Stage 3 | Total | Other off-balance sheet commitments
Disclosure Of Provision Matrix [Line Items]
Total exposure	$ 163	$ 256	$ 263
ECL coverage	5.38%	2.57%	4.53%
Lifetime expected credit losses | Stage 3 | Total | Total other lending
Disclosure Of Provision Matrix [Line Items]
Total exposure	$ 181	$ 267	$ 268
ECL coverage	7.10%	4.93%	4.86%
Lifetime expected credit losses | Purchased credit-impaired (PCI)
Disclosure Of Provision Matrix [Line Items]
Total exposure	$ 83	$ 72	$ 106
Total on- and off-balance sheet	$ 1,331	$ 1,401	$ 1,699
ECL coverage	12.02%	9.08%	7.06%
Lifetime expected credit losses | Purchased credit-impaired (PCI) | Total
Disclosure Of Provision Matrix [Line Items]
Total exposure	$ 84	$ 72	$ 106
ECL coverage	0%	0%	0%
Lifetime expected credit losses | Purchased credit-impaired (PCI) | Total | Private clients with mortgages
Disclosure Of Provision Matrix [Line Items]
Total exposure	$ 0	$ 0	$ 0
ECL coverage	0%	0%	0%
Lifetime expected credit losses | Purchased credit-impaired (PCI) | Total | Real estate financing
Disclosure Of Provision Matrix [Line Items]
Total exposure	$ 0	$ 0	$ 0
ECL coverage	0%	0%	0%
Lifetime expected credit losses | Purchased credit-impaired (PCI) | Total | Total real estate lending
Disclosure Of Provision Matrix [Line Items]
Total exposure	$ 0	$ 0	$ 0
ECL coverage	0%	0%	0%
Lifetime expected credit losses | Purchased credit-impaired (PCI) | Total | Large corporate clients
Disclosure Of Provision Matrix [Line Items]
Total exposure	$ 49	$ 35	$ 65
ECL coverage	0%	0%	2.42%
Lifetime expected credit losses | Purchased credit-impaired (PCI) | Total | SME clients
Disclosure Of Provision Matrix [Line Items]
Total exposure	$ 22	$ 23	$ 2
ECL coverage	0%	0%	0%
Lifetime expected credit losses | Purchased credit-impaired (PCI) | Total | Total corporate lending
Disclosure Of Provision Matrix [Line Items]
Total exposure	$ 71	$ 58	$ 67
ECL coverage	0%	0%	2.21%
Lifetime expected credit losses | Purchased credit-impaired (PCI) | Total | Lombard
Disclosure Of Provision Matrix [Line Items]
Total exposure	$ 0	$ 0	$ 0
ECL coverage	0%	0%	0%
Lifetime expected credit losses | Purchased credit-impaired (PCI) | Total | Credit cards
Disclosure Of Provision Matrix [Line Items]
Total exposure	$ 0	$ 0	$ 0
ECL coverage	0%	0%	0%
Lifetime expected credit losses | Purchased credit-impaired (PCI) | Total | Commodity trade finance
Disclosure Of Provision Matrix [Line Items]
Total exposure	$ 0	$ 0	$ 0
ECL coverage	0%	0%	0%
Lifetime expected credit losses | Purchased credit-impaired (PCI) | Total | Ship / aircraft financing
Disclosure Of Provision Matrix [Line Items]
Total exposure	$ 0	$ 0	$ 0
ECL coverage	0%	0%	0%
Lifetime expected credit losses | Purchased credit-impaired (PCI) | Total | Consumer financing
Disclosure Of Provision Matrix [Line Items]
Total exposure	$ 0	$ 0	$ 0
ECL coverage	0%	0%	0%
Lifetime expected credit losses | Purchased credit-impaired (PCI) | Total | Financial intermediaries and hedge funds
Disclosure Of Provision Matrix [Line Items]
Total exposure	$ 0	$ 0	$ 0
ECL coverage	0%	0%	0%
Lifetime expected credit losses | Purchased credit-impaired (PCI) | Total | Other off-balance sheet commitments
Disclosure Of Provision Matrix [Line Items]
Total exposure	$ 13	$ 14	$ 39
ECL coverage	0%	0%	0%
Lifetime expected credit losses | Purchased credit-impaired (PCI) | Total | Total other lending
Disclosure Of Provision Matrix [Line Items]
Total exposure	$ 13	$ 14	$ 39
ECL coverage	0%	0%	0%

FVM - Fair value hierarchy - As

FVM - Fair value hierarchy - Assets (Detail) - USD ($) $ in Millions	Jun. 30, 2024	Mar. 31, 2024	Dec. 31, 2023
Disclosure Of Fair Value Measurement Of Assets [Line Items]
Financial assets at fair value held for trading	$ 162,025	$ 160,104	$ 169,633
Derivative financial assets	139,597	159,229	176,084
Brokerage receivables	25,273	22,796	21,037
Financial assets at fair value not held for trading	123,266	99,612	104,018
Financial assets measured at fair value through other comprehensive income	2,167	2,078	2,233
Non-financial assets - Precious metals and other physical commodities	6,445	6,466	5,930
Other non-financial assets measured at fair value	43	35	31
Total assets measured at fair value	458,817	450,320	478,966
Equity instruments
Disclosure Of Fair Value Measurement Of Assets [Line Items]
Financial assets at fair value held for trading	113,429	104,520	104,325
Financial assets at fair value not held for trading	2,993	3,130	3,241
Government bills / bonds
Disclosure Of Fair Value Measurement Of Assets [Line Items]
Financial assets at fair value held for trading	10,997	12,659	15,830
Financial assets at fair value not held for trading	25,079	21,083	19,107
Investment fund units
Disclosure Of Fair Value Measurement Of Assets [Line Items]
Financial assets at fair value held for trading	7,139	8,198	9,645
Financial assets at fair value not held for trading	1,486	1,517	1,592
Corporate and municipal bonds
Disclosure Of Fair Value Measurement Of Assets [Line Items]
Financial assets at fair value held for trading	18,365	18,250	15,069
Financial assets at fair value not held for trading	14,609	14,809	17,000
Financial assets measured at fair value through other comprehensive income	267	246	276
Loans
Disclosure Of Fair Value Measurement Of Assets [Line Items]
Financial assets at fair value held for trading	11,666	16,105	23,456
Financial assets at fair value not held for trading	6,252	5,878	6,510
Asset-backed securities
Disclosure Of Fair Value Measurement Of Assets [Line Items]
Financial assets at fair value held for trading	370	262	248
Financial assets at fair value not held for trading	1,608	1,668	1,704
Foreign exchange
Disclosure Of Fair Value Measurement Of Assets [Line Items]
Derivative financial assets	50,974	61,951	78,659
Interest rate contracts
Disclosure Of Fair Value Measurement Of Assets [Line Items]
Derivative financial assets	48,840	52,546	55,597
Equity / index contracts
Disclosure Of Fair Value Measurement Of Assets [Line Items]
Derivative financial assets	33,392	37,675	35,473
Credit derivative contracts
Disclosure Of Fair Value Measurement Of Assets [Line Items]
Derivative financial assets	3,031	3,024	3,969
Commodity contracts
Disclosure Of Fair Value Measurement Of Assets [Line Items]
Derivative financial assets	2,582	3,011	1,883
Auction rate securities
Disclosure Of Fair Value Measurement Of Assets [Line Items]
Financial assets at fair value not held for trading	191	1,211	1,208
Securities financing transactions
Disclosure Of Fair Value Measurement Of Assets [Line Items]
Financial assets at fair value not held for trading	53,337	32,938	36,909
Financial assets for unit-linked investment contracts
Disclosure Of Fair Value Measurement Of Assets [Line Items]
Financial assets at fair value not held for trading	16,963	16,482	15,884
Commercial paper and certificates of deposit
Disclosure Of Fair Value Measurement Of Assets [Line Items]
Financial assets measured at fair value through other comprehensive income	1,891	1,783	1,948
Level 1
Disclosure Of Fair Value Measurement Of Assets [Line Items]
Financial assets at fair value held for trading	124,602	116,980	118,975
Derivative financial assets	836	1,146	622
Brokerage receivables	0	0	0
Financial assets at fair value not held for trading	34,766	31,065	30,717
Financial assets measured at fair value through other comprehensive income	62	67	68
Non-financial assets - Precious metals and other physical commodities	6,445	6,466	5,930
Other non-financial assets measured at fair value	0	0	0
Total assets measured at fair value	166,712	155,725	156,312
Level 1 | Equity instruments
Disclosure Of Fair Value Measurement Of Assets [Line Items]
Financial assets at fair value held for trading	112,416	103,929	102,602
Financial assets at fair value not held for trading	92	111	105
Level 1 | Government bills / bonds
Disclosure Of Fair Value Measurement Of Assets [Line Items]
Financial assets at fair value held for trading	5,603	5,972	6,995
Financial assets at fair value not held for trading	17,262	14,065	14,306
Level 1 | Investment fund units
Disclosure Of Fair Value Measurement Of Assets [Line Items]
Financial assets at fair value held for trading	5,677	6,022	8,392
Financial assets at fair value not held for trading	395	371	367
Level 1 | Corporate and municipal bonds
Disclosure Of Fair Value Measurement Of Assets [Line Items]
Financial assets at fair value held for trading	896	1,052	984
Financial assets at fair value not held for trading	61	60	62
Financial assets measured at fair value through other comprehensive income	62	67	68
Level 1 | Loans
Disclosure Of Fair Value Measurement Of Assets [Line Items]
Financial assets at fair value held for trading	0	0	0
Financial assets at fair value not held for trading	0	0	0
Level 1 | Asset-backed securities
Disclosure Of Fair Value Measurement Of Assets [Line Items]
Financial assets at fair value held for trading	10	4	3
Financial assets at fair value not held for trading	0	0	0
Level 1 | Foreign exchange
Disclosure Of Fair Value Measurement Of Assets [Line Items]
Derivative financial assets	331	416	347
Level 1 | Interest rate contracts
Disclosure Of Fair Value Measurement Of Assets [Line Items]
Derivative financial assets	0	0	0
Level 1 | Equity / index contracts
Disclosure Of Fair Value Measurement Of Assets [Line Items]
Derivative financial assets	0	0	0
Level 1 | Credit derivative contracts
Disclosure Of Fair Value Measurement Of Assets [Line Items]
Derivative financial assets	0	0	0
Level 1 | Commodity contracts
Disclosure Of Fair Value Measurement Of Assets [Line Items]
Derivative financial assets	3	7	1
Level 1 | Auction rate securities
Disclosure Of Fair Value Measurement Of Assets [Line Items]
Financial assets at fair value not held for trading	0	0	0
Level 1 | Securities financing transactions
Disclosure Of Fair Value Measurement Of Assets [Line Items]
Financial assets at fair value not held for trading	0	0	0
Level 1 | Financial assets for unit-linked investment contracts
Disclosure Of Fair Value Measurement Of Assets [Line Items]
Financial assets at fair value not held for trading	16,957	16,458	15,877
Level 1 | Commercial paper and certificates of deposit
Disclosure Of Fair Value Measurement Of Assets [Line Items]
Financial assets measured at fair value through other comprehensive income	0	0	0
Level 2
Disclosure Of Fair Value Measurement Of Assets [Line Items]
Financial assets at fair value held for trading	29,381	30,734	28,045
Derivative financial assets	136,437	155,710	172,903
Brokerage receivables	25,273	22,796	21,037
Financial assets at fair value not held for trading	80,555	59,843	64,865
Financial assets measured at fair value through other comprehensive income	2,105	2,011	2,165
Non-financial assets - Precious metals and other physical commodities	0	0	0
Other non-financial assets measured at fair value	0	0	0
Total assets measured at fair value	273,750	271,093	289,015
Level 2 | Equity instruments
Disclosure Of Fair Value Measurement Of Assets [Line Items]
Financial assets at fair value held for trading	827	344	1,403
Financial assets at fair value not held for trading	5	1	38
Level 2 | Government bills / bonds
Disclosure Of Fair Value Measurement Of Assets [Line Items]
Financial assets at fair value held for trading	5,319	6,652	8,763
Financial assets at fair value not held for trading	7,817	7,019	4,801
Level 2 | Investment fund units
Disclosure Of Fair Value Measurement Of Assets [Line Items]
Financial assets at fair value held for trading	1,222	1,943	1,124
Financial assets at fair value not held for trading	421	458	548
Level 2 | Corporate and municipal bonds
Disclosure Of Fair Value Measurement Of Assets [Line Items]
Financial assets at fair value held for trading	16,569	16,152	12,801
Financial assets at fair value not held for trading	14,338	14,532	16,722
Financial assets measured at fair value through other comprehensive income	205	179	207
Level 2 | Loans
Disclosure Of Fair Value Measurement Of Assets [Line Items]
Financial assets at fair value held for trading	5,246	5,499	3,837
Financial assets at fair value not held for trading	3,699	3,710	4,252
Level 2 | Asset-backed securities
Disclosure Of Fair Value Measurement Of Assets [Line Items]
Financial assets at fair value held for trading	192	139	112
Financial assets at fair value not held for trading	1,108	1,169	1,525
Level 2 | Foreign exchange
Disclosure Of Fair Value Measurement Of Assets [Line Items]
Derivative financial assets	50,521	61,337	78,060
Level 2 | Interest rate contracts
Disclosure Of Fair Value Measurement Of Assets [Line Items]
Derivative financial assets	48,437	52,144	55,190
Level 2 | Equity / index contracts
Disclosure Of Fair Value Measurement Of Assets [Line Items]
Derivative financial assets	32,239	36,489	34,174
Level 2 | Credit derivative contracts
Disclosure Of Fair Value Measurement Of Assets [Line Items]
Derivative financial assets	2,553	2,590	3,456
Level 2 | Commodity contracts
Disclosure Of Fair Value Measurement Of Assets [Line Items]
Derivative financial assets	2,563	3,001	1,869
Level 2 | Auction rate securities
Disclosure Of Fair Value Measurement Of Assets [Line Items]
Financial assets at fair value not held for trading	0	0	0
Level 2 | Securities financing transactions
Disclosure Of Fair Value Measurement Of Assets [Line Items]
Financial assets at fair value not held for trading	53,069	32,840	36,857
Level 2 | Financial assets for unit-linked investment contracts
Disclosure Of Fair Value Measurement Of Assets [Line Items]
Financial assets at fair value not held for trading	6	25	7
Level 2 | Commercial paper and certificates of deposit
Disclosure Of Fair Value Measurement Of Assets [Line Items]
Financial assets measured at fair value through other comprehensive income	1,891	1,783	1,948
Level 3
Disclosure Of Fair Value Measurement Of Assets [Line Items]
Financial assets at fair value held for trading	8,042	12,390	22,613
Derivative financial assets	2,325	2,373	2,559
Brokerage receivables	0	0	0
Financial assets at fair value not held for trading	7,945	8,704	8,435
Financial assets measured at fair value through other comprehensive income	0	0	0
Non-financial assets - Precious metals and other physical commodities	0	0	0
Other non-financial assets measured at fair value	43	35	31
Total assets measured at fair value	18,354	23,502	33,639
Level 3 | Equity instruments
Disclosure Of Fair Value Measurement Of Assets [Line Items]
Financial assets at fair value held for trading	185	247	321
Financial assets at fair value not held for trading	2,896	3,017	3,097
Level 3 | Government bills / bonds
Disclosure Of Fair Value Measurement Of Assets [Line Items]
Financial assets at fair value held for trading	75	35	73
Financial assets at fair value not held for trading	0	0	0
Level 3 | Investment fund units
Disclosure Of Fair Value Measurement Of Assets [Line Items]
Financial assets at fair value held for trading	240	234	129
Financial assets at fair value not held for trading	670	688	678
Level 3 | Corporate and municipal bonds
Disclosure Of Fair Value Measurement Of Assets [Line Items]
Financial assets at fair value held for trading	900	1,045	1,284
Financial assets at fair value not held for trading	210	217	215
Financial assets measured at fair value through other comprehensive income	0	0	0
Level 3 | Loans
Disclosure Of Fair Value Measurement Of Assets [Line Items]
Financial assets at fair value held for trading	6,419	10,606	19,618
Financial assets at fair value not held for trading	2,553	2,167	2,258
Level 3 | Asset-backed securities
Disclosure Of Fair Value Measurement Of Assets [Line Items]
Financial assets at fair value held for trading	169	119	133
Financial assets at fair value not held for trading	500	500	180
Level 3 | Foreign exchange
Disclosure Of Fair Value Measurement Of Assets [Line Items]
Derivative financial assets	121	197	253
Level 3 | Interest rate contracts
Disclosure Of Fair Value Measurement Of Assets [Line Items]
Derivative financial assets	403	402	407
Level 3 | Equity / index contracts
Disclosure Of Fair Value Measurement Of Assets [Line Items]
Derivative financial assets	1,154	1,186	1,299
Level 3 | Credit derivative contracts
Disclosure Of Fair Value Measurement Of Assets [Line Items]
Derivative financial assets	478	434	513
Level 3 | Commodity contracts
Disclosure Of Fair Value Measurement Of Assets [Line Items]
Derivative financial assets	16	2	13
Level 3 | Auction rate securities
Disclosure Of Fair Value Measurement Of Assets [Line Items]
Financial assets at fair value not held for trading	191	1,211	1,208
Level 3 | Securities financing transactions
Disclosure Of Fair Value Measurement Of Assets [Line Items]
Financial assets at fair value not held for trading	268	98	52
Level 3 | Financial assets for unit-linked investment contracts
Disclosure Of Fair Value Measurement Of Assets [Line Items]
Financial assets at fair value not held for trading	0	0	0
Level 3 | Commercial paper and certificates of deposit
Disclosure Of Fair Value Measurement Of Assets [Line Items]
Financial assets measured at fair value through other comprehensive income	$ 0	$ 0	$ 0

FVM - Fair value hierarchy - Li

FVM - Fair value hierarchy - Liabilities (Detail) - USD ($) $ in Millions	Jun. 30, 2024	Mar. 31, 2024	Dec. 31, 2023
Disclosure Of Fair Value Measurement Of Liabilities [Line Items]
Financial liabilities at fair value held for trading	$ 33,493	$ 35,758	$ 34,159
Derivative financial liabilities	149,069	163,042	192,181
Brokerage payables designated at fair value	46,198	46,628	42,522
Debt issued designated at fair value	113,209	116,806	128,289
Other financial liabilities designated at fair value	31,875	28,140	29,484
Total financial liabilities measured at fair value through profit or loss	373,844	390,374	426,635
Equity instruments
Disclosure Of Fair Value Measurement Of Liabilities [Line Items]
Financial liabilities at fair value held for trading	17,438	19,356	18,606
Corporate and municipal bonds
Disclosure Of Fair Value Measurement Of Liabilities [Line Items]
Financial liabilities at fair value held for trading	7,186	7,132	5,071
Government bills / bonds
Disclosure Of Fair Value Measurement Of Liabilities [Line Items]
Financial liabilities at fair value held for trading	7,437	7,828	9,464
Investment fund units
Disclosure Of Fair Value Measurement Of Liabilities [Line Items]
Financial liabilities at fair value held for trading	1,357	1,378	954
Foreign exchange
Disclosure Of Fair Value Measurement Of Liabilities [Line Items]
Derivative financial liabilities	52,014	59,107	89,887
Interest rate contracts
Disclosure Of Fair Value Measurement Of Liabilities [Line Items]
Derivative financial liabilities	47,264	50,273	52,920
Equity / index contracts
Disclosure Of Fair Value Measurement Of Liabilities [Line Items]
Derivative financial liabilities	41,380	45,825	41,380
Credit derivative contracts
Disclosure Of Fair Value Measurement Of Liabilities [Line Items]
Derivative financial liabilities	3,827	3,731	4,700
Commodity contracts
Disclosure Of Fair Value Measurement Of Liabilities [Line Items]
Derivative financial liabilities	1,967	2,642	1,458
Loan commitments measured at FVTPL
Disclosure Of Fair Value Measurement Of Liabilities [Line Items]
Derivative financial liabilities	1,835	682	1,172
Financial liabilities related to unit-linked investment contracts
Disclosure Of Fair Value Measurement Of Liabilities [Line Items]
Other financial liabilities designated at fair value	17,080	16,612	15,992
Securities financing transactions
Disclosure Of Fair Value Measurement Of Liabilities [Line Items]
Other financial liabilities designated at fair value	7,699	5,121	7,416
Over-the-counter debt instruments
Disclosure Of Fair Value Measurement Of Liabilities [Line Items]
Other financial liabilities designated at fair value	7,096	6,407	6,076
Level 1
Disclosure Of Fair Value Measurement Of Liabilities [Line Items]
Financial liabilities at fair value held for trading	24,476	26,785	27,684
Derivative financial liabilities	876	967	771
Brokerage payables designated at fair value	0	0	0
Debt issued designated at fair value	0	0	0
Other financial liabilities designated at fair value	0	0	0
Total financial liabilities measured at fair value through profit or loss	25,352	27,752	28,454
Level 1 | Equity instruments
Disclosure Of Fair Value Measurement Of Liabilities [Line Items]
Financial liabilities at fair value held for trading	16,956	18,996	18,266
Level 1 | Corporate and municipal bonds
Disclosure Of Fair Value Measurement Of Liabilities [Line Items]
Financial liabilities at fair value held for trading	33	34	28
Level 1 | Government bills / bonds
Disclosure Of Fair Value Measurement Of Liabilities [Line Items]
Financial liabilities at fair value held for trading	6,171	6,596	8,559
Level 1 | Investment fund units
Disclosure Of Fair Value Measurement Of Liabilities [Line Items]
Financial liabilities at fair value held for trading	1,315	1,159	832
Level 1 | Foreign exchange
Disclosure Of Fair Value Measurement Of Liabilities [Line Items]
Derivative financial liabilities	326	372	457
Level 1 | Interest rate contracts
Disclosure Of Fair Value Measurement Of Liabilities [Line Items]
Derivative financial liabilities	0	0	0
Level 1 | Equity / index contracts
Disclosure Of Fair Value Measurement Of Liabilities [Line Items]
Derivative financial liabilities	0	0	0
Level 1 | Credit derivative contracts
Disclosure Of Fair Value Measurement Of Liabilities [Line Items]
Derivative financial liabilities	0	0	0
Level 1 | Commodity contracts
Disclosure Of Fair Value Measurement Of Liabilities [Line Items]
Derivative financial liabilities	2	3	0
Level 1 | Loan commitments measured at FVTPL
Disclosure Of Fair Value Measurement Of Liabilities [Line Items]
Derivative financial liabilities	0	0	0
Level 1 | Financial liabilities related to unit-linked investment contracts
Disclosure Of Fair Value Measurement Of Liabilities [Line Items]
Other financial liabilities designated at fair value	0	0	0
Level 1 | Securities financing transactions
Disclosure Of Fair Value Measurement Of Liabilities [Line Items]
Other financial liabilities designated at fair value	0	0	0
Level 1 | Over-the-counter debt instruments
Disclosure Of Fair Value Measurement Of Liabilities [Line Items]
Other financial liabilities designated at fair value	0	0	0
Level 2
Disclosure Of Fair Value Measurement Of Liabilities [Line Items]
Financial liabilities at fair value held for trading	8,906	8,771	6,315
Derivative financial liabilities	143,744	156,208	185,815
Brokerage payables designated at fair value	46,198	46,628	42,522
Debt issued designated at fair value	100,223	102,823	113,012
Other financial liabilities designated at fair value	28,484	25,490	26,878
Total financial liabilities measured at fair value through profit or loss	327,555	339,920	374,542
Level 2 | Equity instruments
Disclosure Of Fair Value Measurement Of Liabilities [Line Items]
Financial liabilities at fair value held for trading	417	294	248
Level 2 | Corporate and municipal bonds
Disclosure Of Fair Value Measurement Of Liabilities [Line Items]
Financial liabilities at fair value held for trading	7,118	6,966	4,981
Level 2 | Government bills / bonds
Disclosure Of Fair Value Measurement Of Liabilities [Line Items]
Financial liabilities at fair value held for trading	1,260	1,232	905
Level 2 | Investment fund units
Disclosure Of Fair Value Measurement Of Liabilities [Line Items]
Financial liabilities at fair value held for trading	38	216	118
Level 2 | Foreign exchange
Disclosure Of Fair Value Measurement Of Liabilities [Line Items]
Derivative financial liabilities	51,640	58,684	89,394
Level 2 | Interest rate contracts
Disclosure Of Fair Value Measurement Of Liabilities [Line Items]
Derivative financial liabilities	47,021	49,966	52,673
Level 2 | Equity / index contracts
Disclosure Of Fair Value Measurement Of Liabilities [Line Items]
Derivative financial liabilities	38,001	41,522	38,046
Level 2 | Credit derivative contracts
Disclosure Of Fair Value Measurement Of Liabilities [Line Items]
Derivative financial liabilities	3,456	3,205	4,081
Level 2 | Commodity contracts
Disclosure Of Fair Value Measurement Of Liabilities [Line Items]
Derivative financial liabilities	1,951	2,618	1,437
Level 2 | Loan commitments measured at FVTPL
Disclosure Of Fair Value Measurement Of Liabilities [Line Items]
Derivative financial liabilities	1,547	127	135
Level 2 | Financial liabilities related to unit-linked investment contracts
Disclosure Of Fair Value Measurement Of Liabilities [Line Items]
Other financial liabilities designated at fair value	17,080	16,612	15,992
Level 2 | Securities financing transactions
Disclosure Of Fair Value Measurement Of Liabilities [Line Items]
Other financial liabilities designated at fair value	7,699	5,121	7,416
Level 2 | Over-the-counter debt instruments
Disclosure Of Fair Value Measurement Of Liabilities [Line Items]
Other financial liabilities designated at fair value	3,705	3,757	3,471
Level 3
Disclosure Of Fair Value Measurement Of Liabilities [Line Items]
Financial liabilities at fair value held for trading	111	202	161
Derivative financial liabilities	4,448	5,867	5,595
Brokerage payables designated at fair value	0	0	0
Debt issued designated at fair value	12,986	13,983	15,276
Other financial liabilities designated at fair value	3,391	2,650	2,606
Total financial liabilities measured at fair value through profit or loss	20,936	22,703	23,638
Level 3 | Equity instruments
Disclosure Of Fair Value Measurement Of Liabilities [Line Items]
Financial liabilities at fair value held for trading	66	66	92
Level 3 | Corporate and municipal bonds
Disclosure Of Fair Value Measurement Of Liabilities [Line Items]
Financial liabilities at fair value held for trading	35	132	62
Level 3 | Government bills / bonds
Disclosure Of Fair Value Measurement Of Liabilities [Line Items]
Financial liabilities at fair value held for trading	5	0	0
Level 3 | Investment fund units
Disclosure Of Fair Value Measurement Of Liabilities [Line Items]
Financial liabilities at fair value held for trading	4	3	4
Level 3 | Foreign exchange
Disclosure Of Fair Value Measurement Of Liabilities [Line Items]
Derivative financial liabilities	48	51	36
Level 3 | Interest rate contracts
Disclosure Of Fair Value Measurement Of Liabilities [Line Items]
Derivative financial liabilities	243	307	246
Level 3 | Equity / index contracts
Disclosure Of Fair Value Measurement Of Liabilities [Line Items]
Derivative financial liabilities	3,379	4,302	3,333
Level 3 | Credit derivative contracts
Disclosure Of Fair Value Measurement Of Liabilities [Line Items]
Derivative financial liabilities	371	525	619
Level 3 | Commodity contracts
Disclosure Of Fair Value Measurement Of Liabilities [Line Items]
Derivative financial liabilities	14	20	21
Level 3 | Loan commitments measured at FVTPL
Disclosure Of Fair Value Measurement Of Liabilities [Line Items]
Derivative financial liabilities	288	555	1,037
Level 3 | Financial liabilities related to unit-linked investment contracts
Disclosure Of Fair Value Measurement Of Liabilities [Line Items]
Other financial liabilities designated at fair value	0	0	0
Level 3 | Securities financing transactions
Disclosure Of Fair Value Measurement Of Liabilities [Line Items]
Other financial liabilities designated at fair value	0	0	0
Level 3 | Over-the-counter debt instruments
Disclosure Of Fair Value Measurement Of Liabilities [Line Items]
Other financial liabilities designated at fair value	$ 3,391	$ 2,650	$ 2,606

FVM - Valuation adjustments res

FVM - Valuation adjustments reserves on the balance sheet (Detail) - USD ($) $ in Millions	Jun. 30, 2024	Mar. 31, 2024	Dec. 31, 2023
Valuation Adjustment Reserves On The Balance Sheet [Line Items]
Own credit adjustments on financial liabilities designated at fair value	$ (1,062)	$ (1,315)	$ (1,287)
of which: debt issued designated at fair value	(1,085)	(1,334)	(1,297)
of which: other financial liabilities designated at fair value	23	19	10
Credit valuation adjustments	(104)	(118)	(145)
Funding / Debit valuation adjustments	(81)	(107)	(116)
Other valuation adjustments	(1,745)	(2,135)	(2,654)
of which: liquidity	(1,230)	(1,588)	(2,051)
of which: model uncertainty	$ (516)	$ (547)	$ (603)

FVM - Valuation adjustments_ De

FVM - Valuation adjustments: Deferred day-1 P&L (Detail) - USD ($) $ in Millions	3 Months Ended			6 Months Ended
	Jun. 30, 2024	Mar. 31, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Deferred Day-1 Profit Or Loss [Line Items]
Reserve balance at the beginning of the period	$ 384	$ 404	$ 399	$ 404	$ 422
Profit / (loss) deferred on new transactions	59	42	78	101	169
(Profit) / loss recognized in the income statement	(55)	(62)	(75)	(116)	(188)
Foreign currency translation	(1)	0	(1)	(1)	(1)
Reserve balance at the end of the period	$ 388	$ 384	$ 402	$ 388	$ 402

FVM - Level 3 instruments_ Valu

FVM - Level 3 instruments: Valuation techniques and inputs (Detail) - Level 3 $ in Billions	3 Months Ended
	Jun. 30, 2024 USD ($)	Dec. 31, 2023 USD ($)
Financial assets and liabilities at fair value held for trading, Financial assets at fair value not held for trading: Corporate and municipal bonds
Disclosure Of Fair Value Measurement [Line Items]
Financial assets measured at fair value	$ 1.1	$ 1.5
Financial liabilities measured at fair value	$ 0	$ 0.1
Financial assets and liabilities at fair value held for trading, Financial assets at fair value not held for trading: Corporate and municipal bonds | Relative value to market comparable | Bond price equivalent (% of par) | low
Disclosure Of Fair Value Measurement [Line Items]
Significant unobservable input(s)	0.19	0.05
Financial assets and liabilities at fair value held for trading, Financial assets at fair value not held for trading: Corporate and municipal bonds | Relative value to market comparable | Bond price equivalent (% of par) | high
Disclosure Of Fair Value Measurement [Line Items]
Significant unobservable input(s)	1.26	1.26
Financial assets and liabilities at fair value held for trading, Financial assets at fair value not held for trading: Corporate and municipal bonds | Relative value to market comparable | Bond price equivalent (% of par) | weighted average
Disclosure Of Fair Value Measurement [Line Items]
Significant unobservable input(s)	0.95	0.99
Financial assets and liabilities at fair value held for trading, Financial assets at fair value not held for trading: Corporate and municipal bonds | Discounted expected cash flows | Discount margin | low
Disclosure Of Fair Value Measurement [Line Items]
Significant unobservable input(s)	0.0243	0.0135
Financial assets and liabilities at fair value held for trading, Financial assets at fair value not held for trading: Corporate and municipal bonds | Discounted expected cash flows | Discount margin | high
Disclosure Of Fair Value Measurement [Line Items]
Significant unobservable input(s)	0.3055	0.0491
Financial assets and liabilities at fair value held for trading, Financial assets at fair value not held for trading: Corporate and municipal bonds | Discounted expected cash flows | Discount margin | weighted average
Disclosure Of Fair Value Measurement [Line Items]
Significant unobservable input(s)	0.0687	0.0463
Financial assets and liabilities at fair value held for trading, Financial assets at fair value not held for trading: Traded loans, loans mandatorily at fair value, loan commitments and guarantees
Disclosure Of Fair Value Measurement [Line Items]
Financial assets measured at fair value	$ 9.3	$ 22
Financial liabilities measured at fair value	$ 0	$ 0
Financial assets and liabilities at fair value held for trading, Financial assets at fair value not held for trading: Traded loans, loans mandatorily at fair value, loan commitments and guarantees | Relative value to market comparable | Loan price equivalent (% of par) | low
Disclosure Of Fair Value Measurement [Line Items]
Significant unobservable input(s)	0.01	0.01
Financial assets and liabilities at fair value held for trading, Financial assets at fair value not held for trading: Traded loans, loans mandatorily at fair value, loan commitments and guarantees | Relative value to market comparable | Loan price equivalent (% of par) | high
Disclosure Of Fair Value Measurement [Line Items]
Significant unobservable input(s)	1.14	1.20
Financial assets and liabilities at fair value held for trading, Financial assets at fair value not held for trading: Traded loans, loans mandatorily at fair value, loan commitments and guarantees | Relative value to market comparable | Loan price equivalent (% of par) | weighted average
Disclosure Of Fair Value Measurement [Line Items]
Significant unobservable input(s)	0.74	0.88
Financial assets and liabilities at fair value held for trading, Financial assets at fair value not held for trading: Traded loans, loans mandatorily at fair value, loan commitments and guarantees | Discounted expected cash flows | Credit spread | low
Disclosure Of Fair Value Measurement [Line Items]
Significant unobservable input(s)	0.0019	0.0019
Financial assets and liabilities at fair value held for trading, Financial assets at fair value not held for trading: Traded loans, loans mandatorily at fair value, loan commitments and guarantees | Discounted expected cash flows | Credit spread | high
Disclosure Of Fair Value Measurement [Line Items]
Significant unobservable input(s)	0.1779	0.2681
Financial assets and liabilities at fair value held for trading, Financial assets at fair value not held for trading: Traded loans, loans mandatorily at fair value, loan commitments and guarantees | Discounted expected cash flows | Credit spread | weighted average
Disclosure Of Fair Value Measurement [Line Items]
Significant unobservable input(s)	0.0367	0.0614
Financial assets and liabilities at fair value held for trading, Financial assets at fair value not held for trading: Investment fund units
Disclosure Of Fair Value Measurement [Line Items]
Financial assets measured at fair value	$ 0.9	$ 0.8
Financial liabilities measured at fair value	0	0
Financial assets and liabilities at fair value held for trading, Financial assets at fair value not held for trading: Equity instruments
Disclosure Of Fair Value Measurement [Line Items]
Financial assets measured at fair value	3.1	3.4
Financial liabilities measured at fair value	0.1	0.1
Debt issued designated at fair value
Disclosure Of Fair Value Measurement [Line Items]
Financial liabilities measured at fair value	13	15.3
Other financial liabilities designated at fair value
Disclosure Of Fair Value Measurement [Line Items]
Financial liabilities measured at fair value	$ 3.4	$ 2.6
Other financial liabilities designated at fair value | Discounted expected cash flows | Funding spread | low
Disclosure Of Fair Value Measurement [Line Items]
Significant unobservable input(s)	0.0106	0.0051
Other financial liabilities designated at fair value | Discounted expected cash flows | Funding spread | high
Disclosure Of Fair Value Measurement [Line Items]
Significant unobservable input(s)	0.0201	0.0201
Derivative financial instruments: Interest rate contracts
Disclosure Of Fair Value Measurement [Line Items]
Financial assets measured at fair value	$ 0.4	$ 0.4
Financial liabilities measured at fair value	$ 0.2	$ 0.2
Derivative financial instruments: Interest rate contracts | Option model | Volatility of inflation | low
Disclosure Of Fair Value Measurement [Line Items]
Significant unobservable input(s)	0.01	0.01
Derivative financial instruments: Interest rate contracts | Option model | Volatility of inflation | high
Disclosure Of Fair Value Measurement [Line Items]
Significant unobservable input(s)	0.06	0.06
Derivative financial instruments: Interest rate contracts | Option model | IR-to-IR correlation | low
Disclosure Of Fair Value Measurement [Line Items]
Significant unobservable input(s)	0.71	0.04
Derivative financial instruments: Interest rate contracts | Option model | IR-to-IR correlation | high
Disclosure Of Fair Value Measurement [Line Items]
Significant unobservable input(s)	0.99	1
Derivative financial instruments: Interest rate contracts | Option model | Volatility of interest rates | low
Disclosure Of Fair Value Measurement [Line Items]
Significant unobservable input(s)	0.0048	0.0045
Derivative financial instruments: Interest rate contracts | Option model | Volatility of interest rates | high
Disclosure Of Fair Value Measurement [Line Items]
Significant unobservable input(s)	0.0149	0.0154
Derivative financial instruments: Credit derivative contracts
Disclosure Of Fair Value Measurement [Line Items]
Financial assets measured at fair value	$ 0.5	$ 0.5
Financial liabilities measured at fair value	$ 0.4	$ 0.6
Derivative financial instruments: Credit derivative contracts | Discounted expected cash flows | Credit spread | low
Disclosure Of Fair Value Measurement [Line Items]
Significant unobservable input(s)	0.0003	0.0001
Derivative financial instruments: Credit derivative contracts | Discounted expected cash flows | Credit spread | high
Disclosure Of Fair Value Measurement [Line Items]
Significant unobservable input(s)	0.2967	0.2421
Derivative financial instruments: Credit derivative contracts | Discounted expected cash flows | Credit correlation | low
Disclosure Of Fair Value Measurement [Line Items]
Significant unobservable input(s)	0.50	0.50
Derivative financial instruments: Credit derivative contracts | Discounted expected cash flows | Credit correlation | high
Disclosure Of Fair Value Measurement [Line Items]
Significant unobservable input(s)	0.66	0.66
Derivative financial instruments: Credit derivative contracts | Discounted expected cash flows | Credit volatility | low
Disclosure Of Fair Value Measurement [Line Items]
Significant unobservable input(s)	0.60	0.60
Derivative financial instruments: Credit derivative contracts | Discounted expected cash flows | Credit volatility | high
Disclosure Of Fair Value Measurement [Line Items]
Significant unobservable input(s)	0.60	0.60
Derivative financial instruments: Credit derivative contracts | Discounted expected cash flows | Recovery rates | low
Disclosure Of Fair Value Measurement [Line Items]
Significant unobservable input(s)	0	0.14
Derivative financial instruments: Credit derivative contracts | Discounted expected cash flows | Recovery rates | high
Disclosure Of Fair Value Measurement [Line Items]
Significant unobservable input(s)	1	1
Derivative financial instruments: Equity / index contracts
Disclosure Of Fair Value Measurement [Line Items]
Financial assets measured at fair value	$ 1.2	$ 1.3
Financial liabilities measured at fair value	$ 3.4	$ 3.3
Derivative financial instruments: Equity / index contracts | Option model | Equity dividend yields | low
Disclosure Of Fair Value Measurement [Line Items]
Significant unobservable input(s)	0	0
Derivative financial instruments: Equity / index contracts | Option model | Equity dividend yields | high
Disclosure Of Fair Value Measurement [Line Items]
Significant unobservable input(s)	0.19	0.17
Derivative financial instruments: Equity / index contracts | Option model | Volatility of equity stocks, equity and other indices | low
Disclosure Of Fair Value Measurement [Line Items]
Significant unobservable input(s)	0.04	0.04
Derivative financial instruments: Equity / index contracts | Option model | Volatility of equity stocks, equity and other indices | high
Disclosure Of Fair Value Measurement [Line Items]
Significant unobservable input(s)	1.35	1.42
Derivative financial instruments: Equity / index contracts | Option model | Equity-to-FX correlation | low
Disclosure Of Fair Value Measurement [Line Items]
Significant unobservable input(s)	(0.40)	(0.40)
Derivative financial instruments: Equity / index contracts | Option model | Equity-to-FX correlation | high
Disclosure Of Fair Value Measurement [Line Items]
Significant unobservable input(s)	0.77	0.77
Derivative financial instruments: Equity / index contracts | Option model | Equity-to-equity correlation | low
Disclosure Of Fair Value Measurement [Line Items]
Significant unobservable input(s)	0.10	(0.50)
Derivative financial instruments: Equity / index contracts | Option model | Equity-to-equity correlation | high
Disclosure Of Fair Value Measurement [Line Items]
Significant unobservable input(s)	1	1
Loan commitments measured at FVTPL
Disclosure Of Fair Value Measurement [Line Items]
Financial liabilities measured at fair value	$ 0.3	$ 1
Loan commitments measured at FVTPL | Relative value to market comparable | Loan price equivalent (% of par) | low
Disclosure Of Fair Value Measurement [Line Items]
Significant unobservable input(s)	0.0015	0.0035
Loan commitments measured at FVTPL | Relative value to market comparable | Loan price equivalent (% of par) | high
Disclosure Of Fair Value Measurement [Line Items]
Significant unobservable input(s)	0.0100	0.0102

FVM - Level 3 instruments_ Sens

FVM - Level 3 instruments: Sensitivity to changes in unobservable input assumptions (Detail) - USD ($) $ in Millions	3 Months Ended
	Jun. 30, 2024	Mar. 31, 2024	Dec. 31, 2023
Disclosure Of Sensitivity Analysis Of Fair Value Measurement To Changes In Unobservable Inputs Assets And Liabilities [Line Items]
Favorable changes	$ 2,192	$ 2,327	$ 2,815
Unfavorable changes	(2,021)	(2,133)	(2,538)
Traded loans, loans measured at fair value, loan commitments and guarantees
Disclosure Of Sensitivity Analysis Of Fair Value Measurement To Changes In Unobservable Inputs Assets And Liabilities [Line Items]
Favorable changes	453	441	635
Unfavorable changes	(433)	(407)	(600)
Securities financing transactions
Disclosure Of Sensitivity Analysis Of Fair Value Measurement To Changes In Unobservable Inputs Assets And Liabilities [Line Items]
Favorable changes	34	37	30
Unfavorable changes	(31)	(33)	(32)
Auction rate securities
Disclosure Of Sensitivity Analysis Of Fair Value Measurement To Changes In Unobservable Inputs Assets And Liabilities [Line Items]
Favorable changes	8	39	67
Unfavorable changes	(6)	(25)	(21)
Asset-backed securities
Disclosure Of Sensitivity Analysis Of Fair Value Measurement To Changes In Unobservable Inputs Assets And Liabilities [Line Items]
Favorable changes	44	54	39
Unfavorable changes	(48)	(58)	(36)
Equity instruments
Disclosure Of Sensitivity Analysis Of Fair Value Measurement To Changes In Unobservable Inputs Assets And Liabilities [Line Items]
Favorable changes	428	447	430
Unfavorable changes	(403)	(428)	(413)
Investment fund units
Disclosure Of Sensitivity Analysis Of Fair Value Measurement To Changes In Unobservable Inputs Assets And Liabilities [Line Items]
Favorable changes	140	142	135
Unfavorable changes	(141)	(144)	(137)
Loan commitments measured at FVTPL
Disclosure Of Sensitivity Analysis Of Fair Value Measurement To Changes In Unobservable Inputs Assets And Liabilities [Line Items]
Favorable changes	85	148	313
Unfavorable changes	(110)	(176)	(343)
Interest rate derivative contracts, net
Disclosure Of Sensitivity Analysis Of Fair Value Measurement To Changes In Unobservable Inputs Assets And Liabilities [Line Items]
Favorable changes	139	209	217
Unfavorable changes	(81)	(102)	(103)
Credit derivative contracts, net
Disclosure Of Sensitivity Analysis Of Fair Value Measurement To Changes In Unobservable Inputs Assets And Liabilities [Line Items]
Favorable changes	124	117	140
Unfavorable changes	(128)	(117)	(131)
Foreign exchange derivative contracts, net
Disclosure Of Sensitivity Analysis Of Fair Value Measurement To Changes In Unobservable Inputs Assets And Liabilities [Line Items]
Favorable changes	3	4	5
Unfavorable changes	(4)	(4)	(4)
Equity / index derivative contracts, net
Disclosure Of Sensitivity Analysis Of Fair Value Measurement To Changes In Unobservable Inputs Assets And Liabilities [Line Items]
Favorable changes	651	563	521
Unfavorable changes	(546)	(498)	(443)
Other
Disclosure Of Sensitivity Analysis Of Fair Value Measurement To Changes In Unobservable Inputs Assets And Liabilities [Line Items]
Favorable changes	83	126	281
Unfavorable changes	$ (90)	$ (141)	$ (276)

FVM - Movements of level 3 inst

FVM - Movements of level 3 instruments - Assets (Detail) - Level 3 - USD ($) $ in Billions	6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023
Investment fund units
Disclosure Of Fair Value Measurement Of Assets [Line Items]
Balance at the beginning of the period	$ 0.8
Balance at the end of the period	0.9
Corporate and municipal bonds
Disclosure Of Fair Value Measurement Of Assets [Line Items]
Balance at the beginning of the period	1.5
Balance at the end of the period	1.1
Equity instruments
Disclosure Of Fair Value Measurement Of Assets [Line Items]
Balance at the beginning of the period	3.4
Balance at the end of the period	3.1
Financial assets at fair value held for trading
Disclosure Of Fair Value Measurement Of Assets [Line Items]
Balance at the beginning of the period	22.6	$ 1.5
Total gains / (losses) included in comprehensive income - Net gains / (losses) included in income	0.3	(0.5)
Total gains / (losses) included in comprehensive income - of which: related to Level 3 instruments held at the end of the reporting period	(0.3)	(0.6)
Purchases	0.9	0.5
Sales	(11.6)	(1.9)
Issuances	0.8	1.1
Settlements	(5.7)	0
Transfers into Level 3	1.6	0.1
Transfers out of Level 3	(0.7)	(0.3)
Foreign currency translation	(0.1)	0
Balance at the end of the period	8	26.7
Financial assets at fair value held for trading | Credit Suisse
Disclosure Of Fair Value Measurement Of Assets [Line Items]
Assets acquired		26.2
Financial assets at fair value held for trading | Investment fund units
Disclosure Of Fair Value Measurement Of Assets [Line Items]
Balance at the beginning of the period	0.3	0.1
Total gains / (losses) included in comprehensive income - Net gains / (losses) included in income		0
Total gains / (losses) included in comprehensive income - of which: related to Level 3 instruments held at the end of the reporting period		0
Purchases		0
Sales		0
Issuances		0
Settlements		0
Transfers into Level 3		0
Transfers out of Level 3		0
Foreign currency translation		0
Balance at the end of the period	0.2	0.1
Financial assets at fair value held for trading | Investment fund units | Credit Suisse
Disclosure Of Fair Value Measurement Of Assets [Line Items]
Assets acquired		0.1
Financial assets at fair value held for trading | Corporate and municipal bonds
Disclosure Of Fair Value Measurement Of Assets [Line Items]
Balance at the beginning of the period	1.3	0.5
Total gains / (losses) included in comprehensive income - Net gains / (losses) included in income	(0.1)	(0.4)
Total gains / (losses) included in comprehensive income - of which: related to Level 3 instruments held at the end of the reporting period	0	(0.4)
Purchases	0.3	0.3
Sales	(0.5)	(0.6)
Issuances	0	0
Settlements	0	0
Transfers into Level 3	0	0
Transfers out of Level 3	(0.1)	0
Foreign currency translation	0	0
Balance at the end of the period	0.9	1
Financial assets at fair value held for trading | Corporate and municipal bonds | Credit Suisse
Disclosure Of Fair Value Measurement Of Assets [Line Items]
Assets acquired		1.1
Financial assets at fair value held for trading | Loans
Disclosure Of Fair Value Measurement Of Assets [Line Items]
Balance at the beginning of the period	19.6	0.6
Total gains / (losses) included in comprehensive income - Net gains / (losses) included in income	0.5	(0.1)
Total gains / (losses) included in comprehensive income - of which: related to Level 3 instruments held at the end of the reporting period	(0.2)	(0.1)
Purchases	0.4	0
Sales	(9.9)	(1.1)
Issuances	0.8	1.1
Settlements	(5.7)	0
Transfers into Level 3	1.4	0
Transfers out of Level 3	(0.6)	(0.2)
Foreign currency translation	(0.1)	0
Balance at the end of the period	6.4	23.5
Financial assets at fair value held for trading | Loans | Credit Suisse
Disclosure Of Fair Value Measurement Of Assets [Line Items]
Assets acquired		23.1
Financial assets at fair value held for trading | Equity instruments
Disclosure Of Fair Value Measurement Of Assets [Line Items]
Balance at the beginning of the period	0.3
Total gains / (losses) included in comprehensive income - Net gains / (losses) included in income	0
Total gains / (losses) included in comprehensive income - of which: related to Level 3 instruments held at the end of the reporting period	0
Purchases	0
Sales	0
Issuances	0
Settlements	0
Transfers into Level 3	0
Transfers out of Level 3	(0.1)
Foreign currency translation	0
Balance at the end of the period	0.2
Derivative financial instruments
Disclosure Of Fair Value Measurement Of Assets [Line Items]
Balance at the beginning of the period	2.6	1.5
Total gains / (losses) included in comprehensive income - Net gains / (losses) included in income	0	(0.1)
Total gains / (losses) included in comprehensive income - of which: related to Level 3 instruments held at the end of the reporting period	0	(0.1)
Purchases	0	0
Sales	0	0
Issuances	0.6	0.5
Settlements	(0.5)	(0.3)
Transfers into Level 3	0.3	0.1
Transfers out of Level 3	(0.6)	(0.2)
Foreign currency translation	0	0
Balance at the end of the period	2.3	3
Derivative financial instruments | Credit Suisse
Disclosure Of Fair Value Measurement Of Assets [Line Items]
Assets acquired		1.4
Derivative financial instruments | Interest rate contracts
Disclosure Of Fair Value Measurement Of Assets [Line Items]
Balance at the beginning of the period	0.4	0.5
Total gains / (losses) included in comprehensive income - Net gains / (losses) included in income	0	0.1
Total gains / (losses) included in comprehensive income - of which: related to Level 3 instruments held at the end of the reporting period	0.1	0.1
Purchases	0	0
Sales	0	0
Issuances	0	0.1
Settlements	(0.1)	0
Transfers into Level 3	0.1	0
Transfers out of Level 3	0	0
Foreign currency translation	0	0
Balance at the end of the period	0.4	0.8
Derivative financial instruments | Interest rate contracts | Credit Suisse
Disclosure Of Fair Value Measurement Of Assets [Line Items]
Assets acquired		0.2
Derivative financial instruments | Equity / index contracts
Disclosure Of Fair Value Measurement Of Assets [Line Items]
Balance at the beginning of the period	1.3	0.7
Total gains / (losses) included in comprehensive income - Net gains / (losses) included in income	0	(0.1)
Total gains / (losses) included in comprehensive income - of which: related to Level 3 instruments held at the end of the reporting period	0	(0.1)
Purchases	0	0
Sales	0	0
Issuances	0.5	0.3
Settlements	(0.2)	(0.2)
Transfers into Level 3	0.1	0
Transfers out of Level 3	(0.4)	(0.2)
Foreign currency translation	0	0
Balance at the end of the period	1.2	1.1
Derivative financial instruments | Equity / index contracts | Credit Suisse
Disclosure Of Fair Value Measurement Of Assets [Line Items]
Assets acquired		0.5
Derivative financial instruments | Credit derivative contracts
Disclosure Of Fair Value Measurement Of Assets [Line Items]
Balance at the beginning of the period	0.5	0.3
Total gains / (losses) included in comprehensive income - Net gains / (losses) included in income	(0.1)	0
Total gains / (losses) included in comprehensive income - of which: related to Level 3 instruments held at the end of the reporting period	0	0
Purchases	0	0
Sales	0	0
Issuances	0.1	0.1
Settlements	(0.1)	0
Transfers into Level 3	0.1	0
Transfers out of Level 3	0	0
Foreign currency translation	0	0
Balance at the end of the period	0.5	0.6
Derivative financial instruments | Credit derivative contracts | Credit Suisse
Disclosure Of Fair Value Measurement Of Assets [Line Items]
Assets acquired		0.2
Financial assets at fair value not held for trading
Disclosure Of Fair Value Measurement Of Assets [Line Items]
Balance at the beginning of the period	8.4	3.7
Total gains / (losses) included in comprehensive income - Net gains / (losses) included in income	(0.2)	0
Total gains / (losses) included in comprehensive income - of which: related to Level 3 instruments held at the end of the reporting period	(0.3)	0
Purchases	0.3	0.5
Sales	(0.2)	(0.4)
Issuances	1.1	0
Settlements	(1.7)	0
Transfers into Level 3	0.5	0.1
Transfers out of Level 3	(0.2)	(0.1)
Foreign currency translation	(0.1)	0
Balance at the end of the period	7.9	8
Financial assets at fair value not held for trading | Credit Suisse
Disclosure Of Fair Value Measurement Of Assets [Line Items]
Assets acquired		4.2
Financial assets at fair value not held for trading | Loans
Disclosure Of Fair Value Measurement Of Assets [Line Items]
Balance at the beginning of the period	2.3	0.7
Total gains / (losses) included in comprehensive income - Net gains / (losses) included in income	(0.1)	0
Total gains / (losses) included in comprehensive income - of which: related to Level 3 instruments held at the end of the reporting period	(0.1)	0
Purchases	0.2	0.2
Sales	0	0
Issuances	0.7	0
Settlements	(0.3)	0
Transfers into Level 3	0	0
Transfers out of Level 3	(0.1)	(0.1)
Foreign currency translation	(0.1)	0
Balance at the end of the period	2.6	1.6
Financial assets at fair value not held for trading | Loans | Credit Suisse
Disclosure Of Fair Value Measurement Of Assets [Line Items]
Assets acquired		0.8
Financial assets at fair value not held for trading | Equity instruments
Disclosure Of Fair Value Measurement Of Assets [Line Items]
Balance at the beginning of the period	3.1	0.8
Total gains / (losses) included in comprehensive income - Net gains / (losses) included in income	(0.1)	0
Total gains / (losses) included in comprehensive income - of which: related to Level 3 instruments held at the end of the reporting period	(0.1)	0
Purchases	0	0.2
Sales	(0.1)	(0.1)
Issuances	0	0
Settlements	0	0
Transfers into Level 3	0	0
Transfers out of Level 3	0	0
Foreign currency translation	(0.1)	0
Balance at the end of the period	2.9	3.1
Financial assets at fair value not held for trading | Equity instruments | Credit Suisse
Disclosure Of Fair Value Measurement Of Assets [Line Items]
Assets acquired		2.1
Financial assets at fair value not held for trading | Auction rate securities
Disclosure Of Fair Value Measurement Of Assets [Line Items]
Balance at the beginning of the period	1.2	1.3
Total gains / (losses) included in comprehensive income - Net gains / (losses) included in income	0	0
Total gains / (losses) included in comprehensive income - of which: related to Level 3 instruments held at the end of the reporting period	0	0
Purchases	0	0
Sales	0	0
Issuances	0	0
Settlements	(1.1)	0
Transfers into Level 3	0	0
Transfers out of Level 3	0	0
Foreign currency translation	0	0
Balance at the end of the period	$ 0.2	1.3
Financial assets at fair value not held for trading | Auction rate securities | Credit Suisse
Disclosure Of Fair Value Measurement Of Assets [Line Items]
Assets acquired		$ 0

FVM - Movements of level 3 in_2

FVM - Movements of level 3 instruments - Liabilities (Detail) - Level 3 - USD ($) $ in Billions	6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023
Loan commitments measured at FVTPL
Disclosure Of Fair Value Measurement Of Liabilities [Line Items]
Balance at the beginning of the period	$ 1
Balance at the end of period	0.3
Derivative financial instruments
Disclosure Of Fair Value Measurement Of Liabilities [Line Items]
Balance at the beginning of the period	5.6	$ 1.7
Total gains / losses included in comprehensive income - Net gains / losses included in income	(0.8)	0.4
Total gains / losses included in comprehensive income - of which: related to Level 3 instruments held at the end of the reporting period	(0.3)	0.3
Purchases	0	0
Sales	(0.2)	(0.2)
Issuances	1.7	0.8
Settlements	(1.4)	(0.4)
Transfers into Level 3	0.3	0.1
Transfers out of Level 3	(0.6)	(0.3)
Foreign currency translation	0	0
Balance at the end of period	4.4	6.6
Derivative financial instruments | Credit Suisse
Disclosure Of Fair Value Measurement Of Liabilities [Line Items]
Liabilities acquired		4.5
Derivative financial instruments | Interest rate contracts
Disclosure Of Fair Value Measurement Of Liabilities [Line Items]
Balance at the beginning of the period	0.2	0.1
Total gains / losses included in comprehensive income - Net gains / losses included in income	(0.1)	0
Total gains / losses included in comprehensive income - of which: related to Level 3 instruments held at the end of the reporting period	0.1	0
Purchases	0	0
Sales	0	0
Issuances	0	0.1
Settlements	0	(0.1)
Transfers into Level 3	0.1	0
Transfers out of Level 3	0	0
Foreign currency translation	0	0
Balance at the end of period	0.2	0.4
Derivative financial instruments | Interest rate contracts | Credit Suisse
Disclosure Of Fair Value Measurement Of Liabilities [Line Items]
Liabilities acquired		0.2
Derivative financial instruments | Equity / index contracts
Disclosure Of Fair Value Measurement Of Liabilities [Line Items]
Balance at the beginning of the period	3.3	1.2
Total gains / losses included in comprehensive income - Net gains / losses included in income	0	0.5
Total gains / losses included in comprehensive income - of which: related to Level 3 instruments held at the end of the reporting period	0	0.5
Purchases	0	0
Sales	(0.1)	0
Issuances	1.5	0.6
Settlements	(1.1)	(0.3)
Transfers into Level 3	0.2	0
Transfers out of Level 3	(0.5)	(0.1)
Foreign currency translation	0	0
Balance at the end of period	3.4	3.7
Derivative financial instruments | Equity / index contracts | Credit Suisse
Disclosure Of Fair Value Measurement Of Liabilities [Line Items]
Liabilities acquired		1.7
Derivative financial instruments | Credit derivative contracts
Disclosure Of Fair Value Measurement Of Liabilities [Line Items]
Balance at the beginning of the period	0.6	0.3
Total gains / losses included in comprehensive income - Net gains / losses included in income	(0.1)	0
Total gains / losses included in comprehensive income - of which: related to Level 3 instruments held at the end of the reporting period	(0.1)	0
Purchases	0	0
Sales	0	0
Issuances	0.1	0.1
Settlements	(0.2)	0
Transfers into Level 3	0	0.1
Transfers out of Level 3	0	(0.2)
Foreign currency translation	0	0
Balance at the end of period	0.4	0.6
Derivative financial instruments | Credit derivative contracts | Credit Suisse
Disclosure Of Fair Value Measurement Of Liabilities [Line Items]
Liabilities acquired		0.3
Derivative financial instruments | Loan commitments measured at FVTPL
Disclosure Of Fair Value Measurement Of Liabilities [Line Items]
Balance at the beginning of the period	1	0
Total gains / losses included in comprehensive income - Net gains / losses included in income	(0.6)	(0.2)
Total gains / losses included in comprehensive income - of which: related to Level 3 instruments held at the end of the reporting period	(0.2)	(0.2)
Purchases	0	0
Sales	(0.1)	(0.2)
Issuances	0	0
Settlements	0	0
Transfers into Level 3	0	0
Transfers out of Level 3	0	0
Foreign currency translation	0	0
Balance at the end of period	0.3	1.6
Derivative financial instruments | Loan commitments measured at FVTPL | Credit Suisse
Disclosure Of Fair Value Measurement Of Liabilities [Line Items]
Liabilities acquired		2
Debt issued designated at fair value
Disclosure Of Fair Value Measurement Of Liabilities [Line Items]
Balance at the beginning of the period	15.3	10.5
Total gains / losses included in comprehensive income - Net gains / losses included in income	(0.4)	0.4
Total gains / losses included in comprehensive income - of which: related to Level 3 instruments held at the end of the reporting period	0	0.4
Purchases	0	0
Sales	0	0
Issuances	3	2.4
Settlements	(2.9)	(2.5)
Transfers into Level 3	0.7	0.6
Transfers out of Level 3	(2.7)	(0.8)
Foreign currency translation	(0.1)	0
Balance at the end of period	13	19.1
Debt issued designated at fair value | Credit Suisse
Disclosure Of Fair Value Measurement Of Liabilities [Line Items]
Liabilities acquired		8.5
Other financial liabilities designated at fair value
Disclosure Of Fair Value Measurement Of Liabilities [Line Items]
Balance at the beginning of the period	2.6	0.7
Total gains / losses included in comprehensive income - Net gains / losses included in income	(0.1)	0
Total gains / losses included in comprehensive income - of which: related to Level 3 instruments held at the end of the reporting period	0	0
Purchases	0	0
Sales	0	0
Issuances	1.1	0.2
Settlements	(0.5)	(0.1)
Transfers into Level 3	0.4	0
Transfers out of Level 3	(0.1)	0
Foreign currency translation	0	0
Balance at the end of period	$ 3.4	3
Other financial liabilities designated at fair value | Credit Suisse
Disclosure Of Fair Value Measurement Of Liabilities [Line Items]
Liabilities acquired		$ 2.1

FVM - Financial instruments not

FVM - Financial instruments not measured at fair value - Assets (Detail) - USD ($) $ in Millions	Jun. 30, 2024	Mar. 31, 2024	Dec. 31, 2023
Disclosure Of Financial Instruments [Abstract]
Cash and balances at central banks	$ 248,336	$ 271,439	$ 314,060
Amounts due from banks	21,959	22,128	21,146
Receivables from securities financing transactions measured at amortized cost	82,028	101,650	99,039
Cash collateral receivables on derivative instruments	43,637	46,714	50,082
Loans and advances to customers	599,105	605,108	639,669
Other financial assets measured at amortized cost	60,431	62,707	65,455
Not measured at fair value
Disclosure Of Financial Instruments [Abstract]
Cash and balances at central banks	248,300	271,400	314,100
Amounts due from banks	22,000	22,100	21,200
Receivables from securities financing transactions measured at amortized cost	82,000	101,700	99,000
Cash collateral receivables on derivative instruments	43,600	46,700	50,100
Loans and advances to customers	594,600	600,000	633,500
Other financial assets measured at amortized cost	$ 58,200	$ 60,600	$ 63,900

FVM - Financial instruments n_2

FVM - Financial instruments not measured at fair value - Liabilities (Detail) - USD ($) $ in Millions	Jun. 30, 2024	Mar. 31, 2024	Dec. 31, 2023
Disclosure Of Fair Value Measurement Of Liabilities [Line Items]
Amounts due to banks	$ 26,750	$ 47,857	$ 70,962
Payables from securities financing transactions measured at amortized cost	14,872	12,961	14,394
Cash collateral payables on derivative instruments	32,843	37,293	41,582
Customer deposits	756,830	763,959	792,029
Debt issued measured at amortized cost	229,223	226,251	237,817
Other financial liabilities measured at amortized cost excluding lease liabilities	16,300	16,200	15,300
Not measured at fair value
Disclosure Of Fair Value Measurement Of Liabilities [Line Items]
Amounts due to banks	26,800	47,800	71,000
Payables from securities financing transactions measured at amortized cost	14,900	12,900	14,400
Cash collateral payables on derivative instruments	32,800	37,300	41,500
Customer deposits	757,300	764,800	792,900
Debt issued measured at amortized cost	233,800	230,900	241,300
Other financial liabilities measured at amortized cost excluding lease liabilities	$ 16,200	$ 16,000	$ 15,200

Derivative instruments (Detail)

Derivative instruments (Detail) - USD ($) $ in Millions	Jun. 30, 2024	Mar. 31, 2024	Dec. 31, 2023
Derivative [Line Items]
Derivative financial assets	$ 139,597	$ 159,229	$ 176,084
Derivative financial liabilities	149,069	163,042	192,181
Notional values related to derivative financial assets and liabilities	12,526,000	12,461,000	12,369,000
Other notional values	20,526,000	21,346,000	20,366,000
Interest rate
Derivative [Line Items]
Derivative financial assets	48,800	52,500	55,600
Derivative financial liabilities	47,300	50,300	52,900
Notional values related to derivative financial assets and liabilities	3,472,000	3,469,000	3,524,000
Other notional values	20,200,000	21,010,000	20,074,000
Credit derivative
Derivative [Line Items]
Derivative financial assets	3,000	3,000	4,000
Derivative financial liabilities	3,800	3,700	4,700
Notional values related to derivative financial assets and liabilities	170,000	206,000	275,000
Foreign exchange
Derivative [Line Items]
Derivative financial assets	51,000	62,000	78,700
Derivative financial liabilities	52,000	59,100	89,900
Notional values related to derivative financial assets and liabilities	7,148,000	7,014,000	6,913,000
Other notional values	213,000	224,000	180,000
Equity / index
Derivative [Line Items]
Derivative financial assets	33,400	37,700	35,500
Derivative financial liabilities	41,400	45,800	41,400
Notional values related to derivative financial assets and liabilities	1,432,000	1,439,000	1,397,000
Other notional values	96,000	92,000	95,000
Commodity
Derivative [Line Items]
Derivative financial assets	2,600	3,000	2,000
Derivative financial liabilities	2,000	2,600	1,600
Notional values related to derivative financial assets and liabilities	153,000	152,000	143,000
Other notional values	18,000	20,000	16,000
Other
Derivative [Line Items]
Derivative financial assets	800	1,000	400
Derivative financial liabilities	2,600	1,500	1,600
Notional values related to derivative financial assets and liabilities	$ 151,000	$ 182,000	$ 117,000

Offsetting financial assets (De

Offsetting financial assets (Detail) - USD ($) $ in Billions	Jun. 30, 2024	Mar. 31, 2024	Dec. 31, 2023
Derivative financial instruments
Disclosure Of Offsetting Of Financial Assets [Line Items]
Assets based on IFRS netting	$ 139.6	$ 159.2	$ 176.1
Further netting potential not recognized on the balance sheet	(124.4)	(141.5)	(162.8)
of which: netting of recognized financial liabilities	(101.3)	(115.7)	(133)
of which: netting with collateral received	(23.1)	(25.8)	(29.8)
Assets, after consideration of further netting potential	15.2	17.7	13.3
Cash collateral receivables on derivative instruments
Disclosure Of Offsetting Of Financial Assets [Line Items]
Assets based on IFRS netting	43.6	46.7	50.1
Further netting potential not recognized on the balance sheet	(27.2)	(28.8)	(32.9)
of which: netting of recognized financial liabilities	(24.6)	(26)	(29.7)
of which: netting with collateral received	(2.5)	(2.8)	(3.2)
Assets, after consideration of further netting potential	$ 16.5	$ 17.9	$ 17.2

Offsetting financial liabilitie

Offsetting financial liabilities (Detail) - USD ($) $ in Billions	Jun. 30, 2024	Mar. 31, 2024	Dec. 31, 2023
Derivative financial instruments
Disclosure Of Offsetting Of Financial Liabilities [Line Items]
Liabilities based on IFRS netting	$ 149.1	$ 163	$ 192.2
Further netting potential not recognized on the balance sheet	(132.4)	(147.9)	167.9
of which: netting of recognized financial assets	(101.3)	(115.7)	(133)
of which: netting with collateral pledged	(31.1)	(32.1)	(35)
Liabilities, after consideration of further netting potential	16.7	15.2	24.2
Cash collateral payables on derivative instruments
Disclosure Of Offsetting Of Financial Liabilities [Line Items]
Liabilities based on IFRS netting	32.8	37.3	41.6
Further netting potential not recognized on the balance sheet	(19)	(22.6)	(26.4)
of which: netting of recognized financial assets	(16.5)	(19.8)	(23.2)
of which: netting with collateral pledged	(2.5)	(2.8)	(3.2)
Liabilities, after consideration of further netting potential	$ 13.8	$ 14.7	$ 15.2

Other financial assets measured

Other financial assets measured at amortized cost (Detail) - USD ($) $ in Millions	Jun. 30, 2024	Mar. 31, 2024	Dec. 31, 2023
Disclosure Of Financial Assets [Line Item]
Debt securities	$ 41,489	$ 43,031	$ 45,057
Loans to financial advisors	2,601	2,615	2,615
Fee- and commission-related receivables	2,460	2,429	2,576
Finance lease receivables	6,001	5,948	6,288
Settlement and clearing accounts	529	395	338
Accrued interest income	2,599	2,981	3,163
Other	4,752	5,308	5,418
Total other financial assets measured at amortized cost	$ 60,431	$ 62,707	$ 65,455

Other non-financial assets (Det

Other non-financial assets (Detail) - USD ($) $ in Millions	Jun. 30, 2024	Mar. 31, 2024	Dec. 31, 2023
Other Non-Financial Assets [Line Items]
Precious metals and other physical commodities	$ 6,445	$ 6,466	$ 5,930
Deposits and collateral provided in connection with litigation, regulatory and similar matters	2,761	2,736	2,726
Prepaid expenses	1,889	2,048	2,080
Current tax assets	1,866	1,620	1,456
VAT, withholding tax and other tax receivables	1,106	952	1,327
Properties and other non-current assets held for sale	151	156	188
Other	2,295	2,239	2,342
Total other non-financial assets	$ 16,514	$ 16,217	$ 16,049

Other financial liabilities mea

Other financial liabilities measured at amortized cost (Detail) - USD ($) $ in Millions	Jun. 30, 2024	Mar. 31, 2024	Dec. 31, 2023
Disclosure Of Financial Liabilities [Line Items]
Other accrued expenses	$ 3,115	$ 3,063	$ 3,270
Accrued interest expenses	6,872	6,482	6,692
Settlement and clearing accounts	1,815	2,234	1,519
Lease liabilities	5,097	5,213	5,502
Other	4,484	4,364	3,868
Total other financial liabilities measured at amortized cost	$ 21,383	$ 21,356	$ 20,851

Other financial liabilities des

Other financial liabilities designated at fair value (Detail) - USD ($) $ in Millions	Jun. 30, 2024	Mar. 31, 2024	Dec. 31, 2023
Disclosure Of Financial Liabilities [Line Items]
Financial liabilities related to unit-linked investment contracts	$ 17,080	$ 16,612	$ 15,992
Securities financing transactions	7,699	5,121	7,416
Over-the-counter debt instruments and other	7,096	6,407	6,076
Total other financial liabilities designated at fair value	$ 31,875	$ 28,140	$ 29,484

Other non-financial liabilities

Other non-financial liabilities (Detail) - USD ($) $ in Millions	Jun. 30, 2024	Mar. 31, 2024	Dec. 31, 2023
Other Non-Financial Liabilities [Line Items]
Compensation-related liabilities	$ 7,771	$ 6,530	$ 9,746
of which: net defined benefit liability	757	772	796
Current tax liabilities	1,303	1,447	1,460
Deferred tax liabilities	319	330	325
VAT, withholding tax and other tax payables	1,070	888	1,120
Deferred income	763	670	635
Other	494	524	802
Total other non-financial liabilities	$ 11,720	$ 10,388	$ 14,089

Debt issued designated at fai_3

Debt issued designated at fair value (Detail) - USD ($) $ in Millions	Jun. 30, 2024	Mar. 31, 2024	Dec. 31, 2023
Issued debt instruments
Equity-linked	$ 55,911	$ 56,608	$ 60,573
Rates-linked	25,811	25,940	28,883
Credit-linked	6,510	6,756	7,730
Fixed-rate	15,271	17,359	20,541
Commodity-linked	3,507	3,618	3,844
Other	6,200	6,525	6,718
of which: debt that contributes to total loss-absorbing capacity	4,585	4,476	4,629
Total debt issued designated at fair value	113,209	116,806	128,289
of which: issued by UBS AG with original maturity greater than one year	93,943	70,648	73,544
of which: issued by Credit Suisse AG with original maturity greater than one year		26,089	29,948
of which: issued by Credit Suisse International with original maturity greater than one year	$ 721	$ 946	$ 1,471
Unsecured portion of debt instruments issued by UBS AG with original maturity greater than one year	99%	99%

Debt issued measured at amort_3

Debt issued measured at amortized cost (Detail) - USD ($) $ in Millions	3 Months Ended
	Jun. 30, 2024	Mar. 31, 2024	Dec. 31, 2023
Disclosure Of Financial Liabilities [Line Items]
Short-term debt	$ 34,944	$ 32,485	$ 38,530
Senior unsecured debt	143,832	143,540	147,547
of which: contributes to total loss-absorbing capacity (TLAC)	100,765	98,973	101,939
of which: issued by UBS AG standalone with original maturity greater than one year	38,938	16,069	18,446
of which: issued by Credit Suisse AG with original maturity greater than one year		22,529	24,609
Covered bonds	8,524	6,498	5,214
Subordinated debt	14,350	16,446	17,644
of which: eligible as high-trigger loss-absorbing additional tier 1 capital instruments	12,400	12,021	10,744
of which: eligible as low-trigger loss-absorbing additional tier 1 capital instruments	1,225	1,217	1,214
of which: eligible as non-Basel III-compliant tier 2 capital instruments	536	537	538
Debt issued through the Swiss central mortgage institutions	26,011	25,669	27,377
Other long-term debt	1,563	1,613	1,506
Long-term debt	194,279	193,766	199,288
Total debt issued measured at amortized cost	$ 229,223	$ 226,251	$ 237,817
Unsecured portion of total debt issued measured at amortized cost	100%
Secured portion of Covered bonds	100%
Secured portion of Debt issued through the Swiss central mortgage institutions	100%
Secured portion of Other long-term debt	92%

Provisions (Detail)

Provisions (Detail) - USD ($) $ in Millions	Jun. 30, 2024	Mar. 31, 2024	Dec. 31, 2023
Disclosure Of Other Provisions [Line Items]
Provisions related to expected credit losses (IFRS 9, Financial Instruments)	$ 294	$ 328	$ 350
Provisions related to Credit Suisse loan commitments (IFRS 3, Business Combinations)	1,367	1,667	1,924
Provisions related to litigation, regulatory and similar matters (IAS 37, Provisions, Contingent Liabilities and Contingent Assets)	5,013	5,136	6,144
Acquisition-related contingent liabilities (IFRS 3, Business Combinations)	2,619	3,945	3,993
Restructuring, real-estate and other provisions (IAS 37, Provisions, Contingent Liabilities and Contingent Assets)	1,382	1,216	2,123
Total provisions and contingent liabilities	9,293	11,076	12,412
Litigation, regulatory and similar matters
Disclosure Of Other Provisions [Line Items]
Provisions related to litigation, regulatory and similar matters (IAS 37, Provisions, Contingent Liabilities and Contingent Assets)	$ 3,630	$ 3,920	$ 4,020

Provisions - additional informa

Provisions - additional information (Detail) - USD ($) $ in Millions	3 Months Ended
	Jun. 30, 2024	Mar. 31, 2024	Dec. 31, 2023
Disclosure Of Other Provisions [Line Items]
Balance as of 31 December 2023	$ 5,013	$ 5,136	$ 6,144
Balance as of 31 March 2024	5,136
Increase in provisions recognized in the income statement	395
Release of provisions recognized in the income statement	(73)
Reclassification of IFRS 3 contingent liabilities to IAS 37 Provisions	1,171
Provisions used in conformity with designated purpose	(1,605)
Foreign currency translation and other movements	(11)
Balance as of 30 June 2024	5,013
Litigation, regulatory and similar matters
Disclosure Of Other Provisions [Line Items]
Balance as of 31 December 2023	3,630	3,920	4,020
Balance as of 31 March 2024	3,920
Increase in provisions recognized in the income statement	37
Release of provisions recognized in the income statement	(41)
Reclassification of IFRS 3 contingent liabilities to IAS 37 Provisions	1,171
Provisions used in conformity with designated purpose	(1,442)
Foreign currency translation and other movements	(15)
Balance as of 30 June 2024	3,630
Reclassification out of IFRS 3 acquisition-related contingent liabilities to IAS 37 Provisions related to litigation, regulatory and similar matters	944
Total IAS 37 provision related to the funding obligation	1,421
Fair value of a derivative liability accounted for to recognise a funding obligation	1,421
Restructuring
Disclosure Of Other Provisions [Line Items]
Balance as of 31 December 2023	827	662	741
Balance as of 31 March 2024	662
Increase in provisions recognized in the income statement	315
Release of provisions recognized in the income statement	(16)
Reclassification of IFRS 3 contingent liabilities to IAS 37 Provisions	0
Provisions used in conformity with designated purpose	(138)
Foreign currency translation and other movements	4
Balance as of 30 June 2024	827
Real estate related onerous contracts restructuring provision	461	443	448
Personnel-related restructuring provisions	365	218	294
Real estate
Disclosure Of Other Provisions [Line Items]
Balance as of 31 December 2023	233	238	259
Balance as of 31 March 2024	238
Increase in provisions recognized in the income statement	2
Release of provisions recognized in the income statement	0
Reclassification of IFRS 3 contingent liabilities to IAS 37 Provisions	0
Provisions used in conformity with designated purpose	(5)
Foreign currency translation and other movements	(1)
Balance as of 30 June 2024	233
Other
Disclosure Of Other Provisions [Line Items]
Balance as of 31 December 2023	322	$ 317	$ 1,123
Balance as of 31 March 2024	317
Increase in provisions recognized in the income statement	41
Release of provisions recognized in the income statement	(16)
Reclassification of IFRS 3 contingent liabilities to IAS 37 Provisions	0
Provisions used in conformity with designated purpose	(21)
Foreign currency translation and other movements	0
Balance as of 30 June 2024	$ 322

Litigation, regulatory and si_3

Litigation, regulatory and similar matters (Detail) - USD ($) $ in Millions	3 Months Ended
	Jun. 30, 2024	Dec. 31, 2023
Disclosure Of Other Provisions [Line Items]
Balance as of 31 December 2023	$ 5,013	$ 6,144
Balance as of 31 March 2024	5,136
Increase in provisions recognized in the income statement	395
Release of provisions recognized in the income statement	(73)
Reclassification of IFRS 3 contingent liabilities to IAS 37 Provisions	1,171
Provisions used in conformity with designated purpose	(1,605)
Foreign currency translation and other movements	(11)
Balance as of 30 June 2024	5,013
Litigation, regulatory and similar matters
Disclosure Of Other Provisions [Line Items]
Balance as of 31 December 2023	3,630	4,020
Balance as of 31 March 2024	3,920
Increase in provisions recognized in the income statement	37
Release of provisions recognized in the income statement	(41)
Reclassification of IFRS 3 contingent liabilities to IAS 37 Provisions	1,171
Provisions used in conformity with designated purpose	(1,442)
Foreign currency translation and other movements	(15)
Balance as of 30 June 2024	3,630
Reclassification out of IFRS 3 acquisition-related contingent liabilities to IAS 37 Provisions related to litigation, regulatory and similar matters	944
Total IAS 37 provision related to the funding obligation	1,421
Fair value of a derivative liability accounted for to recognise a funding obligation	1,421
Litigation, regulatory and similar matters | Global Wealth Management
Disclosure Of Other Provisions [Line Items]
Balance as of 31 December 2023	1,199	1,235
Balance as of 31 March 2024	1,201
Increase in provisions recognized in the income statement	28
Release of provisions recognized in the income statement	(11)
Reclassification of IFRS 3 contingent liabilities to IAS 37 Provisions	0
Provisions used in conformity with designated purpose	(10)
Foreign currency translation and other movements	(8)
Balance as of 30 June 2024	1,199
Litigation, regulatory and similar matters | Personal & Corporate Banking
Disclosure Of Other Provisions [Line Items]
Balance as of 31 December 2023	152	157
Balance as of 31 March 2024	152
Increase in provisions recognized in the income statement	0
Release of provisions recognized in the income statement	0
Reclassification of IFRS 3 contingent liabilities to IAS 37 Provisions	0
Provisions used in conformity with designated purpose	0
Foreign currency translation and other movements	(1)
Balance as of 30 June 2024	152
Litigation, regulatory and similar matters | Asset Management
Disclosure Of Other Provisions [Line Items]
Balance as of 31 December 2023	2	15
Balance as of 31 March 2024	2
Increase in provisions recognized in the income statement	0
Release of provisions recognized in the income statement	0
Reclassification of IFRS 3 contingent liabilities to IAS 37 Provisions	0
Provisions used in conformity with designated purpose	0
Foreign currency translation and other movements	0
Balance as of 30 June 2024	2
Litigation, regulatory and similar matters | Investment Bank
Disclosure Of Other Provisions [Line Items]
Balance as of 31 December 2023	280	294
Balance as of 31 March 2024	288
Increase in provisions recognized in the income statement	6
Release of provisions recognized in the income statement	(7)
Reclassification of IFRS 3 contingent liabilities to IAS 37 Provisions	0
Provisions used in conformity with designated purpose	(5)
Foreign currency translation and other movements	(1)
Balance as of 30 June 2024	280
Litigation, regulatory and similar matters | Non-core and Legacy
Disclosure Of Other Provisions [Line Items]
Balance as of 31 December 2023	1,862	2,186
Balance as of 31 March 2024	2,142
Increase in provisions recognized in the income statement	0
Release of provisions recognized in the income statement	(22)
Reclassification of IFRS 3 contingent liabilities to IAS 37 Provisions	1,171
Provisions used in conformity with designated purpose	(1,425)
Foreign currency translation and other movements	(4)
Balance as of 30 June 2024	1,862
Litigation, regulatory and similar matters | Group Items
Disclosure Of Other Provisions [Line Items]
Balance as of 31 December 2023	135	$ 134
Balance as of 31 March 2024	134
Increase in provisions recognized in the income statement	3
Release of provisions recognized in the income statement	0
Reclassification of IFRS 3 contingent liabilities to IAS 37 Provisions	0
Provisions used in conformity with designated purpose	(1)
Foreign currency translation and other movements	0
Balance as of 30 June 2024	$ 135

Litigation, regulatory and si_4

Litigation, regulatory and similar matters (Narrative) (Detail) € in Thousands, $ in Thousands, SFr in Millions	6 Months Ended
	Jun. 30, 2024 CHF (SFr)	Jun. 30, 2024 EUR (€)	Jun. 30, 2024 USD ($)	Jun. 30, 2024 USD ($)	Mar. 31, 2024 USD ($)	Dec. 31, 2023 USD ($)
Disclosure Of Litigation Regulatory And Similar Matters [Line Items]
Acquisition-related contingent liabilities (IFRS 3, Business Combinations)				$ 2,619,000	$ 3,945,000	$ 3,993,000
Increase in contingent liabilities related to litigation			$ 200,000
Minimum | Litigation, regulatory and similar matters
Disclosure Of Litigation Regulatory And Similar Matters [Line Items]
Estimated losses not covered by existing provisions				0
Maximum | Litigation, regulatory and similar matters
Disclosure Of Litigation Regulatory And Similar Matters [Line Items]
Estimated losses not covered by existing provisions				$ 1,700,000
Inquiries regarding cross-border wealth management businesses | Investigations in France | UBS
Disclosure Of Litigation Regulatory And Similar Matters [Line Items]
Fine decision French Court | €		€ 3,700,000
Civil damages award announcement of the French Court | €		800,000
Inquiries regarding cross-border wealth management businesses | Investigations in France involving UBS AG | UBS
Disclosure Of Litigation Regulatory And Similar Matters [Line Items]
Bail ("caution") ordered to be paid | €		1,100,000
Fine decision French Court of Appeal | €		3,750
Bail ("caution") ordered to be confiscated, verdict of the French Court of Appeal | €		1,000,000
Civil damages award, verdict of the French Court of Appeal | €		800,000
Fine overturned French Supreme Court | €		3,750
Confiscation overturned French Supreme Court | €		1,000,000
Civil damages award overturned French Supreme Court | €		800,000
Civil damages award reimbursed | €		800,000
Madoff | claims filed in Luxembourg by liquidators of two Luxembourg funds against UBS entities, non-UBS entities and certain individuals | UBS
Disclosure Of Litigation Regulatory And Similar Matters [Line Items]
Minimum total claims against all defendants | €		€ 2,100,000
Madoff | claims filed in the US by BMIS Trustee against UBS entities and various other parties | UBS
Disclosure Of Litigation Regulatory And Similar Matters [Line Items]
Amounts claimed			125,000
Minimum total claims against all defendants			2,000,000
Foreign exchange, LIBOR and benchmark rates, and other trading practices - Foreign exchange-related civil litigation | Claims under the Commodity Exchange Act | UBS
Disclosure Of Litigation Regulatory And Similar Matters [Line Items]
Settlement made			$ 141,000
Mortgage-related matters | DOJ RMBS settlement | Credit Suisse
Disclosure Of Litigation Regulatory And Similar Matters [Line Items]
Increase of customer relief per annum	5%	5%	5%
Mortgage-related matters | Action brought by Asset Backed Securities Corporation Home Equity Loan Trust, Series 2006-HE7 | Credit Suisse
Disclosure Of Litigation Regulatory And Similar Matters [Line Items]
Amounts claimed			$ 374,000
Mortgage-related matters | Action brought by Home Equity Asset Trust, Series 2006-8 | Credit Suisse
Disclosure Of Litigation Regulatory And Similar Matters [Line Items]
Amounts claimed			436,000
Mortgage-related matters | Action brought by Home Equity Asset Trust 2007-1 | Credit Suisse
Disclosure Of Litigation Regulatory And Similar Matters [Line Items]
Amounts claimed			420,000
Mortgage-related matters | Action brought by Home Equity Asset Trust 2007-2 | Credit Suisse
Disclosure Of Litigation Regulatory And Similar Matters [Line Items]
Amounts claimed			495,000
Rates-related matters | Foreign exchange trading business | Credit Suisse
Disclosure Of Litigation Regulatory And Similar Matters [Line Items]
Fine provided in announcement of the European Commission | €		€ 83,300
Rates-related matters | SSA bonds trading business | Credit Suisse
Disclosure Of Litigation Regulatory And Similar Matters [Line Items]
Fine provided in announcement of the European Commission | €		€ 11,900
Customer account matters | Former relationship manager | Credit Suisse
Disclosure Of Litigation Regulatory And Similar Matters [Line Items]
Damage award Geneva criminal court			130,000
Customer account matters | Singapore civil lawsuits | Credit Suisse
Disclosure Of Litigation Regulatory And Similar Matters [Line Items]
Damage award Singapore International Commercial Court			742,730
Customer account matters | Bermuda civil lawsuits | Credit Suisse
Disclosure Of Litigation Regulatory And Similar Matters [Line Items]
Civil damage award Supreme Court of Bermuda			$ 607,350
Bermuda statutory rate	3.50%	3.50%	3.50%
Escrow account release			$ 75,000
Bulgarian former client matter | Credit Suisse
Disclosure Of Litigation Regulatory And Similar Matters [Line Items]
Fine decision Swiss Federal Criminal Court | SFr	SFr 2
Client assets seized decision Swiss Federal Criminal Court | SFr	12
Compensatory claim ordered decision Swiss Federal Criminal Court | SFr	SFr 19
SCFF | Credit Suisse
Disclosure Of Litigation Regulatory And Similar Matters [Line Items]
Highest-ranking managers to have their responsibilities defined	600	600	600
Rate of net asset value offered to fund investors to redeem their fund units	90%	90%	90%
Percentage of tendered and accepted fund units	92%	92%	92%